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Abstract
Chronic ulcers are a major healthcare problem characterised by ineffectual healing 
and infection. Xanthine oxidoreductase (XOR, EC 1.1.3.22), incorporated into a dressing 
or graft may provide enhanced healing and antibacterial activity. XOR is a complex 
molybdoflavoprotein with broad substrate specificity, and in aerobic conditions, generates 
superoxide (0 2 ” ) and hydrogen peroxide (H2O2 ) through purine catabolism. Low levels of 
these species from XOR are known to enhance the proliferation of many mammalian cells 
including human dermal fibroblasts, essential for the healing process (Murrell et al, 1990).
XOR also generates nitric oxide (’NO) from physiological levels o f nitrite, 
optimally at low pH in anoxic conditions (cf the conditions prevailing in a chronic ulcer). 
Nitric oxide contributes to healing in general by increasing perfusion, stimulating 
angiogenesis and killing bacteria. Chronic wounds are known to harbour a range of 
anaerobic and facultative bacteria, many of which are detrimental to wound healing. It has 
been shown that the simultaneous generation of O2 ’" and ’NO by XOR in low oxygen, 
results in the rapid production of peroxynitrite (ONOO-), a very much more potent 
bactericidal species than 02*", ’NO or H2O2 .
Experiments were performed to characterise the effects o f XOR activities on 
factors pertinent to healing to test the hypothesis that XOR incorporated into a dressing or 
dermograft will facilitate ulcer healing. Superoxide generation by xanthine oxidase (XO) 
was characterised, and shown to vary in biological media commonly used for the growth 
of either fibroblasts or bacteria in the laboratory setting. In support o f existing research, 
superoxide generation by XO in low oxygen (1%) was reduced when compared with air. 
Nevertheless, peroxynitrite generation was also observed in low oxygen (1%).
This thesis supports previous research showing that XO enhances the proliferation 
of adult human dermal fibroblasts (HDF) using standard culture conditions in air. In the 
presence of 21% oxygen (air), high levels o f XO (10-50mU ml'1) were shown to be 
cytotoxic to adult fibroblasts whereas lower levels appeared to increase DNA synthesis 
suggesting enhanced proliferation (lm U m f1). This thesis also extends these findings 
showing a similar effect on neonatal HDF. The novel findings in this thesis are that at low 
oxygen tension (p02 below 5%) the growth of adult HDF is not adversely affected in the 
presence of high XO concentrations (5-50mU ml'1 XO); in fact, HDF appear to show 
some evidence o f enhanced proliferation under these conditions. Bacterial strains relevant 
to the chronic wound responded differentially to XO but showed growth inhibition at 10 
and 50mU ml"1 XO. Overall, these findings suggest that an XO-incorporating graft or 
dressing may deliver both proliferative and antimicrobial effects in a hypoxic ulcer setting.
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1 Introduction: The Biology of the Skin
The skin is the largest organ in the body, and is composed of three layers: a 
stratified epithelium (epidermis), an underlying connective tissue stroma (dermis) 











Figure 1.1 Basic diagram to show the three layers of the skin and various associated structures.
American Medical Association Current Procedural Terminology, Revised 1998 edition, http://www.ama- 
assn.org/ama/pub/category/7176.html
The skin is often described as a bilayer organ which refers to the epidermal and 
dermal layers. The average thickness of the bilayer is 1-2 mm being considerably thinner 
in infants and the elderly especially the dermis which is underdeveloped in infants and 
atrophic in the elderly. These layers possess many specific properties that are essential for 
survival some of which are listed below;
Epidermis
• protection from desiccation
• protection from bacterial entry
• protection from toxins




• Protection from trauma due to elasticity and durability properties
• Fluid balance and thermoregulation through regulation of skin blood flow
• Growth factors and cytokines for epidermal replication and dermal repair
1.1 The epidermal layer
The epidermis is a stratified squamous epithelium mostly -100-150pm thick, 
although its thickness is greater (0.8-1.4mm) on the palm and sole (Gawkrodger, 1992). 
The main function of this outer layer of skin is to act as a protective barrier. Around 95% 
of the epidermis is made up o f cells known as keratinocytes (which produce keratin), and 
the rest are melanocytes, Langerhans cells, and Merkel cells (Mechanoreceptors) (Menon, 






1.1.1 Stratum basale (SB)
The SB adjacent to the dermis, is the innermost layer o f the epidermis and is 
mainly composed of a single layer of columnar basal cells. The SB also consists of 
epidermal stem cells which transiently amplify cells to renew the epidermis (Menon, 
2002). These cells are mainly keratinocytes which contain keratin filaments 
(tonofibrilaments) which are attached to the dermal-epidermal basement membrane by 
hemidesmosomes (Figure 1.2). Two keratins, K14 and K5, are expressed in the basal cells 
(Menon, 2002). Melanocytes make up 5-10% of the basal cell population. These cells 
synthesise melanin and transfer it via dendritic processes to neighbouring keratinocytes. 
Melanocytes, being of neural crest origin, are most numerous on the face and other 
exposed sites. Merkel cells are occasionally found in the SB and appear to be associated 
with terminal filaments of cutaneous nerves, having a possible role in sensation. 
Neuropeptide granules, neurofilaments and keratin can be found in the cytoplasm of 
merkel cells (Gawkrodger, 1992).
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1.1.2 Stratum spinosum (SS)
Daughter basal cells migrate upwards to form this layer o f polyhedral cells. 
Adjacent cells are interconnected by an abundance o f desmosomes giving its cells a 
characteristically spiny appearance at light microscope level. Langerhans cells are found 
mostly in this layer; these are dendritic, immunologically active cells. An increase in 
keratin filaments is noticeable in this layer. Keratin tonofibrils form a supportive mesh in 
the cytoplasm of these cells. Keratins 1 and 10 are the biochemical markers for this layer 
(Menon, 2002). Lipid-enriched lamellar bodies, also known as Odland bodies, 
keratinosomes and membrane-coating granules, begin to appear in the SS which supply 
the extracellular domains with specialised lipid components. Lamellar bodies are 0.2 to 
0.5|im in diameter (Menon, 2002).
1.1.3 Stratum granulosum (SG)
Compared with the basal layer and in the uppermost layers o f the SS, the cells 
begin to elongate and flatten. Cells become flattened and lose their nuclei in the granular 
cell layer. Keratohyalin (KHG) granules characterise the SG, and are present in the 
cytoplasm together with membrane-coating granules (which expel their lipid contents into 
the intercellular spaces) (Gawkrodger, 1992).
1.1.4 Stratum corneum (SC)
The stratum comeum is the outermost layer of the epidermis. Terminally 
differentiated keratinocytes can be found in this layer which is comprised of overlapping 
polyhedral comified cells with no nuclei (comeocytes). In the SC, cells adhere to each 
other using lipid glue giving a brick-and-mortar organisation, and in human skin it usually 
consists of 18 to 21 layers o f cells (Menon, 2002). The comeocyte cell envelope is 
broadened, and the cytoplasm is replaced by keratin tonofibrils in a matrix formed from 
the keratohyalin granules (Gawkrodger, 1992).
1.2 The Dermal-Epidermal Basement Membrane (BM)
Basement membranes are collections of extracellular matrix (ECM) molecules 
organised in specific patterns which separate epithelium, endothelium, nerve and muscle 
from neighbouring connective tissue stroma (Timpl, 1989). The dermal-epidermal 
basement membrane (BM) forms an extensive interface between the dermis and the 
epidermis, and is one of the largest epithelio-mesenchymal junctions in the body. The 
basement membrane maintains tissue architecture, provides anchorage of adjacent cells,
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functions as a selective barrier to migrating or invading cells, and facilitates diffusion or 
temporary storage of macromolecules. It is permeable to oxygen and allows nutrients to 
pass from the dermis into the epidermis. Transmission electron microscopy has shown that 
the BM consists of a lamina lucida, underlying epithelial or endothelial plasma 
membranes, and a lamina densa which is located between the lamina lucida and 










Type IV collagen and 
proteoglycans
Anchoring fibrils: Type VII 
collagen
Anchoring plaques: type IV 
collagen
Figure 1.2 Detailed schematic of the basement membrane zone at the dermo-epidermal junction
Studies of the dermal-epidermal BM suggest that both epithelial tissues and 
differentiated fibroblasts in the dermal layer produce BM components and assist in BM 
assembly. Dermal fibroblasts were shown to synthesise and deposit type IV collagen, type 
VII collagen, and laminin in a linear manner into the BM zone. Whereas, foetal bovine 
keratinocytes were found to synthesise and deposit type IV collagen, type VII collagen, 
laminin, K-laminin, kalanin, and BM associated heparin sulphate proteoglycan (HSPG) 
(Marinkovich et al, 1993). The BM is rich in the adhesive proteins, laminin and 
fibronectin which help cells to attach to the appropriate part of the ECM. Laminin 
promotes the attachment of epithelial cells to the basal lamina, whereas fibronectin 
anchors the epidermal cells from above and the dermal cells from below.
1.3 The Dermal Layer
The dermal layer is defined as a dynamic and thick layer of connective tissue 
matrix that is in constant turnover. This layer contains specialised structures, and is found 
immediately below and intimately connected with the epidermis. It varies in thickness,
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being thin (0.6mm) on the eyelids and thicker (3mm or more) on the back, palms and 
soles. The dermis is divided into a thin upper layer known as the papillary dermis that lies 
beneath the epidermis. The papillary dermis contains anchoring epidermal rete pegs and is 
composed of loosely interwoven collagen. The papillary dermis is the most biologically 
active part o f the dermis producing proteins that provide direction for epidermal 
replication. The upper dermis also contains the highest blood flow. Coarser and 
horizontally running bundles of collagen are found in the deeper and thicker reticular 
dermis. Collagen fibres make up 70% of the dermis and impart a toughness and strength to 
the structure. Elastin fibres are loosely arranged in all directions in the dermis and provide 
elasticity to the skin. They are numerous near hair follicles and sweat glands, and less so 
in the papillary dermis. The ground substance or matrix o f the dermis is made up of 
complex polysaccharide, a protein complex known as glycosaminoglycan or GAG 
component, as well as hyaluronic acid. The matrix is semi fluid which allows movement 
of dermal structures, cell and connective tissue orientation, nutrient diffusion to the cells, 
scaffolding for cell migration, viscosity and hydration. In the dermis, chondroitin sulphate 
is the main GAG, along with dermatan sulphate and hyaluronic acid. GAGs often exist as 
high molecular weight polymers with a protein core. These structures are known as 
proteoglycans.
The dermis also contains dermal dendrocytes (dendritic cells with a probable 
immune function), mast cells, macrophages and lymphocytes, platelets and endothelial 
cells. However, the primary cell type is the fibroblast which synthesises ECM proteins 
collagen and elastin, other connective tissue and matrix or ground substance. Fibroblasts 
produce the key adhesion proteins used to attach epidermal cells to the BM and are used 
for epidermal cell migration and proliferation. For example, fibronectin is a key fibroblast 
derived signal protein that is important in cutaneous healing and has numerous roles in the 
orchestration of v/ound healing (Grinnell, 1984).
Collagen synthesised by fibroblasts, is the major structural protein o f the dermis. 
The main amino acids in collagen are glycine, proline and hydroxyproline. There are over 
eight types of collagen, at least five of which are found in skin:
• Type I- found in the reticular dermis (Predominant matrix protein o f dermis, besides
structure; provides a contact orientation for dividing and migrating epithelial cells)
• Type Ill-found in the papillary dermis
• Types IV and VII- found in the basement membrane structures
• Type VUI-found in endothelial cells
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Tropocollagen is formed from three polypeptide chains which are coiled around 
each other in a triple helix. Assembled collagen fibrils are lOOnm wide, with cross- 
striations visible with electron microscopy every 6nm. Ehlers-Danlos syndrome is 
characterised by aberrant collagen production and can result in hyperextensible skin, easy 
bruising and ‘cigarette paper’ scars, to mention but a few o f the clinical manifestations 
(Byers et al, 1981; Byers, 1989).
1.3.1 Fibroblasts
As mentioned previously, fibroblasts are the main cell type within the dermis. 
Under electron microscopy, the developing fibroblast has an abundant cytoplasm, with a 
well developed endoplasmic reticulum and prominent ribosomes, suggesting active 
protein synthesis.
Numerous factors control fibroblast activity, in particular cytokines, such as 
transforming growth factor p (TGF-P) which appears to play an important role in fibrotic 
disorders such as scleroderma, in which there is up regulation in the production of  
extracellular matrix precursor molecules for types I and type III collagen. Much work has 
been aimed at controlling the physiological effects of this molecule (Leroy et al, 1990).
Fibroblasts adhere to proteins, which they secrete, including several forms of 
collagen (types I, III, IV and VI), fibronectin and laminin, which allows the fibroblasts to 
be suspended in the ECM of the ground substance (Mauch and Kreig, 1990). The ground 
substance itself appears to be important in the control o f fibroblast growth. Laminin 
fragments induce growth via a specific receptor, and this has been linked to the growth 
associated with wound damage or tissue remodelling, as these fragments become exposed 
(Mauch and Krieg, 1990). Fibronectin and collagens I, II and III (and their fragments) 
have also been shown to be chemotactic to human dermal fibroblasts. This could be 
important in wound healing, in that collagen degradation during tissue injury releases 
peptides from the matrix, recruiting fibroblasts to the area for repair (Mauch and Kreig, 
1990). Some o f these migrating fibroblasts do not only produce the ground substance, but 
can also differentiate into myofibroblasts, which express a-(smooth muscle) actin. 
Myofibroblasts can form very tight fibronexus junctions with the neighbouring fibronectin 
in the granulation tissue of the damaged area and are involved in wound contraction 
(Grinnell, 1994).
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1.4 Biology of successful wound healing
Wound healing is a complex process of many overlapping phases. It involves a 
complex interaction between a variety o f ECM components, cell types and soluble 
mediators, which is coordinated by a wide array o f cytokines and growth factors. 
Nevertheless, despite its complexity, wound healing can be loosely divided into 4 






The process of skin wound healing begins at the moment o f injury, whether it is 
intentional, such as a surgical incision, or unintentional, as in trauma. Damage to blood 
vessels initiates a haemostatic cascade o f blood clotting, platelet aggregation and 
degranulation. A blood clot, or thrombus, fills the defect in the skin and seals the wound, 
providing protection against bacterial infection and fluid loss (Mast and Schultz, 1996). 
Thrombus formation occurs via an interaction between endothelial cells, platelets trapped 
in a fibrin meshwork and coagulation factors (Grinnell, 1984). Platelets are important, not 
only in recognising and occluding the defect, but also in promoting blood coagulation and 
in secreting growth factors for fibroblasts and perhaps other cells implicated in the wound 
healing process. Growth factors released from platelets and other injured cells, rapidly 
diffuse from the wound into the surrounding tissues and blood system (Figure 1.3). 
Trapped cells within the clot, predominantly platelets, trigger an inflammatory response 
by the release o f vasodilators and chemoattractants and activation o f the complement 
cascade.
Injuries that damage the microvasculature result in localised low oxygen tension 
(hypoxia) in the wound (Niinikoski et al, 1972). Hypoxia inducible factor-1 (HIF-1) has 
been identified as a transcription factor that is induced by hypoxia and is known to be 
important in triggering the transcription of growth factors such as TGF-pl, platelet 
derived growth factor (PDGF), endothelin-1, fibroblast growth factor (FGF-2), vascular 
endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) (Kourembanas et 
al, 1991; Falanga et al, 1991a; Helfman and Falanga, 1993; Onimaru, et al, 2002; Brogi et 
al, 1994; D ’Arcangelo et al, 2000). These factors support healing by stimulating 
angiogenesis, fibroblast proliferation and collagen synthesis (Falanga et al, 1993; Falanga
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and Kirsner, 1993). Angiogenesis is vital for the delivery o f oxygen, nutrients and growth 
factors necessary to initiate wound healing. These cellular and tissue responses occur in 
response to hypoxia for effective repair and re-establishment o f tissue homeostasis.
1.4.2 Inflammation
The early stages of inflammation are characterised by neutrophils invading the 
wound almost immediately, following formation of the blood clot. The role o f these cells 
is to continue to produce proinflammatory cytokines, such as tumour necrosis factor-a 
(TNF-a) and interleukins. Neutrophils are also important in controlling infection by 
removal of bacteria by phagocytosis, and by removal o f other foreign material such as 
damaged ECM, by the release of enzymes (elastase and collagenase). This early protease 
activity is important in the debridement o f the wound, although, in the absence of 
infection, neutrophils do not seem necessary for the normal healing of wounds. After 
approximately 24 hours neutrophils reduce in number and macrophages predominate. 
Circulating monocytes are chemotactically drawn into the wound, by TGF-p or fragments 
of fibronectin and become activated macrophages. Macrophages secrete pro-inflammatory 
cytokines and engulf and destroy bacteria. Interest has also focused on the role of 
macrophages in coordinating the transition from inflammation to proliferation through the 
release o f soluble mediators, which include PDGF, TNF-a, TGF-p, insulin growth factor 
1 (IGF-1) (Figure 1.3). Cytokines interleukin (IL)-4 and interferon-gamma (IFN-y) 
differentially modulate VEGF release, from normal human keratinocytes and fibroblasts. 
Under normal circumstances, neutrophils disappear from the wound after about 3 days and 
the inflammatory phase begins to decline. Macrophages continue to secrete growth factors 
that stimulate migration of fibroblasts, epithelial cells, and vascular endothelial cells into 
the wound, in preparation for the next phase o f repair.
Many wound related cells including both neutrophils and macrophages also 
possess specialised enzymes that can reduce molecular oxygen to produce reactive oxygen 
species (ROS). These ROS include H2O2 and (V - which disinfect the wound, and at low 
concentrations act as signalling molecules to support wound healing. Lactate accumulation 
is a common characteristic of wounds in which glycolysis, occurs both aerobically and 
anaerobically, contributing to its production. In a study carried out by Wagner et al (2004) 
increased proliferation of cultured fibroblasts by exogenous lactate was mediated by 
intracellular oxidant production. Hydroxyl radicals have also been shown to stimulate 
lymphocyte proliferation (Novogrodsky et al, 1982).
1.4.3 Proliferation
The fibrin clot, which is formed in the inflammatory phase, is used as a provisional 
matrix by fibroblasts that specifically recognise fibrin and are able to migrate into the 
wound bed. Fibroblasts begin to proliferate and the cellularity of the wound increases. 
Furthermore, fibroblasts are the key cells involved in the production of ECM. They are 
known to produce collagen, tenascin, fibronectin, and proteoglycans (such as hyaluronic 
acid). Production of ECM is seen clinically as the formation of granulation tissue. This 
repair phase often lasts several weeks (Mast and Schultz, 1996). As the number of 
macrophages in the wound decrease, other cells in the wound such as fibroblasts, 
keratinocytes and endothelial cells, begin to synthesise and secrete a range of growth 





































Figure 1.3 A summary of the cytokine supply for wound healing
Whilst new matrix is synthesised, the existing matrix in and around the wound 
margin is degraded by proteinases such as matrix metalloproteinases (MMPs) and serine 
proteinases (plasmin). Proteinases are enzymes that cleave peptide bonds in the central 
regions of polypeptides and are classified into groups due to mechanisms of catalytic 
activity, namely; serine, metallo-, cysteine and aspartic proteinases. Serine and 
metalloproteinases are also termed ‘neutral proteinases’ as their activity is optimal at a 
neutral pH. These proteinases play an important role in ECM degradation and are both 
calcium, and zinc dependent. MMPs are of particular research interest (Table 1.1), and are 
well known for their proteolytic activity. They exist as single chain proenzymes that are
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secreted as latent zymogens requiring activation for proteolytic activity. In the wound 
healing process MMPs play an important role in the regulation of cellular migration and 
ECM remodelling following injury (Tomasek et al, 1997; Shi et al, 1999). Fibroblast 
MMP production has in fact been shown to be increased in tissues that exhibit increased 
rates of healing, for example foetal fibroblasts (Gould et al, 1997). MMPs have also been 
shown to be necessary in the epithelial resurfacing o f cutaneous wounds (Agren, 1999a). 
MMPs are regulated by specific tissue inhibitors (TIMPs) which are believed to be 
important in healing by preventing excessive tissue degradation.
Some keratinocytes at the wound edge proliferate, whilst others undergo 
transformation to enable phagocytosis o f debris and migration across the wound bed. 
Keratinocyte migration and wound contraction results in re-epithelialisation and wound 
closure. Inhibition of keratinocyte growth factor (KGF) receptor signalling has been 
shown to reduce the proliferation rate o f epidermal keratinocytes at the wound edge,
resulting in substantially delayed reepithelialisation o f the wound (Wemer et al, 1994).
Subgroup Name O ther names MMP
Number
Substrate
Collagenases Collagenase 1 Interstitial collagenase
(Fibroblast-type
collagenase)
MMP-1 Collagen types I, II, III, VI, 
X, gelatins, proteoglycans




Collagenase 3 Rat interstitial 
collagenase
MMP-13 Gelatins, collagen types IV, 
V, X, XI, elastin, 
fibronectin, proteoglycans
Gelatinase A 72 KDa gelatinase 
Type IV collagenase
MMP-2 Gelatins, collagen types IV, 
V, elastin, proteoglycans
Gelatinases Gelatinase B 92 KDa type IV 
collagenase
MMP-9 Gelatin, Collagen types II, 
IV, V, IX, X,
Stromelysin 1 Transin,
proteoglycanase, CAP
MMP-3 Proteoglycans, fibronectin, 
laminin, elastin
Stromelysin 2 Transin 2 MMP-10 See MMP-3
Stromelysins Stromelysin 3 Furin motif MMP-11 Gelatin, fibronectin, 
proteoglycan










Collagen type IV, gelatin
Table 1.1 Classification of matrix metalloproteinases
A number of MMPs have been isolated and characterised, and are known to share common features that 
allow their classification as a family (Woessner and Nagase, 2000). The MMP family can be divided into 4 
main subgroups, mainly based on their substrate preferences. These members include collagenases,
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gelatinases, matrilysins, stromelysins and membrane-type matrix metalloproteases. MMPs are known to 
function at a neutral pH, contain zinc at their active site and require calcium for stability.
1.4.4 Remodelling
Once closure is achieved, remodelling of the scar occurs, over months or years, 
with a reduction of both cell content and blood flow in scar tissue. TGF-p has been 
implicated as a mediator of excessive ECM deposition in scar tissue and in fibrosis.
Figure 4.1 summarises the normal wound healing processes that lead to the 























Figure 1.4 A summary of the wound healing process.
Wound healing can be divided into haemostasis (Orange), inflammation (Blue), cell proliferation (Green) 
and tissue remodelling (Yellow). Immediately after injury, platelets and coagulation factors result in 
thrombus formation. Platelets and other damaged cells secrete inflammatory mediators triggering an 
inflammatory response. Lymphocytes and macrophages act to control infection and debride the wound, and 
they also secrete growth factors to stimulate migration of wound-related cells into the wound. New collagen 
matrix is synthesised by fibroblasts and old matrix degraded by MMPs (Harding et al, 2002). Migration of 
keratinocytes and fibroblasts across the wound, results in contraction and wound closure.
CHAPTER 2
2 Introduction: Impaired healing of chronic
wounds
A wound is considered chronic or non-healing if  it does not heal in an orderly or 
timely sequence, or if the healing process does not result in structural integrity (Robson,
1997). Furthermore, wounds that heal improperly may not possess the necessary 
mechanical integrity to remain healed. In 1997, Tallman defined chronic wounds as those 
that do not appear to follow the normal healing process in less than 4 weeks.
2.1 Pathogenesis of chronic wounds
The term chronic wound covers a wide range o f disease states that exist in three 
principal forms, decubitus (stasis) ulcers, vascular ulcers and diabetic ulcers. An ulcer can 
be defined as an area of skin loss extending through the epidermis into the dermis.
2.1.1 Decubitus (stasis) ulcers
Decubitus ulcers are a result of impaired capillary flow, reducing vascular or 
nutrient supply to the skin. The bony sites of the body are most prone to ulceration where 
the forces o f compression can reach as much as 2600mmHg (Lindan et al, 1965). Both the 
degree o f pressure and the duration have been found to be important in necrosis (Falanga, 
1993c). It is thought that the application of an external force may cause interstitial 
pressure to rise and exceed the 12mmHg present in the venous capillary limb. This results 
in an increase in total tissue pressure, increased capillary filtration, oedema (an excessive 
accumulation of serous fluid in the extracellular spaces o f tissue), and cell autolysis. 
Lymphatic channels are occluded, resulting in further oedema and autolysis (Reuler and 
Cooney, 1981). Fibrinolysis (the breakdown o f fibrin in blood clots), is also altered 
following ischaemia, which may be due to endothelial cell damage and epidermal injury. 
Fibrin thrombi are a common feature o f decubitus ulcers.
2.1.2 Vascular ulcers
Ulceration due to vascular causes is multifactorial and can be a result of both
arterial and venous disease. Arterial disease is caused by hypertension (abnormally high
blood pressure) and either progressive atherosclerosis (fatty deposits on the inner lining of
the arterial wall) or by arterial embolisation (blockage) o f the peripheral vessels. These
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factors lead to ischaemia of the skin and arterial (or ischaemic) ulceration (Falanga, 
1993a).
Venous disease is a result of chronic venous insufficiency, and the resulting 
venous hypertension results in the formation of venous ulcers (Falanga, 1993a). However, 
not all patients with venous disease develop active skin ulcerations. Venous insufficiency 
develops because of inadequate calf muscle pump action after the onset of, primary (with 
no obvious underlying aetiology) or secondary (as seen after deep venous thrombosis), 
valvular incompetence. When these valves become incompetent, the backflow o f venous 
blood causes venous congestion and hypertension. Two hypotheses have been proposed to 
explain venous ulceration, once venous hypertension develops. The first states that 
distension of the capillary beds occurs because of increased stasis. This leads to leakage of 
fibrinogen into the surrounding dermis. Over time, a fibrinous pericapillary cuff is formed, 
impeding the delivery o f oxygen and other nutrients or growth factors to the affected 
tissue (Falanga et al, 1987; Falanga et al, 1992b). It has been shown that the 
transcutaneous oxygen pressure of the skin surrounding a venous ulcer is decreased, 
suggesting that there are forces obstructing the normal vascularity o f the area. The 
resulting hypoxic injury leads to fibrosis and then ulceration. The other hypothesis 
suggests that the endothelium is damaged by increased venous pressure and leukocyte 
activation. Proteolytic enzymes and free radicals are released, escape through the leaky 
vessel walls, and damage the surrounding tissue, leading to injury and ulceration. 
Haemoglobin, from the red blood cells, also leaks into the extravascular space, causing the 
brownish discoloration commonly noted. The typical venous ulcer is shallow and appears 
near the bony projections of the ankle joint, in combination with an oedematous and 
indurated leg. These ulcers may also present with a weeping discharge from the leg. 
Vascular ulcers are distinct with regard to their location, appearance, bleeding, and 
associated pain.
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Figure 2.1 Venous Stasis Ulcer
2.1.3 Diabetic ulcers
The diabetic ulcer is characterised by neuropathy, ischaemia, and infection. The 
clinical result of neuropathy is due to the biomechanical properties of the foot being 
altered due to failure of motor nerves. This sensory impairment causes what is known as 
‘Insensate foot’ and leads to the breakdown of skin after prolonged pressure or trauma and 
the occurrence of ulcers over bony prominences. Autonomic nerve failure also causes a 
decrease in sweating and blood flow, resulting in dry and easily damaged skin which is 
more sensitive to the effects of pressure (Falanga, 1993c).
The overwhelming factor that causes ischaemia in diabetic patients is 
atherosclerosis, which typically involves the distal arteries. The prevalence of peripheral 
vascular disease in diabetic patients is estimated to be 45% after 20 years of disease. 
Furthermore, in comparison with the general population, patients with diabetes mellitus 
are at a 4- to 6-fold increased risk of the development of atherosclerotic macro-vascular 
disease (Kannel, 1985; Keen and Jarret, 1979). Therefore, these patients have a 
substantially increased risk of amputation due to peripheral vascular disease (Most and 
Sinnock, 1983). Infection also plays a large part in the perpetuation of ulcerations and is 
aided by the well known negative effects of diabetes on neutrophil function (Falanga, 
1993c).
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Figure 2.2 Diabetic Foot Ulcer
2.2 Chronic wound environment and the factors 
involved in impaired healing
Chronic wounds possess features that are specific to the wound type and the 
individual. However, many factors related to wound chronicity have been identified, and 
are common to various wound types. As a result, the treatment of chronic wounds has 
been targeted to common factors by similar therapeutic methods. Normal wound healing is 
a tightly regulated balance of new tissue formation and the destructive mechanisms 
required to remove damaged tissue. Within this complex environment there are many 
stages that precisely control the biological processes required to achieve normal wound 
repair. A variety of factors have been identified that are believed to play a role in the 
impaired healing of chronic wounds. These include hypoxia/ischaemia, reactive oxygen 
species, imbalances in cytokine levels and proteolytic enzymes/inhibitors, excessive fibrin 
deposition, failure of reepithelialisation, prolonged/impaired inflammation, a defective 
wound matrix, infection, and cell senescence and are covered in more detail this section. 
Systemic factors are also important, such as advanced age, malnutrition, and disease.
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2.2.1 Hypoxia/ ischaemia
Whatever their initial cause, chronic wounds usually result from a lack o f oxygen 
and nutrients to the tissues involved. Although hypoxia is to some degree a result of 
normal tissue injury, and may even stimulate normal repair, chronic ischaemia is clearly a 
pathological condition that inhibits normal healing. Prolonged hypoxia or ischaemia is a 
common characteristic o f the chronic wounds, and is implicated in their development, 
perpetuation and aberrant healing.
When a cell is deprived of oxygen, it switches to anaerobic metabolic pathways. 
This produces less adenosine triphosphate (ATP) energy for normal cellular activities, and 
causes an increase in lactic acid. If oxygen deprivation is short term, as in normal healing, 
the cell can function relatively normally until oxygen levels are restored. If hypoxia is 
prolonged or severe, as in chronic wounds, the cell will become ischaemic. A build up of 
lactic acid in the cell lowers intra-cellular pH. This denatures the cellular proteins and they 
become unable to perform their normal functions. In particular, the proteins in the cell 
membrane denature and the membrane begins to leak. The cell and its internal organelles 
swell and start to rupture resulting in leakage o f cytosolic enzymes into the circulation. 
The cell releases inflammatory mediators, such as prostaglandins causing pain and 
inflammation to the area. At this stage, the cell can still recover if  the oxygen supply is 
restored. Further stress and continued hypoxia however, leads to necrosis or cell death 
(McCord, 1985).
Low oxygen tension is well established in chronic wounds (Falanga et al, 1987; 
Falanga, 1991b; Falanga et al, 1992b; Moosa et al, 1987; Falanga et al 1994), particularly 
in venous ulceration and ulcers due to atherosclerosis and diabetes (Pecoraro et al, 1991a; 
Pecoraro, 1991b). Mean values as low as 13mmHg have been quoted for venous ulcers in 
comparison to mean reference values of 75mmHg (Falanga et al, 1992b). Low pH has also 
been measured by Dissemond et al (2003) who measured pH values ranging from 5.45 to 
8.65 in 39 patients with chronic wounds o f varying origins. Furthermore, over a period o f  
12 months, individual values varied up to 1.73 units, showing pH to be a dynamic factor. 
In low oxygen tension, human-derived fibroblast cultures synthesise larger amounts of 
TGF-p 1, and the proliferative activity of dermal fibroblasts is enhanced (Falanga et al, 
1991a; Falanga and Kirsner, 1993). TGF-p is a potent growth factor that stimulates the 
production of collagen types I, II, III, IV, V,VII, elastin and fibronectin. Studies by Uitto 
et al (1974) have also shown that oxygen is required for procollagen hydroxylation. These 
results suggest that the ischaemia in chronic wounds may lead to the synthesis o f a less 
stable procollagen, or to fibres with decreased strength. However, even with the possibility
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of impaired collagen synthesis, it is also believed that hypoxia may account for the fibrotic 
response seen in many chronic wounds (e.g lipodermatosclerosis of venous ulceration). 
This fibrotic tissue may then interfere with normal tissue repair. This suggests that, 
optimal oxygen concentrations may be required to allow appropriate cellular repair and 
synthesis of appropriate amounts and quality of matrix material.
As briefly mentioned in section 1.4.2 ROS generation is important in reducing 
infection and cellular signalling to support the wound healing processes. These ROS are 
generated by an enzyme known as Nicotinamide adenine dinucluotide phosphate 
(NADPH) oxidase which is associated with many wound related cells and defects in this 
enzyme and low wound p02 are associated with impaired healing in humans (Gordillo and 
Sen, 2003). The concentration of O2 necessary to achieve half maximal ROS production 
(the Km) is in the range of 45 to 80mmHg, with maximal ROS production seen at 
>300mmHg (Allen et al, 1997). Therefore, it is likely that the ischaemic environment of 
the chronic ulcer would compromise the function o f these enzymes.
2.2.2 Chronic inflammation
Whatever the cause o f chronic wounds, one o f the hallmarks is the presence of 
chronic inflammation (Agren et al, 2000). Although, the importance of local inflammation 
in the healing process of acute wounds is well established, excessive or prolonged 
inflammation may delay healing and increase scar potential. An inflammatory response in 
the wound environment may be caused by complement degradation products; 
polymorphonuclear leukocyte products; oxygen free radicals; enzymes e.g proteinases and 
microbial products. Infection ischaemia, necrotic or damaged tissue, or foreign matter can 
prolong inflammation in the chronic wound environment. Neutrophils and macrophages 
are phagocytic cells that secrete TNF-a, IL-1 and IL-8 during the inflammatory response. 
TNF-a initiates the proinflammatory cascade and promotes IL-1 p synthesis. Studies have 
shown the TNF-a and IL-ip were increased in chronic wounds when compared with acute 
wound fluid (Mast and Schultz, 1996). Tumour necrosis factor-a and IL-1 p are implicated 
in the upregulation o f adhesion molecules such as ICAM-1 and VCAM. ICAM-1 and 
VC AM have been shown to be upregulated in venous ulcers allowing the migration of 
inflammatory cells into the wound. Weyl et al (1996) demonstrated perivascular 
accumulation of ICAM-1 and VCAM ligands, LFA-1 and VLA-4-positive inflammatory 
cells in leg ulcers.
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2.2.3 Excessive proteinase production in the chronic wound
Imbalance of proteinases in the chronic wound environment appears to be 
responsible for the continuous breakdown o f the newly formed ECM. Excessive 
proteinase activity in the chronic wound is probably due to prolonged inflammation, and 
the ongoing recruitment and activation of inflammatory cells, such as neutrophils and 
macrophages, which are attracted to the wound site by inflammatory cytokines. Excessive 
proteinase activity is therefore thought to contribute to tissue injury by overwhelming their 
inhibitors and binding to their substrates.
Fluid derived from chronic wounds has been shown to contain several leukocyte 
proteinases including serine proteinases, human leukocyte elastase (HLE), cathepsin G 
(CG), and urokinase-type plasminogen activator (uPA), and MMPs (Yager et al, 1997; 
Stacey et al, 1993). Excessive, inappropriate or prolonged activities of these leukocyte- 
derived proteinases are thought to play a role in the chronic ulcer environment (Barrick et 
al, 1999). Neutrophils and macrophages also secrete large amounts of elastase, which may 
cause constant degradation of granulation tissue that is crucial for cell migration and 
wound repair (Heiden et al, 1996; Herrick et al, 1997). Elastase activity is 10- 40-fold 
increased in chronic wounds when compared with acute wounds (Rao et al, 1995). 
Inhibitor inactivation may also contribute to the presence of active proteinases in chronic 
wounds, as inactivated aj-proteinase inhibitor and ct2 -macroglobulin which are 
responsible for the inactivation of thrombin and plasmin respectively, have been detected 
in chronic wound fluid (Yager et al, 1997; Rao et al, 1995).
2.2.3.1 Imbalance between MMPs and their inhibitors
Much of the research on impaired healing in chronic wounds has focused on 
imbalances in MMPs and their inhibitors (TIMPS) and their role in the disruption of ECM 
remodelling. Numerous studies have shown increased in MMP activity in fluid taken from 
chronic leg ulcers, in particular, increases in gelatinase and collagenase activity has been 
reported (Wysoki et al, 1993; Bullen et al, 1995; Weckroth et al, 1996). Furthermore, in 
fluid derived from pressure ulcers, levels of gelatinases MMP-2 and MMP-9 were found 
to be elevated more than 10-fold and 25-fold respectively, and increased levels of both 
total and active collagenase were measured (Yager et al, 1996). Collagenases have the 
unique ability to degrade the major structural ECM proteins in the dermis, namely the 
triple helical type I and type II collagens at Gly775-Leu(lle)776. After this initial and 
specific cleavage, % and 'A cleavage products are formed, and collagen is spontaneously 
denatured (helix to coil transition) to gelatine (Miller et al, 1976). Gelatin is further
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degraded by a multitude of enzymes, in particular by gelatinases of types MMP-2 and -9 
(M urphys al, 1985).
Fibroblasts derived from unwounded skin from diabetics have shown elevated 
production of MMP-2 and pro-MMP-3 when compared with their non-diabetic 
counterparts (Wall et al, 2003). This may contribute to the increased risk of non-healing 
foot ulceration in diabetics. The growth o f patient matched and chronic wound fibroblasts 
in three-dimensional collagen lattice systems showed the ability of chronic wound 
fibroblasts to reorganise the ECM was impaired. These studies described significantly 
decreased levels of MMP-2 and MMP-1 and an increased production o f tissue inhibitors 
metalloproteinase-1 and -2 by chronic wound fibroblasts. (Cook et al, 2000). This result 
contrasts with numerous studies that report an increase in MMP activity and a decrease in 
TIMP activity; however, this suggests that it is an imbalance that is important in the 
disruption of ECM reorganisation. Furthermore, studies o f normal human dermal 
fibroblasts in three-dimensional culture, indicates that hypoxia increases MMP-1 synthesis 
which is not restored by reoxygenation (Kan et al, 2003). Studies also indicate that a 
slower rate of proliferation, a greater collagenase activity and expression of collagenase 
mRNA by aging fibroblasts could be some of the main reasons for attenuation o f wound 
healing in elderly patients (Khorramizadeh et al, 1999).
As well as chronic ulcer fluid, and chronic ulcer fibroblasts, studies on tissue 
biopsies taken from the ulcer bed have been used to determine proteinase activity, as it is 
thought wound fluid may not give an accurate impression o f tissue levels of proteinases 
(Ashcroft et al, 1997). MMP levels recorded in chronic wound fluid are due to the 
activities o f a variety of cell types such as inflammatory cells, keratinocytes as well as 
fibroblasts. Therefore, it is thought that local production and activation o f MMPs in the 
tissue may give a clearer understanding of the impaired healing o f chronic wounds. 
Studies using type II diabetic mice show that in the early stages o f wound healing, protein 
levels o f pro-MMP-2 and -9 are significantly reduced within wound tissue as well as the 
levels o f active MMP-3 within the fluid. However, when human diabetic chronic wound 
fluid is compared with acute wound fluid, increased MMP-2 and reduced MMP-9 is 
detected. These differences may be due to the difference between tissue and wound fluid 
(Wall S. J et al, 2002). Excessive MMP-1 and MMP-2 activity has been observed in skin 
biopsies taken at the earlier stages o f chronic venous insufficiency, (Herouy et al, 1998).
Decreased levels of active TIMPs, which inhibit MMPs preventing excessive ECM
degradation, has also been reported in chronic wound fluid (Bullen et al, 1995, Yager et
al, 1996). Studies have also shown that TIMPs, appear to to be complex-bound and
inactivated (Bullen et al, 1995; Wysocki et al, 1993). Biopsies taken from chronic wounds
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have also been found to be characterised by a decrease in TIMP-1 (Vaalamo et al, 1996). 
TIMPs-1 and -2 are responsible for the inhibition of collagenases, MMPs-1 and -2 
respectively (Howard et al, 1991). As well as TIMPs, plasminogen activator and growth 
factors such as PDGF and TGF-P (Cullen et al, 1997; O ’Kane and Ferguson, 1997) are 
known to regulate MMP activity within the wound. MMP production is also stimulated by 
inflammatory cytokines, such as IL-1, TNF-a and ECM proteins. For example, studies 
carried out by Han et al (2000), show the activation of pro-MMP-2 in dermal fibroblasts 
by TNF-a, and collagen. This suggests that the prolonged inflammation that is 
characteristic of chronic wounds may result in excessive MMP-2 production from 
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Figure 2.3 Proposed pathway for activation of pro-MMP2 in human dermal fibroblasts.
Activation o f pro-MMP2 by TNF-a and collagen, resulting in NF-kB mediated induction o f MT1-MMP 
(Membrane type metalloproteinase) (Han et al, 2000).
2.2.4 Degradation of the matrix components
Studies have shown that chronic wound fibroblasts synthesise comparable amounts 
of ECM as normal fibroblasts; suggesting that the defective wound matrix within chronic 
wounds is likely to be due to alterations in protease activity (Hasan et al, 1997). However, 
this contrasts with some studies by Herrick et al (1996) who reported a reduction in 
collagen production but similar amounts of fibronectin. However, this study used 
fibroblasts taken from venous ulcers and site-age matched individuals as controls, rather 
than fibroblasts from the patients themselves, as in the previously mentioned study. This 
difference might account for the variation in the observed outcome. The initial wound 
matrix contains glycosaminoglycans and fibronectin. Fibronectin is an adhesive 
glycoprotein that promotes cell adhesion, migration, differentiation and proliferation of
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macrophages and fibroblasts (Grinnell, 1984). Fibronectin appears to be particularly 
susceptible to proteolysis (Wysocki and Grinnell, 1990). Extensively degraded adhesion 
proteins such as vitronectin and fibronectin have been described in some chronic wounds 
(Grinnell et al, 1992). Furthermore, diabetic and venous ulcers have been shown to 
contain decreased levels o f fibronectin, and its degraded products (Grinnell and Zhu, 
1996; Palolahti et al, 1993). Excessive protease activity in wounds may prevent cell 
adhesion necessary for normal wound closure. Other enzymes and proteases, including 
urokinase, play an important role in matrix degradation and in facilitating cellular 
migration. Urokinase enhances the synthesis of plasminogen an inactive protease 
precursor that is abundant in blood. Plasminogen is cleaved locally by other proteases, 
called ‘plasminogen activators’, to yield the active serine protease plasmin. Plasmin has an 
important role in wound healing and angiogenesis by allowing the cellular migration of 
microvascular cells through a fibrin matrix and restoring blood flow by helping to break 
up blood clots (Figure 2.4).
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Figure 2.4The fibrinolytic pathway.
Inactive protease plasminogen is cleaved by plasminogen activators, tissue type and urokinase type, and by 
initiation of the contact phase (intrinsic pathway). This pathway is activated when Factor XII, which 
activates prokallikrein (inactive form of kallikreins which are serine proteases), and High molecular weight 
(HMW) kininogen (coagulation protein which acts as a cofactor) are exposed to a negatively-charged 
surface, or a “foreign” surface, for example collagen, basement membrane, lipopolysaccharide, or non- 
physiological surfaces such as glass. The active plasmin is then able to cleave fibrin. Fibrinolysis is 
regulated by inhibitors such as Thrombin activatable fibrinolysis inhibitor (TAFI).
2.2.5 Reduced levels of active growth factors
Growth factors are essential regulatory peptides involved in the cellular activities
that take place in wound repair. Chronic wounds show reduced levels of PDGF, Basic
fibroblast growth factor (bFGF), epidermal growth factor (EGF), and TGF-P compared
with acute wounds (Falanga, 1992; Higley et al, 1995). Endothelial growth factor receptor
(EGF-R) was also shown to be downregulated in the bed of venous ulcers, and
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upregulated in the wound edge (Falanga et al, 1995). Keratinocyte growth factor 
expression in wounded skin o f diabetic mice is significantly reduced and delayed, possibly 
contributing to impaired re-epithelialisation (Werner et al, 1994). A hypothesis for the 
pathogenesis of venous ulceration, suggests that macromolecules leaking into the dermis 
bind to growth factors or ECM molecules ‘trapping’ them and making them unavailable to 
the repair process (Falanga and Eaglestein, 1993). Fibrin persists in chronic wounds 
because fibrin is capable of forming less readily degradable complexes (Claudy et al, 
1991). Other molecules bound to fibrin, such as fibronectin may facilitate binding of  
growth factors, as suggested by the ‘trap hypothesis’. This suggests that there is not a lack 
of growth factors in the chronic wound environment, but that they are bound or inactivated 
by excessive proteolytic activity (Falanga, 1993b). However, a local lack o f growth factors 
has not been demonstrated in chronic wounds. Expression of PDGF receptor-a and ~p 
chains and VEGF receptors are upregulated in venous ulcers (Peschen et al, 1998a). 
Expression of bFGF (Peschen et al, 1998b), TGF-P (Mast and Schultz, 1996) and Insulin­
like growth factor-1 (IGF-1) have shown to be increased in chronic wounds.
2.2.6 Role of inflammatory networks
An intact and correctly functioning neurosensory system is essential to the 
inflammatory response. Evidence does suggest that denervation impairs cutaneous 
microvascular function in healing (Carr et al, 1993). The loss of neuropeptide homeostasis 
is particularly relevant in diabetic wounds, decubitus ulcers and ulcers developed as a 
result of spinal cord injury. The inflammatory response is mediated by cutaneous sensory 
nerves by the release of neuropeptides, such as substance P, which stimulates the 
proinflammatory responses o f keratinocytes, fibroblasts and endothelial cells. Neural 
endopeptidase (NEP) is responsible for the breakdown and thus regulation of substance P, 
and is found to be upregulated in the skin o f diabetic patients and in diabetic ulcer 
fibroblasts (Antezana et al, 2002). Furthermore, NEP enzyme activity in mutant diabetic 
murine skin significantly exceeds that found in nondiabetic murine skin. The NEP 
inhibitor thiorpan was also found to improve wound closure kinetics in diabetic mice and 
appeared to enhance the inflammatory response (Spenny et al, 2002). It is therefore 
thought, that NEP may have an involvement in the disruption o f the proinflammatory 
response and impairment of normal wound healing. Diabetes may also be responsible for a 
delayed infiltration o f inflammatory cells into the wound space, resulting in a lack of 
cytokines that promote cell growth and wound repair.
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2.2.7 Cellular senescence and inhibition of cell proliferation
The Hayflick model o f cellular aging was developed with human neonatal 
fibroblasts. These fibroblasts showed they undergo proliferation and passage 40 to 60 
times until they were no longer able to replicate, and it is this point that is referred to as 
cellular senescence (Hayflick and Moorhead, 1961). Chronic ulcers appear to contain a 
large number of fibroblasts that are arrested because of senescence, and accumulation of  
these cells within the tissues is though to mediate impaired dermal healing. It has been 
suggested that prolonged inflammation, delayed wound closure and extended exposure to 
chronic wound fluid affects cellular activity in the wound bed resulting in non­
proliferative senescent cellular phenotype (Mulder and Vande Berg, 2002).
Fibroblast senescence, decreased population-doubling, and proliferation o f chronic 
wound fibroblasts has been extensively covered in the literature (Stanley et al, 1997, 
Mendez et al, 1998; Vande Berg et al, 1998; Agren et al, 1999b). Studies by Bucalo et al 
(1993) have shown that venous ulcer fluid inhibits the proliferation of human dermal 
fibroblasts. Furthermore, dermal fibroblasts derived from ulcers older than 3 years grow at 
a slower rate when compared with ulcers that are less than 3 years old, and have a reduced 
proliferative response to platelet-derived growth factor. It is thought that this decrease in 
proliferative potential may be due to an increasing percentage of senescent fibroblasts 
(Agren et al, 1999b). Cells have also been shown to become less responsive to growth 
factors as they reach higher passage numbers. This is thought to be due to decreased 
receptors, lowered binding affinities of growth factor receptors and decreased efficiency o f  
internalisation of the growth factor receptor complex (Reenstra et al, 1993). Venous ulcer 
fibroblasts taken from different patients have shown differing responses to growth factors 
(Stanley et al, 1997). Therefore replicative senescence in wound fibroblasts and reduction 
in proliferation provides a possible reason for the failure o f wounds to respond to 
treatment (Mendez et al, 1998; Vande Berg et al, 1998).
However, these findings contrast with those o f Herrick et al (1996) and Cook et al 
(2000). Differences may relate in part to cell culture techniques used, as Vande Berg et al 
(1998), showed that fibroblast senescence varied with biopsy site within the ulcer. 
Stephens et al (2003a) assessed cellular proliferation, senescence, telomere length, and 
ECM reorganisational ability, and observed that chronic wound fibroblasts demonstrated 
no evidence of senescence. It is therefore possible, that the distinct phenotype of chronic 
wound fibroblasts is not simply due to the aging process, mediated through replicative 
senescence, but instead reflects disease-specific cellular alterations of the fibroblasts 
themselves.
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2.2.8 The microbiology of chronic ulcers
2.2.8.1 Bacterial colonisation and infection
Chronic ulcers occur in individuals and tissues that are prone to bacterial invasion 
due to local factors such as impaired vascular supply, trauma and systemic factors. 
Chronic ulcers are commonly contaminated with a variety o f endogenous microorganisms, 
primarily o f faecal, oral, and cutaneous origin. Studies have shown that the mean number 
of bacterial species in leg and foot ulcers ranges from 1.6 to 4.4 (Tentolouris et al, 1999; 
Bowler and Davies, 1999; Kontiainen and Rinne, 1988). The interaction between ulcer 
and bacteria can be separated into four levels: contamination, colonisation, critical 
colonisation and infection (Schultz et al, 2003). Contamination and colonisation are not 
thought to impair healing; whereas critical colonisation has been used to describe the stage 
at which bacteria begin to adversely affect healing in the absence of the typical clinical 
features o f infection. In clinical terms infection is recognised by increased local pain, 
cellulitis, local abscess, necrotising faciitis, osteomyelitis, bacteraemia, or sepsis. Studies 
have shown that 86% of ulcers with no clinical signs of infection contained more than one 
bacterial species (Hansson et al, 1995). The progression from wound colonisation to 
infection depends not only on the bacterial count or the species present, but also on the 
host immune response, the number of different species present, the virulence o f the 
organisms and synergistic interactions between the different species. There is increasing 
evidence that bacteria within chronic wounds live within biofilm communities, in which 
the bacteria are protected from host defences and develop resistance to antibiotic 
treatment.
Although the polymicrobial nature o f many chronic ulcers involves aerobic, 
facultative and anaerobic microorganisms, (Ademiluyi et al, 1988; Daltrey et al, 1981; 
Gilchrist and Reed, 1989; Hansson et al, 1995; Bowler and Storr, 1998) delayed wound 
healing with or without clinical signs of infection has frequently been associated with 
aerobic or facultative pathogens (Danielsen et al, 1996; Eriksson et al, 1984; Gilliland et 
al, 1988; Madsen et al, 1996; Schraibman, 1990). However, anaerobic bacteria have also 
been isolated from chronic wounds using stringent anaerobic techniques. In 1999 Bowler 
and Davies, extensively studied the microbiology o f 74 leg ulcers and reported 220 
isolates from 44 infected leg ulcers compared with 110 isolates from 30 non-infected leg 
ulcers (Table 2.1). Statistical analysis also indicated a significantly greater mean number 
of anaerobic bacteria, particularly Peptostreptococcus spp. and Prevotella spp., per 
infected ulcer in comparison with the noninfected ulcer group. Subsequently, research by
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Stephens et al (2003b) has shown anaerobic organisms to be present in the deep tissues of 
14 out of 18 wounds as shown by a comparison o f surface wound swabs and punch biopsy 
methods of isolation. Several o f the anaerobic bacteria found in tissue biopsies were not 
found in tissue swabs implying that the latter do not give an accurate indication of the 
microflora present in the chronic wound. Furthermore, these ulcers were classified as 
noninfected with routine diagnostic tests and would not have been identified without the 
strict isolation and extended incubation techniques used in this study. Chronic ulcers are 
not only able to support a complex interaction o f aerobic and facultative anaerobes, but 
they are also able to harbour obligate anaerobes, thus confirming the existence of a 
hypoxic environment.
2.2.8.2 Bacteria and impaired healing
The deep dermal tissues of all chronic wounds harbour microorganisms and the 
presence of microbes per se is not indicative of wound infection. However, the possibility 
that a critical microbial load might directly affect the healing outcome in both acute and 
chronic wounds has been considered for several decades, with a direct relationship first 
being demonstrated by Bendy and Landman (1964). Since then work by Robson (1997) 
and others has led to the widely-held opinion that non-healing is associated with a 
bacterial load of more than 105 bacteria per gram of tissue.
The precise interaction between microbes in the wounds and impaired healing is 
unknown. The concept o f bacterial synergy which recognises the importance of  
interspecies interactions has been purported to occur in chronic wounds through studies 
such as that by Bowler and Davies (1999). They found the growth and pigmentation of 
some Gram-negative anaerobes to be enhanced by some facultative anaerobes through the 
provision of an essential, unidentified growth factor. Furthermore, enhanced virulence 
caused by synergistic interactions between aerobic and anaerobic bacteria in polymicrobial 
populations has been well documented (Brook, 1988; Brook, 1987; Rotstein et al, 1985a 
and b) and, although this has not been directly related to impaired healing and infection in 
leg ulcers, the effects in soft tissue infections are well recognised (Kingston and Seal, 
1990).
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Microbial isolates (aerobic and Infected leg Noninfected Microbial isolates (Obligate Infected Noninfected
facultative anaerobes) Ulcers leg ulcers anaerobes) leg leg ulcers
ulcers
Coagulase-negative staphylococcus ✓ y Peptostreptococcus asaccharolyticus y y
Micrococcus sp. y Peptostreptococcus anaerobius y y
Staphylococcus aureus y y Peptostreptococcus magmus y y
Streptococcus agalactiae (Grp B) y Peptostreptococcus micros y y
P-Hemolytic streptococcus (Grp G) y y Peptostreptococcus prevotii y y
Streptococcus spp. (fecal) y y Peptostreptococcus tertradius y
Streptococcus spp. (Vridans) y y Peptostreptococcus indolicus y y
Germella morbillorum y y Peptostreptococcus sp. y
Corynebacterium xerosis y Streptococcus intermedius y y
Corynebacterium sp. y y Clostridium clostridioforme y y
Clostridium sporogenes y
Escherichia coli y y Eubacterium aerofaciens y
Klebsiella pneumoniae y y Lactobacillus acidophilus y
Klebsiella oxytoca y y Propionibacterium acnes y
Enterobacter cloacae y y Propionibacterium avidum y
Citrobacter ffeundii y Propionibacterium granulosum y
Citrobacter amalonaticus y
Proteus mirabilis y y Bacteroides ffagilis y
Morganella morganii y Bacteroides ureolyticus y y
Pseudomonas aeruginosa y y Bacteroides distasonis y
Pseudomonas paucimobilis y Bacteroides capillosus y
Stentrophomonas maltophilia y Bacteroides thetaiotaomicron y
Flavimonas orizihabitans y Prevotella oralis y y
Prevotella bivia y y
Candida albicans y Prevotella buccalis y
Candida parapsilosis y Prevotella sp. y




Porphyromonas gingivalis y y
Gram-negative pigmenting bacillus y y
Fusobacterium necrophorum y
Veillonella spp. y y
Number of isolates (n = 24) 24 13 Number of isolates (n = 33) 28 20
Table 2.1 The microbiology of infected and noninfected leg ulcers.
Leg ulcers were defined as infected on the basis of clinical signs, and were swab sampled and investigated 
for aerobic, facultative and anaerobic organisms using stringent isolation and identification techniques 
(Bowler and Davies, 1999).
With regard to specific pathogens, beta-haemolytic streptococci, (Schraibman, 
1990; Robson, 1997), S. aureus, Enterobacteriaceae and Pseudomonas species (Trengove 
et al, 1996) have all been implicated as having potentially adverse effects on wound
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healing. However, the impact of these species may vary in different settings, e.g, over 
60% of arterial and diabetic ulcers colonised with S. aureus went on to develop infection 
compared with only 20% of venous ulcers similarly infected.
Several studies support the idea that bacteria can in fact inhibit the growth of 
fibroblasts (Henke et al, 1998; Letzelter et al, 1998). However, studies using bacterial 
supernatants have only a limited effect (Larjava et al, 1987) or even stimulate proliferation 
(Kilcullen et al, 1998). Bacterial endotoxins (e.g. lipopolysaccharide complex associated 
with the outer cell membrane of Gram-negative bacteria), have been shown to inhibit 
human cellular migration (Pitaru et al, 1987). However, this mode o f action does not apply 
to the Gram-positive Peptostreptococcus spp. Interestingly, volatile fatty acids are the 
principle metabolic component of anaerobic cocci, and have been shown to change the 
growth and cellular responses of human fibroblasts (Rittenberg and Ehrlich, 1992; 
Davidson et al, 1993; Jeng et al, 1999). Cellular wound repopulation may also occur by 
an indirect mechanism via production and activation of MMPs. Bacteria such as P. 
gingivalis, P. aeruginosa and E. coli are able to alter MMP-1, -2, -3, -7 and -9 production 
and activation by epithelial cells (DeCarlo et al, 1998). As MMPs are known to be 
involved in wound repopulation in vivo and in vitro this is a potential mechanism by 
which bacterial supernatants are involved in impaired wound closure. Studies also suggest 
that Gram-positive anaerobic cocci (GPAC) and their metabolites interfere with normal 
wound healing responses by disruption o f inflammation, proliferation and remodelling 
phases o f wound repair (Wall I. B et al, 2002). GPAC produce a range o f terminal short 
chain fatty acids (SCFA) including butyrate, acetate, isovalerate, isocaproate, and n- 
caproate. These SCFA are thought to be responsible for the malodour o f infected leg 
ulcers, hyperlipidemia and impaired healing responses (Figure 2.5). Peptostreptocci are 
known to produce a range of proteolytic enzymes such as collagenases and 
aminopeptidases which could impair wound healing and prolong inflammation. Studies by 
Stephens et al (2003b), found that Peptostreptococcus spp. isolated from chronic venous 
leg ulcers and their supernatants, significantly reduced keratinocyte and fibroblast 
proliferation, impaired keratinocyte re-epithelialisation and endothelial cell proliferation, 
suggesting that these microorganisms may contribute to the delayed re-epithelialisation, 
impaired ECM reorganisation and angiogenesis in chronic wounds.
Studies by Schmidtchen et al (2002) o f proteinases of the clinically significant
bacterial species P. aeruginosa, E. faecalis, P. mirabilis and S. pyogenes have shown that
they are able to degrade the major human antibacterial peptide LL-37 which has shown
antibacterial activity against both gram-negative and gram-positive bacteria (Sorensen et
al, 2001). This degradation leads to loss o f LL-37 binding to bacteria and ultimately
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abolished bacterial killing. The study suggests how bacterial pathogens can overcome the 
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Figure 2.5 Impaired wound healing responses by Peptostreptococcus spp. and their metabolites.
SCFA = Short chain fatty acids. GPAC = Gram-positive anaerobic cocci. (Wall I. B et al, 2002).
2 . 2 .8 . 3  A n t i b i o t i c  r e s i s t a n c e  a n d  c h r o n i c  w o u n d s
Antibiotics were first isolated in the 1930s and ‘40s, and were used as a first line of 
treatment for bacterial infections in a variety of infectious diseases. However, soon after 
their introduction the first signs of resistance began to emerge (Moellering, 1995). Further 
antibiotics were developed by modifications of the original penicillin and the generation of 
other molecules, but resistance has continued to be an ongoing problem (Harrison and 
Svec, 1998). Hospitals, particularly intensive care units are an important environment for 
the development and spread of resistant bacteria, due to the use of high doses of antibiotics 
in conjunction with a high concentration of people, giving an enhanced potential for cross 
infection (Gold and Moellering, 1996). The molecular basis of resistance relies on four 
basic mechanisms: Antibiotic modification, blocking antibiotic entry or removal at a rate 
higher than uptake, alterations to the target rendering the antibiotic less efficient and by 
the production of an alternative target (Hawkey, 1998). Resistance can be intrinsic or
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acquired, and may arise by spontaneous mutation o f the genome in the presence or 
absence o f antibiotics to leave a particular bacterium with an advantage over non-mutant 
types. DNA can also be acquired from resistant bacteria in the form of plasmids. Plasmids 
are pieces of DNA outside of the host genome that can confer resistance on the recipient 
that was once sensitive to a particular antibiotic. The overuse of antibiotics forces 
bacterial evolution by selecting out those individuals that are resistant to the strategy in 
use.
Systemic antibiotics are generally accepted as being the preferred choice for 
treating infection in chronic ulcers, provided that ischaemia does not interfere. With an 
increasing population at risk of developing chronic wounds, antibiotic resistance is an 
important issue. The polymicrobial nature o f chronic wounds is likely to provide an 
appropriate environment for genetic exchange between bacteria. In fact, the first two cases 
of vancomycin resistant S. aureus (VRSA) in the United States were both isolated from 
chronic wound patients (Howell-Jones et al, 2005). Studies have also found that half of 
the S. aureus isolated from leg ulcers were meticillin resistant S. aureus (MRSA) and 
more than one-third of P. aeruginosa isolates to be resistant to ciprofloxacin (Colsky et al,
1998). Tentolouris et al (1999) found that 40% of S. aureus isolated from infected diabetic 
foot ulcers to be MRSA and had a prevalence o f 15% in all ulcer patients. Furthermore, 
there were significantly more MRSA isolates in patients that had received prior antibiotic 
therapy, with those that had not. In a follow up study, the prevalence of MRSA in the 
ulcer patients had almost doubled, (30%) in a three year period. It also appears that 
populations of wound patients can show wide variation in the level o f antibiotic resistance 
encountered, which may be due to prior antibiotic therapy and the level o f contact with 
healthcare institutions (Howell-Jones et al, 2005). Whilst the additional impact of 
antibiotic-resistant organisms on wound healing is not known, the overall morbidity, 
mortality and cost associated with infections in hospital patients caused by antibiotic 
resistant organisms has been shown to be 1.3- to 2-fold higher, than infections caused by 
antibiotic-sensitive organisms (Cosgrove et al, 2003). Due to the proliferation o f antibiotic 
and antiseptic resistant strains o f bacteria around the world, attention is increasingly being 
focused alternative methods o f controlling bacterial infection in chronic wounds. 
Healthcare professionals have already begun to look towards more ‘traditional’ methods 
of combating and preventing wound infections such as povidone-iodine (a form of iodine 
commonly used in skin cleansing), as a means of preventing and treating infection in a 
range of acute and chronic wounds (Flynn, 2003).
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2.2.8.4 Measures to counteract resistance
To overcome bacterial resistance a number o f strategies have been introduced. A 
prime aim is to reduce antibiotic use by increased education on their effectiveness, 
regulatory measures on their availability, public health surveillance to reduce outbreaks 
and further research into alternatives (Murray, 1994). The apparent fitness of bacterial 
strains may also be an area for exploitation by using a particular treatment that may 
combat resistance. It has been noted that in the absence of antibiotic, some resistant 
strains o f bacteria are not as fit as the wild type, non-resistant strains (Levy, 1994). By the 
removal of the antibiotic, the resistant strains will be out-competed by the non-resistant 
strains until the main infectious agents will consist o f the antibiotic-sensitive bacteria. The 
antibiotic can then be reintroduced and the drug regains its efficacy. However, the above 
set of experimental observations apparently did not take into account the effect of multiple 
generations and “forced evolution” (Lenski, 1997). Cells which are transfected with a 
resistance plasmid do not compare well with the wild-type in the absence o f the antibiotic 
to which it now has resistance to. Over time however, the resistant strain begins to evolve 
a strategy to overcome this short fall and over -500 generations will compete with the 
wild-type as effectively without the antibiotic present (Spratt, 1996; Schrag et al, 1997).
The reduction in drug usage over time may still mediate an effect in a mixed 
population with reversions back to the resistant wild type but at a much slower rate than 
was previously thought. Work by Levin et al (1997) using mathematical models of 
population growth, shows an increased likelihood o f reversion only if  the sensitive strains 
have some advantage. This may be in the form o f reduced drug concentrations and helped 
by the relative proportions of sensitive and resistant strains in the population. Therefore, 
along with the education and surveillance strategies suggested above, alternative 
treatments are required. With the increasing need for a reduction in the use of antibiotics, 
other strategies need to be sought. Education and surveillance strategies will work in the 
medium to long term, but it is what to do in the meantime to combat infection whilst the 
long-term measures begin to show their effect, that is important.
Figure 2.6 summarises the impaired healing responses that result in prolonged 
ulceration.
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Figure 2.6 Summary of impaired healing in chronic wounds.
Orange=Haemostasis Blue ^Chronic Inflammation (Excessive protease activity), Green=Impaired cell 
proliferation/migration (Degradation of growth factors adhesion proteins due chronic inflammation), 
Yellow=Impaired Tissue Remodelling (Reduced ECM production and excessive degradation by proteases).
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2.3 Existing approaches and associated problems for 
chronic wound treatment
Many approaches are used in the treatment o f chronic wounds, firstly to try and 
reduce the likelihood of a chronic wound forming, and secondly to attempt to rectify the 
aberrant healing once a chronic wound has occurred Figure 2.7.
Chronic, nonhealing wound
Reassess for complicating factors 
(Disease/impaired blood flow/infection)
Appropriate dressing




Reconstruction with grafts or flaps
Amputation
Figure 2.7 Treatment of a chronic nonhealing wound.
The flow chart demonstrates the general process that is followed in order to encourage a chronic wound to 
heal. Treatment can take from months to years, and in the event that treatment is unsuccessful, amputation is 
the final outcome.
2.3.1 Basic care
Pressure relief by good nursing care, use o f mattresses and cushions is extremely 
important for patients at risk from pressure ulceration (Colin, 1996). Furthermore, regular 
debridement of callus, nail care, and pressure offloading footwear are fundamental to the 
care o f foot disease from diabetic neuropathy (Boulton, 1986). Use o f compression 
bandages and stockings are an essential and effective component to managing venous 
ulceration (Kitahama et al, 1982; Falanga, 1993a; Agren et al, 2000). The beneficial 
effects o f compression therapy are well documented (Fletcher et al, 1997). It is thought 
that by applying external pressure the leakage o f the dilated capillaries is prevented,
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oedema removed and the superficial capillary perfusion improved (Fagrell, 1982). There 
are a variety o f bandaging systems some producing up to 70% complete healing in three 
months (Guest et al, 1999), 95% healing in 3 months has even been reported using 
individualised and optimised compression techniques (Olofsson et al, 1996). Furthermore, 
high compression, bandaging systems appear to produce better short term results than low 
compression systems (Fletcher et al, 1997; Backhouse et al, 1987). These basic methods 
of care should feature in all new treatments (Harding et al, 2002).
2.3.2 Dressings
Major focus of chronic wound care in recent years has been the development of 
dressings that promote a moist environment to assist healing. Winter showed in an animal 
model that re-epithelialisation of a partial thickness acute wound proceeded 1.5 times 
more rapidly if  the wound was occluded (Winter, 1962). Occlusive dressings have not 
shown such dramatic effects in clinical studies on patients with chronic wounds, but they 
may still benefit patients by reducing pain and by improving convenience of use and cost 
effectiveness. Advances in dressing technology have not yet resulted in the development 
o f materials that correct abnormalities in the healing cascade, with the exception of 
dressings containing hyaluronic acid, which specifically promotes healing.
2.3.3 Topical treatments
Considerable research has gone into the application o f exogenous growth factors in 
an attempt to stimulate healing. The function of growth factors in the wound setting is to 
attract various cell types to the wound, stimulate cellular proliferation, promote 
angiogenesis, and regulate synthesis and degradation o f the ECM. However, the success of  
exogenous growth factor application to chronic wounds for therapeutic purposes has been 
limited, and is not as effective as when used to treat acute wounds and has also been less 
impressive than in animal models of wounding (Table 2.2). However, this is unsurprising 
given the complex nature of wound healing and several reasons have been proposed. For 
example, a lack of an orderly progression of cytokines and the insufficiency of application 
of individual growth factors to induce wound healing. ‘Bound’ endogenous growth factors 
would also be unable to work in an ordered manner. This idea has also been suggested by 
the inability o f grafted epithelial cell cultures to remain on the cell bed but stimulate 
wound closure from the wound margin. It is therefore thought, that a skin equivalent graft 
may produce growth factors in the correct order and amounts. Another possible reason for 
this difference may be due to the protease-rich nature o f chronic wound fluid, resulting
33
from resident cells and bacteria within the wound. Chronic wound fluid has been shown to 
decrease the proliferation of fibroblasts, endothelial cells, and keratinocytes, whereas 
acute wound fluid stimulates their growth (Katz et al, 1991).
Growth Factor or cytokine Effect on wound Current use
TGF p Re-epithelialisation Initial studies in venous ulcers 
encouraging
Neovascularisation
Increased granulation tissue and 
collagen
PDGF Re-epithelialisation Licensed for the treatment of 
neuropathic diabetic foot ulcers
Neovascularisation
Increased granulation tissue and 
collagen
FGF Re-epithelialisation Biological effects in pressure ulcers
Neovascularisation of a 
provisional matrix
No effect on diabetic or venous 
ulcers to date




Improved healing in acute 
wounds
Pilot studies in infected diabetic foot 
ulcers encouraging
Table 2.2Growth factors, wound healing and their use in chronic ulcer treatment.
Growth factors are known to have a range of important functions to encourage normal wound healing. 
However, the beneficial effects of exogenous growth factor application to chronic wounds for therapeutic 
purposes has been limited (Harding et al, 2002).
So far, only PDGF has been licensed for use in the treatment o f uninfected 
neuropathic diabetic foot ulcers. Research also suggests that it may be o f some benefit in 
the treatment o f pressure ulcers and other nondiabetic and non-pressure-related refractory 
chronic ulcers (Harrison-Balestra et al, 2002). Although not yet licensed, granulocyte 
colony stimulating factor has been evaluated for treating infected foot ulcers in diabetic 
patients and was associated with more rapid resolution o f cellulitis and decreased 
antibiotic requirements (Gough et al, 1997). Furthermore, FGF has been assessed for 
treating pressure ulcers (Robson et al, 1992). Topical application of human recombinant- 
EGF, to patients with venous ulceration has also been attempted, but failed to significantly 
enhance re-epithelialisation o f venous ulcers (Falanga et al, 1992a). In the future, growth 
factors may be administered sequentially, in combination, or at timed intervals to more 
closely mimic the normal healing process. The diversity of growth factors and types of 
chronic wound suggest that these factors have potential as new treatments if patient’s 
individual requirements can be met (Harding et al, 2002).
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2.3.4 Skin Grafts
Over the past decade, the development o f tissue replacements has been a rapidly 
advancing aspect of wound care and a number of grafts and skin-equivalents are used in 
the treatment of chronic ulcers.
2.3.4.1 Autologous skin grafts
Venous leg ulcers have been successfully treated by autologous skin grafting 
(using a patients own skin), using split thickness and pinch skin grafting techniques. For 
successful management of pressure ulcers, both cutaneous and subcutaneous tissues need 
to be grafted, particularly over bony prominences. This is best achieved by 
fasciocutaneous or musculocutaneous flap surgery.
2.3.4.2 Bioengineered skin equivalents
Twenty years ago cultured epidermal autografts, in which a small skin biopsy 
(lcm 2) is harvested and cultured to produce large epidermal sheets, were developed to 
help treat patients with extensive bums. Unfortunately, these have had only limited 
success, due to the 3- to 4-week period required to produce sufficient amounts of skin for 
grafting, which may be too long for bums patients (Langer and Vacanti, 1993), graft 
fragility, difficulty in application, poor rate of uptake, and the frequent occurrence of 
infection (Eldad et al, 1987). However, the potential benefit o f the technology was evident 
and led to the development of skin equivalents, in which donor tissue with limited 
immunogenicity is used to construct epidermal, dermal and combined epidermal and 
dermal grafts. There are now several commercially available products (Table 2.3, Figure 
2.8 and 2.9). The relatively low direct cost of tissue replacements has made this wound 
care option increasingly popular. Bioengineered skin equivalents are absorbed into the 
wound bed and are thought to improve chronic ulcers, at least in part, by altering the 
profile of cytokines within the chronic wound. The exact method o f action however, is 
unknown. Recent studies carried out by Martin et al (2003) showed that conditioned 
media from tissue-engineered human fibroblast-derived dermis, contained potent 
angiogenic factors such as hepatocyte growth factor/scatter factor and IL-8. These findings 
may explain in part the enhanced healing seen in clinical applications of human 
fibroblast-derived dermis on chronic wounds. There still remains a need to improve 
uptake o f these grafts by improved angiogenesis and to tackle recurrent infection.
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Type of skin 
substitute
Composition Current use
Epidermal Cultured autologous epidermal cells 
Cultured allogenic epidermal cells
Used for severe bum injuries 





Acellular allogenic human skin/dermal 
matrix
Bovine collagen with chondroitin 6- 
sulphate and dermal fibroblasts 
Non-immunogenic neonatal Fibroblasts 
on nylon (polygalactin) mesh (Figure 2.8)
Approved for treating bums
Approved for treating bums
Treatment of diabetic foot 
ulceration (Gentzkow et al, 1996) of 
6 weeks or longer duration. In 
clinical trials. Also in trials for use 








Bovine collagen Type I matrix, allogenic 
human fibroblasts, and epidermal cells 
(human keratinocytes). Both fibroblasts 
and keratinocytes derived from neonatal 
foreskin (Figure 2.9).
Collagen matrix substrate with fibroblasts 
and epidermal cells 
Absorbable bovine collagen sponge 
matrix, favourable for host cell migration. 
Neonatal keratinocytes and fibroblasts, 
that secrete cytokines normally found in 
acute wounds.
Licenced for treating diabetic foot 
ulcers (Veves et al, 2001) and 
venous leg ulcers (Falanga et al, 
1998)
Trials for venous leg ulcers and 
diabetic foot ulcers.
Table 2.3 Currently available skin substitutes used in the treatment of chronic wounds.
A range of skin substitutes have been developed with varying compositions many of which have been used 
in the treatment of chronic wounds. Note. All of these products have been used to treat bums. The table was 
adapted from Harding et al (2002).
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Figure 2.8Dermagraft- Neonatal fibroblasts cultured on a polyglactin mesh.
Dermagrafit is stored frozen and warmed in saline bath before application. Edges are trimmed and applied to 
wound within ulcer boundary (U.S. Department of Health and Human Services, 2001)
Figure 2.9Apligraf- a bilayered skin equivalent.
Apligraf was developed by Organogenesis and is a cellular, bi-layered skin substitute with an upper 
epidermal layer and a lower dermal layer. There are no blood vessels, sweat glands, immune cells or 
melanocytes, however, if the bi-layer is cut, it will heal itself. Apligraf is supplied frozen, and lying on a 
culture gel (left, Copyright University o f Florida, 1998). Small slits are made in it, after which it is trimmed 
and laid onto the wound surface so that the edges overlap the ulcer edge (right).
2.3.5 Current advances for acceleration of healing
There is a strong theoretical basis to justify the further development and clinical 
evaluation of proteinase inhibitors as a means of improving the healing of chronic ulcers. 
A potent, selective inhibitor of MMP-3 has been described by Fray et al (2003) for 
possible progression into clinical trials for the topical treatment of chronic wounds. The 
progression of gene therapy may also have important benefits, allowing genes important in 
healing to be delivered directly into a wound. Interest is presently focused on vascular 
endothelial growth factor (VEGF), a key component in the promotion of angiogenesis 
(Taub et al, 2000). Studies have also shown that PDGF is stabilised by thrombospondin-1 
(TSP-1), an ECM protein that enhances the biological effects of PDGF in proliferative 
tissue repair. It is suggested that the effect of TSP-1 along with its matrix-modulating
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activities may have important clinical utility regarding topical growth factor therapy in 
wound healing, since high proteolytic activity is believed to be partially responsible for 
limiting the efficacy of this treatment (Krishnaswami et al, 2002).
Recent studies carried out by White et al (2003) have demonstrated that the human 
homeobox gene Prx-2 is strongly upregulated in fibroblasts within foetal, but not adult, 
mesenchymal tissues during healing. This gene was shown to affect a number o f foetal 
fibroblastic responses believed to be important in mediating scarless healing in vivo’, such 
as cellular proliferation, ECM reorganisation, and MMP-2 and hyaluronic acid production. 
It is hoped, that a further understanding o f these processes will enable the targeting of 
specific therapies in wound healing, both to effect scarless healing and to stimulate healing 
in chronic, nonhealing wounds. Recent developments also include the use o f bone-marrow 
derived stem cells (Badiavas et al, 2003) to heal chronic wounds. Furthermore, a potential 
treatment also lies in the development of skin replacements from embryonic stem cells. 
However, the ethical implications of using such technology will first have to be addressed.
Hyperbaric oxygen therapy, which involves placing a patient in a chamber filled 
with pure oxygen at pressures above one atmosphere, has previously shown to improve 
the oxygenation o f tissue and stimulate healing. In addition to wound hyperoxia, increased 
wound 'NO production caused by hyperbaric oxygen therapy also appears important in 
diabetic wound repair (Boykin, 2000). A systematic review of small studies suggests that 
hyperbaric oxygen may provide real benefits, for example, there appears to be a reduction 
in the risk o f major amputation diabetic patients (Roeckl-Wiedmann et al, 2005). 
Dressings are also being improved to maximise healing; for example, a novel 'NO- 
modified hydrogel has also been developed, by Masters et al (2002), to release 'NO over a 
time period of up to 48 hours, to supply the wound with therapeutic levels o f 'NO. 
Preliminary studies were carried out in a diabetic mouse model of impaired healing, 
showing similar healing to that observed in control mice. Recent therapeutic strategies 
have also included the targeting of reactive oxygen species with antioxidants, as it is 
thought that reactive oxygen species may play a role in the tissue damage due to 
prolonged inflammatory responses in chronic wounds (Dissemond et al, 2002). Studies 
have also shown that application of honey as a dressing on wounds is beneficial to wound 
healing, with claims that it reduces inflammation and infection, debrides necrotic tissue, 
reduces oedema and promotes angiogenesis, granulation and epithelialisation (Molan et al, 
2001). Maggot (larval) biotherapy seems to be effective for the debridement o f chronic 
wounds and acceleration of healing (Horobin et al, 2003). Lucilia sericata larval secretion 
has been shown to modify fibroblast adhesion and spreading across ECM protein surfaces 
(Horobin et al, 2003).
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2.3.6 The burden of chronic wounds
Chronic wounds remain a significant clinical problem as they are timeconsuming, 
expensive and difficult to treat. Complications o f lower extremity wounds are the number- 
one reason for hospitalisation of patients with diabetes and account for 1 0 % of all direct 
costs related to diabetes care (Harrington et al, 2000). As many as 15% of people with 
diabetes are thought to develop a foot ulcer in their lifetime (Harrington et al, 2000), and 
15-20% of these diabetic ulcers eventually require a lower extremity amputation (Ramsey 
et al, 1999; Ollendorf et al, 1998). Chronic ulcers are associated with morbidity and high 
treatment costs (Harrington et al, 2000; Thomas et al, 1996). Venous ulcerations of the 
lower extremities represent an increasing healthcare problem. It has been estimated that 
about 0 .1 % of the population of developed countries have venous leg ulcers and more than 
90% are over the age of 60 years (Cornwall et al, 1986; Baker et al, 1991; Nelzen et al, 
1994). Studies have calculated the cost of wounds to the NHS to be about £lbn a year 
(Harding, 2002) and the total annual cost for the treatment o f leg ulcers probably amounts 
to over 400 million pounds in the UK (Ruckley, 1997). Only about half of the patients 
heal their ulcers in a-five year period and once healed, venous ulcers often recur (Nelzen 
et al, 1994; Nelzen et al, 1997; Morrell et al, 1998). With an aging population the 
numbers of people with diabetes and associated chronic ulcers these figures are expected 




3 Introduction: An alternative approach for 
promoting the healing of chronic wounds
As previously discussed a number o f methods have been used in order to facilitate 
the correct healing o f chronic wounds. Over the last decade skin grafts and improved 
dressing have become increasingly important in the treatment o f chronic wounds and 
bums, however they also have several limitations that need to be addressed. This project 
aims to investigate the effects of reactive oxygen and nitrogen species (RONS), 
particularly those generated by xanthine oxidoreductase (XOR) on wound-related cells 
with a view to facilitate wound healing. This section reviews how RONS can affect a 
multitude of cellular and physiological processes many o f which are important to the 
wound healing process and natural antibiotic systems.
3.1 RONS involved in cellular and physiological 
processes
The study of free-radicals and their generation has continued for many decades and 
it has long been understood that free radicals have many detrimental effects such as in 
ageing, reperfusion injury and in certain forms of cancer. Their role in physiology has 
usually been seen as a pathological one, with the dogma being that radicals were so 
reactive and unselective that they could not be involved in normal biochemical processes. 
More recently an increasing body of evidence implicates a whole range o f these species in 
important cellular and physiological processes within healthy organisms including man. 
These are summarised here.
3.1.1 The major types of RONS and their generating systems in 
living organisms.
Living organisms contain many systems for both the generation and removal, 
inhibition and scavenging of reactive oxygen and nitrogen species. A complex balance 
exists in health, and imbalances can result in disease. Therefore, RONS can be both 
protective and aetiological as outlined below.
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3.1.1.1 Reactive oxygen and nitrogen species classification and 
nomenclature.
The term ROS includes both oxygen radicals and certain nonradicals that are 
oxidising agents and/or are easily converted into radicals (HOC1, HOBr, O3 , ONOCF, ]0 2 , 
H2 O2). Therefore, all oxygen radicals are ROS, but not all ROS are oxygen radicals. A 
summary of the nomenclature of reactive oxygen (ROS) and nitrogen species (RNS) and 
whether they are classed as radicals or nonradicals is provided in table 3.1.
Free radicals3 Nonradicals
Reactive oxygen species (ROS)
Superoxide, 0 2* Hydrogen peroxide, H20 2
Hydroxyl, *OH Hypobromous acid, HOBrb
Hydroperoxyl, H 0 2* Hypochlorous acid, HOClc
Peroxyl, R 0 2* Ozone 0 3
Alkoxyl, RO* Singlet oxygen ( 0 '2Ag)
Carbonate, C 03* Organic peroxides, ROOH
Carbon dioxide, C 02* Peroxynitrite, ONOO d 
Peroxynitrous acid, ONOOHd
Reactive nitrogen species (RNS)
Nitric oxide, *NO Nitrous acid, H N 02
Nitrogen dioxide, N 0 2* Nitrosyl cation, NO+
Nitroxyl anion, NO 
Dinitrogen tetroxide, N20 4 
Dinitrogen trioxide, N20 3 
Peroxynitrite, ONOO d 
Peroxynitrous acid, ONOOH 
Nitronium (nitryl) cation, N 02+ 
Alkyl peroxynitrites, ROONO 
Nitryl (nitronium) chloride, N 0 2Cle
Table 3.1Nomenclature of reactive species enzyme reactions
Peroxynitrite and H20 2 are frequently erroneously described in the literature as free radicals. RNS is also a 
collective term including nitric oxide and nitrogen dioxide radicals, as well as nonradicals such as H N 02 and 
N20 4. ‘Reactive’ is not always an appropriate term: H20 2, ‘NO and 0 2*“ react quickly with only a few 
molecules, whereas *OH reacts quickly with almost everything. R 0 2\  R O \ HOC1, HOBr, N 0 2*, ONOO”, 
N 0 2+ and 0 3 have intermediate reactivites.
aA free radical is any species that contains one or more unpaired electrons, that is, electrons singly
occupying anatomic or molecular orbital.
bHOBr could also be regarded as a ‘reactive bromine species’.
cHOCl can also be refered to as a reactive chlorine species.
dONOO” and ONOOH are often included as ROS.
eN 0 2Cl is a chlorinating and nitrating species that can be formed by reaction of HOC1 with N 0 2 .
(Table modified from Halliwell and Whiteman, 2004).
41
3 . 1 .1 . 2  P h y s i o l o g i c a l  R O S  g e n e r a t i n g  s y s t e m s
The superoxide anion is formed by the reduction of molecular oxygen and is 
mediated by enzymes such as Nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidases, xanthine oxidase or nonenzymatically by redox-reactive compounds such as the 
semi-ubiquinone compound of the mitochondrial electron transport chain. Superoxide 
dismutases (SODs) convert O2*- enzymatically into H2O2 . In biological tissues O2*” can 
also be converted nonenzymatically into H2O2 and singlet oxygen. In the presence of 
reduced transition metals (e.g., ferrous or cuprous ions), H2O2 can be converted into the 
highly reactive hydroxyl radical (*OH). Alternatively, H2O2 may be converted into water 
by the enzymes catalase or glutathione peroxidase (Figure 3.1). In animal cells catalase is 
located in a cell organelle called the peroxisome. Peroxisomes are involved in the 
oxidation of fatty acids, and the synthesis of cholesterol and bile acids. Hydrogen peroxide 
is a by product of fatty acid oxidation.
Because O2 *” and *NO are readily converted by enzymes or nonenzymatic 
chemical reactions into nonradical species such as singlet oxygen, H2O2 , or ONOO" i.e., 
species which can in turn give rise to new radicals, the regulatory effects of these 
nonradical species have also been included. Most of the regulatory effects are indeed not 
directly mediated by O2 *” but rather by its reactive oxygen species (ROS) derivatives. 
Frequently, different reactive species coexist in the reactive environment and make it 














Figure 3.1 Pathways of reactive oxygen species (ROS) production and clearance in biological systems.
GSH, glutathione; GSSG glutathione disulfide (adapted from Droge, 2002).
3 . 1 .1 . 3  P h y s i o l o g i c a l  R N S  g e n e r a t i n g  s y s t e m s
It is generally accepted that the physiological source of Nitric oxide (*NO) in 
higher organisms is by the oxidative deamination of L-arginine. This process is catalysed
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by Nitric oxide synthase (NOS), a complex enzyme which is dependent on the availability 
of oxygen for its activity. Nitric oxide is generated by a variety of cell types, including 
endothelial cells (Palmer et al, 1987), hepatocytes (Curran et al, 1989), neurons 
(Garthwaite et al, 1988), neutrophils (Schmidt et al, 1989) and macrophages (Hibbs et al, 
1987). Nitric oxide has been shown to be generated by macrophages that have been 
stimulated by interferon gamma and E. coli lipopolysaccharide (Marietta et al, 1988). 
Depending on the microenvironment, *NO can be converted to various other reactive 
nitrogen species (RNS) such as nitrosyl cation (NO+), nitroxyl anion (NO-) or 
peroxynitrite (ONOO-). Some of the effects may be mediated through the intermediate 
formation of S'-nitroso-cysteine or S-nitro-glutathione (Droge, 2002).
3.1.2 The role of RONS in physiological systems
As previously stated, RONS are implicated in numerous systems which control 
physiological mechanisms in the body. Studies suggest that a physiological rate of ROS 
production activates signalling pathways necessary for cell growth and proliferation while 
an excessive production of ROS, overmatching the antioxidant capacities o f the cell, leads 
to an oxidative stress that results in metabolic disturbances and cell death. With relevance 
to this thesis the role of RONS in wound healing with particular emphasis on their role in 
cellular proliferation and their antibacterial properties will be discussed.
3.1.2.1 ROS and cell proliferation
A range of mechanisms have been proposed whereby O2 ’- and H2O2 , both from 
exogenous sources or generated celullarly, can influence cell proliferation and possibly 
function as cellular “messengers” along with the possibility o f cellular oxidative stress that 
may occur if  these species are present to excess (Burdon, 1995). A wide variety of normal 
cell types generate and release (V - or H2O2 in vitro either in response to specific 
cytokine/growth factor stimulus or constitutively in the case of tumour cells. Expression of 
NADPH oxidase and low O2 ’- generation (approx 0.06 nmol/min per 106 cells) by 
cytokine- or ionophore-stimulated human fibroblasts is known. Studies have also shown 
that these cells also contain an ectoplasmic enzyme, distinct from NADPH oxidase, which 
can generate O2 *- (2.10±0.14 nmol/min per 1 0 6 cells) at levels similar to phorbol ester- 
stimulated monocytes on exogenous NADH stimulation. These species at submicromolar 
levels appear to act as intra and intercellular ‘messengers’ capable of promoting growth 
responses in culture.
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3.1.2.1.1 Regulation of cell division in mammals
Proliferation occurs by cell division, and for this to take place, a cell must double 
its mass and duplicate all its components (Pardee, 1989; Laskey et al, 1989). Most of these 
processes take place during the period between cell division known as interphase. Within 
interphase there is a specific period during which time DNA is replicated. This is refered 
to as the S-phase (Laskey et al, 1989). Present evidence suggests that the growth regulated 
biochemical events critical for cell proliferation to occur in the period between mitotic 
division and the S-phase known as the G]-phase. The G]/S transition is the boundary prior 
to DNA replication and is a key regulatory point in the cell division cycle. The cells o f an 
organism divide at very different rates, the major difference being the time they spend in 
Gi. Cells that are quiescent are essentially arrested in G1 and are often referred to as being 
in the Go -phase.
3.1.2.1.2 Mechanism of action
ROS are able to elicit signal transduction events, such as protein tyrosine 
phosphorylation and early gene activation reminiscent of cell stimulation by growth 
factors (Devary et al, 1992). More importantly, “traditional” proliferative signals, such as 
those delivered by the activation of growth factor receptors and G-proteins of the Ras 
family, are accompanied by intracellular production o f endogenous oxygen species, which 
are, in turn, necessary for downstream propagation o f mitogenic signalling. In fact, ROS 
and H2O2 , in particular, have been convincingly shown to operate as key signalling 
molecules in the cascades triggered by PDGF (Sundaresan et al, 1995), EGF (Bae et al, 
1997), and cytokine and antigen receptors (Pani et al, 2000) and to be required for 
proliferative response to oncogenic Ras (Irani et al, 1997).
The mechanisms by which ROS act may involve direct interaction with specific
receptors or oxidation of growth signal transduction molecules such as protein kinases,
protein phosphatases, transcription factors, or transcription factor inhibitors. It is also
possible that H2O2 may modulate the redox state and activity o f these important signal
transduction proteins indirectly through changes in cellular levels of GSH and GSSG. The
effects of ROS essentially depend on the overall redox status of the cell that is crucial for
the activity o f nuclear transcription factors (Xanthoudakis et al, 1992), and signaling of
proliferation or death (Kamata and Hirata, 1999; McCord, 1985). In mammals, these
ambivalent signals are mediated by three subgroups of mitogen-activated kinases
(MAPKs): ERKs (extracellular signal regulated kinases), JNKs (c-jun N-terminal
Kinases), and p38 MAPKs. The ERK pathway plays a major role in regulating cell growth
and differentiation in response to growth factors, cytokines and phorbol esters (Robinson
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and Cobb, 1997). JNKs and p38 MAPKs, described as SAPKs (Stress activating Protein 
Kinase), are involved in stress responses and cell death (Kyriakis and Avruch, 2001). The 
pro-apoptotic effect of JNK results probably from the inhibition of anti-apoptotic 
molecules such as Bcl2 and NF-kB (Deng et al, 2001; Baichwal and Baeuerle, 1997). In 
normal cells, persistant ROS production leads to activation of the JNK pathway, and 
apoptosis, whereas low concentrations or transiently high levels of ROS induce the 
proliferation of normal cells through activation of the ERK pathway (Nicco et al, 2005).
Cytokines

























STAT NF-kB AP-1 Gene
Transcription
Figure 3.2. Reactive oxygen species control over gene expression.
Intracellular ROS signal changes in gene expression via redox-sensitive signal transducers, a group made up 
of monomeric G-proteins (Ras and Rac), protein kinase C (PKC), the ratio o f GSH and GSSG, and 
thioredoxin. ROS species promote nuclear translocation and binding o f STAT (Signal Transducers and 
Activators of Transcription) to promoter elements. N F -kB is usually maintained in the cytoplasm in an 
inactive form by the association of the inhibitory factor I-kB. Upon stimulation I-kB dissociates and active 
N F -kB translocates to the nucleus. N F -kB activation is modulated by glutathione, thioredoxin and PKC. The
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AP-1 transcription factor is composed of a Jun and Fos heterodimer. AP-1 is activated by three MAP Kinase 
pathways that regulate the transcription of jun  and fos, and phosphorylate these proteins. The three 
transcription factors STAT, NF-kB, and AP-1 may act independently or cooperatively for the activation 
transcription of genes. The STAT transcription factor for example, is involved in regulating many aspects of 
cell growth differentiation and survival (Adapted from Lum and Roebuck, 2001).
3.1.2.2 Nitric oxide in wound healing
Nitric oxide is a small molecule o f diverse function and profound importance in 
biological systems, at low levels ‘NO is a key signalling molecule in eukaryotes (Robbins 
and Grisham, 1997). Nitric oxide is well known for mediating the relaxation of smooth 
muscle in vasodilation, inhibition of platelet aggregation and adhesion and angiogenesis. 
Evidence clearly implicates ‘NO in the wound healing process. Several studies have 
suggested an association between decreased ‘NO production and delayed wound healing 
(Stallmeyer et al, 1999; Schaffer et al, 1997a). Healing is impaired during systemic 
administration of ‘NO synthesis inhibitors (Schaffer et al, 1996) and in inducible nitric 
oxide synthase (iNOS) knockout mice. Studies using iNOS knockout mice showed that 
cutaneous wound closure was delayed after wounding, and that the effect could be 
reversed by the delivery of the iNOS gene by an adenoviral vector at the wound site 
(Yamasaki et al, 1998). The impaired wound healing common in people with diabetes has 
also shown to be associated with reduced wound ‘NO synthesis at the wound site (Schaffer 
et al, 1997b).
As mentioned previously, L-arginine, has been shown to be a unique substrate for 
‘NO synthesis, and is therefore indirectly involved in many regulatory mechanisms 
relevant to wound healing, such as angiogenesis and cell proliferation (Schwentker et al, 
2002). Supplemental L-arginine has been shown to improve healing in both animal and 
human wounds (Barbul et al, 1990 and 1985; Seifter et al, 1978; Holt et al, 1992). 
Furthermore, data show that the impaired healing o f diabetic wounds can be partially 
corrected by L-arginine supplementation, and that this effect is accompanied by enhanced 
wound ‘NO synthesis (Shi et al, 2003). Examination of the influence of arginine dietary 
supplements has also suggested that their beneficial effects are lost in mice without the 
iNOS gene (Shi et al, 2000).
Numerous compounds that spontaneously produce ‘NO under physiologic 
conditions (‘NO donors) have been identified. The exogenously applied ‘NO donors 
mimic the normal biologic functions o f endogenous ‘NO. Several classes of ‘NO donor 
exist, including S-nitrosothiols (Butler and Rhodes, 1997) and ‘NO-nucleophile complexes 
(NONOates or diazeniumdiolates) (Maragos et al, 1991; Keefer et al, 2001). For example, 
exogenous ‘NO supplementation at the wound site by an ‘NO donor (molsidomine) is also 
known to partly reverse impaired healing in diabetes. Additionally, direct generation of
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'NO via a chemical reaction between sodium nitrite and ascorbic acid can stimulate 
vasodilation in healthy skin when applied through a gas permeable membrane. However, 
the duration o f the 'NO release and the dose control was limited in this system. Materials 
that are suitable for prolonged, localised 'NO release at the site of a dermal wound are still 
under development. A polethyleneimine (PEI)-nitric oxide donor that was applied to full­
thickness wounds in aged rats did not favourably affect the wound healing process (Bauer 
et al, 1998). Wounds to which PEI or PEI-'NO were applied experienced impaired wound 
healing when compared to untreated wounds, indicating that PEI itself may contribute to 
dermal toxicity and failure to enhance wound healing. Sustained delivery of an elevated 
and prolonged dose of 'NO well beyond physiological levels also resulted in increased 
inflammation in the PEI-'NO treated wounds. Physiologically relevant levels of 'NO at the 
wound site have been shown to have beneficial effects on wound healing. Studies carried 
out by Masters et al (2002) using hydrogel dressings supplemented with low 0.5mM and 
high 5mM doses o f 'NO, showed no alteration in fibroblast proliferation, however, In vitro 
studies o f fibroblasts in culture with the 'NO hydrogels where also shown to have an 
increased production of ECM. In addition, preliminary studies carried out in a diabetic 
mouse showed increased thickness o f granulation and scar tissue in animals exposed to 
higher dose 'NO suggesting that endothelial cell migration and angiogenesis may be 
increased. Therefore, rather than accelerating wound closure, 'NO in this study appears to 
improve the quality of the tissue in the healing wound. When considering wounds that do 
not remain healed, the formation of scar and granulation tissue may play an important role 
in creating a more mechanically stable wound. Similar findings have been reported in 
studies examining the effect o f growth factors on wound healing in animals such as 
PDGF-BB (LeGrand, 1998).
3.1.2.2.1 Modes of action of nitric oxide in wound healing
Nitric oxide acts as a cellular messenger and is known to directly regulate the 
expression and activity o f several transcription factors, including NF-kB, which in turn 
modulate the synthesis and release o f multiple wound healing-participating 
cytokines/proteins. It is thought that 'NO functions via multiple mechanisms to improve 
wound healing including vasodilation, antibacterial activity, increased cell proliferation, 
migration via up-regulation of growth factors and receptors, and up-regulation of matrix 
synthesis. The well-known and vasodilatory and antibacterial action of'N O  is likely to be 
important in the process of wound healing, particularly because vasodilation increases 
blood flow in the microvasculature, thus facilitating the delivery o f both nutrients and 
cells to the site of injury. During the early post injury stages, 'NO may act to prevent
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infection, thereby also preventing excess inflammation. Nitric oxide is thought to 
encourage fibroblast and keratinocyte migration via growth factor up-regulation (Frank et 
al, 1999; Reenstra et al, 2004). Nitric oxide and cyclic guanosine monophosphate (cGMP) 
have been shown to promote growth factor induced DNA synthesis in human dermal 
fibroblasts, suggesting another possible mechanism by which ’NO may promote skin 
wound healing (Dhaunsi and Ozand, 2004). Particularly as similar improvements in 
wound healing appear to occur following application o f either growth factors or ‘NO and it 
is thought to be attributed to their interrelated mechanisms of action. For example, a 
proposed mechanism for impaired healing in diabetic patients is reduced fibroblast 
proliferation caused by impaired growth factor expression (Reenstra et al, 2004). These 
linked growth factor-’NO mechanisms may also affect other cells important in wound 
healing such as endothelial cells and keratinocytes, and some studies have suggested that 
growth o f the latter cell type is modulated by ’NO in a manner similar to that observed in 
fibroblasts (Krischel et al, 1998, Wetzler et al, 2000). Reports of the effects of 'NO on 
keratinocytes are conflicting because inflammatory stimuli have been implicated for 
induction of ’NO production by keratinocytes via iNOS and, conversely, EGF, which 
promotes the proliferation of keratinocytes, suppresses the production of ’NO by an 
unknown mechanism (Heck et al, 1992).
Expression of ’NO by macrophages and other cell types has been shown to be 
important in regulation of their angiogenic activity, specifically by enhancing the 
expression o f VEGF (Xiong et al, 1998; Frank et al, 1999). Additionally, the importance 
of ’NO in wound angiogenesis has been shown by examining the impaired wound healing 
in endothelial nitric oxide synthase (eNOS)-deficient mice (Lee et al, 1999). In vitro 
endothelial cell sprouting assays showed that eNOS is required for proper endothelial cell 
migration, proliferation, and differentiation. Furthermore, angiogenesis was significantly 
reduced in vivo in eNOS knockout mice compared to wild-type controls. Inhibition of  
angiogenesis and inability to provide sufficient nutrients to the wound site are described as 
primary reasons for the development o f chronic wounds (Iocono et al, 1998). 
Angiogenesis is severely impaired in diabetics, contributing to the inability of diabetic 
ulcers to heal properly.
One of the most significant positive effects attributed to ’NO is increased collagen
production, which enhances the quality o f granulation tissue and can increase wound
strength (Witte et al, 2000; Thornton et al, 1998; Schaffer et al, 1997a; Lee et al, 1999).
Studies have shown that increased ’NO synthesis in vivo, enhances collagen synthesis by
wound fibroblasts, and cells transfected with the iNOS gene, and implanted
subcutaneously, result in increased collagen accumulation in rats (Witte et al, 2000;
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Thornton et al, 1998). Conversely, inhibition o f ’NO synthesis by competitive inhibitors, 
results in decreased wound mechanical strength and collagen accumulation (Schaffer et al, 
1997a and 1996). Furthermore, Lee et al (1999) observed a 38% decrease in wound tensile 
strength in mice deficient in eNOS when compared to wild-type controls.
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Figure 3.3 A summary of the roles of *NO in wound healing
Nitric oxide has a wide variety of functions which form an essential part of the wound healing processes. 
Other activities include antimicrobial activities which are covered in the next section.
3 . 1 .2 . 3  T h e  d a m a g i n g  e f f e c t s  o f  R O N S  w i t h  e m p h a s i s  o n  t h e i r
a n t i b a c t e r i a l  r o l e
Free radicals have previously been implicated in bacterial cytotoxicity (Akaike et 
al, 1992; Bowdy et al, 1990; Pabst et al, 1982) and especially in the respiratory burst of 
macrophages and neutrophils (Morel et al, 1991; Miller and Britigan, 1997; Hampton et 
al, 1998). The range and variety spans singlet oxygen and O2 *” from the oxidation of 
NADPH in the neutrophil membrane to the generation of “bleach” in hypochlorous acid 
generation by myeloperoxidase in phagosomes within a restricted environment (Byun et 
al, 1999; Saran et al, 1999). Inflammatory situations and bacterial infections, which are 
rich in exuded inflammatory cells, contain a range of free-radical generating systems in 
the form of activated cells. The macrophage has also been shown to generate oxygen 
radicals under resting conditions and following phagocytosis (Drath and Kamowsky 1975; 
Kamowsky et al, 1975). Extracellular 02*” generation is primarily associated with 
phagocyte defence against disease. In both neutrophils and monocytes this is 
accomplished by a trans-plasma-membrane enzyme, NADPH oxidase, which oxidises
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intracellular NADPH via flavin adenine dinucleotide (FAD) and cytochrome 6 .2 4 5  and 
reduces oxygen on the outer surface to form O2 ’”. Studies carried out by Takeuchi et al 
(1999) have also shown that H2O2 results in oxidative DNA damage and decreased 
survival o f strictly anaerobic Prevotella. melaninogenica as found in chronic wounds.
Nitric oxide at elevated concentrations inhibits terminal oxidases (Stevanin et al, 
2000) and aconitases (Gardner et al, 1997) and therefore is also a potent bactericidal agent 
that may limit the persistence of bacteria in a number o f different environments. Long et al 
(1999) demonstrated the mycobacteriocidal actions o f exogenous 'NO treatment and 
suggested this as a possible therapy in patients with pulmonary tuberculosis. Intragastric 
levels of *NO have been measured to be between 10 and lOOppm and this is suggested as 
having biological effect in the stomach (Weitzeberg and Lundberg, 1998). Acidified nitrite 
which generates ’NO has also been shown to kill various gut pathogens much more 
efficiently than acid alone (Benjamin et al, 1994; Dykhuizen et al, 1996). Nitrates are 
generally excreted in the urine at higher concentrations compared to the low level of 
measurable nitrites (Green et al, 1981). However bacteria that cause urinary tract 
infections (UTIs) may convert nitrate to nitrite using a nitrate reductase enzyme and the 
detection o f nitrite in the urine has been used for a diagnostic tool for UTIs. Acidification 
and vitamin C intake have been used as treatment against UTIs (Weitzeberg and 
Lundberg, 1998).
Reactions and effects that were once attributed to either ’NO or (V" have had to be 
reassessed. The evidence comes from the combination o f the radicals forming the strong 
oxidant ONOO" (Beckman et al, 1990; Beckman and Koppemol, 1996). In many 
pathological conditions (including inflammation, sepsis, and ischemia/ reperfusion), 
simultaneous cellular production o f O2 *" and ’NO may occur, from various sources 
potentially leading to the formation of ONOO". The biological formation of ONOO" is 
mainly due to the diffusion-limited reaction between ’NO and O2 *”, a reaction that occurs 
with a second order rate constant o f approximately 1 x 1010 M ' 1 S’ 1 (Radi et al, 2001). This 
reaction leads to the modulation o f the effect of each individual radical. For example, O2 ’" 
can reduce the effects o f ’NO by causing the generation o f ONOO" (Rubbo et al, 1994). In 
the same manner the capture of 0 2 *" by ’NO has been suggested as the modification of 
actions previously described for 0 2 ’" alone (Bautista and Spitzer, 1994; Wink et al, 1994).
Peroxynitrite is a potent and versatile oxidant with strong oxidising, nitrating and
hydroxylating properties that can inflict damage on a wide range o f biological molecules.
The peroxynitrite anion has a pKa of 6 . 8  and is relatively stable under these basic
conditions. However ONOO" is protonated (around 20%) at a physiological pH, and under
these conditions, the half-life of the protonated species, peroxynitrous acid, is about 1
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second. Peroxynitrous acid decomposes to form potent oxidants with the reactivity of  
hydroxyl radical and nitrogen dioxide (Beckman et al, 1990). Such damage is mediated 
through the oxidation of sulphydryl compounds, lipids, proteins and DNA, leading to 
cellular damage and cytotoxity. Reaction with DNA can lead to oxidation and/or nitration 
of bases to initiate a complex series of transformations involving base damage or strand 
breaks as well as reactions with the deoxyribose portion o f the DNA. Following strand 
breakage a secondary effect has been suggested involving the activation of the nuclear 
enzyme poly(ADP-ribose) synthetase (PARS) and apoptosis. Single (not double) strand 
breakage is an obligatory signal for PARS activation. PARS causes the ADP-ribosylation 
of a number o f important proteins involved in repair including topoisomerase I and II, 
DNA polymerase a  and p and DNA ligase 2. This ribosilation tends to decrease their 
activity and therefore has an effect on the cell function (Szabo et al, 1996). Activation of 
PARS can also deplete cell energy stores by using up the electron transport substrate, 
NAD+, which can then go on to cause acute cell dysfunction. Peroxynitrite can also nitrate 
tyrosine residues in cellular proteins forming nitro-tyrosine (Beckman and Koppemol, 
1996; Radi et al, 2001; Brunelli et al, 1995).
As a result of these effects on cell function ONOO" is powerfully cytotoxic, 
contributing to tissue injury in a variety of human diseases that include atherosclerosis, 
heart disease and a number o f neurodegenerative disorders. In addition, peroxynitrite has 
also been shown to be formed by macrophages during bacterial engulfment (Ischiropoulos 
et al, 1992) and to function as a powerful bactericidal agent (Zhu et al, 1992; Brunelli et 
al, 1995). Peroxynitrite has been found to be toxic to common infective bacteria (Brunelli 
et al, 1995; Millar et al, 2002). Studies carried out by Motohashi and Saito (2002) showed 
that ONOO", generated gradually from SIN-1, penetrates through the cell membrane of 
Salmonella typhimurium, damages the DNA and induces the SOS response. The SOS 
response is an inducible DNA repair system that allows bacteria to survive sudden 
increases in DNA damage. Figure 3.4 outlines the generation and cellular and 
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Figure 3.4The physiological effects o f ‘NO and ONOO" generation.
Nitric oxide synthase (NOS) converts L-arginine to ‘NO which is responsible for a variety o f cellular effects 
which are discussed above. Nitric oxide also binds to the enzyme guanylate cyclase (GC) which results in 
GC activation. Activated GC cleaves two phosphate groups from the compound Guanylate triphosphate 
(GTP) to form Cyclic guanosine monophosphate (cGMP) which is used to phosphorylate proteins including 
the smooth muscle contractile protein called myosin resulting in relaxation and increased blood flow in the 
vessel exposed to ‘NO. Signalling by cGMP is mediated by three cGMP effector molecules, protein kinase G 
(PKG), cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE) and cGMP-gated ion channels. 
cGMP-PDE degrades cGMP. Cyclic guanosine monophosphate is also involved in signal transduction in the 
nervous system and inhibition of platelet aggregation. Nitric oxide and 0 2‘” rapidly react to form ONOO” 
which can result in a number of damaging cellular effects. NP-SH also stands for non protein thiol damage. 
For example the damage o f glutathione which maintains the intracellular redox state. EC = Endothelial cell.
3.2 Xanthine Oxidoreductase (XOR)
XOR activity was first measured in bovine milk, by Schardinger in 1902, when 
investigating the hydroxylation of hypoxanthine to xanthine. Research has since shown 
XOR to belong to a group of proteins known as oxidoreductases. This refers to the redox 
activity of the enzyme and the fact that the enzyme can function with a range of substrates 
to yield a range of products over a variety of environmental conditions. The enzyme is a 
homodimer of 150kDa subunits and exists in two interconvertable forms, xanthine
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dehydrogenase (XDH) and xanthine oxidase (XO). XDH preferentially reduces NAD+, 
whereas XO does not reduce NAD+, preferring molecular oxygen. XDH and XO are often 
cumulatively referred to as Xanthine oxidoreductase (XOR).
3.2.1 Distribution and activity of XOR with particular reference 
to the skin
XOR has been isolated from a range o f species and tissues and shows a diversity of 
activities to certain substrates. The bovine milk enzyme is the most commonly studied and 
differs from certain sources of the human enzyme in the rate at which it catalyses purines 
(Parks and Granger, 1986). These investigators showed that the human heart enzyme had 
reduced activity towards purines whereas the liver enzyme displayed similar activity to 
that of bovine milk.
The presence of XOR is variable within different tissues o f a specific species and 
between species. Histochemistry of laboratory rodents in a study carried out by Gossrau et 
al (1990), showed epithelial cells of a wide range of external and internal surface epithelia, 
including stratified squamous epithelia of skin, to contain highly a effective XOR and 
SOD system. It was hypothesised that this system may have a general antimicrobial 
function. Studies have also shown XOR activity to be significantly increased in the distal 
end o f ischaemic skin flaps after 1 hour and that activity remained elevated at 6  hours. 
Allopurinol also significantly reduced neutrophil concentrations at the distal ends of skin 
flaps suggesting that XOR activity is associated with an increase in neutrophils. 
Allopurinol was also found to reduce skin necrosis (Rees et al, 1994). The average human 
plasma activity o f XO is reported to be 2.1 ±0.8 (xlO' 3 U ml'1) (Liu et al, 2003).
Furthermore, in a study carried out by Picard-Ami et al (1991) activity o f XOR 
was measured after varying intervals of ischaemia and in rats following reperfusion. 
Control pig and human skin were found to contain minimal enzyme activity, almost 40 
times less than that o f the rat. In the rat, XOR activity was stable throughout a prolonged 
period o f ischaemia, and a significant decrease in activity was found after 1 2  hours of 
reperfusion. In humans XOR activity was unaffected by ischaemia time, and in the pig, it 
did not increase until 24 hours of ischaemia.
3.2.2 Enzyme structure
Xanthine Oxidoreductase exists as a homodimer containing three redox centres 
namely the molybdopterin cofactor centre, the FAD centre and the iron-sulphur centre.
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3.2.2.1 Molybdopterin cofactor centre
Xanthine oxidase belongs to a group of mononuclear molybdenum enzymes that 
possess, at their active site, a molybdopterin cofactor (MO) that is essential for activity 
(Hille, 1996). Molybdenum is incorporated into proteins as the molybdenum cofactor that 
contains a mononuclear molybdenum atom coordinated to the sulphur atoms of a pterin 
derivative named molybdopterin. Molybdenum-cofactor-containing enzymes catalyze the 
transfer of an oxygen atom, ultimately derived from or incorporated into water, to or from 
a substrate in a two-electron redox reaction (Kisker et al, 1997). In 1996 Hille suggested 
that the reason for the possession o f pterin cofactor to be the provision o f a method by 
which electrons can be shuttled away from the molybdenum active site to allow a more 
rapid turnover and modulation o f the molybdenum reduction potential. The molybdopterin 
cofactor known to be the site at which the purine substrates xanthine and hypoxanthine are 
oxidised to urate and xanthine respectively in the presence of oxygen as an electron 
acceptor.
3.2.2.2 FAD centre
Purified XO occurs as a brown solution which is due to the presence of a flavin 
moiety which is known as flavin adenine dinucleotide (FAD) (Ball, 1939; Corran et al, 
1939). Flavin is known to be important for enzyme turnover and the generation of 0 2 *". In 
the absence of oxygen and any other oxidising substrate the enzyme will gain electrons 
from hydroxylation of a purine substrate. This enzyme will now not be able to turnover as 
it is loaded with electrons and cannot return to the oxidised state without passing them on 
to an acceptor substrate. Oxygen has been shown to accept electrons from the electron rich 
enzyme with the formation of 0 2 *". This allows the turnover of the enzyme to carry out 
further hydroxylations of purine substrates. Oxygen is supposed to bind and receive its 
electrons from the flavin thus allowing further turnover of the enzyme by utilising a 
second site removed from the molybdopterin.
The flavin is the apparent site at which NADH will donate electrons and cause the 
generation of NAD+. The electron-rich enzyme again in the presence o f oxygen will give 
up its electrons to generate 0 2 *" radical and allow further turnover of the enzyme. The 
flavin specific inhibitor Diphenyliodonium (DPI) has been shown to inhibit the oxidation 
of NADH to NAD+ by XO and also therefore to inhibit the production of O2 *" radical by 
the same means o f denying the enzyme electrons (Sanders et al, 1997).
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3.2.2.3 Iron-sulphur centre
Iron is also required for the activity o f xanthine oxidation (Richert and Westerfeld, 
1954; Palmer et al, 1964). Studies by Palmer in 1964, also suggest that the iron is reduced 
from a ferrous to a ferric state during enzyme turnover. Furthermore, studies carried out by 
Bray and colleagues (1961), used Electron spin resonance (EPR) techniques to show a 
paramagnetic signal from resting XO enzyme occurred following those attributable to MO 
and FAD and therefore suggesting an involvement in electron transport mechanisms that 
were carried out in this order. Studies carried out by Lowe et al (1972) have attributed this 
iron signal to an iron sulphur moiety (Fe-S).
3.2.3 Superoxide generation by XOR
XOR participates in a range of reactions and is particularly well known for its role 
in purine metabolism. Figure 3.5 below details the oxidation o f hypoxanthine to xanthine 
and xanthine to uric acid by XOR with the associated cofactors and products. When XOR 
catalyzes the aerobic oxidation o f xanthine, it generates an unstable reduced form of  
oxygen, the superoxide anion, and it is this radical that directly reduces cytochrome c 
(McCord and Fridovich, 1968).
H2O + O2 O2 H2O + O2 O2
Hypoxanthine XOR < y  ^ Xanthine XOR s  ^ Urate
( 1) (2)
Figure 3.5 XOR-catalysed superoxide generation.
XOR-catalyses the oxidation of the purine substrates hypoxanthine to xanthine (1) and xanthine to urate (2). 
In the presence of oxygen the electrons donated to XOR from the oxidation of these substrates are used to 
reduce molecular oxygen resulting in the formation of 0 2'~.
These reactions can be inhibited by blocking the molybdenum centre o f the 
enzyme with purine analogues such as allopurinol and oxypurinol. This reaction occurs in 
the presence of oxygen as the electron acceptor and is rate dependent on its concentration 
(Fridovich and Handler, 1962). The Michaelis constant (Km) for xanthine and 
hypoxanthine are ~ 6 pM under room air conditions and the Km for oxygen reduction was 
27pM and 800jllM for the reduction of cytochrome c (Fridovich and Handler, 1962).
The oxidation of NADH to NAD+ is shown in figure 3.6 with the electron again 
being given to oxygen to produce CV-. This reaction is not affected by the molybdenum 
site inhibitors allopurinol and oxypurinol in the presence o f oxygen but is inhibited by
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NAD+ and also by the FAD specific inhibitor diphenyliodonium (DPI) (Sanders et al, 
1997). The Km for the oxidation of NADH in both bovine-derived and human milk 
enzymes was calculated by Sanders et al (1997), to be 1.23 and 0.597pM respectively. 
This reaction was dependent on the availability of oxygen in the absence of any other 
electron acceptor. The Km for oxygen utilisation in this system was not been calculated but 
it was suggested, by Sanders et al (1997), that NADH oxidation was linearly increased 
over the physiological range in the absence o f other electron acceptors.
Figure 3.6XOR-catalysed superoxide generation.
3.2.4 Nitric oxide generation by XOR
In 1997 work carried out by Millar et al, provided the first description o f the 
nitrate and nitrite reductase activities of XO with 'NO as the end product. Furthermore, 
under hypoxic conditions and in the presence of NADH or hypoxanthine, XOR is capable 
of catalysing the reduction of organic and inorganic nitrates and nitrites to *NO (Millar et 
al, 1998).
With conditions occurring during ischaemia, myocardial XO and nitrate levels 
were determined to generate up to 20pM nitrite within 10-20min that can be further 
reduced to *NO with rates comparable to those of maximally activated NOS. Thus, XO 
catalyzed nitrate reduction to nitrite and *NO occurs and can be an important source of 
‘NO production in ischaemic tissues (Li et al, 2003). The pH dependence of nitrite and 
‘NO formation also indicate that XO-mediated nitrate reduction occurs via an acid 
catalysed mechanism. Based on work carried out in our group, it has also been proposed 
that XO, abundant in milk, serves to sterilise the neonatal gut by way of ‘NO production 
(Stevens et al, 2000).















Figure 3.7 A schematic diagram showing XOR-catalysed reduction of nitrates and nitrites.
Under anaerobic conditions, organic nitrates are reduced at the FAD site to inorganic nitrite, which can itself 
be subsequently further reduced to 'NO at the MO site. Organic nitrites are similarly reduced at FAD, in this 
case directly to 'NO. In contrast to organic nitrites but similarly to in organic nitrites, inorganic nitrates are 
reduced at MO.
3.2.5 Peroxynitrite generation by XOR
It is known, that whatever the origin, *NO and (V - react rapidly to form ONOO" 
which is a powerful and destructive oxidant (Saran and Bors, 1990). As discussed, XO is 
capable of producing both 'NO and 02*" simultaneously and it has been shown that 
ONOO" can be produced by XO itself (Godber et al, 2000b). Superoxide is generated by 
donation of electrons from the substrates, such as xanthine or NADH, to oxygen. 
Production of 'NO from nitrite reduction by electrons derived from NADH or xanthine. 
Nitric oxide is produced in the absence of oxygen but as oxygen concentrations increase, 
the two electrons donated to the enzyme per xanthine can be split to reduce, by one 
electron reductions, both oxygen and nitrite. Simultaneous generation of 'NO and 02*~ 
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Figure 3.8 XOR-catalysed peroxynitrite generation.
Under hypoxic conditions, XOR can generate ‘NO; however, if  0 2 concentrations rise to around 70 
pM/about 50mmHg (Millar unpublished data), pairs o f electrons derived from either hypoxanthine, 
xanthine, or NADH, can be used to reduce nitrite or 0 2 (the preferred substrate), therefore generating ’NO 
and 0 2*~, respectively. ‘NO and 0 2"  can react together forming ONOO” (Huie and Padmaja, 1993).
3 .2 .5 .1  R o l e s  f o r  t h e  X O R - c a t a l y s e d  g e n e r a t i o n  o f  R O N S
Reactive oxygen species have been long recognised as important mediators of 
inflammation, injury, and cell death. Xanthine oxidase is traditionally thought to be an 
important source of free radical-induced cellular injury and is implicated as a key enzyme 
contributing to ischaemia-reperfusion injury (Parks and Granger, 1998). However, over 
the last ten years, there has been accumulating evidence of the advantageous biological 
effects of both ROS and RNS. It is known that XOR has bactericidal properties in the 
presence of hypoxanthine and is activated in response to bacterial infection in vivo 
(Tubaro et al, 1980). In the presence of nitrite, ONOO- can be generated by XOR alone. 
This may also explain the presence of XOR in milk with a possible role in sterilisation of 
the neonatal gut. The enzyme is upregulated by proinflammatory cytokines and is thought 
to have a defensive role due to its production of ROS. In 1997 Umezawa et al, carried out 
studies in mice, looking at induction of *NO and XOR in response to Salmonella 
typhimurium infection and showed that mortality rates where improved by XOR 
inhibitors. XOR is also known for its affinity for acidic polysaccarides (Adachi et al, 
1993), such as occur in many bacterial capsules (Harrison, 2002). The optimal pH for 
anaerobic XOR-catalysed generation of ‘NO in the presence of xanthine is pH 6 or less 
(Godber et al, 2000b). XOR-catalysed production of ‘NO, a prerequisite for ONOO-
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generation, was shown to occur at maximal rates of approximately lpmol min"1 mg'1, 
significant in physiological terms. Km values for nitrite were, however, in the millimolar 
range (Godber et al, 2000b); levels that would have to be obtained in order to achieve 
maximal rates. It is known, that at least in anaerobic culture, bacteria can excrete 
millimolar levels o f nitrite (DeMoss and Hsu, 1991). It is possible that by way o f nitrite 
secretion, bacteria might initiate their own destruction (Harrison, 2002). First, the 
conversion of XDH to the more efficient ROS-generating enzyme form, XO, is stimulated 
by bacterial lipopolysaccharide structures (Takeyama et al, 1996). Further, circulating 
enzyme may bind to glycosaminoglycans (Adachi et al, 1993), which are similar to 
structural components found on the surface o f some bacteria (Roberts, 1996). Therefore, 
by utilising circulating substrate the enzyme can generate microbicidal RONS in tight 
proximity to microbes. Indeed, the antimicrobial function of XOR has been demonstrated 
in milk (Millar et al, 2002; Stevens et al, 2000; Hancock et al, 2002) where it is believed 
that XOR-generated RONS afford protection to the suckling neonate from diseases, such 
as gastroenteritis, early post partum. This mechanism also has been shown to be effective 
in Cape buffalo where an anti-microbial role for circulating XOR in the control of 
trypanosome infection has been established (Wang et al, 2002).
As mentioned previously, NOS is dependent on the availability o f oxygen for its 
activity and thus ineffective in a hypoxic environment, where vasodilatory and 
antimicrobial properties o f *NO would be advantageous. Conversely previous research has 
shown that XOR is capable of generating ‘NO at a range o f oxygen tensions and as a result 
may be beneficial in encouraging wound healing in the hypoxic environment of a chronic 
wound.
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3.3 Aims and objectives
As outlined in the introduction, chronic wounds are characterised by hypoxia, providing 
an ideal environment for the growth of facultative and anaerobic bacteria. Clearly for 
correct wound healing, treatments are required which are bactericidal but allow dermal 
fibroblast proliferation. The enzyme XO has special redox properties and is known to 
facilitate both microbial killing and cell proliferation through the generation of reactive 
oxygen and nitrogen species. Therefore, in this study, I have addressed the following 
questions:
1. What specific reactive species are generated by purified XO in a simulated chronic 
ulcer environment at varying oxygen tensions?
2. Can XO-generated species improve wound healing by enhancing proliferative 
activity of dermal fibroblasts in a hypoxic ulcer environment?
3. Can XO-generated species also be antimicrobial in the same environment?
Primary investigations involved the measurement of XO-generated species at 
varying enzyme concentrations using the pterin assay, cytochrome c assay and the 
dihydrorhodamine assay. These experiments were conducted in a variety o f biological 
media, used in the culture of fibroblasts and bacteria, to provide an understanding o f the 
levels o f species to which wound-related cells could be exposed in varying conditions in 
vivo, most particularly low oxygen. The effects o f these XO-generated species on human 
dermal fibroblasts (HDF) at a range o f oxygen tensions including hypoxia were 
determined by the measurement of viability and proliferation using the MTT assay, and 
BrdU incorporation.
Further investigations involved the study o f bacterial species relevant to chronic 
wounds and how these were affected by species generated by XO in appropriate 
environments. Bacterial viability of facultative strains was assessed by growth curves, 
diffusion zone assays and viable colony counts.
Overall, the objective o f this research was to investigate ways in which 
exploitation of the special redox properties of XO can provide a novel way to improve the 
clinical effectiveness o f wound dressings and tissue engineered dermal replacements.
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CHAPTER 4
4 Assessment of XOR activity by detection of its 
products
4.1 Introduction
This chapter follows the development o f several assays that were used to measure 
some of the important species generated by XOR. Assays were used to determine levels of  
species generated by the enzyme in PBS, fibroblast and bacterial culture medium, in air 
and in hypoxia.
4.1.1 XOR generated species
XOR is a molybdoflavoprotein (Bray et al, 1975), existing as a homodimer, each 
147 kDa subunit of which contains one molybdenum atom, one FAD and two Fe2 S2 
centres (Bray et al, 1975; Hille, 1996). XOR has a wide specificity for reducing substrates, 
although its conventionally accepted role is in purine catabolism, where it catalyses the 
oxidation of hypoxanthine to xanthine and xanthine to uric acid. High concentrations are 
found in mammalian milk and liver, expressed in the vascular endothelium and measured 
in the circulation (Parks and Granger, 1986; Kayyali et al, 2001; Houston et al, 1999). In 
mammals, XOR occurs in two interconvertable forms, xanthine dehydrogenase (XDH, EC 
1.1.1.204), which predominates in vivo, and xanthine oxidase (XO, EC 1.1.3.22). During 
ischaemia the purine bases xanthine and hypoxanthine accumulate (Jones et al, 1968), and 
endothelial XDH is converted into reversible and irreversible forms of XO (McKelvey et 
al, 1988; Parks et al, 1988). Both forms o f the enzyme can reduce molecular oxygen, 
although only XDH can reduce NAD+, which is its preferred electron acceptor. Reduction 
of oxygen leads to 0 2 *~and H2O2 generation. The roles for oxygen free radicals in the 
bactericidal activities o f phagocytic cells, and in mediating tissue damage after acute 
ischaemia are well documented (McCord, 1985). More recently, an increasing body of 
evidence suggests a role for ROS in signal transduction (Thannickal and Franburg, 2000).
Peroxynitrite can also be produced by the enzyme in the presence of inorganic 
nitrite, molecular oxygen and a reducing agent. Peroxynitrite generation by the 
physiologically predominant dehydrogenase form of the enzyme is greater than the 
oxidase form under aerobic conditions but the oxidase form generates more ONOO" in 
hypoxia. These differences can be explained in terms of the production of 'NO, the
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essential precursor o f ONOO" formation in combination with O2 ’". Under anaerobic 
conditions, rates o f 'NO production in the presence of XO or XDH are comparable. As 
oxygen levels increase, levels of 'NO fall much more rapidly in the case of XO. The 
reasons for this may be explained in terms of competition between nitrite and molecular 
oxygen for donated electrons. It is well established that reducing substrates, other than 
NADH, donate electrons to the molybdenum centre o f XOR, while molecular oxygen 
accepts electrons at the FAD site. Organic nitrite however, accepts electrons directly from 
the molybdenum site. XO is known to reduce molecular oxygen some six times faster than 
does XDH, implying the XO will have fewer electrons available for the reduction of nitrite 
than will XDH; a situation that will be exacerbated as oxygen tensions increase (Sanders, 
1997). Peak ONOO" generation is reported to occur at 7pM oxygen (0.6%) oxygen 
(Godber et al, 2000a). However, Millar 2004 reports that optimal ONOO" formation 
occurs at 70pM oxygen ( - 6 % oxygen) with purine substrates in both cases reaching 
around 25nmol min' 1 mg' 1 ONOO" at their peak. Both studies point to hypoxia but it 
appears to be at varying intensities.
The physiological dissolved oxygen concentration range of plasma is 120-135pM 
(10-11 %) on the arterial side to 55-70pM (4.8 - 6.1%) on the venous side (West, 1990). 
However, in chronic venous ulcers, mean values as low as 13mmHg (1.7% oxygen) have 
been quoted (Falanga et al, 1992b). Plasma nitrite can be generated from nitrate reduction, 
the reaction of'NO with oxygen and cyt c catalysed formation of nitrite from 'NO (Torres 
et al, Pearce et al, 2002) and ranges from 10 to 50pM in normal adults but can rise to 
130jaM in patients with sepsis (Evans et al, 1993) (See Table 4.1). This suggests that 




Xanthine Oxidase 0.2|iU ml'1 1.52-200 pU ml'1
Xanthine 0.65|liM 21pM
Hypoxanthine 1.43, 1.65jiM 18.8,81.6pM
Nitrite 10 to 50pM Up to 130pM (Evans et al, 1993)
Table 4.1 Plasma concentrations of relevant substances (Millar, 1999)
Inoue et al (2002) has shown evidence o f 3-nitrotyrosine formation in healthy 
adults suggesting that normal physiological processes can lead to the formation of ONOO" 
in plasma. We have also found that the optimum pH for the production of'NO from XOR 
under hypoxic conditions is about 5.5. Therefore, ulcers present an environment in which 
the production o f ‘NO in the presence o f XOR would be at or near its peak.
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A possible problem exists for a functional ONOO" forming enzyme utilising 
xanthine in the form of the reported scavenging activity o f the product urate. Scavenging 
of ONOO" by uric acid has been suggested to decrease ONOO" neurotoxicity in diseases 
such as multiple sclerosis (Hooper et al, 1997). However, the reaction o f ONOO" with uric 
acid has given conflicting results. Skinner et al (1998) showed that ONOO" and uric acid 
react to give an 'NO donor species having downstream effects on vascular relaxation 
whereas the reaction of ONOO" with CO2 was shown to be 920 times faster than ONOO" 
with uric acid at physiological CO2 concentrations (Squadrito et al, 2000). The picture is 
further complicated with ONOO" permeation o f erythrocytes in the presence of CO2 
(Romero et al, 1999). The suggestion therefore that the simultaneous formation o f uric 
acid and ONOO” by XO does not automatically lead to scavenging in physiological 
environments due to the competing reactions. Further to these observations, using NADH 
as the donor substrate can lead to the simultaneous reduction o f nitrite and oxygen by XO 
and derive ONOO" in the complete absence o f purines and urate.
4.1.2 Measurement of reactive species
Previous studies carried out by Murrell et al, 1990, showed that addition o f XOR 
into cell culture enhanced the proliferation o f adult human dermal fibroblasts. Therefore 
Murrells methodology was used as a starting point for enzyme assays with a view to 
derive a greater understanding of the potential effects o f the enzyme in the presence of 
high and low oxygen concentration along with substrates at levels similar to physiological 
levels that may be found in the chronic wound fluid. Murrell used ImM hypoxanthine, 
20mM HEPES buffer with XO 0 - lOOmU ml' 1 in fibroblast growth medium. A similar 
system formed the basis o f the assays in this chapter with some modifications as described 
below. Nitrite (ImM) was also added to assays (levels previously used by Dr. Millar) to 
generate ONOO" at the lower oxygen concentrations, for a possible antimicrobial role for 
the enzyme.
Superoxide was measured using the cytochrome c assay. This method has been
used to measure rates o f formation of O2 ’" by numerous enzymes, whole cells, and
vascular tissue (Azzi et al, 1975; Landmesser et al, 2003; Massey, 1959). There are
several precautions which must be taken when using this reaction to detect O2 *". Reduction
of cytochrome c is not absolutely specific for O2 ’”. Cellular reductants such as ascorbate
and glutathione are capable o f reducing cytochrome c and may be present in high
concentration within tissue extracts, as are cellular reductases that enzymatically mediate
cytochrome c reduction. Additionally, enzymes such as xanthine oxidase are capable of
reducing quinines or redox-active dyes that may also be present and whose reduced forms
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are capable of directly reducing cytochrome c. It is important therefore to demonstrate 
specificity o f this reaction for O2 *~ by the extent of inhibition of cytochrome c reduction 
by exogenous SOD. Reduced cytochrome c can be re-oxidised by cytochrome oxidases, 
cellular peroxidases, and oxidants, including H2O2 and ONOO- (Thomson et al, 1995). 
These influences cause an apparent decrease in cytochrome c reduction therefore 
underestimating the rate of O2 *- formation. To this effect enzyme inhibitors (lOpM CN for 
cytochrome oxidase) or scavengers o f reactive species (100U ml' 1 catalase for H2 O2 , 
lOmM urate for ONOO-) can be added to the reaction mixture to avoid this draw back. 
The applicability of the cytochrome c method for in vivo detection is limited because it is 
relatively insensitive and can be interfered with by a variety of endogenous reductants. 
However, the use of the cytochrome c reaction has received “gold standard” status for the 
detection o f O2 ’- , particularly with in vitro assays such as will be described and activated 
leukocytes.
Dihydrorhodamine, DHR is a probe widely used to detect several reactive species 
(’OH, ONOO-, NO2 ’, peroxidase-derived species), but is poorly responsive to 0 2 *", H2 O2 
and ’NO (Buxser et al, 1999). Although a direct reaction of DHR 123 with H2 O2 does not 
occur, it can be catalyzed by haem-containing peroxidases such as HRP (LeBel et al,
1992) or other haem compounds, including cytochrome c (Royall and Ischiropoulos,
1993).
4.1.3 Use of the oxygen controlled cabinet
Enzyme assays and cellular incubation with XOR were to be carried out, as closely
as possible under conditions which prevail in the chronic wound. With regard to oxygen
tension, the chronic wound is known to be hypoxic (Section 2.2.1). Mean values as low as
13mmHg which is around 1.7% oxygen have been quoted for venous ulcers (Falanga et al,
1992b). Therefore, as air is around 21% oxygen, to mimic the chronic wound
environment as closely as possible it was necessary to control the oxygen tension using a
sealable hypoxia cabinet (Don Whitley Scientific miniMACS Workstation A03000). This
cabinet allowed for the delivery of customised mixtures o f three different gases and the
manipulation o f a large number o f reactions at one oxygen concentration. The hypoxia
cabinet could also be environmentally controlled including temperature and humidity
adjustments. For the purposes of these experiments the cabinet was operated on a single
cylinder o f mixed gas at the relevant oxygen concentration for the experiment, special
mixed gases were supplied by British Oxygen Corporation (BOC) and typically contained
5% CO2 and 0-5% oxygen balanced nitrogen. Once the relevant cylinder had been
attached the cabinet was purged twice using the automatic commissioning sequence that
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lasts for 75 minutes and prepares the cabinet for use. At the start of each experiment the 
percentage of atmospheric oxygen inside the cabinet was confirmed using an oxygen 
meter (Analox Mini 02DII). The meter was calibrated in air in accordance with the 
manufacturer’s instructions.
Figure 4.1 Oxygen controlled cabinet
The sleeve door system allows for the manipulation of samples without altering the environment inside the 
cabinet. Hands are inserted into sleeves and a foot-pedal controlled vacuum is used to remove the air in the 
sleeves, a second foot-pedal is used to replace the air with the relevant gas from the cylinder which is also 
supplying the cabinet. This process is repeated 3 times before the doors into the cabinet are opened.
4.1.4 Chapter aims
This chapter aims to develop several assays for the measurement of XO-generated 
species such as O2’” and ONOO". These assays will be used to measure XO-generated 
species at varying concentrations of substrate and enzyme, in both fibroblast and bacterial 
growth medium and in variable oxygen in order provide information on the levels of XO- 
generated species that dermal fibroblasts and bacteria would be exposed to under these 
culture conditions. These observations will indicate the levels of XO-generated species 
that could potentially be produced in a chronic ulcer setting.
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4.2 Materials and Methods
4.2.1 Enzyme Characterisation
4.2.1.1 Protein determination using the Bio-Rad assay
The protein concentration o f a commercial preparation of XO (See above) was 
assessed using a Bio-Rad protein assay. This technique works on the change in absorbance 
maximum when Coomassie Brilliant Blue G-250 reacts with peptides, and shifts from 
465nm to 595nm. Protein binding results in a brown to blue colour change, the intensity of 
the blue colouring is dependent on the concentration o f protein. The Coomassie blue dye 
binds to primarily basic and aromatic amino acid residues, especially arginine.
4.2.1.1.1 Materials
Bovine Serum Albumin (BSA), Bio-Rad Reagent, (Bio-Rad, Hertfordshire, UK), 
96-well, flat-bottomed tissue culture test plates (Fisher Scientific, Loughborough, UK), 
Xanthine Oxidase (XO), (From buttermilk X02B), Suspension in 60% saturated 
ammonium sulphate solution containing sodium salicylate and EDTA. Lactoperoxidase 
not detected, (Biozyme Laboratories Ltd, Gwent, UK).
4.2.1.1.2 Protocol
Doubling dilutions of protein standards from 0 to 1.35mg ml' 1 were added to the 
wells o f a 96-well plate, in triplicate, in a total volume of lOpl of standard per well. 10pl 
of sample was also added to separate wells in triplicate. All dilutions were made in Milli­
es purified water 200pl of Bio-Rad protein assay reagent working solution was added to 
all sample wells and incubated at room temperature for 5 minutes to allow colour 
development. The absorbance across the plate was read at 595nm a multi-well plate reader 
(Dynex Technologies, MRX TC II). The concentration of protein in test samples was 
determined with reference to a graph plotted from the absorbance readings o f the standard 
samples.
4.2.1.2 Protein determination using the Bio-Rad DC protein assay
The Bio-Rad DC  protein assay was also used to assess the protein concentration of 
xanthine oxidase. This is a colourimetric assay that is very similar to the Lowry assay. The 
assay is based on the reaction of protein with an alkaline copper tartrate solution and Folin 
reagent. There are two steps that lead to colour development: the reaction between protein 
and copper in an alkaline medium, and the subsequent reduction of Folin reagent by the
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copper-treated protein. Colour development is primarily due to the amino acids tyrosine 
and tryptophan, and to a lesser extent, cystine, cysteine, and histidine. Proteins affect the 
reduction of the Folin reagent by the loss of 1, 2, or 3 oxygen atoms, thereby producing 
one or more o f several possible reduced species that have a characteristic blue colour with 
maximum absorbance at 750nm and minimum absorbance at 405nm.
4.2.1.2.1 Materials
Reagent A (Alkaline copper tartrate solution) and Reagent B (Folin Reagent), Bio- 
Rad, Hertfordshire, UK, Far UV quartz cuvette (200-2500nm, working volume 3.5ml), 
Fisher Scientific, Loughborough, UK
4.2.1.2.2 Protocol
A volume of 300jil o f the protein standard (doubling dilutions 0 tol.35mg ml' 
’BSA) or samples diluted in Milli-Q purified water was reacted with l,200pl Reagent A. 
A further 4,800jil of Reagent B was also added. The reaction mixtures were then 
incubated at room temperature (approximately 25°C) for 15 minutes. 2mls of standard 
solution or sample was added into crystal cuvettes, and readings were taken in triplicate. 
Absorbance was read at 750nm using the Hitachi U-2010 spectrophotometer.
4.2.1.3 Comparison of Oxidase and dehydrogenase activity by the
pterin assay
A sensitive, fluorometric assay for XO and XDH has been developed over several 
decades (Lowry et al, 1949; Haining and Legan, 1967; Markley et al, 1973; Beckman et 
al, 1989). This method is based on the use o f pterin (2-amino-4-hydroxypteridine) as a 
substrate for XOR, which is oxidised to the fluorescent compound isoxanthopterin (2- 
amino-4,7-dihydroxypteridine, DtP). This fluorometric assay is 100-500 times more 
sensitive than the traditional spectrophotometric assay o f urate formation from xanthine 
and enzyme activity as low as 0.1 pmol min' 1 ml' 1 can be measured. The protocol from the 
Beckman et al, 1989 assay will now be described and, in this case, was used to check the 
relative proportion and specific activity of both XO and XDH in the Biozyme XO. XO 
activity is assayed in the presence o f the pterin substrate alone, using oxygen as an 
electron acceptor for the reduced enzyme. With the addition of methylene blue, an 
electron acceptor from the Fe-S clusters of XO and XDH, the combined activity of XO 
and XDH are assayed (methylene blue is used instead o f NAD+ as an electron acceptor, as 
NADH fluorescence overlaps with that of IXP). Allopurinol is added to the sample to 
inhibit XOR activity, thus allowing the calculation of XO- and XDH-specific generation
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of IXP [both lactoperoxidase in the presence of H2O2 and aldehyde oxidase were shown to 
catalyse pterin-IXP conversion but were not allopurinol inhibitable (Beckman et al 1989)]. 
Finally the addition of an IXP internal standard of a known concentration, allows for the 
correction of any fluorescence quenching and the quantification of IXP production. The 
XOR catalysed conversion of pterin to IXP and the role of methylene blue and allopurinol 








Figure 4.2 XOR catalysed generation of IXP from the pterin substrate.
Electrons donated to XOR during the oxidation of pterin to IXP (leading to increased fluorescence) are 
accepted by 0 2 at the FAD-containing moiety in XO, however in the presence of methylene blue electrons 
are accepted at the Fe-S cluster-containing moiety o f XO and XDH. Allopurinol inhibits the oxidation of 
pterin at the Mo-containing moiety.
4.2.1.3.1 Materials
Allopurinol, isoxanthopterin (IXP), methylene blue (MB), and pterin (2-amino-4- 
hydroxypteridine) (Pt) (Sigma Aldrich Company Ltd. Dorset, UK). Quartz crystal cuvettes 
(Fisher Scientific UK Ltd. Leicestershire, UK). Xanthine oxidase (Biozyme Laboratories. 
Gwent, UK).
4.2.1.3.2 Protocol
To analyse XO and XDH in the Biozyme enzyme the protocol described in 
Beckman et al, 1989 was followed, except for minor adjustments. In a final volume of 1ml 
the final concentrations of the reagents used for this assay were as follows; lOOng ml'1 
XO, lOpM pterin, lOpM methylene blue (MB), lOpM allopurinol (A) and lOOnM IXP. 
Stock concentrations of XO (lng ml'1), pterin (ImM) and IXP (lOpM) were made up on 
the day of the experiment. ImM stocks of MB and allopurinol were made up prior to the
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experiment and stored at -20°C. The assay was initiated by adding 860jnl PBS and a 
magnetic stirring flea to a quartz-crystal cuvette. The cuvette was placed into a Hitachi F- 
4500 fluorescence spectrophotometer (set at: excitation wavelength (Ex) 345nm, emission 
wavelength (Em) 390nm, monochromator Ex slit width 5nm, Em slit width 5nm, and the 
photomultiplier voltage set at 700V) with stirring set at 50rpm. The run was started 
immediately after the addition of lOOpl of lng ml' 1 XO. All other additions were carried 
out as shown on the trace below (Figure 4.3). Measurements were carried out for a 
sufficient time after each addition to the cuvette to enable rate calculations. All 
incubations were at room temperature.
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Data Mode : Fluorescence
Delay Time : 0 sec Slit (EX/EM) : 5.0 nm / 5.0 nm 
PMT Voltage : 700 V Response : 0.004 sec
Figure 4.3 A typical trace from the Time-Scan XOR assay.
XO is assayed in the presence of pterin alone (with oxygen as the acceptor substrate), whereas the combined 
activites of XO and XDH are measured in the presence of methylene blue, which replaces the need of NAD+ 
as an electron acceptor for XDH. Following the inhibition of XOR activity using allopurinol, the 
measurement of the fluorescence change following the addition of a known concentration of IXP (which acts 
as an internal standard) allows the quantification of IXP generation by XO and XDH. Additions were made 
to the cuvette at varying time points as indicated by the arrows. The Y axis = Fluorescence Intensity and the 
X axis= Time (Sec). IXP= isoxanthopterin, MB=Methylene Blue.
From the data recorded the change in fluorescence per unit time was calculated, 
and using the change in fluorescence readings following the addition of the IXP standard 
(lOOmM final concentration) it was possible to calculate [IXP] generated, as shown in 
equation 1 .
[IXP] =AF* (IXPc / Fixp)
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Equation 4.1 Calculation of Isoxanthopterin Generation in XOR Activity Time-Course Assay.
Where AF= Change in fluorescence units per unit time, IXPc = concentration of IXP standard added, and 
Fixp — the change in fluorescence units immediately following the addition of the IXP standard.
4.2.2 Development of methods for the measurement of XO 
activity in cell growth medium
4.2.2.1 Cytochrome c assay for superoxide generation by XO
The cytochrome c -  based method o f measuring CV- was adapted from the method 
of McCord and Fridovich (McCord and Fridovich, 1968; McCord and Fridovich, 1969). 
The reduction of ferricytochrome c to ferrocytochrome c was followed by 
spectrophotometer at 550nm to determine 0 2 *" generation by XOR in the following 
process:
Fe3+ cyt c + 0 2 *”-> Fe2+ cyt c + O2 
In some of the assays SOD and/ or catalase was added to the reaction to try and 
determine the actual levels of O2 *" being generated. SOD was first discovered in 1969 
(McCord and Fridovich, 1969) and catalyses the following antioxidant reaction:
2 0 2*- + 2H H2 0 2 + 0 2 
SOD converts 0 2 *" to H2O2 and O2 , therefore slowing the rate o f cytochrome c 
reduction, and making it possible to determine proportion of cytochrome c reduction that 
is attributable to O2 *- generation. Superoxide dismutase functions to remove O2 ’-, however 
in that process the ROS H2 O2 is generated, which is more stable compared to 0 2 *". 
Furthermore, H2O2 can also be generated by XOR. Hydrogen peroxide can reoxidise 
cytochrome c so the enzyme catalase was used in some o f the assays as it functions in the 
disposal o f H2 O2 by the following process (Hancock, 1999):
2 H 2O 2  -> 2H20  + O 2
4.2.2.1.1 Materials
Hypoxanthine (C5H4N 4 O); xanthine (2,6-dihydroxypurine, C5H4 N4 O2);
cytochrome c (From horse heart); disposable spectrophotometer cuvettes (Polystyrene, 
without stopper), superoxide dismutase (SOD), Sodium nitrite (NaN0 2 ) crystalline 
(hereafter referred to as “nitrite”); Catalase; Allopurinol; HEPES; 96-well plate seals, 
Luria-Bertani Broth (see appendix 8.2) (Sigma-Aldrich Co Ltd, Poole, UK). Dulbecco’s 
phosphate buffered saline (PBS), Dulbecco’s Modified Eagles Medium (DMEM, without 
phenol red see appendix 8.1), Penicillin/Streptomycin, L-Glutamine (Gibco, Life Tech,
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Paisley, UK). Foetal claf serum (FCS) (GlobePharm Ltd, UK). Sodium hydroxide pellets 
(NaOH), Hydrochloric acid (HCL) (BDH laboratory supplies, Poole), UK. XO (Biozyme 
Laboratories, Gwent, UK). 96-well flat-bottomed plates (Fisher Scientific, Loughborough, 
UK).
4.2.2.1.2 Protocol
Using a final volume of 2 or 3mls, the standard reagents used for these assays were 
as follows, 20-50pM cytochrome c, ImM Hypoxanthine, PBS, and XO (for specific 
details see results). All solutions were prepared in PBS and maintained on ice until 
required with the exception o f hypoxanthine which remained at room temperature 
(approximately 25°C) until use. The reduction o f cytochrome c was followed using a 
spectrophotometer (Hitachi U-2010 UK) with a 1cm light path in 3ml plastic cuvettes at 
550nm. The spectrophotometer was fitted with a circulating fluid regulator so that the 
reaction could be maintained at 37°C throughout the experiment. The initial rate of 
reaction was measured as the linear slope o f the absorbance readings. Activity was 
expressed as nmol (V" produced min' 1 by using the extinction coefficient for reduced 
cytochrome c o f 21.1 mM' 1 cm’1.
Experiments were also carried out for measurement on a 96-well plate reader 
(DYNEX MRX TC II) with a final volume o f 200pl. Final concentrations of all reagents 
were as described above. For experiments carried out in hypoxia, PBS, DMEM, or Luria- 
Bertani broth (LB) was placed in the cabinet in vented T75 flasks 24 hours before the 
experiement. In the case of the DMEM, 1% Penicillin/Streptomycin, 5% FCS and 1% L- 
Glutamine were added 2 hours before the start o f the experiment this is to prevent 
degradation at 37°C before addition to the cells in the cell culture experiments. All 
additions to the plates were made in the hypoxia cabinet. Once the additions had been 
made to the plates they were sealed with clear film and transferred to the plate reader (this 
step generally took around 3 minutes). The XOR catalysed O2 ”  generation and reduction 
of cytochrome c and the role o f SOD and catalase are shown in Figure 4.4.
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Figure 4.4 XOR Catalysed Generation of Superoxide and Reduction of Cytochrome c.
Electrons donated to XOR during the oxidation o f hypoxanthine or xanthine to xanthine or urate 
respectively, are accepted by 0 2 at the FAD-containing moiety in XOR forming 0 2‘” and leading to the 
reduction of cytochrome c. SOD was used to convert 0 2’- to H20 2 and 0 2 to determine the SOD inhibitable 
portion o f the cytochrome c reduction. Catalase was used to remove H20 2 from the system to prevent the 
reoxidation of cytochrome c by XOR-and SOD-generated H20 2.
4.2.2.1.2.1 C alculation of superoxide generation
In order to determine the generated by XOR, the extinction coefficient or 
molar absorbtivity (s) for cytochrome c, 21100 M’1 cm’1, was used. Superoxide generation 
was calculated for the cuvette and the 96-well plate method using the Beer-Lambert Law 
which is the linear relationship between absorbance and concentration of an absorbing 
species thus:
A= ebc
Equation 4.2 Beer-Lambert Law
A =Absorbance, 8 =molar absorbtivity (M '1 cm '1), b=Pathlength through the sample, c concentration of the 
compound in solution.
In the cuvette method, the light from the spectrophotometer is passed through the 
side of the cuvette which has a 1cm pathlength. In the 96-well plate method, the light from 
the spectrophotometer is passed through the base of the plate which means that the 
pathlength is the depth of liquid in the well correlating with the volume used. The Beer- 
Lambert law allows for the calculation of the absolute O2 ”  generation in the two different 
measuring systems by taking into account the differing pathlengths. A paper published by 
Smith et al (2001) described how the differences in pathlengths can be corrected allowing 
only a small amount of error to be introduced. This correction was carried out as follows. 
The 96-well plates used in the lab were manufactured by orange scientific and the product 
data sheet gave a radius of each well of 0.335cm. Therefore, the base of a well could be 
calculated as n x R2 = 0.352cm2. For the 96-well plate assays a final volume of 200pil was
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used which has a 0.2cm3 area. Therefore, the pathlength was calculated as follows 
0.2/0.352 = 0.568 cm and provides a theoretical pathlength that is just over half that o f the 
cuvette. Therefore if  the cuvette pathlength is 1cm and the 96-well plate has a pathlength 
of 0.586, lcm/0.568cm = 1.760. Therefore the 96-well plate absorbance values must be 
multiplied by 1.760 to account for the difference in pathlength. Therefore the absolute (V" 
generated in the cuvette and the 96-well plate was calculated as follows:
Cuvette
A / e (21100 M' 1 cm'1) = Superoxide M' 1 cm' 1 
96 well plate
A / 8  (21100 M' 1 cm'1) x Pathlength (0.568) = Superoxide M ' 1 cm' 1 
Or
A x 1.760*/ 8  (21100 M ' 1 cm'1) = Superoxide M' 1 cm' 1 
* Pathlength correction
In order to test this, the spectrophotometer was blanked with a cuvette containing 
PBS, this cuvette was removed and replaced with a cuvette containing 50pM cytochrome 
c which gave a reading of 0.570 absssonm (n = 1) a 96-well plate assay was also carried out 
simultaneously in which the PBS wells were subtracted from the wells containing 50pM 
cytochrome c giving and average value of 0.2927 absssonm (n = 3). Therefore, in order to 
test the theoretical pathlength 0.2927 x 1.760 = 0.515 absssonm- With this correction the 96- 
well plate measurement is still slightly less than the cuvette measurement a reduction in 
absorbance of around 9.7 %.
4.2.2.2 Oxidation of Dihydrorhodamine for peroxynitrite generation 
by XO
Peroxynitrite generation was measured using the oxidation o f Dihydrorhodamine 
(DHR) to rhodamine as described by Kooy et al (1994) and Crow (1997). Authentic 
peroxynitrite causes the oxidation of DHR to rhodamine which has an absorbance peak at 
500nm with a high molar extinction coefficient (74500M'1 cm'1). This assay was followed 
spectrophotometrically and was adapted for use in a cuvette or a 96-well plate (Figure 
5.2). Assays were carried out using SIN-1 as a positive control for ONOO" generation at 
0-500pM. Measurements o f ONOO" generation by XO using DHR (Figure 4.5) were 











Figure 4.5 XO-catalysed oxidation of dihydrorhodamine to rhodamine
In the presence o f oxygen, electrons donated to XO during the oxidation of hypoxanthine accepted by 0 2 at 
the FAD-containing moiety in XOR forming 0 2'~ and H20 2. Under hypoxic conditions, XOR can generate 
NO«; however, if  0 2 concentrations rise to around 70pM/about 50mmHg (Millar unpublished data), pairs of 
electrons derived from either hypoxanthine, xanthine, or NADH, can be used to reduce nitrite or 0 2 (the 
preferred substrate), therefore generating *NO and 0 2'~, respectively. *NO and 0 2’“ can react together 
forming ONOO (Huie et al, 1993). HOONO = Peroxynitrous acid.
Some assays were also carried out in the presence the iron chelator 
Diethylenetriaminepentaacetate (DTPA) (O.lmM) to prevent iron mediated reactions with 
XO-generated H2O2 particularly the Fenton reaction (Figure 4.6). DPI, which blocks the 
ability of the FAD site to transfer electrons to molecular oxygen, was also used to simulate 
hypoxia by reducing the production of 0 2‘- and shifting the balance of competition for 
electrons to nitrite, effectively increasing *NO production. Thus resulting in ONOO- 
generation.
Figure 4.6Fenton reaction.
Iron and H20 2 can react together to generate hydroxyl radicals in a reaction that is termed the Fenton 
reaction.
4.2.2.2.1 Materials
Acetonitrile (methyl cyanide), Sodium nitrite (NaN02) crystalline, SIN-1 (3- 
Morpholinosydononimine), Dihydrorhodamine 123, HEPES Buffer (1M) (Sterile filtered 
Cell culture tested), DTPA (Diethylenetriaminepentaacetic acid) (Sigma-Aldrich, Co. Ltd, 
Poole, UK), DPI (diphenyliodonium chloride) (ICN Biomedicals Inc, Aurora Ohio, USA).
Fe2+ + H20 2̂  Fe3+ + ’OH + OH 
Fe3+ + H20 2-> Fe2+ + *OOH +
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4.2.2.2.2 Protocol
In experiments on the generation of ONOO- by XO the following assay procedure 
was used. Reaction solutions were made up fresh from frozen DHR stock solutions 
(lOmM) to give final concentrations of O.lmM DHR, O.lmM DTPA in 2 or 3mls o f PBS. 
This was then placed into a spectrophotometer at 37°C and the absorbance at 500nm was 
measured over time with a 1 cm light path.
This assay was also reduced to a 200pl volume and read on a plate reader 
(DYNEX MRX TC II) using a 490nm filter (See results figure 4.67 for wavelength scan 
results at 500nm and 490nm). Reagents were as described above.
4.2.3 Statistical analysis
Statistical analysis o f data collected was performed using GraphPad Prism Version 
4.00 (GraphPad Software Inc.). Statistical analysis performed was the unpaired t-test for 
comparisons between independent samples, and a one-way ANOVA statistical test with 
Dunnett’s post test for analysis o f variance between XO concentrations.
4.3 Results
4.3.1 Enzyme characterisation
4.3.1.1 Protein determination using the Bio-Rad assay
Each new batch of XO (Biozyme) was assessed for protein content using a Bio- 
Rad assay. Protein assays were performed in order to determine the concentration of 
protein in each batch of enzyme. The protein content o f the first batch o f XO (XO 1) was 
assessed using the Bio-Rad Protein assay methodology (Figure 4.7). According to the data 
sheet included with the enzyme, the protein concentration of XO was measured by 
Biozyme to be at 10.5 mg ml' 1 using a Lowry assay.
As shown in figure 4.7 the protein concentration of the enzyme was found to be 
6.2mg ml' 1 using the Bio-Rad protein assay, and the protein concentration was 
considerably lower than was indicated by the data sheet (10.5mg ml'1). Therefore, a 























Figure 4.7Standard curve for protein determination of XO using the Bio-Rad assay.
A 1:100 dilution of XO gave an absorbance of 0.39nm and a protein content of 0.062mg m l'1 as extrapolated 
from the graph (See section 4.2.1.1.1 for methodology). The final protein content was 6.2mg ml'1 after 
correction for the dilution factor, r2 = 0.96. Mean ±  SD.
4.3.1.2 Protein determination using the Bio-Rad DC protein 
assay
The results shown in figure 4.7 show the protein level to be 6.2mg ml' 1 using a 
Bio-Rad assay. In order to determine the true protein concentration o f the enzyme a 
second assay called the Bio-Rad DC  Protein Assay, which is described as being similar to 
the Lowry assay was used (Figure 4.8).
The observed protein concentration using the Bio-Rad DC  assay was determined to 
be 10.81 mg ml' 1 which is extremely close to the protein concentration shown on the data 
sheet (10.5mg ml'1). Therefore this value will be considered to reflect the tme protein 
concentration. The Bio-Rad DC  assay will also used to measure all new batches of  
xanthine oxidase. The Bio-Rad DC  assay was used to determine the concentration of a 
second batch of XO (XO 2) to show that the result was reproducible between batches 
(Figure 4.9).
The extrapolated protein values from Figure 4.9 indicate that the protein content of 
X 02 is 10.49 mg ml' 1 which was extremely close both to the previous batch o f enzyme 
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Figure 4.8 Standard curve for protein determination of XO using the Bio-Rad D C  assay.
A 1:10 and a 1:100 dilution of XO gave absorbances of 0.135nm and 0.015 respectively and a corresponding 
protein content of 1.182mg ml'1 and 0.098mg ml'1, as extrapolated from the graph (see section 4.2.1.1.2). 
The final protein content was 11.82mg m l'1 and 9.8mg m l'1 after correction for the dilution factor. The final 
concentration was taken as an average of the corrected protein concentration values 10.81 mg m l'1, r2 = 
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Figure 4.9 Standard curve for protein determination of X 02 using the Bio-Rad D C  assay.
A 1:10 and a 1:20 dilution of XO gave absorbances of 0.123 nm and 0.055 respectively and a corresponding 
protein content of 1.160mg ml'1 and 0.469mg ml'1, as extrapolated from the graph. Therefore, after 
correction for the dilution factor, the final protein content was indicated to be 11.6mg ml'1 and 9.38mg ml"1. 
The final concentration was taken as an average of the corrected protein concentration values 10.49mg ml'1. 
r2 = 0.984
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4 . 3 .1 . 3  C o m p a r i s o n  o f  o x i d a s e  a n d  d e h y d r o g e n a s e  a c t i v i t y  b y  t h e  
p t e r i n  a s s a y
A fluorometric pterin assay was used to determine whether the Biozyme XO 
contains any of the dehydrogenase form of the enzyme (Figure 4.10). This figure shows 
that with XO alone IXP is not generated. However, when pterin is added, around 0.5nM 
IXP is generated per second. The addition of methylene blue does not increase the rate of 
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Figure 4.10 Measurement of XO and XDH activity in commercially available XO (Biozyme).
Experiments were carried out using XO (lOOng m l'1), Pterin (Pt) (10pM), Methylene Blue (MB) (lOpM), 
Allopurinol (A) (lOpM) made up to 1ml in PBS. MEAN ±  SD. n = 8.
4.3.2 Development of methods for the measurement of XO 
activity cell growth medium
4 .3 .2 .1  C y t o c h r o m e  c a s s a y  f o r  s u p e r o x i d e  g e n e r a t i o n  b y  X O
4.3.2.1.1 Superoxide generation by XO in air in PBS
Superoxide production by XO in air was initially measured using the cytochrome c 
assay. Cytochrome c reduction was rapid at high enzyme concentrations; a measurable 
rate was observed at 7.7mU ml’1 XO which reduced cytochrome c at 0.088 Abs550nm 
min’1 and produced around 4nmole min'1 m l'1 of O2 *” which was SOD inhibitable (Figure 
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Figure 4.11 Initial rate of XO-catalysed superoxide generation by XO in PBS in air
Experiments were carried out in air using final concentrations o f cytochrome c (20gM), XO (7.7mU m l'1), 
xanthine (20pM), SOD (667U ml"1) in a 3ml final volume o f PBS at 37°C with stirring. This figure shows 
the initial rate of O2”  generation nmole min"1 ml"1 and was calculated as described in the methods from the 
raw absorbance data, n = 1.
A wider range of SOD concentrations were then assessed to determine whether a 
lower concentration could be used for further experiments. The assay was also developed 
for use in a 96-well plate format to preserve expensive reagents and increase the number 
of samples that could be assayed at one time. Figure 4.12 shows the rate of O2 ”  generation 
by XO (2mU ml"1) and the inhibition of this rate by SOD. All control experiments of
incomplete reaction mixtures gave a zero rate of cytochrome c reduction. Superoxide
generation by XO (2mU m l'1) was shown to be at around 5nmoles min'1 m l'1 and a 
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Figure 4.12 Initial rate of superoxide generation by XO at varying SOD concentrations.
Experiment was carried out in air using cytochrome c (20|iM), XO (2mU ml"1), xanthine (20pM), and SOD 
(0.5, 1, 1.95, 3.9, 7.8, 15.65, 31.25, 62.5, 125, 250, 500, 1000 U m l'1) in a final volume o f 200pl PBS at
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37°C. This figure shows the initial rates of superoxide generation (nmole min ml’1) and was calculated as 
described in the methods from the raw absorbance data, n = 3. Mean ±  SD.
The experiment shown in figure 4.12 was repeated using slightly different SOD 
concentrations to check that the assay was reproducible. The results in Figure 4.13 show a 
partial inhibition at of CF’” generation by XO at 0.5U m l'1 SOD with complete inhibition 
at 5U ml'1. Furthermore a concentration of 5U ml'1 SOD was similar to 3.9U ml'1 SOD 
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Figure 4.13 Initial rate of superoxide generation by XO at varying SOD concentrations.
Experiment was carried out in air using final concentrations o f cytochrome c (20pM), XO (2mU m l'1), 
xanthine (20pm) and SOD (0, 0.005, 0.05, 0.5, 5 and 50U m l'1) in a final volume of 200pl PBS at 37°C. This 
figure shows the initial rates of superoxide generation (nmole min'1 m l'1) calculated from the raw absorbance 
data as described in the methods. Statistical analysis used was One-way ANOVA with Dunnetf s multiple 
comparisons test using 0 SOD as the control. ** P < 0.01.
A comparison was also made between the cuvette method and the 96-well plate 
method to ensure that the assays were equally sensitive and producing similar reaction 
profiles for assessment of the levels of CV- generation. Figure 4.14 shows that the rate of 
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Figure 4.14 Comparison of the rate of superoxide generation by XO in a cuvette and 96-well plate.
Experiment was carried out in air using final concentrations o f xanthine (20pM), cytochrome c (20pM) and 
XO (2mU m l'1) in a final volume of 200pl PBS at 37°C. This figure shows the initial rates o f superoxide 
generation (nmole min'1 ml"1) and was calculated from the raw absorbance data as described in the methods. 
The experiment was carried out on two separate occasions. 96-well plate data: All n = 6, except XO n = 9. 
Cuvette data: PBS + NE n = 2, NS n = 1, XO n = 6. Mean ± SD.
The comparison of the 96-well plate and cuvette method was repeated in Figure 
4.15-4.19 with more attention to temperature control. Assay reagents were warmed in a 
water bath set at 37°C prior to the experiment. A wider range of enzyme concentrations 
were also used to determine the sensitivity of the assay for (V - detection at low XO 
concentrations. Superoxide generation in the 96-well plate (Figure 4.15 and 4.16) and the 
cuvette (Figure 4.17) was assessed and comparison of the initial rates of O2 ’- generation 
(Figure 4.18) show that the rate of cytochrome c reduction in the cuvette method is at least 
twice as fast as the 96-well plate method. The assays also indicate that the cytochrome c 
method does not measure 0 2 *~ generation from the enzyme at concentrations below 
250pU ml'1 XO in either the 96-well plate method or the cuvette method. The comparison 
of the 96-well plate and cuvette shown in figure 4.18 was also repeated on a separate 
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Figure 4.15Timecourse of superoxide generation at a range of concentrations of XO in a 96-well plate.
Experiment was carried out in air using final concentrations o f xanthine (20pM), cytochrome c (20pM) and 
XO (0, 16, 31, 63, 125, 250, 500, 1000, 2000pU m l1) in a final volume o f200pl PBS at 37°C. PBS wells 
contained 200pl PBS alone. No Substrate (NS) wells contained XO (2000pU m l'1) and cytochrome c 
(20pM) diluted in PBS for a final concentration of 200pl. Absorbance readings were taken every 30 seconds 
over a 15 minute time period at 550nm. Superoxide generation (nmole m l'1) was calculated using Beer- 
lamberf s equation as described in the methods section using the raw absorbance data. Mean ±  SD. n = 3.
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Figure 4.16 Rate of superoxide generation at a range of concentrations of XO in a 96-well plate.
Experiment was carried out in air using final concentrations o f xanthine (20pM), cytochrome c (20pM) and 
XO (0, 16, 31, 63, 125, 250, 500, 1000, 2000pU m l'1) in a final volume o f 200pl PBS at 37°C. PBS wells 
contained 200pl PBS alone. No Substrate (NS) wells contained XO (2000pU m l'1) and cytochrome c 
(20pM) diluted in PBS for a final concentration of 200pl. Initial rates o f superoxide generation per minute 
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Figure 4.17 Rate of superoxide generation at a range of XO concentrations in a cuvette.
Experiment was carried out in air using final concentrations o f xanthine (20pM), cytochrome c (20pM) and 
XO (0, 125, 250, 500, 1000, 2000pU m l'1) in a final volume of 3mls PBS at 37°C. PBS cuvette contained 
3ml PBS alone. No Substrate (NS) cuvette contained XO (2000pU m l'1) and cytochrome c (20pM) diluted 
in PBS for a final concentration of 3mls. Rate o f change in absorbance per minute (550nm m in'1) was 
calculated from the raw data as shown in the methods. Mean ±  SD. n = 3. The initial rate of superoxide 






















Figure 4.18 Comparison of superoxide generation by XO in a 96-well plate and a cuvette.
Experiment was carried out in air using final concentrations o f xanthine (20pM), cytochrome c (20pM) and 
XO (0, 125, 250, 500, 1000, 2000pU m l'1) in a final volume of 200pl PBS (96-well plate) or 3mls PBS 
(Cuvette) at 37°C. The initial rate o f superoxide generation per minute (nmole m in'1 m l'1) was calculated 
from the raw data as shown in in the methods. Mean ±  SD. n = 3.
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Figure 4.19 Comparison of the 96-well plate and cuvette methods at a range of XO concentrations.
Experiment was carried out in air using final concentrations of xanthine (20pM), cytochrome c (20pM) and 
XO at (0, 16, 31, 63, 125, 250, 500, 1000, 2000pU m l'1) in a final volume of200pl PBS (96-well plate) or 
3mls PBS (Cuvette) at 37°C. The rate of superoxide generation per minute (nmole min'1 ml'1) was calculated 
from the raw data as shown in the methods. Mean ±  SD. n — 6.
Further assays were carried out to determine whether shaking of the 96-well plate 
prior to measurements and stirring of the cuvettes during the experiment significantly 
changed the reaction rates and could possibly account for the differences seen between the 
96-well plate and the cuvette. Cell based assays would also be carried out in a static 
reaction volume so this assay investigates the effect of a static and agitated reaction 
volume on the rate of O2 *” generation by XO. The results in figure 4.20 show little 
difference between the rate of 0 2 *" production with or without shaking the 96-well plate 
prior to measurements at varying concentrations of XO. There is also little difference 
between stirring the cuvettes during the experiments compared with inverting the cuvette 
prior to the experiments (figure 4.21). Therefore for subsequent experiments 96-well 
plates will not be shaken for 15 seconds prior to measurements and cuvettes will only be 
inverted three times before measurements are taken for future experiments. A comparison 
of Figure 4.20 and 4.21 also shows that there is still considerable difference in the rate of  
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Figure 4.20 Comparison of the rate of superoxide generation in a 96-well plate data with and without 
shaking
Experiment was carried out in air using final concentrations of cytochrome c (20pM), xanthine (20pm) and 
XO (0, 250, 500, 1000, 2000pU m l1) in a final volume of 200pl PBS in a 96-well plate at 37°C. The assays 
were carried out with or without a 15 second shake before measurements began at 550nm. Initial rates of 


























Figure 4.21 Comparison of the rate of cytochrome c reduction in a stirred and unstirred cuvette at 
varying XO concentrations
Experiment was carried out in air using final concentrations of cytochrome c (20pM), XO (0, 500, 1000, 
2000pU m l'1), xanthine (20pm) in a final volume of 3mls in cuvettes at 37°C. Cuvettes were either stirred 
with a magnetic flea (Stirred) or inverted three times before measurements (Not stirred) at 550nm. Initial 
rates of superoxide generation (nmole min'1 m l'1) were calculated from the raw data as described in the 
methods. Assays were carried out on two separate occasions and the n numbers are as follows: XO (OpU ml' 
') n=2, XO (500 and lOOOpU m l'1) n=6, XO (2000pU m l'1) n=8. Mean±SD.
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Due to the slight discrepancy between the rates of O2 ’- production in the 96-well 
plate and the cuvette method the expected rate o f 0 2 ”  production was calculated to 
determine whether the 96-well plate or the cuvette method was closer to the expected rate. 
Figure 4.22 shows that the expected rate of O2 ’- generation is roughly calculated at 
4nmoles min' 1 ml' 1 assuming all donated electrons produce (V -. However as H2 O2 is also 
generated by the enzyme, it is likely that 2 nmoles superoxide min' 1 ml"1 is a closer 
estimation. The closest rate in the previous assays to this theoretical rate was achieved 
using the cuvette method which produced around 1.5nmoles superoxide min' 1 ml"1. At this 
stage it was decided that further development o f the cytochrome c assay would be carried 
out using the cuvette method o f measurement.
Xanthine (1000 nmole) x XO (0.002U ml'1) x 2 Superoxide =
4nmoles superoxide min'1 ml'1
Figure 4.22 Calculation of the expected superoxide generation rate
The international unit (U) is defined as that amount of enzyme which will convert 1 micromole of substrate 
to product in 1 minute under defined conditions (generally 25°C or 30°C and the optimum pH). Xanthine 
provides XO with two electrons therefore in theory two 0 2*“ can be produced however, it is likely in 
practice, that as the enzyme also produces H20 2 these electrons also go onto produce hydrogen peroxide as 
well as 0 2*~. The hypothesised scheme for 0 2*_and H20 2 generation during the re-oxidation of reduced XO 
with 0 2 was confirmed in 1981 (Porras et al., 1981). It was concluded that a fully reduced (six electron 
reduced) XO monomer could generate two H20 2 and two 0 2*_molecules. Therefore it is likely that 4nmole 
superoxide min'1 ml'1 is an overestimation of the actual 0 2*~ produced it is likely to be roughly half this 
value at around 2nmole min'1 ml'1.
The assays shown below were carried out using substrate and enzyme 
concentrations based on assays carried out by Murrell et al (1990) which showed 
enhanced proliferation o f adult human dermal fibroblasts. Hypoxanthine was used at ImM 
as the substrate for XO and XO was used at ImU ml' 1 as Murrell showed increased 
proliferation between 0.001 and ImU ml' 1 XO. Cytochrome c was also increased to 
50pM. The controls for the cytochrome c assay were therefore repeated at these 
concentrations o f substrate and enzyme (Figure 4.23). This figure shows that cytochrome c 
is not reduced by hypoxanthine (ImM) alone or in combination with SOD, or by XO 
(ImU ml'1) alone or in combination with SOD. Cytochrome c is only reduced in the 
presence of hypoxanthine (ImM) and XO (ImU ml'1) which is shown to generate around 
0.4nmole min' 1 ml' 1 0 2 *". SOD at 3.3U ml' 1 partially inhibits this reaction showing that 
O2 *" is largely responsible for the reduction of cytochrome c. A higher concentration of 
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Figure 4.23 Initial rates of superoxide generation by XO with hypoxanthine.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H) 
(ImM), XO (Im U m l'1) and SOD (3.3U m l'1) were diluted in a final volume o f 3mls PBS at 37°C. This 
figure shows the initial rate of superoxide generation (nmole m in'1 m l'1) and was calculated as described in 
the methods. Mean ±  SD. n = 2.
Murrell’s studies with adult human dermal fibroblasts showed visible detachment 
and detachment from the culture surface of cells treated with lOmU ml'1 XO therefore the 
O2 ’- generation by XO at lOmU m l'1 was also assessed with a range of SOD 
concentrations (Figure 4.24). This figure shows that XO (lOmU ml*1) produces a rate of 
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Figure 4.24 Inhibition of XO-generated superoxide by SOD.
Experiment was carried out in air using final concentrations o f cytochrome c (50pM), XO (lOmU m l'1), 
hypoxanthine (ImM ) and SOD (0, 0.006, 0.06, 0.6, 6.6U ml"1) diluted in a final volume of 3mls PBS at 
37°C. Initial rates o f superoxide (nmoles min'1 m l'1) were calculated from the raw data as described in the 
methods No substrate (NS) = XO (lOmU ml’1) and SOD (6.6U m l'1) diluted in 3mls PBS. Mean ±  SD. n 
=2 .
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The rate of O2 ’” generation was assessed at varying XO concentrations which 
covered a range that would be used in the cell culture experiments. Measurements were 
made at varying XO concentrations from 0 to lOmU ml'1 using hypoxanthine as a 
substrate. The rate of CV" production was shown to increase with increasing 
concentrations of XO (Figure 4.25 and Table 4.2).
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Figure 4.25 Initial rates of superoxide generation at 0 to lOmlJ ml 1 XO.
Experiments were carried out in air using final concentrations of Cytochrome c (50pM), XO (0, 0.001, 0.01, 
0.1, 1 and lOmU m l'1)and hypoxanthine (ImM ) diluted in a final volume o f 3mls PBS at 37°C. This graph 
shows the initial rate of superoxide generation (nmoles min'1 m l1) by XO at 0 to lOmU m l'1 XO as 
calculated from raw absorbance data. All n = 6. Except XO (O.OOlmU m l'1) n = 3 and (lOmU m l'1) XO n = 
8. Mean ±  SD.
XO m l' m l1 Superoxide nmol min 1 m l1 SD N
X Y
0 0.000 0.008 6
0.001 0.000 0.004 6
0.01 0.009 0.006 6
0.1 0.073 0.011 6
1 0.748 0.066 6
10 6.825 0.302 8
Table 4.2 Initial rates of superoxide generation at 0 to lOmlJ ml ofXO
Experiments were also carried out to assess the effect of varying concentrations of 
hypoxanthine on O2”  generation by XO (Figure 4.26). Figure 4.26 shows that the rate of 
O2 *” generation increases with increasing hypoxanthine until around 5pM hypoxanthine. 
As the substrate concentration continues to increase to 1 mM hypoxanthine the rate of CV"
generation plateaus at a rate of 0.7nmole 02*" min'1 ml'1.
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Figure 4.26 Initial rates of superoxide generation by XO with varying hypoxanthine.
Experiments were carried out in air using a final concentration of cytochrome c (50pM), XO (Im U m l'1), 
with hypoxanthine at (0.5, 1 ,5 , 10, 50, 100, 500, lOOOpM) in a final volume o f 2mls PBS at 37°C. N 
numbers are as follows 0.5: n = 3, 1 - 50: n = 6, 100: n = 5, 1000: n = 9. Mean±SD.
The cell culture buffer HEPES (20mM) was routinely used in the cell culture 
experiments carried out by Murrell et al, 1990. However, HEPES has been reported to 
have scavenging activity (Simpson et al, 1988). Therefore, a series of experiments were 
carried out to determine whether there was any effect on the O2 *” production in the 
presence and absence of HEPES. Figure 4.27 indicates that there is no significant 
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Figure 4.27 Initial rates of superoxide generation by XO with and without HEPES buffer.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), XO (Im U ml"1), 
hypoxanthine (ImM ) with (+ HEPES, 20mM) or without HEPES (-HEPES) in a 3mls total volume o f PBS 
at 37°C. Initial rates o f superoxide generation (nmole min"1 ml"1) were calculated from the raw absorbance 
data as shown in the methods. These experiments were carried out in triplicate on three separate occasions. 
M ean±SD The n numbers for this experiment are as follows; - HEPES: NS and NE n = 2, XO (Im U ml"1) n
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= 9, XO (lOmU m l1) n = 6. + HEPES: NS and NE, n = 7, XO (Im U m l'1) n = 9, XO (lOmU m l'1) n = 3. 
There is no significant difference between assays carried out with or without HEPES. At XO (ImU m l'1) P = 
0.6406 (two-tailed unpaired t test).
New batches of XO enzyme were routinely tested to assess the activity was 
comparable with the previous batch of enzyme. There is little difference between the old 
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Figure 4.28 Comparison of old and new batch of XO.
Experiments were carried out in air using final concentrations o f XO (0.1 and ImU m l'1), with hypoxanthine 
(ImM ) and HEPES (20mM) in 3mls PBS at 37°C. Initial rates of superoxide generation (nmole m in'1 m l'1) 
were calculated from the raw data as described in the methods. These experiments were carried out in 
triplicate on three different occasions. The n numbers for this experiment are as follows OLD: No substrate 
(NS) and XO (0.1 mU m l'1), n = 8, and for XO (ImU ml"1) n = 9. NEW: Control n = 5, XO (0.1 mU ml'1) n = 
8, XO (Im U m l'1) n = 9. Mean±SD There is no significant difference between old and new batch of 
enzyme at either concentration of XO. At XO (ImU m l‘) P value = 0.0697 and at XO (O.lmU m l'1) P value 
= 0.9923 (two-tailed unpaired t test).
In the previous assays (Figure 4.23-4.28) cytochrome c for the assessment of XO- 
generated (V - was carried out in cuvettes rather than 96-well plates due to unexplained 
differences in the rate of (V - generation in the 96-well plate and the cuvette (Figure 4.14- 
4.21). The nature of the ongoing studies made it important to increase the number of 
samples that could be tested at one time and experiment that could be easily transferred to 
hypoxia. Therefore, the cuvette and a 96-well plate method were compared again and it 
was at this stage that the temperature setting of the 96-well plate reader was carefully 
considered. It was noted that the heated base plate of the reader was only reaching 32°C 
when set at 37°C via the software. Therefore the system was recalibrated to achieve an 
actual temperature at the sample of 37°C. All reagents were warmed in a water bath prior 
to the experiments and the plate was placed in an incubator between additions. The results 
of these changes are shown below in figure 4.29-4.30. Figure 4.29A) and B) show the 
difference in the absorbances values in the 96-well plate and the cuvette method before the
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pathlength correction. Figure 4.30A) and B) shows a comparable timecourse of CV- 
generation over a ten minute time period and comparable rates of reduction. Therefore this 
improved 96-well plate methodology is suitable for determining rates of (V - generation 
and will be developed for O2’- measurements in hypoxia.
Figure 4.29-4.30
A) Cuvette
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Figure 4.29 Comparison of cytochrome c reduction by XO in a cuvette or a 96-well plate.
Experiments were carried out using final concentrations o f cytochrome c (50pM), hypoxanthine (ImM), XO 
(ImU ml ') in a final volume o f 200pl PBS at 37°C. Measurements were taken over a 10 minute time period 








0 .0 00 '
-0.025-
0 2 4 6 128 10
0 .0 0 8 -.— 96 well plate 
—  Cuvette
•= 0 .0 0 6 -
0 .004-
<  0 .0 0 2 -
0.000-
96 well C u v ette
Time (mins) XO 1 mU ml'
Figure 4.30 Comparison of cytochrome c reduction in 96-well plate and cuvette.
Experiments were carried out using final concentrations of hypoxanthine (ImM), cytochrome c (50pM), XO 
(ImU ml ') at 37°C measurements were taken in air every minute for lOmins. Graph A shows a time course 
of absorbance values corrected for pathlength and zeroed for comparison. For the 96-well plate data, to 
correct for pathlength 1.760 was multiplied by the 96-well plate raw absorbance values (Figure 4.30A). For 
both the 96-well plate and the cuvette values the time 0 absorbance value was subtracted from the rest o f the 
data so that both sets o f data began at zero and could be graphed together for comparison (Figure 4.31 A). 
Graph B shows the initial rate o f change in absorbance ( A A b s 55onm m in'1) of 96-well plate data and cuvette 
data. Statistical analysis using unpaired t test showed no significant difference (P>0.05) P = 0.088. n =3.
The O2 *- generating activities of four batches of stock XO were compared in a 96- 
well plate for future assays and are labelled as A, B, C and D (Figure 4.31). This figure 
shows that batch A has a reduced rate of O2*" generation whereas batches B-C appear to 
have similar activities. Therefore, batch B was used for continuation of the cytochrome c 
assays (Figure 4.32-^4.73). Batch B was also used for fibroblast experiments in Chapter 5 
and batch C was used for bacterial experiments (Chapter 6).
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Figure 4.31. Comparison of the initial rates of superoxide generation by four batches of XO.
Experiments were carried out in air using hypoxanthine (ImM ) and XO (lOmU m l'1) in a final volume of 
200pl PBS at 37°C. Cytochrome c reduction at 550nm measured in air every minute for a duration of 20mins 
expressed as the initial rate of superoxide generation (nmole m l'1 m in'1). Mean ±  SD. n = 3.
Xanthine oxidoreductase at 50mU ml'1 was also measured in PBS to determine 
whether cytochrome c reduction at this concentration of XO would be measurable with 
ImM hypoxanthine as the substrate. Nitrite (ImM) was also included in this experiment as 
this substrate will be used in the cell based experiments along with ImM hypoxanthine as 
a substrate for the generation of *NO and ONOCT. Figure 4.32 shows that nitrite and 
hypoxanthine do not reduce cytochrome c either alone or in combination. Cytochrome c is 
not reduced by nitrite and 50mU ml'1 XO. However, the reduction of cytochrome c by 
hypoxanthine and 50mU m l'1 XO is rapid both with (shown in red in figure 4.32) and with 
out nitrite (shown in blue in figure 4.32); the graph just catches a peak in absorbance at 
around 1 minute. The absorbance values then return to baseline levels after around 9 
minutes suggesting that the cytochrome c has been reduced and then is rapidly re-oxidised. 
The reaction was also measured over a longer period of time as both fibroblasts and 
bacteria would be exposed to the enzyme and substrates for a longer duration in culture. 


















Figure 4.32 Timecourse of cytochrome c reduction by XO at 50mU ml"1.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), hypoxanthine 
(ImM ) (H), nitrite (ImM ) (N) and XO (50mU ml"1) diluted in a final volume o f 200pl PBS at 37°C. 
Measurements were taken in air at 1 minute intervals over a 1 hour time period, however, only selection of 
time points are shown on the graph for clarity. This experiment shows that neither nitrite alone nor nitrite 
with XO causes any reduction in cytochrome c. n = 3. M ean±SD.
The previous experiment shown in figure 4.32 was repeated with fewer samples so 
it was possible to add the enzyme to the relevant wells and begin the readings immediately 
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Figure 4.33. Cytochrome c reduction and superoxide generation by 50mU ml"1 XO.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), hypoxanthine 
(ImM), nitrite (ImM ) and XO (50mU ml"1) diluted in a final volume o f 200pl PBS at 37°C. Measurements 
were taken in air at 1 minute intervals over a 20 minute time period. Timecourse o f cytochrome c reduction 
at 550nm by XO. n = 3. Mean ±  SD.
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Experiments were carried out to determine whether the initial reduction of 
cytochrome c shown in figure 4.33 was due to 0{~  generation by XO. Figure 4.34A shows 
that at 50mU m l'1 XO without SOD in PBS has a rapid initial rate of cytochrome c 
reduction followed by a re-oxidation of cytochrome c as shown in the previous assays 
(shown in blue) and addition of increasing concentrations of SOD completely inhibits the 
reduction of cytochrome c with complete inhibition occurring at 50U ml'1 SOD (shown in 
red). Figure 4.34B shows the inhibition of the initial rate of O2’- generation by XO (50mU 
m l1) at concentrations of SOD above 10U m l'1 suggesting that the reduction of 
cytochrome c is due to 0 2’" generation at 5nmole m in'1 ml'1 (Figure 4.34B). Therefore, this 
level of SOD will be used in subsequent assays carried out in culture medium to determine 
the proportion of cytochrome c reduction that is due to the presence of 02*~. The assay was 
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Figure 4.34 Effect of varying concentrations of SOD on superoxide generation by XO in PBS
Experiments were carried out using final concentrations o f cytochrome c (50pM), hypoxanthine (ImM), 
nitrite (ImM ) and XO (50mU m l'1) and SOD at (1, 5, 10, 50 and 100U m l'1) diluted in a final volume of 
200pl PBS at 37°C. Graph A shows the timecourse of the reduction of cytochrome c. Measurements were 
taken in air at 1 minute intervals over a 1 hour time period. Graph B shows the initial rates of superoxide 
generation (nmole m in'1 m l'1) calculated as described in the methods using the raw data in figure 4.34A). n = 
3. M ean±SD.
The previous assay (figure 4.34) was repeated using catalase instead of SOD to 
determine whether H2O2 , which is known to be capable of the re-oxidation of cytochrome 
c was responsible for the re-oxidation effect shown in figures 4.32-4.34. Catalase, which 
converts H2O2 to H2O and O2 , was used at concentrations between 0-2500U m l'1. Figure 
4.35 clearly shows the dose dependent reversal of the re-oxidation of cytochrome c by 
catalase. Compared with the control (which did not contain catalase and is shown in blue 
in figure 4.35), between 50mU m l'1 and 250U m l'1 catalase (shown in red in figure 4.35) 
prevented the re-oxidation of cytochrome c, confirming that at high XO concentrations 
(50mU m l'1) H2 O2 as well as 02*~ is being generated by XO under these conditions. This 
assay was also repeated on a separate occasion which supported the findings shown in the 
figure below (data not shown).
[Catalase U ml'1]
ooH— 1— 1— 1— 1— | 1-  — 1---------- 1---------- 1---------- 1
0 2 4 6 8 10 50 100 150 200
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Figure 4.35 Effect of varying concentrations of catalase on superoxide generation by XO in PBS.
Experiments were carried out using final concentrations of cytochrome c (50pM), hypoxanthine (ImM), 
nitrite (ImM ), XO (50mU m l'1) and catalase at (25, 50, 250, 500 and 2500 U m l'1) diluted in a final volume 
of 200pl PBS at 37°C. Measurements were taken in air at 1 minute intervals over a 3 hour time period, n = 3. 
Mean±SD.
The effect of the XO inhibitor allopurinol on O2 *- generation by XO was assessed 
to show that the O2 ’” generation that was measured in the previous assays was due to XO. 
Figure 4.36 shows that the reduction of cytochrome c by XO (shown in blue) is decreased 
in the presence of 0.5 and ImM allopurinol (ImM is shown in red). However, both of
95
these concentrations appear to inhibit cytochrome c reduction to a similar extent. 
However, these concentrations do not completely inhibit the reduction of cytochrome c 
compared with controls containing only hypoxanthine and nitrite. This is likely to be due 
to the fact that allopurinol acts as a ‘suicide’ substrate initially donating electrons to the 
enzyme before binding tightly and inhibiting any further activity. Allopurinol will also 
compete for the active site with hypoxanthine. Therefore the low levels of O2 *” that are 
observed even at high concentrations of allopurinol are likely to have been generated by 
the enzyme before complete inhibition occurs. This result suggests that (V - generation is 
largely due to XO activity.
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Figure 4.36 Effect of allopurinol on the reduction of cytochrome c by XO in PBS.
Experiments were carried out using final concentrations o f cytochrome c (50|iM), hypoxanthine (H) (1 mM), 
nitrite (N) (ImM ) and XO (50mU ml"1) and allopurinol (A) at (0.01, 0.05, 0.1, 0.5 and 1U ml"1) diluted in a 
final volume of 200pl PBS at 37°C. Measurements were taken in air at 1 minute intervals over a 1 hour time 
period, n = 3. Mean±SD.
Superoxide generation by XO at 1, 10 and 50mU m l1 which are the concentrations 
to be used in the fibroblast and bacterial experiments were assessed in PBS in air and at 
1% O2 . As determined by preliminary experiments shown in figure 4.34-4.35, catalase 
was included in these assays at 250U m l'1 to prevent to re-oxidation of cytochrome c by 
H20 2 and a possible underestimation of 0 2‘", and SOD was used at 50U m l'1. Catalase and 
SOD were used both individually and in combination to determine the actual 02*“ 
generation by XO. Figure 4.37A in the absence of SOD and catalase shows that 
cytochrome c reduction by XO (ImU ml'1) in the presence of hypoxanthine and nitrite, 
cytochrome c reduction is gradual (shown in purple). However, with 10 (shown in green) 
and 50mU ml'1 XO both in the presence and absence of nitrite (shown in blue) the 
cytochrome c shows an initial rapid reduction of cytochrome c followed by re-oxidation to 
control levels. Figure 4.37B shows that O2*” generation by 50mU ml'1 XO peaks at around
96
20nmoles ml*1 (V - both in the presence and absence of nitrite and (shown in red and blue) 
and lOmU ml'1 XO peaks at 15nmoles ml'1 O2 ’" (shown in green). A gradual rate o f 02*” 
generation is observed at ImU ml"1 XO (shown in purple). These rates are completely 
inhibited by SOD, although, after an hour the cytochrome c appears to be slightly reduced 
(Figure 4.38). Figure 4.39A shows that the addition of catalase prevents the re-oxidation 
of cytochrome c at high XO concentrations over a 3 hour time period. Superoxide 
generation is also increased compared with figure 4.37B O2 *" generation in the presence of 
catalase at 50mU ml"1 XO peaks at around 30nmoles ml'1 02*~ with hypoxanthine alone 
(shown in red), and in presence of nitrite although the rate does appear slightly reduced 
(shown in blue), and lOmU ml"1 XO peaks at 15nmoles ml'1 O2 ’" (shown in green). 
Addition o f a combination of both catalase and SOD to the assay (Figure 4.39) shows a 
significant reduction in the rate observed in the presence o f catalase alone. However, a rate 
of cytochrome c reduction in the presence o f 50mU ml"1 XO in the presence of 
hypoxanthine is observed which is reduced when nitrite is also included. Compared with 
catalase alone the majority o f the rate is inhibited suggesting that it is due to O2 *" 
generation. Figure 4.41 shows that the initial rates o f 02*” generation without SOD and 
catalase is around 4nmole min'1 ml'1 with XO and hypoxanthine and slightly lower at 
3nmole min"1 ml'1 with the addition of nitrite. Superoxide generation is slightly increased 
with the addition of catalase to 6 and 5nmoles min"1 ml"1 respectively and O2 '- generation 
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Figure 4.37 Timecourse of cytochrome c reduction in PBS by XO in air.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H) 
(ImM), nitrite (N) (ImM ) and XO at (1 10 and 50mU m l'1) in a final volume of 200pl PBS at 37°C in a 
sealed 96-well plate. Graph A shows a timecourse o f cytochrome c reduction at 550nm over a 3 hour time 
period. Graph B shows a timecourse o f superoxide generation (nmoles m l'1) calculated from the raw data in 
graph A. Absorbance values o f wells containing PBS and cytochrome c were subtracted from the data before 
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Figure 4.38 Timecourse of cytochrome c reduction in PBS by XO at 21% with SOD.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H) 
(ImM), nitrite (N) (ImM), SOD (50U m l'1) and XO at (1, 10 and 50mU m l'1) in a final volume of 200pl 
PBS at 37°C. Graph A shows a timecourse of cytochrome c reduction at 550nm over a 3 hour time period. 
Graph B shows a timecourse of superoxide generation (nmoles m l'1) calculated from the raw data in graph 
A. Absorbance values of wells containing PBS and cytochrome c were subtracted from the data before 
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Figure 4.39 Timecourse of cytochrome c reduction in PBS by XO in 21% 0 2 with catalase.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H) 
(ImM), nitrite (N) (ImM ), catalase (CAT) (250U m l1) and XO at (1, 10 and 50mU m l'1) in a final volume 
of 200gl PBS at 37°C. Graph A shows a timecourse of cytochrome c reduction at 550nm over a 3 hour time 
period. Graph B shows a timecourse of superoxide generation (nmoles m l'1) calculated from the raw data in 
graph A. Absorbance values o f wells containing PBS and cytochrome c were subtracted from the data before 
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Figure 4.40 Timecourse of cytochrome c reduction in PBS by XO at 21% 0 2with SOD and catalase.
Experiments were carried out in air using final concentrations of cytochrome c (50jiM), hypoxanthine (H) 
(ImM ), nitrite (N) (ImM ), catalase (CAT) (250U ml'1), SOD (50U m l'1) and XO at (1 10 and 50mU m l'1) in 
a final volume o f 200pl PBS at 37°C. Graph A shows a timecourse o f cytochrome c reduction at 550nm over 
a 3 hour time period. Graph B shows a timecourse o f superoxide generation (nmoles m l'1) calculated from 
the raw data in graph A. Absorbance values of wells containing PBS and cytochrome c were subtracted from 
the data before analysis, n = 4. Mean bars were removed for clarity.
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Figure 4.41 Initial rates of superoxide generation in PBS by XO at 21% 0 2 with catalase and SOD.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), hypoxanthine (H) 
(ImM ), nitrite (N) (ImM). catalase (CAT) (250U m l1), SOD at (50U m l'1) and XO at (0, 1, 10 and 50mU 
m l1) in a final volume o f200pl PBS at 37°C. Initial rates o f superoxide generation (nmole min m l'1) were 
calculated from the raw data shown in figure 4.37-4.40 n = 4. Mean±SD.
4 .3 .2 .1 .2  S u p e r o x i d e  g e n e r a t i o n  b y  X O  in  P B S  in  1 %  0 2
Superoxide generation by XO in PBS was repeated in hypoxia (1% oxygen) to 
mimic the low oxygen environment of the chronic wound, and to compare with the levels 
of O2 *" generated in 21% O 2 (Figure 4.37-4.41). Compared with the previous assay carried 
out in air in the absence of SOD and catalase (figure 4.37) at 1% oxygen (figure 4.42) 
there is little reduction of cytochrome c suggesting O2 ’” generation is minimal or absent at 
1% oxygen. Therefore, the addition of SOD (figure 4.43) had no effect compared with 
figure 4.42. Interestingly, however, when catalase is added, which breaks H2O2 down to 
H20  and O2 , cytochrome c reduction is observed in the presence of 50mU m f1 XO with 
hypoxanthine and to a lesser extent when nitrite is also included (figure 4.44). Addition of 
both catalase and SOD (figure 4.45) produced a result that was almost identical to that 
seen in figure 4.44 showing cytochrome c reduction by XO (50mU m l'1) with 
hypoxanthine in the presence and absence of nitrite, with a reduced rate of reduction when 
nitrite was also included. This results suggesting that the observed rates in figure 4.44 are 
not due to 02*~ generation, or that SOD is inactivated by XO-generated RONS. Overall, 
however, the rate of 02*” generation by XO when compared with 21% oxygen (figure 
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Figure 4.42Timecourse of cytochrome c reduction in PBS by XO in 1% oxygen
Experiments were carried out in 1% oxygen using final concentrations o f cytochrome c (50pM), 
hypoxanthine (H) (ImM), nitrite (N) (ImM ) and XO at (0, 1, 10 and 50mU m l1) in a final volume o f 200pl 
PBS at 37°C in a sealed 96-well plate. Graph A shows a timecourse o f cytochrome c reduction at 550nm 
over a 3 hour time period. Graph B shows a timecourse of superoxide generation (nmoles m l1) calculated 
from the raw data in graph A. Absorbance values of wells containing PBS and cytochrome c were subtracted 
from the data before analysis. Experiments were carried out on two separate occasions in quadruplicate 
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Figure 4.43 Timecourse of cytochrome c reduction in PBS by XO in 1% oxygen with SOD.
Experiments were carried out in 1% oxygen using final concentrations of cytochrome c (50pM), 
hypoxanthine (H) (ImM), nitrite (N) (ImM), SOD (50U m l1) and XO at (0, 1, 10 and 50mU m l'1) in a final 
volume of 200pl PBS at 37°C in a sealed 96-well plate. Graph A shows a timecourse of cytochrome c 
reduction at 550nm over a 3 hour time period. Graph B shows a timecourse o f superoxide generation 
(nmoles m l'1) calculated from the raw data in graph A. Absorbance values o f wells containing PBS and 
cytochrome c were subtracted from the data before analysis. Experiments were carried out on two separate 
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Figure 4.44 Timecourse of cytochrome c reduction in PBS by XO in 1% oxygen with catalase.
Experiments were carried out in 1% oxygen using final concentrations of cytochrome c (50pM), 
hypoxanthine (H) (ImM), nitrite (N) (ImM), catalase (CAT) (250U ml’1) and XO at (0, 1, 10 and 50mU ml’ 
') in a final volume o f 200pl PBS at 37°C in a sealed 96-well plate. Graph A shows a timecourse of 
cytochrome c reduction at 550nm over a 3 hour time period. Graph B shows a timecourse of superoxide 
generation (nmoles ml’1) calculated from the raw data in graph A. Absorbance values o f wells containing 
PBS and cytochrome c were subtracted from the data before analysis. Experiments were carried out on two 
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Figure 4.45 Reduction of cytochrome c by XO at 1% 0 2 in PBS
Experiments were carried out in 1% oxygen using final concentrations o f cytochrome c (50pM), 
hypoxanthine (H) (ImM), nitrite (N) (ImM), SOD (50U m l'1), catalase (CAT, 250U m l'1) and XO at (0, 1 
10 and 50mU m l'1) in a final volume o f 200gl PBS at 37°C in a sealed 96-well plate. Graph A shows a 
timecourse o f cytochrome c reduction at 550nm over a 3 hour time period. Graph B shows a timecourse of 
superoxide generation (nmoles m l1) calculated from the raw data in graph A. Absorbance values o f wells 
containing PBS and cytochrome c were subtracted from the data before analysis. Experiments were carried 
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Figure 4.46 Initial rates of superoxide generation by XO in PBS at 1% 0 2 with catalase and SOD.
Experiments were carried out in 1% oxygen using final concentrations of cytochrome c (50|iM), 
hypoxanthine (H) (ImM), nitrite (N) (ImM), catalase (CAT) (250U m l1), SOD (50U m l1) and XO at (0, 1, 
10 and 50mU m l1) in a final volume of200pl PBS at 37°C. Mean±SD. n=8.
4.3.2.1.3 Superoxide generation by XO in bacterial culture medium in air
Superoxide generation by XO in bacterial culture medium (Luria-Bertani Broth) 
was also assessed using the cytochrome c assay to determine the levels of O2 *” that 
bacteria would be exposed to in culture. Cytochrome c was added to bacterial culture 
medium and the absorbance followed at 550nm for 3 hours. Luria-Bertani broth (LB) 
alone was found to reduce cytochrome c over time and the addition of catalase and SOD 






Figure 4.47 Timecourse of the reduction of cytochrome c by bacterial culture medium in air.
Experiment was carried out in air using final concentrations o f cytochrome c (50pM), SOD (50mU m l1) and 
catalase (lOOmU m l'1) diluted in bacterial culture medium (LB) for a 200pl final volume. Reduction of 
cytochrome c was followed at 550nm for 3 hours in a sealed 96-well plate at 37°C. M ean±SD. n = 4.
107
Cytochrome c was reduced by XO (lOmU m l'1) alone in LB demonstrating that 
XO substrates were present in the medium. This reduction was also inhibited by SOD 
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Figure 4.48 Timecourse of the reduction of cytochrome c by XO in LB
Experiments were carried out in air using final concentrations of cytochrome c (50pM), XO (lOmU ml ') 
and SOD (50U ml"') diluted in bacterial culture medium (LB) for a 200pl final volume. Reduction of 
cytochrome c was followed at 550nm for 3 hours in a sealed 96-well plate at 37°C. Mean±SD. n = 4.
The reduction o f  cytochrome c by 10 and 50mU m l'1 XO was followed in figure 
4.49-4.52. These figures showed similar results to those found in PBS. An initial rapid rate 
o f  reduction and re-oxidation o f  cytochrome c in the absence o f  SOD and catalase was 
observed in the presence o f  50mU m f1 XO with hypoxanthine, in the presence and 
absence o f  nitrite. A similar profile was also shown in the presence o f  lOmU m l'1 XO 
with hypoxanthine and nitrite at slightly reduced rate (Figure 4.49). With the addition o f  
SOD, the reduction o f  cytochrome c is almost entirely prevented (Figure 4.50) suggesting 
that the observed rates are due to 02*” generation. Alternatively, addition o f  catalase 
prevented the re-oxidation o f  cytochrome c and showed increased 02*“ generation (Figure 
4.51). Interestingly, the reduction o f  cytochrome c by XO at 50mU m l'1 with 
hypoxanthine appeared considerably greater in the presence o f  nitrite (Figure 4.51). 
Addition o f  both catalase and SOD (figure 4.52) shows a reduced rate o f  cytochrome c 
reduction compared with catalase alone. However, the rates at 10 and 50mU m l'1 are not 
completely inhibited by the addition o f  SOD. Furthermore, in the presence o f  catalase 
alone (figure 4.51), it was noted that the rate o f  reduction at 50mU ml'1 XO with 
hypoxanthine and nitrite was greater than in the absence o f  nitrite. With the addition o f  
SOD these rates appear to be the same (figure 4.52). Figure 4.53 shows that in LB in air 
around 2-3 nmoles min'1 ml'1 o f  O2’” are produced by 50mU m l'1 XO and around
108
1.5nmoles min ml’1 of O2 *” is produced by lOmU ml’1 XO. These levels of (V - generation 
are considerably reduced when compared with 02*” generation by XO in PBS at 21% O2 , 
which showed initial rates of generation of 4-6 nmoles O2”  at 50mU ml'1 XO and 2.5 
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Figure 4.49 Timecourse of cytochrome c reduction by XO in air in LB.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H)
(ImM ), nitrite (N) (ImM ) and XO (0, 10, 50mU m l1) diluted in bacterial culture medium (LB) for a 200pl 
final volume in a sealed 96-well plate at 37°C. Graph A shows a timecourse o f cytochrome c reduction at 
550nm over a 3 hour time period. Graph B shows a timecourse of superoxide generation (nmoles m l1) 
calculated from the raw data in graph A. Luria Broth wells were subtracted from the raw data before
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Figure 4.50 Timecourse of cytochrome c reduction by XO in air in LB with SOD.
Experiments were carried out in air using final concentrations of cytochrome c (50pM), hypoxanthine (H) 
(ImM ), nitrite (N) (ImM ), SOD (50U m l'1) and XO (0, 10 and 50mU m l'1) diluted in bacterial culture 
medium (LB) for a 200gl final volume. Graph A shows a timecourse o f cytochrome c reduction at 550nm 
over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B shows a timecourse o f superoxide 
generation (nmoles ml"1) calculated from the raw data in graph A. Luria Broth wells were subtracted from 
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Figure 4.51 Timecourse of cytochrome c reduction by XO in air in LB with catalase.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), hypoxanthine (H) 
(ImM ), nitrite (N) (ImM ), catalase (CAT) (100U m l'1) and XO (0, 10 and 50mU ml"1) diluted in bacterial 
culture medium (LB) for a 200pl final volume. Graph A shows a timecourse o f cytochrome c reduction at 
550nm over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B shows a timecourse of 
superoxide generation (nmoles ml"1) calculated from the raw data in graph A. Luria Broth wells were 
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Figure 4.52 Timecourse of cytochrome c reduction by XO in air in LB with catalase and SOD.
Experiments were carried out in air using final concentrations o f cytochrome c (50pM), hypoxanthine (H) 
(ImM ), nitrite (N) (ImM ), catalase (CAT) (100U m l'1), SOD (50U m l'1) and (0, 10 and 50mU m l'1) XO 
diluted in bacterial culture medium (LB) for a 200pl final volume. Graph A shows a timecourse of 
cytochrome c reduction at 550nm over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B 
shows a timecourse of superoxide generation (nmoles ml'1) calculated from the raw data in graph A. Luria 
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Figure 4.53 Initial rates of superoxide generation by XO in bacterial culture medium at 21% 0 2.
This assay was carried out using final concentrations of cytochrome c (50jiM), nitrite (N) (ImM), 
hypoxanthine (H) (ImM), SOD (50U m l'1), catalase (CAT) (100U m l'1) and XO at (0, 10, 50mU m l'1) in 
bacterial culture medium (LB) for a 200pl final volume. The initial rate o f superoxide generation was 
calculated using timecourse assays of superoxide generation (figure 4.49-52B). Statistical analysis used was 
One-way ANOVA with Dunnett’s post test using H+N as the control. Mean±SD. n = 4.
4.3.2.1.4 Superoxide generation by XO in bacterial culture medium in 1%
oxygen
The reduction of cytochrome c in bacterial culture medium (LB) at 1% oxygen 
showed a slight rate of reduction comparable to that shown in air. Addition of SOD and 
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Figure 4.54Timecourse of cytochrome c reduction by bacterial culture medium in 1% oxygen.
Experiment was carried out in 1% oxygen using final concentrations o f cytochrome c (50pM), SOD (50mU 
m l'1) and catalase (CAT) (lOOmU m l'1) diluted in bacterial culture medium (LB) for a 200pl final volume. 
Reduction o f cytochrome c was followed at 550nm for 3 hours in a sealed 96-well plate at 37°C. M ean±SD. 
n = 8
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Xanthine oxidase (50mU ml'1) in LB without the addition of substrates is capable 
of the reduction of cytochrome c in 1% oxygen (figure 4.55), confirming that there are 
substrates in the LB that can be utilized by XO. However, this reduction is only slightly 
inhibited by SOD which suggests that the reduction of cytochrome c may be due to other 
XO-generated products, or that SOD has been inactivated or overwhelmed by XO 
generated products at 50mU m l'1. As seen in previous assays catalase increases 
cytochrome c reduction suggesting that H2O2 is re-oxidising cytochrome c.
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Figure 4.55 Timecourse of cytochrome c reduction by XO in 1% oxygen.
Experiment was carried out in 1% oxygen using final concentrations of cytochrome c (50pM), SOD (50mU 
ml"1) and catalase (CAT) (250mU ml"1) and XO (50mU ml"1) diluted in bacterial culture medium (LB) for a 
200pl final volume. Reduction of cytochrome c was followed at 550nm for 3 hours in a sealed 96-well plate 
at 37°C. Mean±SD. n = 8.
Assessments of O2 ”  generation by XO in 1% oxygen in LB in the absence of both 
SOD and catalase showed reduced rates of 02*“ generation (figue 4.56) compared with in 
air (figure 4.49). Xanthine oxidase at 50mU ml'1 with hypoxanthine both with and without 
nitrite showed similar rates of reduction of cytochrome c, although reduction was slightly 
reduced in the presence of nitrite (Figure 4.56). This reduction of cytochrome c was not 
inhibited by SOD (Figure 4.57) which suggests that the reduction of cytochrome c in 1% 
LB is not due to 02*~ generation. Addition of catalase slightly increases cytochrome c 
reduction which suggests that H2O2 is partially re-oxidising cytochrome c (figure 4.58), 
and addition of both catalase and SOD in figure 4.59, has no effect on the observed 
reduction of cytochrome c. Figure 4.60 show initial rates of cytochrome c reduction at 1% 
oxygen however, these rates are not SOD inhibitable so it is possible that they are not due 
to 02*” generation. Nevertheless, these rates are reduced when compared with at 21% 
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Figure 4.56 Timecourse of the reduction of cytochrome c by XO in LB at 1% 0 2
Experiment was carried out in 1% oxygen using final concentrations o f cytochrome c (50pM), nitrite (N) 
(ImM), hypoxanthine (H) (ImM ) and XO at (0, 10 and 50mU m l1) diluted in bacterial culture medium (LB) 
for a 200pl final volume. Graph A shows a timecourse o f cytochrome c reduction at 550nm over a 3 hour 
time period in a sealed 96-well plate at 37°C. Graph B shows a timecourse of superoxide generation (nmoles 
m l'1) calculated from the raw data in graph A. LB only wells were subtracted from the raw data before 



































Figure 4.57 Timecourse of the reduction of cytochrome c by XO in LB at 1% 0 2 with SOD
Experiment was carried out in 1% oxygen using final concentrations of cytochrome c (50pM), nitrite (N) 
(ImM), hypoxanthine (H) (ImM ) XO at (0, 10 and 50mU m l1) and SOD (50U m l'1) diluted in bacterial 
culture medium (LB) for a 200pl final volume. Graph A shows a timecourse o f cytochrome c reduction at 
550nm over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B shows a timecourse of 
superoxide generation (nmoles m l'1) calculated from the raw data in graph A as shown in the methods. LB 




















































Figure 4.58 Timecourse of the reduction of cytochrome c by XO in LB at 1% 0 2 with catalase
Experiment was carried out in 1% oxygen using final concentrations o f cytochrome c (50pM), nitrite (N) 
(ImM), hypoxanthine (H) (ImM ), XO at (0, 10 and 50mU m l'1) and catalase (CAT) (250U m l'1) diluted in 
bacterial culture medium (LB) for a 200pl final volume. Graph A shows a timecourse of cytochrome c 
reduction at 550nm over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B shows a timecourse 
of superoxide generation (nmoles m l'1) calculated from the raw data in graph A as shown in the methods. LB 
only wells were subtracted from the raw data before analysis. Mean bars were removed for clarity, n = 8.
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Figure 4.59 Timecourse of the reduction of cytochrome c by XO in LB at 1% Oxygen.
Experiment was carried out in 1% oxygen using final concentrations of cytochrome c (50pM), nitrite (N) 
(ImM), hypoxanthine (H) (ImM ) XO at (0, 10 and 50mU m l'1), catalase (CAT) (250U m l'1) and SOD (50U 
ml"1) diluted in bacterial culture medium (LB) for a 200pl final volume. Graph A shows a timecourse of 
cytochrome c reduction at 550nm over a 3 hour time period in a sealed 96-well plate at 37°C. Graph B 
shows a timecourse o f superoxide generation (nmoles m l'1) calculated from the raw data in graph A as 
shown in the methods. LB only wells were subtracted from the raw data before analysis. Mean bars were 
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Figure 4.60 Initial rates of superoxide generation by XO in LB at 1% Oxygen.
Experiment was carried out in 1% oxygen using final concentrations of cytochrome c (50pM), nitrite (N) 
(ImM), hypoxanthine (H) (ImM ), XO at (0, 10 and 50mU m l1) catalase (CAT) (250U m l1) and SOD (50U 
m l'1) diluted in bacterial culture medium (LB) for a 200pl final volume. Initial rate of superoxide generation 
(nmole m in'1 m l'1) was calculated as shown in the methods using the timecourse data shown in figure 4.80- 
483. Mean±SD. n = 8.
4.3.2.1.5 Superoxide generation by XO in fibroblast culture medium in air
Cytochrome c assays were carried out in order to assess O2’” generation by XO 
when added to fibroblast culture medium (DMEM without phenol red, containing 
Penicillin/Streptomycin, L-Glutamine and FCS). Initial experiments in air were carried out 
in cuvettes to determine the levels of 0 2 *” generated in conditions as close as possible to 
those that the dermal fibroblasts will be exposed in culture. Figure 4.61 shows that the 
fibroblast growth medium (DMEM without phenol red, containing 10% FCS, 1% L- 
Glutamine, and 1% FCS) reduces cytochrome c. Cytochrome c was reduced by fibroblast 
growth medium at a rate of approximately 0.005 Abs55onm min'1.
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Figure 4.61 Rate of cytochrome c reduction by fibroblast growth medium.
Experiments were carried out in air using final concentrations of cytochrome c (50gM), and PBS or 
fibroblast growth medium (DMEM without phenol red, 10% FCS, 1% Penicillin and Streptomycin, 1% L- 
Glutamine) in a 3ml final volume at 37°C. The initial rate of change in absorbance was calculated from the 
raw absorbance data ( A b s 55onm m in'1). The experiment was carried out on three separate occasions. 
Mean±SD. PBS n = 8, medium n = 12.
Allopurinol and SOD were also added to the assay in order to determine whether 
the reduction of cytochrome c by fibroblast growth medium was due to XO present in the 
FCS or by O2*- generation in the medium. Cytochrome c reduction by fibroblast growth 
medium is not inhibited by allopurinol or SOD (Figure 4.62), suggesting that the 
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Figure 4.62 Reduction of cytochrome c by fibroblast grow th medium.
Experiments were carried out using cytochrome c (50pM), allopurinol (lOOpM), SOD (70U ml'1) diluted in 
fibroblast growth medium (DMEM 10% FCS, 1% PS, 1% LG) for a 3ml final volume at 37°C. M ean±SD 
PBS, Fibroblast growth medium (M) and M + allopurinol (Alio) n = 5, M+SOD n = 4.
The experiment in figure 4.63 was carried out to determine which of the fibroblast 
growth medium additions were responsible for the reduction of cytochrome c. This figure
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shows that DMEM alone reduces cytochrome c, however, this rate is increased with the 
addition of penicillin/streptomycin and FCS. The addition of L-Glutamine to the DMEM 
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Figure 4.63 Reduction of cytochrome c by varying components of fibroblast culture medium.
Experiment was carried out using cytochrome c (50pM), DMEM without phenol red (D), 10% FCS (F), 1% 
Penicillin streptomycin (PS), 1% L-Glutamine (LG). Mean±SD. PBS n = 5. D, F, LG, PS n = 7. D n = 3. 
D+F and D+PS n = 4. D+LG n = 3.
A brief investigation was also carried out in which the fibroblast growth medium 
was sterile filtered as it would be before addition to cell culture to see if this filtering 
process had any effect on the reduction of cytochrome c (Figure 4.64). Figure 4.64 shows 
that there is no difference between sterile filtered and unfiltered medium in the rate of 
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Figure 4.64 Reduction of cytochrome c by sterile filtered and unfiltered medium.
Experiments were carried out using cytochrome c (50pm), and fibroblast growth medium (M) (DMEM 
without phenol red, 10% FCS, 1% Penicillin and Streptomycin, 1% L-Glutamine) in a 3ml final volume, n =
1.
Experiments also show that DMEM with XO does not appear to reduce 
cytochrome c above the levels seen with DMEM alone (Figure 4.65). Suggesting that
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substrates for XO are not present in DMEM; therefore XO can be diluted in DMEM 
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Figure 4.65 Reduction of cytochrome c by XO in DMEM.
Experiments were carried out using cytochrome c (50|iM), and XO (Im U m l'1) diluted DMEM (without 
phenol red) for a final volume o f 3mls. Mean±SD. DMEM n = 1, DMEM + ImU m l'1 XO, n = 3.
Figure 4.66 shows a comparison of the reduction of cytochrome c by XO and 
hypoxanthine in PBS and fibroblast growth medium. The rate of reduction of cytochrome 
c by XO and hypoxanthine is greater in PBS than in fibroblast growth medium (Figure 
4.66). Furthermore, cytochrome c reduction in the media with hypoxanthine was found to 
be not significantly different compared with media alone. This suggests that there is no 
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Figure 4.66 Reduction in XO activity in fibroblast growth medium.
Experiments were carried out using cytochrome (50pM), HEPES (20mM), XO (Im U m l'1), Hypoxanthine 
(H) (ImM), diluted in PBS or fibroblast growth medium (DMEM without phenol red, 10% FCS, 1% 
Penicillin and Streptomycin, 1% L-Glutamine) (M) for a 3ml final volume at 37°C. M ean±SD. PBS+H n = 
5, XO+PBS+H n = 8, MEDIA and MEDIA+H n = 6, XO+MEDIA+H n = 8. Statistical analysis was 
performed using a two-tailed unpaired t-test. *** P<0.001. PBS+H was used as a control for PBS+H+XO 
(*) and M was used as a control for M+H (NS). M+H was used as a control for M+H+XO (+)
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Further assays to determine whether the FCS addition to the fibroblast culture 
medium was responsible for the reduced rate of cytochrome c reduction by XO observed 
in fibroblast culture medium compared with PBS. Figure 4.67 shows that decreasing the 
FCS concentration of the fibroblast growth medium has no affect on the rate of 
cytochrome c reduction when compared with the no enzyme media control. This result 
suggests that the reduced rate of cytochrome c reduction by XO in fibroblast growth 
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Figure 4.67 Initial rates of cytochrome c reduction by XO in fibroblast medium with varying FCS 
concentration.
Experiments were carried out using cytochrome (50pM), XO (ImU m l'1), hypoxanthine (H) (ImM), HEPES 
(20mM) diluted in PBS or fibroblast growth medium with FCS at 0, 2, and 10% for a 3ml final volume at 
37°C. Mean±SD. n = 6 apart from XO+H+PBS n = 5.
The SOD-inhibitable portion was used to determine O2*” generation by XO in 
fibroblast culture medium in air. Figure 4.70A and B show that compared with the 
hypoxanthine control, cytochrome c reduction is increased with increasing XO 
concentration at 0.5 and ImU ml’1 XO. These rates are also SOD inhibitable which 
suggests that the rates are due to XO-generated 02*'. Figure 4.70C) shows the SOD- 
inhibitable rate of O2’" generation at 0.5 and ImU m l'1 XO in air in fibroblast growth 
medium. At a concentration of 0.5mU ml'1, XO generated 0.056nmoles min'1 ml'1 O2", 













0 .0 0 5 0 -
£
§  0 .0 0 2 5 '
0 .0 0 0 0 -
□  [XO 0.5 mU ml'1]
X
X
M+H 0 5 10 20










0 .0 0 7 5 -
c




■3 0 .0 0 2 5 -
0 .0 0 0 0 -





















0 .5  1
[XO mU ml'1]
Figure 4.68 The SOD-inhibitable rates of superoxide generation by XO.
Experiments were carried out in air using cuvettes containing cytochrome (50pM), hypoxanthine (H) 
(ImM), HEPES (20mM) and XO diluted in fibroblast growth medium (M=DMEM without phenol red, 
Penicillin/Streptomycin, L-Glutamine, and 10% FCS) for a 3ml final volume at 37°C. Graph A shows the 
rate of cytochrome c reduction by 0.5mU m f1 XOand inhibition with SOD (0, 5, 10, 20U cuvette’1). Graph 
B shows the rate o f cytochrome c reduction by ImU m l'1 XO and inhibition with SOD (0, 10, 20, 40U 
cuvette'1). Graph C shows the SOD inhibitable portion of the rate of superoxide generation with XO at (0.5 
and ImU m l'1) Mean±SD. 0.5mU m l'1 XO: n = 3. ImU ml*1 XO: M n = 6, M+H n = 2, 0 n = 4, 10 n -  5, 20 
n = 5, 40 n = 5.
124
4.3.2.1.6 Superoxide generation by XO fibroblast culture medium in 1% 
oxygen
Experiments were carried out at 1% oxygen with varying concentrations of XO in 
fibroblast culture medium and cytochrome c reduction was followed for 3 hours. The 
graphs below show that fibroblast culture medium alone gradually reduces cytochrome c 
at 1% oxygen over 3 hours (Figure 4.69) addition of SOD (Figure 4.70) and catalase 
(Figure 4.71) to the culture medium does not affect the rate o f reduction of the cytochrome 
c in medium alone suggesting that the reduction is not due to 0 2 *" or H2 O2 generation in 
the medium. Without the addition of inhibitors (Figure 4.69) there does not appear to be 
an increased rate of cytochrome c reduction in the presence o f between 0-5mU ml' 1 XO. 
There appears to be a slight rate of reduction in the presence of 50mU ml' 1 XO which is 
absent in the presence of SOD (Figure 4.70). The rate o f cytochrome c reduction at 50mU 
ml' 1 is slightly increased in the presence of catalase (Figure 4.71) but this rate does not 
appear to be inhibited in the presence of both catalase and SOD (Figure 4.72). The rate of  
cytochrome c reduction at 0-50mU ml"1 XO in the absence or presence of SOD is not 
statistically significant when compared with the no enzyme control (figure 4.73). 
However, in the presence o f catalase and with both catalase and SOD the reduction of  
cytochrome c at 50mU ml"1 XO is statistically significant when compared with the no 
enzyme control (Figure 4.73). However, overall the reduction of cytochrome c is low in 
1% O2 in the presence of 0-50mU ml' 1 XO.
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[XO mU ml'1] 








Figure 4.69 Timecourse of cytochrome c reduction in Fibroblast medium by XO in 1% oxygen
DMEM without phenol red was placed in the hypoxia cabinet set at 1% oxygen. 5% FCS, 1% P/S, and 1% 
L-Glutamine was added the following morning. 20% more of each was added to account for dilution o f XO 
and cytochrome c in PBS equilibrated overnight at 1% oxygen. Final concentrations of XO (0, 1, 5, 10, 
50mU m l'1), hypoxanthine (H) (ImM) and nitrite (N) (ImM ) were used. Reduction of cytochrome c was 
followed at 550nm for 3 hours in a 96-well plate. This experiment was carried out on two separate occasions 










Figure 4.70 Timecourse of cytochrome c reduction in Fibroblast medium by XO in 1% oxygen with 
SOD
DMEM without phenol red was placed in the hypoxia cabinet set at 1% oxygen. 5% FCS, 1% PS, and 1% L- 
Glutamine was added the following morning. 20% more o f each was added to account for dilution o f XO 
and cytochrome c in PBS equilibrated overnight at 1% oxygen. Final concentrations of SOD (50mU m l'1), 
XO (0, 1, 5, 10, 50mU ml ), hypoxanthine (H) (ImM ) and nitrite (N) (ImM ) were used. Reduction of 
cytochrome c was followed at 550nm for 3 hours in a 96-well plate. This experiment was carried out on two 
separate occasions in quadruplicate, n = 8. Mean bars were removed for clarity.
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Figure 4.71 Timecourse of cytochrome c reduction in fibroblast medium by XO in 1% oxygen with 
catalase
DMEM without phenol red was placed in the hypoxia cabinet set at 1% oxygen. 5% FCS, 1% P/S, and 1% 
L-Glutamine was added the following morning. 20% more o f each was added to account for dilution o f XO 
and cytochrome c in PBS equilibrated overnight at 1% oxygen. Final concentrations o f catalase (CAT) 
(250mU ml'1), XO (0, 1, 5, 10, 50mU m l1), hypoxanthine (H) (ImM ) and nitrite (N) (ImM ) were used. 
Reduction o f cytochrome c was followed at 550nm for 3 hours in a 96-well plate. This experiment was 
carried out on two separate occasions in quadruplicate, n = 8. Mean bars were removed for clarity.
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Figure 4.72 Timecourse of cytochrome c reduction in fibroblast medium by XO in 1% oxygen with 
catalase and SOD
DMEM without phenol red was placed in the hypoxia cabinet set at 1% oxygen. 5% FCS, 1% P/S, and 1% 
L-Glutamine was added the following morning. 20% more of each was added to account for dilution of XO 
and cytochrome c in PBS equilibrated overnight at 1 % oxygen. Final concentrations of SOD (50mU m l'1), 
catalase (CAT) (250mU m l'1), XO (0, 1, 5, 10, 50mU m l'1), hypoxanthine (H) (ImM ) and nitrite (N) (ImM ) 
were used. Reduction o f cytochrome c was followed at 550nm for 3 hours in a 96-well plate. This 
experiment was carried out on two separate occasions in quadruplicate. n=8. Mean bars were removed for 
clarity.
The rate of O2*” generation was also assessed and presented as bar graphs below 
(Figure 4.54).
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Figure 4.73 Initial rates of superoxide generation by XO in Fibroblast medium at 1% oxygen with 
catalase and SOD.
DMEM without phenol red was placed in the hypoxia cabinet set at 1% oxygen. 5% FCS, 1% P/S, and 1% 
L-Glutamine was added the following morning. 20% more of each was added to account for dilution o f XO 
and cytochrome c in PBS equilibrated overnight at 1% oxygen. Each assay was carried out with and without 
the addition o f SOD (50mU m l'1) and catalase (CAT) (250mU m l'1). XO was used at (0, 1, 5, 10, 50mU ml' 
') with hypoxanthine (ImM ) and nitrite (ImM). These graphs show the combined data from experiments 
carried out on two separate occasions (figure 4.91-4.95). n = 8. Statistical analysis using One-way ANOVA 
with Dunnett’s post test using OmU m l'1 XO as the control.
4 . 3 . 2 . 2  O x i d a t i o n  o f  d i h y d r o r h o d a m i n e  f o r  p e r o x y n i t r i t e  g e n e r a t i o n
4.3.2.2.1 Oxidation of dihydrorhodamine by SIN-1
The oxidation of dihydrorhodamine to rhodamine was used to measure the levels 
of ONOO” generated at varying concentrations of XO. Preliminary experiments were 
carried out using the ONOO" generator 3-morpholinosydononimine (SIN-1) to check that 
the assay was working. SIN-1 is a compound that releases ONOO", and is thought to 
generate equimolar amounts of 02*~and *NO, which rapidly react to form ONOO". Assays 
were carried out in 3ml cuvettes. A comparison was made between a 2ml and a 3ml 
reaction volume in a 3ml cuvette to determine whether the absorbance values using a more 
economical 2ml reaction volume are the same as in a 3ml reaction volume. The 
absorbance values using either a 2ml or a 3ml reaction volume are identical therefore; the 
2ml reaction volume is suitable for subsequent experiments (figure 4.74).
b y  X O
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Figure 4.74 Oxidation of DHR using a 2ml or a 3ml reaction volume in a 3ml cuvette.
Experiment was carried out using a final concentration of SIN-1 at (O.lmg m l'1 or 5000pM), DHR (O.lmM), 
DTPA (O.lmM) in 2ml or a 3ml final volume in 3ml cuvettes at 37°C. Readings were taken every 30 sec 
however; only 2 min readings are shown on the graph for clarity, n = 1.
To reduce the assay volume further, and increase the sample number, a 96-well 
plate assay was also developed. However, the 96-well plate reader had a 490nm filter but 
not a 500nm filter. Therefore, a wavelength scan was carried out in a cuvette using the 
spectrophotometer (HITACHI) to assess whether 490nm would be an acceptable 
measuring wavelength (Figure 4.75). The absorbance peak of oxidized DHR is at 500nm 
(Figure 4.75 B) and 490nm falls on the shoulder of the peak. Therefore at this wavelength 
the absorbance is slightly reduced by an average o f 23.2% when compared with 500nm. 
Therefore, it is possible to use the 490nm filter to follow the oxidation o f DHR but the 
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Figure 4.75 Wavelength scan of the oxidation of DHR.
Wavelength scans were carried out using final concentrations of DHR (O.lmM), DTPA (O.lmM) with and 
without SIN-1 (500pM) in a final volume of 2ml PBS at 37°C using the HITACHI spectrophotometer. Start 
wavelength 700nm finish wavelength 340nm scan speed 800nm per minute. Graph A shows a wavelength 
scan o f unoxidised DHR: No SIN-1 (n = 1). Graph B shows an example of a wavelength scan of DHR 
oxidised by SIN-1 (n = 3).
Abs 500 nm Abs 490 nm Reduction in abs at 490nm 
compared with 500nm (%)
l)Unoxidised DHR-No SIN-1 0.006 0.006 0
2) Oxidised DH R-SIN -1 0.085 0.065 23.5
3) Oxidised D H R-SIN -1 0.098 0.075 23.5
4) Oxidised DH R-SIN -1 0.280 0.217 22.5
Table 4.3Absorbance values at 500nm and 490nm and percentage change in absorbance
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SIN-1 at a range of concentrations was added to a 96-well plate and the absorbance 
change at 490nm followed in a spectrophotometer. Figure 4.76 shows the absorbance over 
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Figure 4.76 Oxidation of DHR at varying concentrations of SIN-1.
DHR (O.lmM), DTP A (O.lmM), SIN-1 (0, 15.6, 31.25, 62.5, 125, 250, 500pM) made up to a final volume 
of 200pl with PBS at 37°C. Absorbance readings were taken every minute for 70mins. The data for every 5 
minute interval up to 65min are shown on this graph for clarity. Mean±SD. n = 3.
The dose dependent increase in absorbance overtime in the presence o f SIN-1 
follows sigmoidal kinetics in the highest concentration range (Figure 4.77). There is an 
initial lag phase in DHR oxidation to rhodamine followed by an increasing rate o f change 
in absorbance until a plateau in reached. The fastest rate of change in absorbance was 
measured and the rate of generation o f ONOO" calculated using the extinction coefficient 
of 75000M'1 cm' 1 for the oxidation o f DHR by ONOO" and a correction factor of 2.2 as 
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Figure 4.77 Peroxynitrite generation at varying concentrations of SIN-1.
Experiments were carried out using DHR (O.lmM), DTPA (O.lmM) and SIN-1 at (0, 15.6, 31.25, 62.5, 125, 
250, 500pM) made up to a final volume o f 200gl with PBS at 37°C. Graph A shows a timecourse of 
peroxynitrite generation. Absorbance readings were taken every 5 minutes for 70 mins and data was 
converted to peroxynitrite generation using the extinction coefficient. Graph B shows the initial rate of 
peroxynitrite generation (nmoles min'1 m l'1) which was calculated using the data in figure 4.80B. 
Mean±SD. n = 3.
4.3.2.2.2 Oxidation of Dihydrorhodamine by XO
The DHR assay was repeated to measure ONOO- generation by XO and its 
substrates hypoxanthine and nitrite with and without the addition of DPI which inhibits 
O2 ’- production and mimics reduced oxygen conditions (Figure 4.78). Previous assays of 
bacterial killing by XOR carried out in our lab by Dr. Millar showed bacterial killing 
occurred at 50mU ml'1 XO, therefore this concentration was the starting point around
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which the preliminary DHR assays are based. Figure 4.78 shows that XO or hypoxanthine 
alone do not oxidise DHR. However, oxidation of DHR occurs in the presence o f XO and 
its substrates, hypoxanthine and nitrite. The oxidation o f DHR occurs both with and 
without the addition of DPI, which inhibits O2 '- generation. However, when DPI is 
included the rate is significantly increased compared with no DPI. Suggesting that ONOO" 
generation is increased when the reduction of oxygen to O2 ”  is inhibited at the FAD site 
as would also be the case in hypoxia. In the presence o f DPI electrons are also used by XO 
to reduce nitrite at the molybdenum site to form 'NO. Thus resulting in the simultaneous 
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Figure 4.78 Timecourse of the oxidation of DHR by XO with DPI.
Experiment was carried out in air using final concentrations of DHR (0.1 mM), DTPA (0.1 mM), DPI 
(0.2mM), hypoxanthine (H) ImM), nitrite (N) (lmM) and XO (50mU m l1) were used in a total volume of 
200pl PBS at 37°C. Absorbance readings were taken every 5 minutes for 70 min. MEAN±SD. All n = 3, 
Except DTPA+H+N+XO n = 7. Mean±SD.
Peroxynitrite generation assays by XO were also carried out in cuvettes that could 
be sealed at a certain oxygen tension and stirred at 37°C. Further assays with XO and its 
substrates were carried out in the absence of DPI in air, with and without the iron chelator 
DTPA. Figure 4.79 shows that hypoxanthine, nitrite and XO oxidized DHR with and 
without DTPA (iron chelator). The rate of DHR oxidation appears to be slightly faster 
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Figure 4.79 Oxidation of DHR by XO in air.
Experiment was carried out in air using final concentrations of XO (50mU m l'1), DHR (O.lmM), DTPA 
(O.lmM), nitrite (N) (ImM), hypoxanthine (H) (ImM ) were used in a 2ml final volume of PBS at 37°C. 
Readings were taken every 23 seconds for 22 minutes; however, an interval of 46 sec is shown the graph for 
clarity, n = 2. Mean±SD.
Preliminary assays were also carried out in hypoxia to see if there were any 
differences in the oxidation of DHR in air and 2% oxygen (figure 4.105). In air as 
previously shown, the rate of DHR oxidation by XO with hypoxanthine and nitrite is 
decreased in the presence of the iron chelator DTPA. In 2% oxygen however, the addition 
of DTPA does not have this effect (Figure 4.80). This figure also shows that at 2% oxygen 
there is a greater rate of DHR oxidation irrespective of the effect of hydroxyl radicals 
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Figure 4.80 Oxidation of DHR in air and 2% Oxygen.
Experiments were carried out using final concentrations o f XO (50mU m l'1),) DHR (O.lmM, DTPA 
(O.lmM), nitrite (N) (ImM), hypoxanthine (H) (ImM ) in a 2ml final volume of PBS in stirred and 
stoppered cuvettes at 37°C. The PBS used for the experiments was equilibrated either in air or alternatively
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in the hypoxia cabinet overnight at 2%. The 2% cuvettes were also prepared and stoppered in the cabinet 
before removing for the relevant time intervals after which they were replaced with the lids removed in the 
cabinet. Cuvettes prepared in air are shown in red and cuvettes prepared in 2% oxygen are shown in blue. 
Readings were taken at various time points over a 60 minute time period. N = 1.
Further studies were carried out in air to see if the rate of DHR oxidation in air in 
the presence of XO with hypoxanthine and nitrite could be inhibited with allopurinol 
(figure 4.81). This figure shows that XO with hypoxanthine in the absence of nitrite 
oxidises DHR and this oxidation is increased when nitrite is included. This oxidation is 
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Figure 4.81 Oxidation of DHR in air.
Final concentrations of (50mU ml'1) XO, DHR (O.lmM), nitrite (N) (ImM), hypoxanthine (H) (ImM) and 
allopurinol (A) (O.lmM) were used in a 2 ml final volume of PBS in stirred and stoppered cuvettes at 37 °C. 
Readings were taken every 30 seconds; however, every 60 second interval for 14 minutes is shown on the 
graph for clarity. All N = 1 except PBS, XO+H+PBS N = 2.
A further assay was carried out in air using XO at changing concentrations 
between 0 and 50mU ml' 1 XO in the presence o f hypoxanthine and nitrite (Figure 4.82A 
and B). Figure 4.82A shows that the substrates alone or XO alone do not oxidise DHR. 
XO in the presence o f nitrite alone also does not oxidized DHR as the presence o f electron 
donating substrate such as hypoxanthine is required. Hypoxanthine and XO are again 
shown to oxidise DHR and as this assay is carried out in the absence o f DTPA it is likely 
that this rate is due to hydroxyl radical formation.
Figure 4.82B shows that hypoxanthine and nitrite XO in the presence of 50mU m f 
1 XO shows an initial fast rate which lasts for 2.5 minutes and then continues to oxidise 
DHR at a reduced rate this effect did not occur at the lower enzyme concentrations that 
were tested. Decreasing concentrations of XO also showed a dose dependent decrease in 
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Figure 4.82 Oxidation of DHR in air.
Experiment was carried out in air graph A shows a timecourse of the oxidation of DHR by controls using 
final concentrations XO (50mU ml'1), DHR (O.lmM), nitrite (N) (ImM), hypoxanthine (H) (ImM) in a 
200pl final volume of PBS at 37°C. Graph B shows a timecourse of the oxidation of DHR by a range of XO 
concentrations. Final concentrations of XO at (0, 0.001, 0.01, 0.1, 1, 2, 5, 10, 20, 50mU ml'1), DHR 
(O.lmM), nitrite (N) (ImM), hypoxanthine (H) (ImM) were diluted in a 200pl final volume of PBS at 37°C. 
Readings were taken every minute, for 30 minutes. Mean±SD. n = 3.
A brief experiment was carried out to determine the effect that urate, the end 
product of purine metabolism, had on the oxidation of DHR to ensure that urate did not 
oxidise DHR (Figure 4.83). This figure shows that uric acid does not oxidise DHR but 
shows a slight reduction of DHR over the 30 minute time period tested (Figure 4.83).
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Figure 4.83 Oxidation of DHR by uric acid.
Experiment was carried out in air using a final concentration of uric acid at (0, 0.0037, 0.0075, 0.0150, 
0.0313, 0.0625, 0.125, 0.25, 0.5mM), DHR (O.lmM) in a final volume of 200pl PBS in air at 37°C. 
Mean±SD. n = 3.
4.4 Discussion
4.4.1 Enzyme characterisation
The measurement of the protein content o f XO was routinely measured for quality 
control between batches of the Biozyme enzyme. The results suggest that compared with 
the Bio-Rad protein assay (Figure 4.7, XO protein content 6.2mg ml'1), the Bio-Rad Dc 
assay (Figure 4.8-4.9 XO protein content 10.49 and 10.8lmg ml' 1 respectively) was the 
most reliable method of protein measurement as it gave the closest values to the data 
sheets (~10.5mg ml' 1 protein). The differences in the measurements by the two methods 
are likely to be due to varying specificities and/or sensitivity for amino acid residues. The 
pterin assay for the detection of XO and XDH activity (figure 4.10) showed that there was 
no XDH present in the Biozyme enzyme preparation. Studies have shown XO to have 
optimal ONOO" generation at lower oxygen concentrations (~7pM O2) when compared 
with XDH (~180pM O2) (Godber et al, 2000a). Therefore XO seems to be more effective 
as a ONOO" generator at the lower oxygen concentrations and therefore may be more 
effective as a dressing additive than XDH in a reduced oxygen environment such as that 
found within the chronic ulcer.
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4.4.2 Development of methods for the measurement of XO 
activity in cell growth medium
4.4.2.1 Cytochrome c assay for superoxide generation by XO
The cytochrome c assay showed that in air, XO (8mU ml'1) in the presence of 
xanthine produces a SOD-inhibitable rate of cytochrome c reduction. The addition of SOD 
dismutates O2 ’" to O2 and H2O2 suggesting that the rate o f cytochrome c reduction is due 
to O2 ’" generation by XO (Okado-Matsumoto and Fridovich, 2001). The rate o f C>2 *~ 
generation by XO (8mU ml'1) was measured to be 4nmoles min'1 ml'1 (Figure 4.11). 
Furthermore, subsequent assays in 96-well plates, using lower concentrations of XO to 
conserve the stock, showed that 2mU ml'1 XO which produced 0.5nmoles min'1 ml'1 was 
inhibited by SOD at concentrations as low as 3.9U ml"1, therefore these assays suggested 
that the concentration of SOD that was required to inhibit the enzyme could be reduced in 
order to conserve reagents in future experiments (figure 4.12 -  4.13).
As previously mentioned, assays were carried out in both cuvettes (3ml volume) 
and in 96-well plates (200pi volume) to try and conserve expensive reagents and increase 
the number of samples that could be assayed at one time. Preliminary assays, suggested 
that either o f these methods were suitable for measuring cytochrome c reduction. 
However, comparisons of these two methods showed that there were differences between 
the rate o f 0 {~  generation in the cuvette and the 96-well plate method. The results shown 
in figure (4.14) suggest that the rate of (V - production is around 3 times faster in the 
cuvette than in the 96-well plate. As the difference between these two assays was 
considerable, the methods were repeated with reagents that were warmed in a water bath 
prior to the experiment to see if  the difference in the rate of (V - generation was due to 
temperature. An increased range of XO concentrations were also used to determine 
whether the two methods had comparable sensitivity at low XO concentrations. The 
results shown in figure 4.15-4.19 support the findings in the previous assays with the rates 
in the cuvette method being around twice as fast as in the 96-well plate method. 
Interestingly, however, the assays do appear to have comparable sensitivity at low enzyme 
concentrations suggesting that the difference is not due to the method o f measurement. 
Assays were also carried out to compare the rate of O2 ’" generation both with and without 
a 15 minute shake mode at the beginning o f the 96-well plate assay, and with and without 
stirring o f the cuvette to determine whether these parameters influenced the rate of O2 *" 
production (figure 4.20-4.21). Neither o f these changes in the methodology affected the 
rate o f O2 ’” generation to a great extent therefore it was decided that future experiments
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would be carried out without shaking the 96-well plate prior to measurements and without 
stirring, in the cuvette to mimic the static cell culture conditions more closely. The 
expected O2 ”  generation rate was roughly calculated (Figure 4.22) and it appeared that the 
cuvette method was closer to the expected O2 " production rate therefore further 
developmental experiments were carried out using the cuvette method.
Cytochrome c assays were carried out in cuvettes to determine the rate o f CV” 
production at a range o f XO concentrations that gave a proliferative response when 
applied to adult dermal fibroblasts (aHDF) according to Murrell et al (1990). Murrell’s 
study used ImM hypoxanthine and range of XO concentrations between 0 and lOmU ml"1 
(enhanced proliferation was observed between 0.001 and O.lmU ml’1). Initial cytochrome 
c assays were therefore carried out using ImM hypoxanthine and ImU ml'1 XO, and 
initial rates of O2 ’” were measured to be 0.4nmole min"1 ml’1 (Figure 4.23). Superoxide 
dismutase inhibited this reaction confirming that O2 ’" is largely responsible (Figure 4.23). 
A higher concentration o f SOD may be required for complete inhibition o f the reduction 
of cytochrome c. Murrell’s studies with aHDF also showed visible damage and 
detachment from the culture plate surface when cells were treated with lOmU ml"1 XO. 
Therefore, the CV- generation by XO at lOmU ml'1 was also assessed (Figure 4.24). This 
figure shows that lOmU ml'1 XO produces around 5nmole min'1 ml'1 (V~, and that the 
reaction was also SOD-inhibitable confirming that the observed rate is largely due to O2 ’". 
Further O2 *" measurements were carried out using an increased number of XO dilutions (0, 
0.001, 0.01, 0.1, 1 and lOmU ml'1). The rate of O2 ’” production was shown to increase 
with increasing concentrations o f XO (Figure 4.25 and Table 4.2).
Experiments were also carried out to assess the effect o f varying concentrations of 
hypoxanthine on (V - generation by XO (ImU ml'1). Figure 4.26 shows that the rate of 
O2 *- generation increases with increasing hypoxanthine until around 5pM hypoxanthine. 
As the substrate concentration continues to increase up to ImM hypoxanthine, and the 
enzyme becomes saturated, the rate of (V~ generation plateaus at a rate o f 0.7nmole O2 ’” 
min'1 ml"1. There does not appear to be any substrate inhibition at the highest 
concentration at ImM hypoxanthine. Hypoxanthine at ImM was used in Murrell’s 
proliferation assays and was also used for the studies in this thesis. A high concentration 
of hypoxanthine is required to supply the enzyme with an excess of substrate, as it will not 
be replenished in vitro as it would physiologically in vivo.
As mentioned previously Murrell et al, (1990) used HEPES buffer in the culture
medium for the proliferation study experiments, this methodology was repeated for some
of the initial fibroblast studies carried out in this thesis. HEPES is a very commonly used
biological buffer; however, previous studies have shown that HEPES has free radical-
139
scavenging properties. Therefore, cytochrome c assays were carried out to determine 
whether HEPES had any effect on O2 *- generation by XO in air. The results suggest that 
HEPES does not significantly effect 02*” generation under these conditions (Figure 4.27). 
Furthermore, as enzymes can lose their activity over time, old and new batches o f XO 
were routinely checked before addition to cell based assays, to ensure the consistency and 
reproducibility o f experiments (figure 4.28).
Whilst carrying out the cuvette assays, it became clear that large quantities of 
reagents were required, and it was time-consuming to produce replicate experiments. 
Therefore, it became increasingly apparent that a 96-well plate method would be 
extremely advantageous. Further cytochrome c assays were carried out to compare the 96- 
well plate and the cuvette methodologies. It was finally found that the temperature at 
which the 96-well plate was actually carried out was lower than the temperature set. 
Therefore, the calibration of the plate reader temperature settings appeared to resolve the 
difference seen in the rate of 02*" generation in the cuvette and the 96-well plate (Figure 
4.29-4.30). To achieve 37°C at the actual plate, the software needed to be set at 40°C. 
With these modifications, the cytochrome c assays for the detection of O2 *” could also be 
carried out in 96-well plates. The 96-well plate methodology was also used to develop an 
assay to measure O2 *- generation in hypoxia.
An initial 96-well plate assay is shown in figure 4.31, lOmU ml’1 XO was used
with ImM hypoxanthine to assess the activity of XO batches as mentioned previously
prior to experiments with fibroblasts and bacteria (figure 4.31). Xanthine oxidoreductase
at a concentration o f 50mU ml'1 was also measured in figure 4.32 using hypoxanthine
(ImM) and nitrite (ImM) as the substrates with 50mU ml'1 XO. Nitrite was also included
in these assays as it will also be included in the cell based experiments to generate 'NO,
and also ONOO- through the simultaneous generation o f O2 *- . Figure 4.32 shows that
nitrite and hypoxanthine do not reduce cytochrome c either alone or in combination and
cytochrome c is not reduced by nitrite and 50mU ml'1 XO. However, the reduction of
cytochrome c by hypoxanthine and 50mU ml'1 XO is rapid both with and with out nitrite.
An observation that was made when carrying out previous assays, although only at higher
XO concentrations, was that cytochrome c was reduced and then rapidly re-oxidised to
baseline levels (Figure 4.32). A repeat of this assay confirmed this finding (Figure 4.33).
Therefore, at high XO concentrations of XO it is possible that this re-oxidation o f the
cytochrome c, underestimates the initial rate of O2 '- generation, and it is also possible that
this re-oxidation effect does not allow a true indication o f the time course of 0 2 *”
generation by XO. To determine whether the reduction observed in figure 4.33 was due to
O2 *- generation, cytochrome c reduction by 50mU ml'1 XO was inhibited by varying
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concentrations of SOD. Figure 4.34A) and B) showed that 50U ml'1 SOD completely 
inhibited XO-generated O2 *" at 5nmoles min"1 ml"1 by dismutation of 0 2 ”  to H2O2 and 
oxygen confirming that the observed rate was due to 02*” generation. Additionally, XO- 
generated H2 O2 was found to be responsible o f the re-oxidisation of cytochrome c at 
50mU ml'1 XO. Figure 4.35 showed that catalase completely prevented the re-oxidation of 
cytochrome c between 50 and 250U ml'1 catalase. Catalase converts H2 O2 to H2O and O2 
thus preventing it from re-oxidising cytochrome c.
The effect o f the XO inhibitor allopurinol on the XO-generated 0 2 ”  was also 
assessed. Figure 4.36 clearly demonstrated inhibition of O2 *" generation. However, even 
at high concentrations o f allopurinol the assay was not inhibited to baseline levels. This is 
likely to be due to the fact that allopurinol is a suicide substrate o f XO, which upon 
oxidation yields the product, alloxanthine or oxypurinol. The latter compound inactivates 
the enzyme by coordinating irreversibly to the reduced form of XO, at MO(IV) thus 
inhibiting the donation of further electrons by substrates at this site (Nakamura, 1991; 
Massey et al, 1970). However, electrons initially donated to XO by allopurinol can go on 
to generate 0 2 ”  until formation of oxypurinol inhibits the enzyme. Therefore this result 
suggests that oxypurinol would be a more suitable inhibitor for this assay.
In order to determine the levels of 02*" that human dermal fibroblasts and bacteria
would be exposed to in culture. Cytochrome c assays were carried out over a 3 hour time
period, and 02*" generation at varying concentrations o f XO was assessed. Assays were
also carried out in PBS, fibroblast growth medium and bacterial growth medium (LB) for
comparison. Experiments were also carried out in hypoxia and in air to provide an idea of
the range o f 02*" that the fibroblasts and bacteria would be exposed to in culture. SOD was
included in these assays to determine the portion o f the cytochrome c reduction that is due
to O2 *". This is particularly important in the assays containing culture medium as there are
likely to be components present that are able to reduce cytochrome c. Catalase was also
used to prevent the re-oxidation of cytochrome c by XO-generated H2O2 . Initial assays
were carried out in PBS at 21% O2 using 1, 10 and 50mU ml'1 XO (Figure 4.37-4.41).
Figure 4.37A) and B) shows that in the absence of SOD and catalase XO at 50mU ml'1
with hypoxanthine (ImM) both in the presence and absence of nitrite (ImM) produces a
rapid reduction of cytochrome c followed by re-oxidation, this effect has been shown in
previous assay (figure 4.35) to be a result of H2 O2 produced by XO along with O2 ”  at high
enzyme concentrations. A slower re-oxidation effect was also observed at lOmU ml"1 XO.
This re-oxidation effect did not occur at ImU ml'1 XO, as O2 *" and thus H2 O2 generation is
slower. Cytochrome c reduction progresses at a gradual rate at ImU ml'1 XO. The addition
of SOD showed that the rates observed in the previous assay were due to O2 ’" generation
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by XO (Figure 4.38A and B). The addition of catalase in figure 4.39A and B was shown to 
prevent the re-oxidation o f cytochrome c by removal of the H2O2 , and to increase O2 ’" 
generation with a maximum generation of between 25 and 30nmoles ml'1 02*” at 10 and 
50mU ml"1 XO (Figure 4.39 B). Addition of both catalase and SOD to the assay (Figure 
4.40) showed inhibition of the rates observed at 1 and lOmU ml"1 XO in figure 4.39. 
However, at 50mU ml'1 XO there was a slight rate of reduction observed. Interestingly, 
this rate was slightly faster in the absence of nitrite which could be due to ONOO" 
generation in the presence of nitrite which is known to re-oxidise cytochrome c. It is 
possible that rapid O2 consumption by XO results in a hypoxic environment in the 96-well 
plate allowing ONOO" formation to occur in air. The rates may also occur at this enzyme 
concentration because the SOD added into this assay may not be able to completely 
scavenge all of the 02*" generated by XO at this concentration in the presence of catalase. 
It is also possible that the generation of O2 from the breakdown of H2O2 also produces an 
increased level of O2 ’" generation, or that SOD is inactivated by these increased 
concentrations of ROS. The initial rate of O2*” generation at 21% oxygen in PBS was 
found to be around 5nmole min'1 ml"1 at 50mU ml"1 XO with hypoxanthine in the presence 
and absence of nitrite (Figure 4.41). Superoxide generation at lOmU ml"1 XO was found to 
be around 2.5nmole min'1 ml'1, and with ImU ml'1 XO around 0.1-0.3nmoles min'1 ml'1 
(Figure 4.41).
The previous XO assays carried out in air (Figure 4.37-4.41), were repeated at 1%
oxygen (Figure 4.42-4.45). In the absence of SOD and catalase figure 4.42 showed little
cytochrome c reduction at 1% oxygen with only a suggestion o f a rate at 50mU ml'1 XO.
This suggests that in the limited oxygen that is available, XO can only produce low levels
of O2 *” at 50mU ml'1 XO. Addition of SOD, however, does not appear to have much effect
on this rate (Figure 4.43). Interestingly, when catalase is added (figure 4.44), there is a
significant increase in cytochrome c reduction in the presence of 50mU ml'1 XO and
hypoxanthine both with and without nitrite, it is possible that these levels are artificially
high due to oxygen used from the breakdown of H2O2 being used by XO to produce O2 *”
and H2 O2 . A further interesting point to note from this graph is that XO (SOmUml'1) in the
presence of hypoxanthine without nitrite reduces cytochrome c to a greater extent that
when nitrite is also included, which was also observed at 21% O2 in the presence of
catalase and SOD. This suggests that O2 ’” may be combining with ‘NO to produce ONOO"
which re-oxidises cytochrome c. Furthermore, in the presence o f catalase and SOD (figure
4.45), the result is identical to that with catalase alone (Figure 4.44) suggesting that the
rates observed in figure 4.44 are not due to O2 *" generation. However, it could be that
there is not enough SOD added to the reaction or that the SOD is inactivated over time by
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XO-generated species. Studies have previously shown that H2O2 and ONOO' are capable 
of inactivating SOD and also catalase (Salo et al, 1988; Salo et al, 1990; MacMillan-Crow 
et al, 1998). However, analysis of the initial rates showed that in PBS at 1% O2 low levels 
of O2 ’" generation were only detected at 50mU ml'1 XO at around 0.2nmoles min'1 ml'1. 
Therefore, compared with experiments carried out in air (-21% oxygen), superoxide 
generation is dramatically decreased at 1% oxygen.
These experiments were also used to determine levels of O2 *' generation in 
bacterial culture medium (LB) at 21% and 1% oxygen. In control experiments, without 
enzyme, at both oxygen concentrations, cytochrome c was reduced in the presence o f LB 
and this reduction was unaffected by the addition of catalase or SOD suggesting that this 
reduction is not a result of H2O2 or 02*' (Figure 4.47 and 4.54). As LB is an undefined 
medium it is difficult to identify exactly what is responsible for the reduction o f the 
cytochrome c however this background rate was taken into consideration when O2 " 
generation was determined. In air, XO was shown to reduce cytochrome c in LB without 
the addition of the substrates, suggesting that LB contains substrates that can be utilized 
by the enzyme (Figure 4.48). This rate was also SOD-inhibitable suggesting that O2 " 
generation by XO was responsible (Figure 4.48). In these assays in PBS the 02*' 
generation by XO at 10 and 50mU ml'1 was assessed with the addition o f hypoxanthine 
(ImM) and nitrite (ImM). The reduction of cytochrome c in LB in the absence of catalase 
and SOD was similar to that shown previously in air at these enzyme concentrations, 
showing a rapid rate of cytochrome c reduction and then re-oxidation (Figure 4.49). 
Addition o f SOD appeared to inhibit these rates suggesting that they were due to 02*' 
generation (Figure 4.50). Addition of catalase abolished the re-oxidation effect and 50mU 
ml'1 XO in the presence of hypoxanthine and nitrite appeared to produce an increased rate 
of cytochrome c reduction compared with hypoxanthine alone (Figure 4.51). It is possible 
that in the LB, XO is able to produce additional species to reduce cytochrome c to a 
greater extent when nitrite is also included. Alternatively, it may be that more hydrogen 
peroxide is formed in the absence of competition for electrons by nitrite resulting in re­
oxidation to a greater extent in the absence of nitrite. Addition of SOD (Figure 4.52) 
largely inhibits these rates although not to control levels. This maybe due to the fact that 
XO in the presence of LB can produce other species reduce cytochrome c. Alternatively, it 
could be that an increased SOD concentration is required, or as previously discussed, that 
the activity of the SOD is inhibited by ROS or ONOO' generation.
At 1% O2 in LB, XO reduced cytochrome c in the absence o f any additional
substrates, as shown previously in 21% O2 in LB, however, the addition o f SOD did not
appear to inhibit this rate in the presence of absence of catalase (figure 4.55). Again, this
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could be due to generation of species in LB by XO that are not SOD inhibitable, or 
inactivation of SOD by XO-generated species. At 1% O2 (figure 4.56), a reduced rate of 
cytochrome c reduction was observed compared with at 21% O2 (figure 4.49), and rates 
were only observed at 50mU ml'1 XO with hypoxanthine in the presence and absence of 
nitrite. These rates only showed a slight inhibition with the addition of SOD (Figure 4.57) 
and addition of catalase only slightly changed the profile o f the graph by slightly reducing 
the re-oxidation effect (Figure 4.58). Addition of catalase and SOD did not inhibit the rate 
observed with catalase alone (Figure 4.59). Overall, these graphs suggest that O2 *- 
generation is reduced in 1% oxygen as compared with in air. It is unclear whether the 
observed rates are due to O2 *” although they were not SOD-inhibitable it is possible 
however, that the SOD is inactivated by XO-generated species.
Superoxide generation by XO was also measured in fibroblast growth medium. 
Initial assays in air showed that fibroblast growth medium alone reduced cytochrome c 
(Figure 4.61). Furthermore, this reduction was not found to be allopurinol or SOD 
inhibitable, suggesting that the rate was not due to CV" generation by XO that could be 
present in the FCS, or by O2 *” generation from other sources present in the fibroblast 
growth medium (Figure 4.62). These rates were subtracted in order to ascertain the levels 
of O2 *- generation by XO in fibroblast growth medium. Analysis o f the individual 
fibroblast growth medium components showed that DMEM (without phenol red), FCS 
and the penicillin streptomycin mixture reduced cytochrome c (Figure 4.63). L-Glutamine, 
did not reduce cytochrome c above levels seen with DMEM alone (Figure 4.63). Sterile 
filtering o f the fibroblast growth medium, as would be done before the addition to cell 
culture, showed that the components o f the fibroblast growth medium that were 
responsible for the cytochrome c reduction were not filtered out (Figure 4.64). 
Furthermore, the data sheet supplied with the DMEM (without phenol red) suggested that 
it did not contain any substrates for XO. However, Figure 4.65 confirmed that the DMEM 
did not contain substrates for O2 ”  generation by XO, therefore DMEM could be used to 
dilute the XO prior to assays using fibroblast growth medium.
Xanthine oxidase reduced cytochrome c considerably faster in PBS than in the
presence o f fibroblast growth medium (Figure 4.66). The lower rate with fibroblast growth
medium could be due to the presence of antioxidants such as SOD in the FCS, or the
reaction o f O2 *- with other components of the medium such as amino acids. However,
figure 4.67 showed that a dilution and removal of FCS did not affect the rate of
cytochrome c reduction in fibroblast growth medium. This suggests that FCS was not
responsible for the reduced rate of cytochrome c reduction, and it is that more likely that
the reduction of cytochrome c reduction is due to reaction of O2 *" with amino acids present
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in the DMEM. In support of this, emerging evidence in the literature suggests an 
important role for nutritional factors such as essential amino acids L-methionine and 
glycine in reducing oxidative stress (Erdmann et al, 2005).
In fibroblast growth medium at 1% 02, O2 *” -generation by XO was measured at 1, 
5, 10 and 50mU ml'1. In the absence of SOD and catalase 50mU ml'1 XO produced a 
slight rate of cytochrome c reduction, suggesting that low levels o f 0 2 *” are produced at 
high enzyme concentrations (Figure 4.69). However, the rate calculations did not show a 
statistical difference compared with the control (Figure 4.73). The addition o f SOD (figure 
4.70) appeared to inhibit the slight rate shown at 50mU ml'1 XO which suggests that the 
slight rate seen in the absence of SOD was due to O2 *” generation. The rate o f cytochrome 
c reduction was increased in the presence of catalase although this increase was not as 
marked as seen in previous assays, which is probably due to the fact that there is less H2 O2 
generation in low oxygen (Figure 4.71). Furthermore this increased rate was not inhibited 
by SOD which suggests that it is not entirely due to O2 ’” generation or that SOD has been 
inhibited by XO-generated species as previously discussed (Figure 4.72). It is unsurprising 
that there is such low 02*” detected in 1% oxygen as oxygen is required for O2 *” generation 
and the O2 *” that will be produced will rapidly react with ‘NO to form ONOO”. It is also 
possible that peroxynitrite generation slightly underestimates the O2 *” generation by 
oxidation o f the cytochrome c.
4.4.2.2 Oxidation of dihydrorhodamine for peroxynitrite generation
by XO
Experiments were carried out to measure ONOO” by following the oxidation of  
dihydrorhodamine (DHR) to rhodamine. Initial experiments were carried out to develop 
the assay for measurements in a reduced volume in a cuvette (Figure 4.74), and a 96-well 
plate to conserve the expensive DHR and increase sample number (Figure 4.75 and Table
4.3). Assessment o f the wavelength scans of DHR oxidized by SIN-1 also showed that the 
existing 490nm filter on the 96-well plate reader was suitable for ONOO” measurements 
avoiding the need to purchase a new and expensive 500nm filter. SIN-1 was used as a 
positive control for ONOO” generation and showed that the assay was detecting ONOO”. 
Dihydrorhodamine was oxidised in a dose-dependent manner by increasing concentrations 
of SIN-1 (Figure 4.76-4.77).
The assay was then used to detect ONOO” generation by XO in air. In the presence
of nitrite XO generates ‘NO in increasing amounts as ambient O2 is reduced, this situation
provides the ideal conditions for generation of ONOO” which requires simultaneous
generation o f ‘NO and O2 ’”. Therefore, initial assays with XO in air were carried out using
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diphenyliodonium chloride (DPI) which inhibits O2 ’- generation thereby simulating 
hypoxia and changing the competition for donated electrons in favour of nitrite, generating 
’NO thus allowing for ideal ONOO" forming conditions. These studies showed that XO 
with hypoxanthine and nitrite where capable o f DHR oxidation in the presence and 
absence o f DPI, albeit to a lesser extent in the absence of DPI (figure 4.78). It is possible 
that the DHR oxidation by XO in the absence of DPI may also represent ONOO" 
generation, by virtue of the possibility that oxygen in the wells has been rapidly consumed 
by XO to generate O2 ’". The increased rate with the addition of DPI is clear evidence of 
ONOO" generation.
The previous assay carried out in air with hypoxanthine, nitrite, XO in the absence 
of DPI showed a slight rate o f DHR oxidation. This assay was repeated in air with and 
without the iron chelator DTPA to determine how this addition affected the oxidation of 
DHR in the presence of XO and its substrates. Figure 4.79 clearly shows that the rate of 
oxidation in the absence of DTPA is faster. This can be explained by the fact that XO 
generates H2 O2 which can combine with iron to produce hydroxyl radicals which are 
known to be detected by the DHR assay. Therefore this reaction is prevented in the 
presence of the iron chelator DTPA, resulting in a slower rate o f DHR oxidation.
Figure 4.80 shows that in air, DHR oxidation in the presence of XO, hypoxanthine 
and nitrite is decreased in the presence o f DTPA. This may be because, as previously 
discussed, DTPA prevents the formation of hydroxyl radicals which are known to oxidise 
DHR. In 2% oxygen however, DTPA does not appear to affect the rate of DHR oxidation. 
This may be due to the fact that in low oxygen availability less H2O2 is generated in 
favour o f ’NO and O2 *” for ONOO" generation resulting in a reduction in hydroxyl radical 
formation (Figure 4.80). This figure also suggests that there is increased generation of 
ONOO" in 2% oxygen.
Interestingly, figure 4.81 shows that XO and hypoxanthine without nitrite oxidises
DHR. It is possible that this oxidation is due to hydroxyl radical formation as this assay
was carried out in the absence o f DTPA which prevents hydroxyl radical formation as
previously discussed. This oxidation is increased with the addition of nitrite which
suggests that ONOO" is contributing to the oxidation as shown by previous assays in the
presence and absence of DTPA. This oxidation is also shown to be inhibited by
allopurinol which confirms that XO is responsible for the oxidation o f DHR. This figure
also shows that allopurinol does not completely inhibit the oxidation o f DHR, due in part,
as mentioned previously, that allopurinol donates electrons to XO to produce oxypurinol
before inactivating the molybdenum site of the enzyme. Also the allopurinol was used at a
lower concentration than the hypoxanthine increasing the chances o f hypoxanthine to be
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used as a substrate due to the fact that the inhibition of XO by allopurinol is competitive. 
Oxypurinol may have been a better choice o f inhibitor under these circumstances.
Figure 4.82A) shows that the substrates alone or XO alone do not oxidise DHR. 
XO in the presence of nitrite alone also does not oxidise DHR as the presence of electron 
donating substrate such as hypoxanthine is required for NO and O2*- generation for 
ONOO" generation by XO. As shown in assays previously discussed hypoxanthine and 
XO are shown to oxidise DHR and as figure 4.82 was carried out in the absence of DTPA 
it is likely that this rate is due to hydroxyl radical formation. Figure 4.82B) shows that 
hypoxanthine and nitrite in the presence of 50mU ml"1 XO produces an initial fast rate 
which lasts for 2.5 minutes and then continues to oxidise DHR at a reduced rate. It is 
possible that this effect is due to substrate depletion, inactivation of the enzyme by its 
products or excessive oxygen consumption by XO resulting in reduced 02*" and 
subsequent ONOO" generation. Furthermore, this effect was not evident at the lower XO 
concentrations that were tested.
The DHR provided a suggestion o f ONOO" by XO, however due to time 
constraints, these assays were not developed any further. However, if  time allowed further 
studies could be carried using another method to confirm these findings. For example 
hydroxylphenyl fluorescein (HPF) is a relatively new probe which can be used to detect 
peroxynitrite (Setsukinai et al, 2003). Although H2O2 was measured indirectly, in the 
cytochrome c assays, it would also be interesting to measure the H2O2 generated by XO in 
culture medium and variable oxygen.
4.4.3 Chapter summary
The results in this chapter highlight the inherent difficulties that are associated 
with the measurement of RONS, particularly in a cell culture environment where 
numerous reactions can take place and are challenging to unravel. Nevertheless, the 
findings of this chapter using pure enzyme confirm previous reports o f superoxide 
generation by XO. Moreover, I have shown that this generation is reduced at low oxygen 
tension at a level similar to that of the chronic wound. The results in this chapter also 
highlight the ROS scavenging properties of cell culture medium and provide a useful 
caveat when using in vitro systems to model the complex environment o f the chronic 
wound. These assays also identify the levels of superoxide that wound-related fibroblasts 
and bacterial cells would be exposed to in vitro. These assays also provide indirect 
evidence of H2 O2 generation by XO. Furthermore, I have found evidence o f ONOO" 




5 Effects of XO-generated products on human 
dermal fibroblasts
5.1 Introduction
As previously dicussed XO is capable o f generating a range o f ROS, which have 
been reported to have proliferative effects on human endothelial cells and cultured 
fibroblastic cells, such as human dermal fibroblasts (Kim et al, 2001; Novogrodsky et al, 
1982; Amstad et al, 1991; Han et al, 2003; Murrell et al, 1990). Studies have indicated 
that H2 O2 , 02*", and *OH all stimulate human dermal fibroblast proliferation (Murrell et al, 
1990). It is thought that ROS derived from both cellular and exogenous sources at 
physiological levels play a critical role as cell signalling “messengers”. However, critical 
balances appear to exist in relation to cell proliferation on one hand and lipid peroxidation 
and cell death on the other. For example, H2O2 at 200pM has been shown to decrease 
fibroblast cell survival, whereas 10pM H2 O2 activates the signal-regulated protein kinase 
pathway, which is required for cell survival. In the latter case, the initiation of signal 
transduction by H2 O2 is mediated by metal-catalyzed free radical formation (Guyton et al, 
1996).
This chapter aims to determine the effects of XO-generated species on human 
dermal fibroblasts at a range o f oxygen concentrations to mimic the hypoxic chronic 
wound environment. It is hypothesised that XO has beneficial wound healing properties 
as, in addition to O2 ’” and H2 O2 generation in air, XO can generate *NO in the presence of 
nitrite in a range o f hypoxic oxygen concentrations. Furthermore, the simultaneous 
generation of both 02*" and ‘NO by XO results in ONOO” formation. As well as O2 '” and 
H2 O2 , ’NO is also known to proliferate dermal fibroblasts (Dhaunsi and Ozand, 2004) 
whereas ONOO" is a powerful antimicrobial that can be damaging to cells. These studies 
investigate the potential proliferative effects of XO-generated species along with toxicity 
on human dermal fibroblasts at a range of oxygen tensions, in order to determine a 
concentration o f XO which would provide maximum inhibitory power over bacterial 
growth in a chronic ulcer (chapter 6) with minimum cytotoxicity o f dermal cells. Human 
dermal fibroblasts (HDF) were used in this study as my thesis is concerned with cutaneous 
ulcers, and fibroblasts are essential for tissue regeneration since adequate proliferation o f 
these cells is essential for resolution o f the wound healing process. The effects o f XO on
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the viability and proliferation of HDF was determined by assessment o f metabolically 
active cells and DNA synthesis.
5.1.1 Chapter aims
The aim of this chapter is to determine the effect of varying concentrations of XO on 
the proliferation and viability o f HDF in a range of oxygen tensions, to mimic the chronic 
ulcer environment. Dermal fibroblasts are vital for the healing process and successful 
wound closure. If XO is to prove useful in a wound setting it is important that it is 
effective against bacteria without having inhibitory effects on the healing process.
5.2 Materials and Methods
5.2.1 Cell culture
5.2.1.1 Origin of primary human dermal fibroblasts (HDF)
Primary neonatal human dermal fibroblasts (nHDF) were commercially supplied 
as a cryopreserved vial of 0.9x106 cells per ampoule. The cells were derived from a 
newborn male. Suppliers assessed 90% viability and tested negative for bacteria, fungi, 
mycoplasma, HIV-1, hepatitis B and C (TCS CellWorks Ltd, Botolph Claydon, UK).
Normal adult human dermal fibroblasts (aHDF) were biopsied from uninjured skin 
of healthy individuals (N l, supplied by Royal Free Hospital, London and N2, N3, supplied 
by The Royal National Hospital for Rheumatic Diseases, Bath) and of a patient with a 
chronic venous leg ulcer (VI) that had been ongoing for at least 8 weeks (supplied by 
D.W. Thomas, Department of Oral Surgery, Medicine and Pathology, University of Wales 
College of Medicine, Cardiff). In all cases, fibroblasts were used between passage 2 and 
12. Demographic information for the healthy individuals is unknown but the patient with 
the leg ulcer was an elderly female (age 65-70). The ulcer was uninfected and the patient 
had received no antibiotics for at least 6 weeks; there were no other systemic problems or 
mixed aetiology.
5.2.1.2 Maintenance, passage and subculture of dermal fibroblasts
5.2.1.2.1 Materials
DMEM (with and without phenol red see appendix 8.1), L-Glutamine 200mM, 
Penicillin/Streptomycin (10,000units ml'1 Penicillin and 10,000pg ml'1 Streptomycin), 
PBS (Gibco Life Tech, Paisley, Paisley, UK); Foetal calf serum (FCS) (GlobePharm Ltd,
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UK); Accutase (TCS CellWorks Ltd, Botolph Claydon, UK); Trypsin EDTA xlO solution 
and cell dissociation solution (Sigma-Aldrich Co Ltd, Poole, UK).
5.2.1.2.2 Protocol
All procedures were carried out using aseptic technique in a laminar flow cabinet 
(Class II, Intermed M.D.H, M20229). Fibroblast growth medium was used for the 
isolation and serial culture of HDF (see appendix 8.1). Once confluence was achieved, 
used media was aspirated and discarded. Cells were rinsed in PBS to remove residual 
FCS. Trypsin/EDTA was added to the cells (5mls of IX trypsin/EDTA, see Appendix 1, 
per 75cm2 surface area) to allow dissociation. The flask was incubated at 37°C for 10 min, 
until there were visible signs of the cells rounding up and detaching into the medium. At 
this point fibroblast growth medium, containing FCS, was added to inactivate the trypsin 
and the cells dispersed by pipetting. The cell suspension was centrifuged (l,200rpm for 5 
minutes), and the pellet resuspended in a 1ml volume of fresh medium. Accutase and cell 
dissociation solution were also initally compared with trypsin; however, trypsin was found 
to be the most suitable (see section 5.3.2.1). To determine a specific cell seeding density, a 
sample (40pl) of the cell suspension was removed for cell counting and assessment of 
viability (trypan blue exclusion assay), using a haemacytometer (See Section 1.4.2.1.7). 
The media was increased to the desired volume for seeding and cells incubated at 37°C in 
a humidified incubator with 5% CO2 in 95% air.
5.2.1.3 Cryopreservation and revival of cells for cell stocks
Cells from almost confluent cultures o f fibroblasts were cryopreserved by freezing 
in liquid nitrogen, to provide cell banks for continuity of experiments.
5.2.1.3.1 Materials
Cryo 1°C Freezing Container and 1ml NUNC Cryo-tubes (Fisher Scientific UK 
Ltd. Leicestershire, UK), Cell Freezing medium- DMSO, (Sigma-Aldrich Co Ltd, Poole, 
UK).
5.2.1.3.2 Protocol
Cells were detached (as for subculture) using trypsin/EDTA, and were resuspended 
at a density o f lx l 06 cells ml'1 in 2ml of cell freezing medium. 1ml of resuspended cells 
were added per cryovial. Cyrovials containing cells were then placed into a freezing 
container and left overnight at -70°C to gradually lower the temperature, prior to transfer 
to the liquid nitrogen store. To revive the cells, the vials were rapidly defrosted in a water
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bath at 37°C. The suspension was then micro-pipetted into a tube and resuspended in a 
suitable volume o f media for the required culture flask (5ml per 75 cm surface area). 
Cells were incubated at 37°C in a 5% CO2 and 95% air mixture. A minimum time o f 16 
hours was allowed for cell attachment and recovery before changing the media.
To determine the required number of culture flasks required for plating cells at a 
recommended seeding density of 2,500 viable cells per cm"2 (TCS Cellworks Ltd), the 
following calculations were carried out.
No. o f cells available/2,500 = cm2 that can be plated
cm2 that can be plated/
effective growth area offlask = no. o f  culture flasks that can be seeded
5.2.1.4 Manually observed cell counts and assessment of viability
using trypan blue
Trypan blue stain was used to test the permeability o f the plasma membrane o f the 
fibroblasts for an indication of the number of viable cells for seeding into the experimental 
assays.
5.2.1.4.1 Materials
Trypan Blue, (Sigma-Aldrich Co Ltd, Poole, UK) Haemocytometer, (Fisher 
Scientific UK Ltd. Leicestershire, UK)
5.2.1.4.2 Protocol
A 40pl volume was collected from cell suspensions after dissociation of a cell 
monolayer. The 40pl was added to 40pl of trypan blue (1:1 dilution), and left for 1-2 
minutes. The trypan blue cell suspension (10pl) was pipetted into opposite chambers o f an 
improved Neubauer haemocytometer. Approximately 10pl of the cell/trypan blue mixture 
was applied to fill the counting chamber and, blue (dead) and clear (viable) cells were 
counted from five o f the nine 1mm2 squares on the counting chamber (as indicated in 
Figure 5.1). The average number of cells per square was used in the calculation o f the 





Figure 5.1 Improved Neubauer Haemocytometer for cell counting.
A One chamber of a haemacytometer slide under lOx objective and lOx ocular. The chamber is divided into 
9 major squares cell counts were taken from the 5 highlighted squares (as indicated by black squares in A). 
B Detailed view of one o f the 9 major squares. Only cells that overlap the top and left borders o f squares 
should be counted to avoid overestimating the cell concentration. O: cells that should be counted; 0 : cells 
that should be ignored.
C ells m l'1 =  M ean cells per square x 2 x 10 000  
Equation 5.1 Cell viability count
Following trypan blue-exclusion protocol cells viable cell counts could be calculated using this equation. 
The percentage of viable cells could be calculated after repeating the above calculation for trypan blue 
stained cells only. (x2: dilution factor, trypan blue dilution, xlO 000: volume correction from volume of 
1mm square under cover slip, 10’4ml, to 1ml).
5.2.2 Characterisation of HDF
5 .2 .2 .1  I m m u n o c y t o c h e m i s t r y
Prior to experimentation with HDF, they were characterized by analysis of a 
number of fibroblast specific proteins, namely the beta-subunit of prolyl-4-hydroxylase 
and disulphide-isomerase using immunocytochemisty.
5.2.2.1.1 Materials
Lab-tek chamber slide, 8-well on glass (Sigma-Aldrich Co Ltd, Poole, UK); 
Fibroblast Primary antibody (mouse anti-human monoclonal 5B5. Isotype: IgGl), 
negative control mouse IgGl, (DakoCytomation Ltd, Ely, UK); VECTA STAIN ABC Kit 
(alkaline phosphatase mouse IgG), (Vector Laboratories Ltd, Orton Southgate, 
Peterborough, UK); methanol, acetone, PBS (10X), Aquamount, (VWR International, 
Poole, UK); Fast Red, Mayer’s haematoxylin, (Sigma-Aldrich Co Ltd, Poole, UK)
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5.2.2.1.2 Protocol
HDF cells from a confluent T75 flask were resuspended in 2mls of fibroblast 
medium. The cell suspension (20pl) was added to each well o f two 8-well chamber slides 
(-100,000 cells well'1). Each slide was then topped up with 500pl of media per well. The 
cells were grown to confluence. The media was carefully aspirated, and each well was 
washed 3 times for 3 minutes each in PBS (IX). The cells where fixed in ice-cold 
methanol/acetone (1:1 v/v) for 3 mins. Each well was washed 3 times in PBS (IX) for 3 
minutes each. Cells were incubated in blocking solution for 30 minutes. The slides were 
incubated overnight in a humidified chamber at 4°C using a 1:50 and 1:100 dilution of the 
fibroblast primary antibody solution. The antibody reacts with the beta-subunit of prolyl- 
4-hydroxylase and disulphide-isomerase, known to be essential for collagen synthesis and 
unique to fibroblasts. A negative control monoclonal primary antibody was used at a 
1:200 dilution. The negative control was a monoclonal mouse IgGl antibody to 
aspergillus niger glucose oxidase (neither present or inducible in mammalian tissues). A 
none antibody control was also included using blocking serum for the duration of the 
primary antibody incubation. The remainder of the protocol was carried out according to 
the Vecta stain ABC kit for secondary antibody application. Briefly, the slides were 
incubated for 5 minutes in 400pl alkaline phosphatase substrate solution (Fast Red; made 
up according to the manufacturers instructions) and stain development was followed using 
the microscope. When cells were sufficiently stained the slides were washed in tap water 
to terminate the reaction. Cells were counterstained for 1 minute using Mayer’s 
haematoxylin. The nuclear staining was checked and the slides were washed in swirling 
tap water for 5 minutes. The slides were then mounted using Aquamount.
5.2.3 Effects of H20 2 and XO on the viability of HDF
5.2.3.1 Colourimetric methylthiazolyldiphenyl-tetrazolium bromide
(MTT) reduction assay
Viability was assessed by using the colourimetric MTT assay. Yellow tetrazolium 
salt (MTT) is reduced in metabolically active cells by the mitochondrial enzyme succinyl 
dehydrogenase to form insoluble purple formazan crystals. These crystals are solublized 
by a detergent and the colour produced is quantified by spectrophotometry at 550nm. 
There is a linear relationship between cell number and absorbance, and the number of 
viable cells and absorbance. Therefore the assay can also be used for an indication of
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proliferation. The protocol follows that of Mossman (1983) and Denizot and Lang (1986) 
with some modifications.
5.2.3.1.1 Materials
MTT, Dimethyl Sulfoxide (DMSO), (Sigma-Aldrich Co Ltd, Poole, UK), Tissue 
Culture Test Plates, 96-well Flat-bottomed plates, (Orange Scientific); DMEM (Without 
phenol red) (Gibco, Life Tech, Paisley, UK)
5.2.3.1.2 Protocol
Human dermal fibroblasts were seeded into plates (see individual figures for 
seeding densities) and incubated at 37°C in a 5% C02/95% air mixture, or in the oxygen 
controlled cabinet (see section 4.1.3) at 0-5% oxygen. After incubation the culture 
medium was removed by inverting the plate and blotting. Cells were treated with 
combinations of XO (0-100mU ml'1) hypoxanthine (ImM) and nitrite (ImM). Cells were 
also treated with H2O2 (0-10,000|iM) and basic fibroblast growth factor (bFGF, 0-50ng 
ml'1) and plates were incubated for between 3 and 72 hours, after which time the media 
was removed by inverting and blotting. Cells were incubated at with lOOpl o f 0.5-lmg ml" 
1 MTT added to the relevant wells in fresh medium (excluding the first column to which 
lOOpl of DPBS was added) and the plates incubated at 37°C generally for 3-4 hours. For 
experiments in low oxygen cells remained in the cabinet for 24 hours prior to the 
application of the test reagents, and during treatment with test reagents and MTT (see 
individual figure legends for the details of each experiment). A stock solution o f MTT was 
dissolved in PBS at 5mg ml'1 and stored at -20°C wrapped in tin foil to keep dark. The 
MTT was filter-sterilized and the small amount of insoluble residue present in some 
batches was removed. Plates were then removed from the incubator and oxygen controlled 
cabinet and DMSO was added to all wells and mixed thoroughly to dissolve the purple 
formazan crystals. After a few minutes at room temperature to ensure that all the crystals 
had dissolved, the absorbances were read on a plate reader (Dynatech MR5000), using a 
test wavelength of 550nm. Absorbances were usually read within 10 minutes o f adding the 
DMSO.
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5.2.4 Effects of XO on the DNA synthesis and proliferation of 
HDF
5.2.4.1 Bromodeoxyuridine assay using chamber slides for cell 
counts
Traditionally, the measurement of cell proliferation has involved the use of [3H]- 
thymidine to allow monitoring of DNA synthesis. However, the bromodeoxyuridine 
(BrdU) assay is based on the incorporation of the pyrimidine analogue 5-bromo-2’- 
deoxyuridine, instead o f thymidine, into the DNA of proliferating cells. The BrdU assay 
has advantages over the [3H]-thymidine assay in that it avoids the need for radioactive 
isotopes.
5.2.4.1.1 Materials
BrdU, polyoxyethylene-sorbitan monolaurate (Tween 20), (Sigma-Aldrich Co Ltd, 
Poole, UK); anti-bromodeoxyuridine antibody, (DakoCytomation Ltd, Ely, UK); 
phosphate buffered saline tablets, (Oxoid, Basingstoke, Hampshire, UK); ethanol, 
hydrochloric acid, (VWR International, Poole, UK); Vectastain Elite ABC peroxidase kit 
(Mouse IgG); 3,3’-diaminobenzidine (DAB) substrate kit for peroxidase, (Vector 
Laboratories Ltd, Petersborough, UK)
5.2.4.1.2 Protocol
Cells were grown to confluence in a T75 flask. Cells were then detached from the 
culture surface using 5mls of Trypsin and centrifuged for 5 minutes at 1,200 rpm. The 
pellet was resuspended in 1ml o f fibroblast medium. Cells were counted manually using a 
haemocytometer and a viable cell count was taken. Cells were diluted and seeded onto 8- 
well slides (see individual figures for seeding densities). Cells were allowed to settle and 
attach for 24 hrs. The medium was carefully aspirated, control and test medium (500pl) 
added to each well and the cells incubated for 4 hrs. The control and test medium was 
carefully removed from each well and transferred into 1ml eppendorf tubes. Each well was 
carefully washed in 500pi of fibroblast medium and then aspirated. A stock solution of 
BrdU (ImM), dissolved in PBS and stored at 4°C, was diluted to lOpM and 400pl was 
added to each well. The slides were incubated at 4°C for between 18hrs (However, the 
BrdU incubation time varies for certain experiments, see individual figures). The next day, 
cells were washed in 500pl of PBS for 5 minutes and were fixed in 300pl 70% alcohol 
diluted in 0.5% PBS-Tween for 30 minutes. The alcohol was removed, and the cells were
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hydrolysed in 300pl 4M HCL for 15 minutes to denature the DNA to the single stranded 
form. Each well was washed 3 times for 5 minutes in 300gl of 0.5% PBS-Tween. A 1:50 
dilution of mouse IgG anti-BrdU primary antibody in 0.5% PBS-Tween 200pl was then
well was washed three times for 5 minutes in 0.5% PBS -Tween. The secondary, anti­
mouse IgG biotinylated antibody and blocking serum were diluted 1:200 in 0.5% PBS- 
Tween according to the instructions in the Vectastain Elite ABC kit, and 300pl was added 
to each well before incubation at room temperature for 30 minutes. Wells were washed 
three times for 5 minutes in PBS (IX). Vectastain Elite ABC substrate reagent (Horse 
radish peroxidase (HRP)-avidin conjugate) was made up in lOmls PBS (IX) and 300 j l i 1 
added to each well for 30 minutes. Slides were washed three times for 5 minutes in PBS 
(IX). The wells of the chamber slides were removed and the slides incubated in DAB- 
reagent for 2 minutes using a DAB substrate kit for peroxidase (Figure 5.2). The nickel 
chloride component was also added to the slides enhancing the final colour of the stain 
(Brown to grey-black). The slides were rinsed in water and counterstained with Mayer’s 
haematoxylin for 1 minute. Slides were mounted in Aquamount, and the cells counted 
under a NIKON inverted light microscope. Cells were counted using an eyepiece graticule 
at X20 magnification. Cell counts within the grid were taken in five random fields of view 
per well.










Figure 5.2 BrdU incorporation and visualisation.
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5.2A.2 Bromodeoxyuridine assay using an ELISA system in a range 
of oxygen tensions
The BrdU ELISA has major advantages over the cell counting method as it is 
faster, allows a larger number of samples to be processed simultaneously, reagents are 
supplied in a stable optimised form and the assay is at least as sensitive as the [ H]- 
thymidine assay.
5.2.4.2.1 Materials
Cell Proliferation Biotrack ELISA System (Amersham Biosciences Ltd, 
Buckinghamshire, UK), Sulphuric acid (VWR International, Poole, UK). Mixed gases 0- 
5% oxygen, 5% CO2 balanced nitrogen.
5.2.4.2.2 Protocol
Proliferation assays were performed using BrdU-incorporation assays (Amersham) 
based on the method by Gratzner (1982). Assays were performed according to 
manufacturer’s instructions with some modifications. Adult dermal fibroblasts were 
seeded into 96-well plates and grown for 24 hours in a 5% CO2 balanced air incubator. 
Fibroblasts to be treated at 21% O2 remained in the incubator for a further 24 hours before 
treatment. Fibroblasts to be treated at 0, 1 ,2  and 5% oxygen were transferred from the 
incubator into the oxygen controlled cabinet (see section 4.1.3) which was purged to the 
relevant gas mixture (0-5% oxygen, 5% CO2 balanced nitrogen) and incubated for a 
further 24 hours. DMEM without phenol red was also placed into the cabinet in a vented 
tissue culture flask to equilibrate to the relevant pC>2 . Fibroblasts were then treated for 72 
hours with XO (0-50mU ml"1), hypoxanthine (ImM), nitrite (ImM) and bFGF at (50ng 
ml"1) diluted in fibroblast growth medium (DMEM without phenol red, 1% 
Penicillin/Streptomycin, 1% L-Glutamine, and 5% FCS) for a final volume o f 200pl. 
BrdU labelling reagent (lOpM) was then added to the cells in the incubator and oxygen 
controlled cabinet for four hours. After 4 hours the plates removed from the incubator and 
oxygen controlled cabinet. At room temperature, solutions supplied in the kit were used to 
fix the cells and denature the DNA for 30min, and block for 30 minutes. Fibroblasts were 
then incubated with lOOpl peroxidase-labelled anti-brdU for 90 minutes. The wells were 
washed 3 times for 15minutes Then, lOOpl 3,3’5,5’-tetramethylbenzidine (TMB) substrate 
was added to the wells until colour had developed (~15 mins). To terminate the reaction 
25 pi sulphuric acid (1M) was added to each well. The absorbance was then read on a plate 
reader at 450nm within 5 minutes.
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5.2.5 Statistical analysis
Statistical analysis of data collected was performed using GraphPad Prism Version
4.00 (GraphPad Software Inc.). Statistical analysis performed using a one-way ANOVA 
statistical test and Dunnett’s post test for analysis of variance between treatments.
5.3 Results
5.3.1 Characterisation of human dermal fibroblasts
5.3.1.1 Immiinocytochemistry
Immunocytochemistry was carried out to confirm that the cells used in the 
following experiments were displaying positive fibroblastic characteristics and fibroblast 
markers. Figures 5.3 to 5.6 show typical growth characteristics, spindle shaped fibroblast 
morphology and positive staining for the beta-subunit of prolyl-4-hydroxylase which is 
essential for collagen biosynthesis and unique to fibroblasts. The fibroblast marker also 
detects disulphide isomerase which is identical to the beta-subunit of prolyl-4- 
hydroxylase. Primary antibody to aspergillus niger glucose oxidase which is neither found 
or induced in mammalian tissues was used as a negative primary antibody control. (Figure 
5.7). A none primary antibody control was also included where no red-staining was 





Figure 5.3 Neonatal human dermal fibroblasts stained with fibroblast marker
Immunocytochemistry of nHDF with mouse anti-human prolyl-4-hydroxylase antibody. Primary antibody 
dilution 1:100. Visualised using Vectastain ABC kit and fast red, and counterstained with Mayer’s 
haematoxylin. Note. This image shows that there is greater than 80% staining showing a homogenous 




Figure 5.4 Neonatal human dermal fibroblasts stained with fibroblast marker
Immunocytochemistry of nHDF with mouse anti-human prolyl-4-hydroxylase antibody. Primary antibody 
dilution 1:50. Visualised using Vectastain ABC kit and fast red, and counterstained with Mayer’s 
haematoxylin. Antibody reacts with P subunit o f proly-4-hydroxylase and disulphide isomerase indicated by 





Figure 5.5 Neonatal human dermal skin fibroblasts stained with fibroblast marker
Immunocytochemistry of nHDF with mouse anti-human prolyl-4-hydroxylase antibody. Primary antibody 
dilution 1:50. Visualised using Vectastain ABC kit and fast red, and counterstained with Mayer’s 





Figure 5.6 Neonatal human dermal skin fibroblasts stained with fibroblast marker
Immunocytochemistry o f nHDF with mouse anti-human prolyl-4-hydroxylase antibody. Primary antibody 
dilution 1:50. Vectastain ABC kit and fast red, and counterstained with Mayer’s haemotoxylin. Note. This 
close up clearly shows localization of the prolyl-4-hydroxylase in the cytoplasm of the cells, indicated by the 
red staining. (X40 magnification).
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Figure 5.7 Negative antibody control.
A) X20 magnification. B) X40 magnification. Immunocytochemistry o f nHDF with monoclonal mouse 
IgGl antibody to aspergillus niger glucose oxidase. Primary antibody dilution 1:200. Visualised using 
VECTASTAIN ABC kit and fast red, and counterstained with Mayer’s haemotoxylin. Note. There is no 
staining o f the prolyl-4-hydroxyalse as indicated by the red stain in figure 5.2-5.5. However, a blue nuclear 
stain is clearly indicated by the Mayer’s haematoxylin.
5.3.2 Effects of H20 2 and XO on the viability of human dermal 
fibroblasts
Metabolically active cells were assessed using the MTT reduction assay after 
exposure to varying concentrations of XO. An extensive range of XO concentrations were 
assayed in order to determine the concentration at which XO became cytotoxic to HDF. 
Murrell et al (1990) previously reported that concentrations of XO above ImU ml"1 caused 
visible damage and detachment. The MTT assay can also detect changes in cell number 
and was also used as an indication as to whether XO enhanced the proliferation of HDF. 
Therefore dermal fibroblasts were exposed to a range of XO concentrations from 0- 
lOOmU m l'1. Initial experiments were carried out using neonatal human dermal fibroblasts 
as they were already available as frozen stocks in the lab. These cells were useful for the 
development of assays, which were optimised for later use on adult HDF.
5 .3 .2 .1  D i s s o c i a t i o n  o f  d e r m a l  f i b r o b l a s t  c u l t u r e s  f o r  s e e d i n g
Cell dissociation solution was initially used to remove cells from the culture plastic 
for seeding of the dermal fibroblasts, and was chosen as it is a less harsh non-enzymatic 
method. However, there were problems with the initial MTT assays as it was difficult to 
derive an accurate cell count for seeding as the cells were not sufficiently dissociated and 
clumped together (Figure 5.8).
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Figure 5.8 Clumps of cells after detachment from culture plastic using cell dissociation solution.
Note: Cells detached in sheets resulting in clumping, preventing accurate cell counts as observed under an 
inverted light microscope.
The alternative dissociation solutions Accutase and trypsin/EDTA that are 
commonly used in cell culture were also tried. Comparison of the methods showed that 
although cell dissociation solution is perhaps less harsh to the cells, the cells lifted from 
the plastic, only after around 45 mins, they also required gentle tapping, and they lifted off 
as sheets rather than individual cells. These sheets did not break up with vigorous 
pipetting and resulted in clumps of cells that were uncountable under the microscope. 
Accutase broke up the cell clumps and provided individual cells from which a cell count 
could be derived. However, the best results were found with trypsin/EDTA, as the cells 
needed only 10 minutes exposure and dissociated easily. Trypsin/EDTA proved to be the 
most successful at dissociating the cells for accurate cell counting and seeding and was 
therefore used for all future experimentation.
5 . 3 .2 . 2  E f f e c t s  o f  X O  o n  t h e  v i a b i l i t y  o f  n H D F  i n  a i r
Prior to treatment of nHDF with XO, measurements were carried out to establish 
the sensitivity of the MTT assay at varying seeding densities. This was achieved by 
determining the relationship between the number of cells per cm2 seeded into the well of a 
96-well plate and the absorbance values at 550nm. Figure 5.9 shows that there is a linear 
relationship between the number of cells and the absorbance from lxlO4 up to around 
5xl04 cells cm'2 with an Absssonm of around 2. This linear portion of the graph shows the 
seeding densities that are most sensitive for detecting changes in cell number. At cell 
numbers above between 5xl04 and lx l0 5 the absorbance values begin to plateau and the 
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Figure 5.9 Cell number versus absorbance using the MTT assay
Neonatal human dermal fibroblasts were seeded into a 96-well plate at varying densities 1.5xl03, 3.0xl03, 
6.0xl03, 1.2xl04, 2.4xl04, 4 .8xl04, 9 .6xl04, 1.9 xlO5 cells cm'2 in fibroblast growth medium (DMEM, 1% 
PS, 1% LG, 10% FCS) and cultured for 24 hours. MTT (lm g m l'1) was added to DMEM without phenol red 
1% PS, 1% LG, 10% FCS and lOOpl added to the plate for 3 hours. Cells were solubilised with lOOpl 
DMSO and the plate was read at 550nm. Mean±SD. n=3.
Neonatal human dermal fibroblasts were initially used to determine the effects of 
XO with hypoxanthine on the viability of skin fibroblasts. Figure 5.10 shows a significant 
decrease in MTT reduction at concentrations above ImU ml'1 XO in the presence of ImM 
hypoxanthine, suggesting a reduction in cell viability. Futhermore, cells in the presence of 
1000U ml'1 XO without the addition of hypoxanthine did not reduce MTT. This result 
suggesting that there are substrates available in the medium that can be utilised by XO or 
that high concentrations of XO are cytotoxic.
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Figure 5.10 Viability of neonatal human dermal fibroblasts at varying XO concentrations.
Cells were seeded in 10% FCS, 1% PS, and 1% LG in phenol red free DMEM at 20,000 cells cm'2 and left 
for 24 hours to adhere to the 96-well plate. Cells were treated for 4 hours with a final concentration of XO at 
0, 0.001, 0.1, 1, 10, 100 and lOOOmU m l'1 XO and hypoxanthine (ImM ) diluted in a final volume of 200pl 
DMEM without phenol red with 1% PS, 1% LG and HEPES (20mM). Cells were then incubated for 3 hours 
with MTT (lm g ml"1). All incubations were carried out 37°C in 95% air/5% CO2 incubator. No substrate 
(NS) wells contained 1000U m l'1 XO without hypoxanthine. Mean±SD. n=4. Results are displayed as a
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percentage of the no enzyme control. Statistical analysis performed was One-way ANOVA with Dunnett’s 
post test.
The experiment above was repeated using a more extensive range of XO 
concentrations Figure 5.11. This figure shows that XO concentrations between 1.562 and 
6.25mU m l'1 XO appear to increase the reduction of MTT by nHDF and concentrations 
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Figure 5.11 Viability of neonatal human dermal fibroblasts at varying XO concentrations.
Cells were seeded in 10% FCS, 1% PS, and 1% LG in phenol red free DMEM at 25, 000 cells cm’2 and left 
for 24 hours to adhere to the 96-well plate. Cells were treated for 4 hours with a final concentration of XO at 
0, 1.562, 3.125, 6.25, 12.5, 25, 50 and lOOmU m f1 XO and hypoxanthine (ImM ) diluted in a final volume of 
200pl DMEM without phenol red with 10% FCS, 1% PS, 1% LG and HEPES (20mM) buffer. Cells were 
then incubated for 3 hours with MTT (lm g m l1) or PBS as a control (See figure 5.9). All incubations were 
carried out 37°C in 95% air/5% C 0 2 incubator. No substrate (NS) wells contained 100U m l'1 XO without 
hypoxanthine. Medium alone wells contained 200pl DMEM without phenol red with 10% FCS, 1% PS, 1% 
LG. Mean±SD. N=4. Results are displayed as a percentage of the no enzyme control. Statistical analysis 
performed was one-way ANOVA with Dunnett’s post test.
The effects of varying concentrations XO on nHDF with increasing cell number 
was also assessed (Figure 5.12A and B). This figure shows that very low seeding densities 
such as 325 cells cm"2 are not sufficient to detect MTT reduction. As the seeding density 
increases to 10,000 cells cm"2 MTT reduction is detected and the assay is sensitive enough 
to show changes in absorbance at high concentrations of XO and at this seeding density 
there is a significant decrease in MTT reduction at concentrations of 6.25mU ml"1 XO and 
above. However, as the seeding density increases, to 20,000-25,000 cells cm'2 figure 5.12 
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Figure 5.12 Effect of seeding density on the viability of nHDF exposed to XO.
Neonatal human dermal fibroblasts were seeded at 162.5, 5,000, 10,000 and 15,000 cells cm'2 and allowed to 
adhere to a 96-well plate for 24 hours. Cells were treated for 4 hours with a final concentration o f XO at 0, 
1.562, 3.125, 6.25, 12.5, 25, 50 and lOOmU ml'1 XO and hypoxanthine (ImM ) diluted in a final volume of 
200pl DMEM without phenol red with 10% FCS, 1% PS, 1% LG and HEPES (20mM) buffer. Cells were 
then incubated for 3 hours with MTT (lm g m l'1) or PBS as a control (See figure 5.10). All incubations were 
carried out 37°C in 95% air/5% CO2 incubator. A) Absorbance values (Abs550nm) at changing XO 
concentrations. B) Data expressed as a percentage o f the no enzyme control.
Assays were repeated to ensure that the assays in the presence of XO were 
reproducible. These assays showed similar results as in the preliminary assays; however it 
appeared that the effects of the enzyme on the viability of the cells was slightly reduced 
compared with previous assays. Cytochrome c assays showed no decrease in XO activity 
and therefore the slight decrease may be due to differences between FCS batches. 
Therefore, for all further experiments the FCS batch was kept constant. The controls in
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Figure 5.13A) showed a slight reduction in viability in the presence of lOOmU m l'1 XO 
without addition of hypoxanthine suggesting that substrates are present in the culture 
medium, most likely in the FCS. Figure 5.13B) showed a significant reduction in viability 
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Figure 5.13 The effect of changing concentrations of XO on nHDF viability.
Neonatal human dermal fibroblasts were seeded at 9,600 cells per cm'2 and left to adhere for 24 hours. Cells 
were then treated for 4 hours with the test reagents diluted in fibroblast growth medium (DMEM, 1% LG, 
1% PS and 10% FCS) and HEPES (20mM) in a final volume of 200pl. Graph A shows MTT reduction by 
cells treated with medium alone (M), XO (lOOmU m l'1) and hypoxanthine (H) (ImM). Graph B shows MTT 
reduction by cells treated with final concentrations o f hypoxanthine (ImM ) and XO (0, 0.00001, 0.0001, 
0.001, 0.01, 0.1, 1, 10, lOOmU m l'1). Experiments were carried out on 3 separate occasions in quadruplicate, 
therefore, n = 12. Mean±SD. Statistical analysis used was one-way ANOVA with dunnett’s post test 
(*P<0.05 ** PO .01).
Analysis of further XO concentrations showed that concentrations of 25mU ml"1 
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Figure 5.14 The effect of changing concentrations of XO on nHDF viability.
Neonatal human dermal fibroblasts were seeded at 9,600 cells cm '  and left to adhere for 24 hours. Cells 
were then treated for 4 hours with the test reagents diluted in fibroblast growth medium (DMEM, 1% LG, 
1% PS and 10% FCS) and HEPES (20mM) in a final volume of 200pl. Graph A shows MTT reduction by 
cells treated with medium alone (M), XO (lOOmU m l'1) and hypoxanthine (H) (ImM). Graph B shows MTT 
reduction by cells treated with final concentrations o f hypoxanthine (ImM) and XO (0, 0.78, 1.56, 3.13, 
6.25, 12.5, 25, 50, lOOmU m l'1). Experiments were carried out on 3 separate occasions in quadruplicate, 
therefore, n=12. Mean ± SD. Statistical analysis used was one-way ANOVA with dunnett’s post test (** 
PO .01).
5 .3 .2 . 3  E f f e c t s  o f  H 20 2 o n  t h e  v i a b i l i t y  a n d  p r o l i f e r a t i o n  o f  n H D F
The MTT reduction assay is generally used for the detection of viable cells as 
shown in the previous graphs. However, it can also be used as a proliferation assay as the 
level of MTT reduction is directly related to cell number. As the previous assays did not 
show any significant increase in cell number in the concentration ranges described by 
Murrell et al (1990), the MTT assay was developed further as a possible method for the 
measurement of proliferation. The FCS concentration was also reduced to try to enhance 
the proliferative response to XO-generated species as the proliferation of the cells at 10% 
FCS may already be at optimal levels. Figure 5.15 shows the growth of nHDF at varying 
concentrations of FCS. After 24 hours at 0.1% FCS the cells show a reduced number of
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viable cells compared with the start of the experiment, indicating that there is some cell 
death at this concentration after 24hours. At 1% FCS the number of viable cells does not 
appear to have increased suggesting that there is little proliferation occurring at 1% FCS 
after 24hours. At 5% FCS there is around half the number of viable cells compared with 
10% FCS after 24 hours; this suggests that 5% FCS would be a suitable concentration for 





Figure 5.15 Growth of nHDF at varying concentrations of FCS
Neonatal human dermal fibroblasts were seeded into 12-well plates at 4,400 cells cm'2 and left to adhere for 
24 hours in fibroblast growth medium (DMEM with 1% LG, 1% P/S and 10% FCS). Cells were then treated 
with test medium (DMEM with 1% PS, 1% LG, and FCS at 0.1, 1, 5 and 10%). At each time point cells 
were trypsinised and washed and resuspended in 200pi medium for cell counts. 20pl of cell suspension was 
mixed with 20pl of trypan blue and added to a haemocytometer for viable cell counts. Five individual counts 
were carried out per well. n=3. Mean±SD.
The previous trypan blue assay shown in figure 5.15 was repeated using the MTT 
assay and an increased number of FCS concentrations (Figure 5.16). After the first four 
hours there is little change in the absorbance suggesting that there is little change in the 
number o f viable cells. However, at 24 hours the absorbance values increase suggesting an 
increased number of metabolically viable cells, with increasing FCS concentrations. After 
28 hours, the absorbance values plateau at concentrations of 5% FCS and below, however, 
at 10% FCS there is a dramatic decrease in absorbance suggesting that there is a sharp 
drop in the number o f viable cells, possible due to depletion of the nutrients of the culture 
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Figure 5.16 Growth of nHDF at varying concentrations of FCS
Cells were seeded at 9,678 cells per cm'2 into a 24-well plate and left to adhere for 24 hours in medium 
without phenol red 10% FCS, 1% LG, 1% PS. Cells were treated with varying levels of FCS 0-10% an 
individual plate was used for each time point 4h, 8h, 24h, 28h. A final concentration of lmg m l'1 MTT was 
added to the plate 3 hours before the end of the incubation. The MTT was then aspirated from the wells and 
the plate was air dried and frozen at -20°C so that all plates could be analysed together. lOOpl DMSO 
usually added to a 96-well plate (0.31 cm2 growth area) therefore 616pl DMSO was added to the wells of 
the 24 well plate (1.91 cm2 growth area).
Previous research carried out by Murrell et al (1990) suggested that XO mediated 
proliferation was predominantly due to H2O2 generation, and several other papers have 
shown that reactive oxygen species including H2 O2 are capable o f causing cell 
proliferation at low concentrations. Several assays were carried out to determine whether 
there is enhanced proliferation after exposure o f nHDF to varying H2O2 concentrations. 
Figure 5.17 shows a significant increase in absorbance for the 10% FCS positive control 
suggesting an increase in viable cells. However, the cells treated with varying 
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Figure 5.17 The effect of H20 2 on the viability of nHDF
Neonatal human dermal fibroblasts were seeded at 20,000 cells cm'2 and left to adhere for 24 hours. Cells 
were then treated for 72 hours with H20 2 (0, 0.05, 0.5, 5 and 50pM) diluted in test medium (DMEM with 
0.2% FCS, 1% LG, 1% PS). Cells were also treated with 10% FCS as a positive control for proliferation. 
MTT (0.5 mg m l'1) was added to the plates at for 3 hours. The assay was carried out in quadruplicate, except 
XO (50mU m l'1) n=8. Mean±SD. Statistical analysis performed was one-way ANOVA with Dunnett’s post 
test using OpM H20 2 as the control (*P<0.05 ** P<0.01).
In Figure 5.18, the FCS concentration was increased to 2% and an increased range 
of H2O2 concentrations were used (0-500]liM, Figure 5.18). This figure showed enhanced 
viability of nHDF between 3.906 and 31.25pM H2O2 and a decrease in viability at 
concentrations of 125pM H2O2 and above.
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Figure 5.18 Treatment of nHDF with H20 2 for 72 hours
Neonatal human dermal fibroblasts were seeded at 8,000 cells cm'2 into a 96-well plates diluted in medium 
(DMEM without phenol red with FCS 2%, PS 1%, LG 1%) and allowed to adhere for 24 hours. Cells were 
treated for 72 hours with H20 2 (0, 0.97, 1.955, 3.906, 7.8, 15.6, 31.3, 62.5, 125, 250, 500pM) and HEPES 
(20mM), diluted in test medium (DMEM, FCS 2%, PS 1%, LG 1%). MTT (0.5mg m l'1) was added to the 
plates at for 3 hours. n=4. Mean±SD. Statistical analysis performed was One-way ANOVA with Dunnett’s 
post test using OpM H20 2 as the control (*P<0.05 ** P<0.01).
The previous H2O2 assay (figure 5.18) was repeated again with further 
modifications to the protocol. The assay shown in figure 5.19 was carried out using an 
extended range of H2O2 concentrations (0-10,000pM) to show the full range of the effects
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of H2O2 on the nHDF. The FCS concentration was also increased to 5% to try to maximise 
the proliferative response to H2O2 as an assay by Kim et al, (2001) showed an increase in 
viable cells and a suggestion of enhanced proliferation at between 0.01 and 10pM H2O2 
and a significant dose dependent decrease in the number of viable cells at concentrations 
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Figure 5.19 Treatment of nHDF with H20 2
Neonatal human dermal fibroblasts were seeded at 4,000 cells per cm'2 into a 24-well plate in medium 
(DMEM without phenol red with 1% LG, 1% PS and 5% FCS) and incubated for 48 hours. Fibroblasts were 
then treated with final concentrations of 0, 0.001, 0.01, 0.1, 1, 10, 100, 1000, and 10,000pM H2C>2 and 
HEPES (20mM) diluted in medium (DMEM without phenol red with 1% PS, 1% LG and 5% FCS). After 
24 hours MTT (0.5mg m l1) was added to the plates for 3 hours. 500pl DMSO was added to the wells to 
dissolve the cells and lOOpl was transferred to a 96 well for absorbance readings at 550nm. n=4. Mean±SD. 
Statistical analysis performed was one-way ANOVA with Dunnett’s post test using OpM H20 2as the control 
(*P<0.05 **P<0.01).
Although Murrell et al (1990) carried out fibroblast proliferation studies in the 
presence of HEPES buffer; studies have shown that HEPES has radical scavenging 
activity. Therefore, assays were carried out to determine whether removal of the HEPES 
buffer affected the response of the dermal fibroblasts to changing concentrations of H2O2 , 
and possibly enhanced the proliferative response. Experiments were carried out for 24, 48 
and 72 hours with changing H2O2 concentrations with and without HEPES buffer (Figure 
5.20A, B and C). Exposure to H2O2 for 24 hours with and without HEPES showed a slight 
decrease in viability in the absence of HEPES with increasing concentrations of H2O2 ; this 
decrease was not present in the presence of HEPES. This is probably due to scavenging of 
the H2O2 by HEPES. A study by Simpson et al (1988) implies that HEPES is capable of 






t5 2 1 0 0 -




1 5 0 -
co —
T> 2 ioo<
3 vT3 3(D oI- o
~  5 0 -
10%  FC S 0
Figure 5.20C)
150*







5 25 100 500
[H20 2 [ilVI]
48 hours
* * * * * * - HEPES 
+ HEPES
5 25 100 500
[H20 2 |iM]
72 hours
I = l -  HEPES 
CZH+ HEPES
A l x i
10%  FCS 5 25
[H20 2 ^M]
100 500
Figure 5.20 Treatment of cells with H20 2 with and without HEPES buffer for 24, 48 and 72 hours.
Neonatal human dermal fibroblasts were seeded in medium (DMEM with 5% FCS, 1% LG, 1% PS) with or 
without HEPES (20mM) at 523.56 cells per cm'2. The medium was replaced with fresh after 3 days. The 
cells were treated 6 days after seeding with H20 2 (0, 5, 25, 100, 500pM) diluted in culture medium (5% 
FCS, 1% PS, 1% LG DMEM) with (+HEPES, 20mM) or without HEPES (-HEPES). Cells were then 
incubated for a further 24 (graph A), 48 (graph B) and 72 (graph C) hours. 10% FCS was also included as a 
positive control for proliferation. n=4. Mean±SD. Statistical analysis performed was one-way ANOVA with 
Dunnett’s post test using OpM H20 2as the control (*P<0.05 ** PO .01).
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The exposure of nHDF to XO was repeated using 5% to determine whether the 
proliferative response was enhanced compared with assays previously carried out using 
10% FCS. Figure 5.21 shows enhanced viability at ImU ml'1 XO, indicating enhanced 
proliferation at this concentration of the enzyme. There also a reduction in the viability of 
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Figure 5.21 Treatment of nHDF with XO
Neonatal human dermal fibroblasts were seeded into 24-well plates at 2419 cells cm'2 and rested for 48 
hours. Cells were then treated with XO (0, 0.2, 0.5, 1, 2, 5, 10, 20, 50mU m l'1) and hypoxanthine (ImM) 
diluted in 5% FCS cells were incubated for 72 hours. 10% FCS (F) was also added as a positive control for 
proliferation. MTT was added for 3 hours. 500pl DMSO added per well lOOpl transferred into a 96-well 
plate. n=4. Mean±SD. Statistical analysis performed was One-way ANOVA with Dunnett’s post test using 
OpM H202as the control (*P<0.05 ** P<0.01).
Assays were also carried out using basic fibroblast growth factor (bFGF) to 
determine a suitable concentration to act as a positive control for fibroblast proliferation 
(Figure 5.22A-C). Figure 5.22A shows that after 24 hours, 25ng m l'1 bFGF and above 
significantly increases absorbance as compared to the control, suggesting an increase in 
viable cells. After 48 hours, figure 5.22B shows an increase in viable cells at the lower 
concentration of 5ng ml"1 bFGF and above. Figure 5.22C shows that after 72 hours the 
absorbance is significantly increased compared with the control at lOng ml'1 bFGF and 
above. The 10% FCS positive control also shows an increase in viable cells after 72 hours. 






























10% FCS 0 5 10 25 50
[bFGFng ml'1]
Figure 5.22 The effect of bFGF on nHDF
Neonatal human dermal fibroblasts were seeded into 24-well plates at 4839 cells cm'2 diluted in medium 
containing 5% FCS and rested for 48 hours before treatments with 10% FCS and bFGF (0, 5, 10, 25 and 
50ng m l'1) for 24, 48 and 72 hours. MTT (0.5mg m l1) was added for 3 hours, n =4. Mean±SD. Statistical 
analysis performed was One-way ANOVA with Dunnett’s post test.
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5.3.2.4 Effects of XO on the viability of human dermal fibroblasts in 
a range of oxygen tensions
Assays in different oxygen concentrations were carried using adult human dermal 
fibroblasts (aHDF) as the majority of chronic ulcers occur in adult patients. Furthermore, 
neonatal fibroblasts are known to have enhanced proliferative capabilities as compared 
with adult fibroblasts (Schneider and Mitsui, 1976). Assays were repeated to determine 
the sensitivity of the MTT assay on aHDF at varying cell densities and after varying 
lengths o f exposure to 0.5mg ml'1 MTT (Figure 5.23). This figure shows that 3226 cells 
cm' and above, is the optimal suitable seeding density to detect changes in cell number 
and between 3 or 4 hours exposure to MTT. There is a slight decrease in sensitivity when 
using a 2 hour incubation with MTT whereas the sensitivity when using a 3 and 4 hour 
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Figure 5.23 Sensitivity and kinetics of the MTT assay at 21% Oxygen.
Adult human dermal fibroblasts (N l) were diluted in 5% FCS DMEM without phenol red, 1% LG, 1% PS 
and seeded into a 96-well plate at 323, 645, 1613, 3226, 6452, 16129, 32258 cells cm"2. The cells were 
incubated for 48h in a 5% C 0 2 95% air incubator. MTT was then added and the cells reincubated for an 
additional 2h, 3h and 4h.
MTT assays were initially carried out to determine the effects of a range of XO 
concentrations between 0 and 50mU ml'1 XO on aHDF at 0% oxygen. These data 
however, were excluded from the data at 1, 2, 5 and 10% oxygen as the cell seeding was 
increased for these assays. Figure 5.24A shows that at 0% oxygen, there was no statistical 
difference between the medium alone control, and wells including substrates or XO alone. 
Addition o f bFGF did not show any increase in absorbance suggesting that there is no 
increase in viable cells or measurable proliferative response. The data taken at 24 hours at 
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Figure 5.24 Treatment of aHDF with XO at 0% oxygen.
Adult human dermal fibroblasts (N l) were seeded at 1129 cells cm'2 into a 96-well plate and allowed to 
adhere to the plate for 48 hours. Cells were treated for 24 hours. Graph A shows the controls and they 
include fibroblast growth medium alone (M=DMEM, 1% P/S, 1% L-Glutamine and 5% FCS) and medium 
plus nitrite (N, ImM), hypoxanthine (H, ImM), hypoxanthine and nitrite (H+N, lmM +lmM ), XO (50mU 
m l'1) and bFGF (lOng m l'1). Graph B shows cells treated with final concentrations o f XO at 0, 0, 0.001, 0.01, 
0.1, 1, 2, 5, 10, 20, 50mU m l'1 with nitrite (ImM ) and hypoxanthine (ImM). The background that was 
observed in wells containing no cells was substracted, and the data were expressed as a percentage of the 
control. Statistical analysis using one-way ANOVA with dunnett’s post test showed no statistical 
significance on either graph when compared with controls, n = 3. Mean±SD.
Figure 5.25 shows that in air (21% O2) there is a significant reduction in cell 
viability at 5, 10 and 50mU ml'1 with only after 3 hours of exposure to XO. However, at 
oxygen concentrations below 21% the cells appear to be unaffected by XO. At 1% oxygen 
there is even a suggestion of increased viability at 50mU m l'1 XO (Figure 5.25). The VI 
fibroblasts, which are normal fibroblasts from a patient with a chronic wound (figure
5.26), also show a significant reduction in viability at 10 and 50mU ml'1 XO at 21% 
oxygen. These results also mirror the previous results in figure 5.25 which showed that 
below 21% oxygen, the fibroblasts were unaffected by XO at O-SOmUml'1.
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Figure 5.25 Treatment of aHDF with XO for 3 hours in 1,2, 5, and 21% 0 2
Cells were seeded at around 3,500 cells cm'2 and allowed to adhere for 48 hours cells were then exposed to 
hypoxanthine (ImM), nitrite (ImM ) and XO (0, 0.01, 0.1, 1, 5, 10, 50mU m l'1) diluted in medium (DMEM 
without phenol red, 5% FCS, 1% LG, 1% PS) for 3 hours. Results are shown as SEM. Statistical analysis 
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Figure 5.26 Treatment of aHDF with XO for 3 hours in 1, 2, 5, and 21% 0 2
Cells were seeded at around 3,500 cells cm'2 and allowed to adhere for 48 hours cells were then exposed to 
hypoxanthine (ImM ), nitrite (ImM ) and XO (0, 0.01, 0.1, 1,5, 10, 50mU m l1) diluted in medium (DMEM 
without phenol red, 5% FCS, 1% LG, 1% PS) for 3 hours. Results are shown as SEM. Statistical analysis 
one-way ANOVA and Dunnett’s post test, n =4.
After a 24h exposure of normal aHDF to XO in 21% oxygen (Figure 5.27), there is 
a significant reduction in cell viability at 5, 10 and 50mU ml'1 XO (Figure 5.27). 
However, as the oxygen concentration decreases, the viability of the fibroblasts does not 
appear to be effected even at high enzyme concentrations. Interestingly, this figure also
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shows a significant increase in viability at 1% oxygen at 10 and 50mU ml"1 XO (Figure
5.27). Similar results are also observed in figure 5.28 with fibroblasts from a chronic 
wound patient (VI). This figure shows a significant reduction in absorbance, and therefore 
viability, at 21% oxygen, whereas, with decreasing oxygen concentrations there appears to 
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Figure 5.27 Treatment of aHDF with XO for 24 hours in 1,2, 5, and 21% 0 2
Cells seeded at around 3,500 cells cm'2 and allowed to adhere for 48 hours cells were then exposed to 
hypoxanthine (ImM), nitrite (ImM ) and XO (0, 0.01, 0.1, 1,5, 10, 50mU m l'1) diluted in medium (DMEM 
without phenol red, 5% FCS, 1% LG, 1% P/S) for 24 hours. Results are shown as SEM. Statistical analysis 
performed was one-way ANOVA with Dunnett’s post test for multiple comparisons. At 21% oxygen n=6, 
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Figure 5.28 Treatment of aHDF with XO for 24 hours in 1,2, 5, and 21% 0 2.
Cells seeded at around 3,500 cells cm'2 and allowed to adhere for 48 hours cells were then exposed to 
hypoxanthine (ImM), nitrite (ImM ) and XO (0, 0.01, 0.1, 1, 5, 10, 50mU ml’1) diluted in medium (DMEM 
without phenol red, 5% FCS, 1% LG, 1% P/S) for 24 hours. Results are shown as SEM. Statistical analysis 
performed was one-way ANOVA with Dunnett’s post test. At all oxygen concentrations n =4.
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Fibroblasts from a separate experiment were seeded at a low density and treated 
with XO for 24 hours. Figure 5.29 also shows pictures of fibroblasts taken after exposure 
to 0-50mU ml'1 XO for 24 hours at 21% O2 . At high XO concentrations greater than 5mU 
ml’1 XO there is an increase in the roundness of the fibroblasts and visible damage and 
detachment from the culture surface, suggesting that excessive toxicity has damaged these 
cells beyond repair, having an appearance similar to that described for apoptotic cells. 
These cells also appear condensed but relatively intact, and the cytoplasm appears to have 
a granular appearance which may be due to the presence o f enlarged vacuoles in the 
cytoplasm which are also features of apoptosis. These observations correspond with the 
assays shown in figure (5.27-5.28) which show that the fibroblasts do not reduce MTT 
suggesting that the cells are dead. However, figure 5.29 does not show any obvious visual 
signs of cell death at 5mU ml'1 XO, whereas, the MTT assay suggests that the metabolic 
viability of fibroblasts exposed to these concentrations o f XO in hyperoxia (21% O2) is 
significantly reduced.
The viability of the aHDF was also assessed after 72 hours exposure to XO at 
range of oxygen concentrations (Figure 5.30). In hyperoxia (21% oxygen) there is a 
significant decrease in MTT reduction at 5mU ml'1 XO and no MTT reduction was 
observed at 10-50mU ml"1 XO indicating an absence o f any viable fibroblasts. As the 
oxygen concentration decreases, at 5% oxygen (normoxia) there is around a 20% 
reduction in viability at lOmU ml'1 XO, and a complete absence of MTT reduction at 
50mU ml'1 XO. At 2% oxygen there is a significant increase in viability at 5mU ml"1 XO, 
and at 1% around a 25% decrease in viability at 50mU ml"1 XO. These findings were 
again similar to assays also carried out using VI fibroblasts. However, at 2% oxygen the 
VI fibroblasts show a significant increase in viability at 50mU ml'1 XO (Figure 5.31).
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20 mU ml'1 XO 100pm 50mU ml'1 XO 100pm
50mU ml'1 XO 100[jm
Figure 5.29 Treatment of aHDF with XO for 24 hours at 21% 0 2
Fibroblasts (N l) were seeded at 1129 cells cm'2 and treated with hypoxanthine (ImM), nitrite (ImM), XO 
(0-50mU m l'1). Cells were then visualised using the inverted microscope and pictures were taken using a 
digital camera.
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Figure 5.30 Treatment of aHDF with XO for 72 hours in 1,2, 5, and 21% 0 2
Adult human dermal fibroblasts (N l, N2 and N3) were seeded at around 3,500 cells cm'2 and allowed to 
adhere for 48 hours. Cells were then exposed to hypoxanthine (ImM), nitrite (ImM ) and XO (0, 0.01, 0.1, 1, 
5, 10, 50mU m l1) diluted in medium (DMEM without phenol red, 5% FCS, 1% LG, 1% PS) for 72 hours. 
bFGF (50ng m l'1) was also added to the plates a positive control for proliferation and showed enhanced 
proliferation compared to the OmU m l'1 XO control at 1 and 2% oxygen (data not shown). Results are shown 
as SEM. Statistical analysis performed was One-way ANOVA with Dunnett’s post test. 12% n=10, 5% 
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Figure 5.31 Treatment of aHDF with XO for 72 hours in 1, 2, 5, and 21% 0 2
Cells seeded at around 3,500 cells cm'2 and allowed to adhere for 48 hours cells were then exposed to 
hypoxanthine (ImM ), nitrite (ImM ) and XO (0, 0.01, 0.1, 1,5, 10, 50mU m l'1) diluted in medium (DMEM 
without phenol red, 5% FCS, 1% LG, 1% PS) for 72 hours. bFGF (50ng m l'1) was also added to the plates a 
positive control for proliferation. Results are shown as SEM. Statistical analysis performed was one-way 
ANOVA with Dunnetf s post test. n=4.
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5.3.3 Effects of XO on the DNA synthesis and proliferation of 
HDF
BrdU incorporation assays were used to assess the proliferation of HDF after 
exposure to varying concentrations of XO and hypoxanthine. Murrell et al (1990) 
previously showed enhanced proliferation of HDF using a [3H]-thymidine incorporation 
assay. However, the immunological BrdU method used in this thesis has advantages over 
methods using [3H]-thymidine in that it avoids radioactive material and the proportion of 
cells labelled by the two methods is the same (Oku, et al 1987).
5 .3 .3 .1  B r o m o d e o x y u r i d i n e  a s s a y  u s i n g  c h a m b e r  s l i d e s  f o r  c e l l  
c o u n t s
Neonatal human dermal fibroblasts were used to develop the initial BrdU assays. 
Fibroblasts were seeded into chamber slides so that the number of proliferating cells could 
be counted under the microscope. In the first set of experiments, cells were seeded at
10,000 cells cm'2 into 8-well chamber slides and incubated for 24 hours. Cells were then 
incubated for 4 hours with hypoxanthine (ImM) and XO (0-0.0ImU ml'1) and then with 
BrdU for 18 hours. The results indicate that after 18 hours, the majority of cells have 
doubled and incorporated BrdU into their nuclei and are positively labelled (figure 5.32- 
5.35). Furthermore, the fibroblasts clearly show several stages of cell division (Figure 
5.33). However, a small percentage of negatively labelled cells are present on the slides 
(Figure 5.34-5.35) it is possible, that these cells are dead.
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Figure 5.32 BrdU labelled nHDF (Substrate only control).
Cells were seeded at 10,000 cells cm"2 and incubated for 24 hours in fibroblast medium (Appendix I) Cells 
were then incubated for a further 4 hours in fibroblast medium incuding hypoxanthine (ImM ) and HEPES 
(20mM) (Substrate only control). The cells were incubated with BrdU (lOpM) for 18 hours and the assay 
was completed as described in the methods in section 5.2.4.1.2. Note. This image shows that the vast 
majority o f cells are positively stained for incorporation of bromodeoxyuridine into the nucleus. (X20 
magnification)
Figure 5.33 BrdU labelled nHDF (Substrate only Control).
Cells were seeded at 10,000 cells cm'2 and incubated for 24 hours in fibroblast medium (Appendix I) Cells 
were then incubated for a further 4 hours in fibroblast medium incuding hypoxanthine (ImM ) and HEPES 
(20mM) (Substrate only control). The cells were incubated with BrdU (10pM) for 18 hours and the assay 
was completed as described in the methods in section 5.2.4.1.2. Note. This image is a magnified image of 
Figure 5.32 and shows several stages of proliferation (X40 magnification).
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Figure 5.34 BrdU labelled nHDF (Substrate only Control).
Cells were seeded at 10,000 cells cm'2 and incubated for 24 hours in fibroblast medium (Appendix I) Cells 
were then incubated for a further 4 hours in fibroblast medium incuding hypoxanthine (ImM ) and HEPES 
(20mM) (Substrate only control). The cells were incubated with BrdU (10pM) for 18 hours and the assay 
was completed as described in the methods in section 5.2.4.1.2. Note. This image shows a single cell that is 
negatively stained for BrdU incorporation (See arrow). Brown nucleus = BrdU positive cell. Blue nucleus = 
negatively stained cell counterstained with Mayer’s haematoxylin. (X40 magnification).
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Figure 5.35 BrdU labelled nHDF treated with XO (0.001 mU m l1).
%
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Cells were seeded at 10,000 cells cm'2 and incubated for 24 hours in fibroblast medium (Appendix I) Cells 
were then incubated for a further 4 hours in fibroblast medium incuding hypoxanthine (ImM ) and HEPES 
(20mM) and 0.00 ImU m l'1 XO. The cells were incubated with BrdU (lOpM) for 18 hours and the assay was 
completed as described in the methods in section 5.2.4.1.2. Note. This image shows a couple o f cells that are 
negatively stained for BrdU incorporation (See arrows). However the cells are predominantly positively 
labeled for BrdU incorporation. Brown nucleus = BrdU positive cell. Blue nucleus = negatively stained cell 
counterstained with Mayer’s haematoxylin. (X40 magnification).
A total cell count of the proliferating cells shown in Figure 5.32-5.35 was carried 
out for each of the test treatments (Figure 5.36). These results suggest that there is a 
significantly increased number of proliferating cells in the 0.00 ImU m l'1 XO treated wells 
compared to the control. Flowever, this increase is not significant in the wells treated with 
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Figure 5.36Count of BrdU positive cells after treatment with XO.
The assay was carried out using BrdU (10pM), XO (0.001 and O.OlmU m l'1), hypoxanthine (ImM ) and 
HEPES (20mM). Values are expressed as mean ±  SD each treatment was carried out in quadruplicate on 
one occasion. Statistical analysis performed was One way ANOVA with Dunnett’s post test for multiple 
comparisons, O.OOlmU m l'1 XO P<0.05 **. Cell counts were taken from five fields of view (1mm'2) of each 
of the test wells.
A second set of experiments were carried out in order to assess whether a reduction 
in the BrdU incubation time to 4 hours would result in a more countable number of BrdU 
positive cells which could be expressed as the percentage of proliferating cells. In these 
experiments the BrdU was added to the test medium for 4 hours. The results clearly show 
an even distribution of both BrdU positive cells and negatively labelled cells 
counterstained with Mayer’s haematoxylin (Figure 5.37-5.39). Therefore, a 4 hour 
incubation with BrdU, was determined as most suitable for a countable percentage of
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BrdU positive cells so that enhanced DNA synthesis between wells may be more easily 
identified.
Figure 5.37 BrdU labelled nHDF with (4 hour BrdU incubation).
Cells seeded at 5,000 cells c m 2 and incubated for 24 hours in fibroblast medium. Cells were then incubated 
with BrdU (lOpM) for 4 hours. The assay was completed as described in the methods in section 5.2.4.1.2. 
Note. This image shows around 50% of the cells to be either positively or negatively stained for BrdU 
incorporation. Brown nucleus= BrdU positive cell. Blue nucleus^ negatively stained cell counterstained with 
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Figure 5.38 BrdU labelled nHDF with (4 hour incubation).
Cells seeded at 5,000 cells cm'2 and incubated for 24 hours in fibroblast medium. Cells were then incubated 
with BrdU (lOpM) for 4 hours. The assay was completed as described in the methods in section 5.2.4.1.2.
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Note. This image indicates both positive and negative nuclear staining. Brown nucleus = BrdU positive cell. 
Blue nucleus = negatively stained cell counterstained with Mayer’s haematoxylin. (X40 magnification).
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Figure 5.39 BrdU labelled nHDF (4 hour incubation).
Cells seeded at 5,000 cells cm'2 and incubated for 24 hours in fibroblast medium. Cells were then incubated 
with BrdU (lOpM) for 4 hours. The assay was completed as described in the methods in section 5.2.4.1.2. 
Note. This image indicates both positive and negative nuclear staining. Brown nucleus = BrdU positive cell. 
Blue nucleus = negatively stained cell counterstained with Mayer’s haematoxylin. (X40 magnification).
Figure 5.40 and 5.41 shows the growth of nHDF and the resulting BrdU 
incorporation over a 32 hour time period. Figure 5.40 shows that all cells have proliferated 
by 24h as all show positive labelling with BrdU. Negatively labelled cells are present in 
the monolayer between 0 and 8 hours, with around 50% labelling with BrdU after 4 hours 
(Figure 5.40). Therefore, this experiment confirms that a 4 hour incubation time with 
BrdU would be suitable for assessment of the percentage of proliferating cells at varying 
XO treatments as compared to a control.
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Figure 5.40 BrdU incorporation for the assessment of nHDF growth.
Four-well chamber slides were seeded at 8824 cells cm'2 and left to adhere for 24 hours in fibroblast growth 
medium (DMEM with PS 1%, LG 1% and FCS 10%). BrdU (lOpM) was then added to each well in fresh 
fibroblast growth medium and after 0, 4, 8, 24, 28 and 32 hours the BrdU was removed from the wells and 
rinsed with PBS. Cells with then fixed and the anti-BrdU antibodies added as described in the methods.
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Figure 5.41 Growth curve of the BrdU incorporation of nHDF over 32 hours.
A graph of the data from figure 5.40 expressed as the percentage o f BrdU positive cells mm'2. Counts were 
repeated four times per well. n=4. Mean±SD.
Although assessment of BrdU incorporation by cell counting appears to work in 
principle it became clear that only a limited number of samples could assayed at one time 
and cell counts proved extremely time consuming. Therefore, it was decided that a 96-well 
ELISA method would be a more suitable option for the continuation of these experiments.
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5 . 3 .3 . 2  B r o m o d e o x y u r i d i n e  a s s a y  u s i n g  a n  E L I S A  s y s t e m  i n  a  r a n g e  
o f  o x y g e n  t e n s i o n s
BrdU ELISA assays were performed according to the manufacturer’s instructions 
with some modifications (see methods section 5.2.4.2). These assays were carried out at 
the same time as the MTT assays shown in Figure 5.24-5.31 at range of oxygen tensions. 
The BrdU ELISA was developed using aHDF seeded into 96-well plates using a 5% FCS 
test medium as shown in section 5.3.2.4.
Before exposure of cells to XO preliminary experiments were carried out to 
determine the sensitivity of the BrdU ELISA, and a suitable seeding density and duration 
of exposure to BrdU for the proliferation assays (Figure 5.42-5.43). Figure 5.42 was 
carried out in air (-21% O2) and shows that around 1000 cells cm"2 is a suitable seeding 
density for the proliferation assays as it is in the lower end of the linear region of the 
graph. A 4 hour BrdU incorporation incubation time was chosen for assessment of DNA 
synthesis for comparisons with the MTT assays, Murrell et al (1990) also used a 4 hour 
incubation time for [3H] thymidine incorporation assays. This experiment was repeated in 
0% oxygen (figure 5.43) using the oxygen controlled cabinet and showed a reduced level 
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Figure 5.42 Sensitivity and kinetics of the cell proliferation ELISA in 21% oxygen.
Adult human dermal fibroblasts were seeded at 323, 645, 1610, 3230, 6450, 16,130, 32,260 cells cm'2 in 
fibroblast medium (DMEM without phenol red with 5% FCS, 1% LG, 1% PS) and cultured in a 5% C 0 2 
95% air incubator for 48 hours. After this time cells were incubated with BrdU (lOpM) for 2 (Blue line), 4 
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Figure 5.43 Sensitivity and kinetics of the cell proliferation ELISA in 0% oxygen.
Adult human dermal fibroblasts were seeded at 323, 645, 1610, 3230, 6450, 16,130 cells cm'2 in fibroblast 
medium (5% FCS DMEM without phenol red, 1% LG, 1% PS) and cultured for 24h in a 5% C 0 2 95% air 
incubator and a further 24h in the controlled oxygen cabinet purged with 5% C 0 2, balanced nitrogen. After 
this time cells were incubated with BrdU (lOpM) for 2 (Blue line), 4 (Green line), 8 (Orange line), and 24 
hours (Red line). n=3.
BrdU assays were initially carried out to determine the effects of a range of XO 
concentrations between 0 and 50mU ml'1 XO on adult human dermal fibroblasts at 0% 
oxygen. This data however, was excluded from the data analysis at 1, 2, 5 and 10% 
oxygen as the cell seeding was increased for these assays. Figure 5.44 shows that at 0% 
oxygen, there was no statistical significance between cells treated with XO and the control 
which did not contain XO. Addition of bFGF did not show any increase in absorbance 
compared with the control (data not shown). These results suggested that there was little 
cell growth at 0% oxygen. However, a small amount of BrdU incorporation occurred, and 
(figure 5.44) suggests that XO has a slight effect on aHDF at 0% oxygen after 24 hours.
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Figure 5.44Treatment of aHDF with XO in 0% oxygen.
Adult human dermal fibroblasts (N l) were seeded at 1129 cells cm'2 at passage 6 into a 96-well plate and 
allowed to adhere to the plate for 48 hours in a 5% C 0 2 95% air incubator at 37°C. Cells were then
190
transferred into the oxygen controlled cabinet purged with 5% C 0 2 balanced nitrogen and incubated for 24 
hours. Cells were then treated inside the cabinet and incubated for a further 24 hours. This figure shows cells 
treated with final concentrations of XO at 0, 0, 0.001, 0.01, 0.1, 1, 2, 5, 10, 20, 50mU ml"1 with nitrite 
(ImM) and hypoxanthine (ImM) diluted in fibroblast medium (DMEM without phenol red, 5% FCS, 1% 
PS, 1% LG). The background that was observed in wells containing no cells was subtracted, and the data 
were expressed as a percentage of the control. Statistical analysis using one-way ANOVA with Dunned’s 
post test showed no statistical significance on either graph when compared with controls, n =3. Mean±SD.
Adult human dermal fibroblasts were then exposed to XO from 0 to 50mU ml"1 at 
1, 2, 5 and 21% oxygen for 72 hours at an increased seeding density (Figure 5.44 and 
5.45). A 72 hour time point was chosen as previous MTT assays indicated increased 
proliferation at 72 hours. Basic fibroblast growth factor (50ng ml'1) was also included as a 
positive control for enhanced DNA synthesis and proliferation, as shown in previous 
assays using nHDF (Figure 5.22C). After 72 hours o f exposure o f normal aHDF to bFGF 
in 0-21% O2 there is a significant increase in DNA synthesis compared with the controls. 
This increase was similar at each oxygen concentration, with a suggestion of increased 
proliferation with increasing oxygen (Figure 5.45A). Figure 5.45B shows that after 72 
hours of exposure o f normal aHDF to XO at 21% oxygen (hyperoxia) there is a significant 
reduction in BrdU incorporation and DNA synthesis at 5, 10 and 50mU ml'1 XO. 
However, at 21% oxygen there is also a significant increase in proliferation at 0.1 mU ml'1 
XO. At 5% oxygen (normoxia) the DNA synthesis is significantly reduced at 50mU ml'1 
XO. At 1 and 2% oxygen, the fibroblasts appear to be unaffected by XO and although it is 
not statistically significant this graph also suggests an increase in DNA synthesis at high 
XO concentrations (Figure 5.45B).
The results from assays carried out on aHDF from the skin o f a chronic wound 
patient (VI) showed some differences compared with those shown in normal aHDF 
(figure 5.45). Incubation of VI fibroblasts with bFGF showed enhanced DNA synthesis 
after 72 hours, although interestingly the proliferative response was significantly enhanced 
at 2% O2 as compared with at 5 and 21% O2 (Figure 5.46A). Incubation of VI fibroblasts 
with XO at 21% oxygen (hyperoxia, figure 5.46B) show a significant dose dependent 
decrease in DNA synthesis at concentrations above ImU ml"1 XO, suggesting that these 
fibroblasts may be more sensitive to the effects o f XO than the normal aHDF. 
Nevertheless, there is only around a 20% decrease in BrdU incorporation at ImU ml'1, 
whereas, at 50mU ml'1 XO there is complete inhibition o f BrdU incorporation suggesting 
that cell proliferation has been ablated, or the cells are dead. In 5% oxygen (normoxia) XO 
slightly inhibits BrdU incorporation at 50mU ml'1. Interestingly however, at 5% there is a 
significant increase in BrdU incorporation at 5 and lOmU ml'1 XO suggesting that there is 
enhanced proliferation at these concentrations of XO. At 2% oxygen, BrdU incorporation 
and DNA synthesis appear to be comparable to the control at low XO concentrations.
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However, at 5mU ml'1 XO and above, there is a significant increase in BrdU incorporation 
and enhanced DNA synthesis.
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Figure 5.45 Treatment of aHDF with XO for 72 hours in 1, 2 5 and 21% oxygen.
Adult human dermal fibroblasts were seeded at around 3500 cells c m 2 and incubated for 24 hours in a 5% 
C 0 2 balanced air incubator. The cells that were treated at 21 % (air) remained in the incubator for a further 
24 hours before treatment. Cells that were treated in 1, 2 and 5% oxygen were transferred into the oxygen 
controlled cabinet (which was purged 5% C 0 2 and the relevant oxygen concentration) and allowed to 
equilibrate for 24h before treatment. Cells were then treated for 72 hours. Graph A shows BrdU 
incorporation by aHDF after 72 hours exposure to bFGF (50ng ml"1) at 2, 5 and 21% oxygen these 
experiments were carried out at the same time as exposure to XO at the same oxygen concentration and the 
data is shown as a percentage of the control (OmU ml"1 XO). Mean±SEM. Graph B shows brdU 
incorporation by aHDF after 72 hours exposure to hypoxanthine (ImM ) and nitrite (ImM ) and XO (0, 0.01, 
0.1, 1 ,5 , 10 and 50mU ml"1 XO) diluted in fibroblast medium containing (DMEM with out phenol red, 5% 
FCS, 1% LG, 1% PS). Mean±SEM. 1% n=8, 2% n = ll ,  5% n=9, 21% n=10. Statistical analysis performed 
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Figure 5.46 Treatment of aHDF with XO for 72 hours in 2, 5 and 21% oxygen.
Adult human dermal fibroblasts were seeded at around 3500 cells cm'2 and incubated for 24 hours in a 5% 
C 0 2 balanced air incubator. The cells that were treated at 21% (air) remained in the incubator for a further 
24 hours before treatment. Cells that were treated in 2 and 5% oxygen were transferred to the anaerobic 
cabinet which was purged 5% C 0 2 and the relevant oxygen concentration for the experiment and incubated 
for 24h before treatment. Cells were then treated for 72 hours. Graph A shows BrdU incorporation by aHDF 
after 72 hours exposure to bFGF (50ng m l1) at 2, 5 and 21% oxygen these experiments were carried out at 
the same time as exposure to XO at the same oxygen concentration and the data is shown as a percentage of 
the control (OmU m l'1 XO). Mean±SEM. Graph B shows brdU incorporation by aHDF after 72 hours 
exposure to hypoxanthine (ImM ) and nitrite (ImM ) and XO (0, 0.01, 0.1, 1, 5, 10 and 50mU m l'1 XO) 
diluted in fibroblast medium containing (DMEM with out phenol red, 5% FCS, 1% LG, 1% PS). 
Mean±SEM. 2% n=4, 5% n=3, 21% n=4. Statistical analysis performed was one way ANOVA with 
Dunnett’s post test (*P<0.05).
5.4 Discussion
Reactive oxygen species have been implicated in both the proliferation and 
cytoxicity of mammalian cells. More specifically, XO has also been shown to produce a
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proliferative response in fibroblasts including aHDF (Preeta and Nair, 2000; Kim et al, 
2001; Murrell et al, 1990). I have confirmed this using aHDF and further shown a similar 
effect in nHDF. Furthermore, I have investigated the effects o f XO on nHDF, which are 
used in commercially available skin grafts, and on aHDF in a range of oxygen tensions to 
mimic the chronic wound environment.
5.4.1 Characterisation of human dermal fibroblasts
Visualisation of human dermal fibroblast morphological features and positive 
staining for prolyl-4-hydroxylase, confirmed that all fibroblasts used in the study belong to 
a homogenous population o f spindle-shaped fibroblastic cells. Figures 5.2-5.7 provide an 
example o f the typical staining observed. Prolyl-4-hydroxylase catalyses the 
hydroxylation o f proline in -X-Pro-Gly- sequences in collagens and related proteins. This 
co-translational and post-translational modification plays a central role in the synthesis of 
all collagens, as 4-hydroxyproline residues are essential for the folding o f the newly 
synthesized collagen polypeptide chains into triple-helical molecules.
5.4.2 Effects of XO on the viability of human dermal fibroblasts
Experiments to determine the effect o f XO on HDF using the MTT assay were 
initially carried out using nHDF. During the development o f this assay, problems were 
found with dissociation of the fibroblast monolayer and difficulty in obtaining accurate 
cell counts for seeding into experimental assays due to cell clumping (figure 5.8). Cells 
were initially dissociated using cell dissociation solution, a non-enzymatic method of 
removal as it was thought that this method would be less harsh to the cells. Accutase and 
trypsin/EDTA were also assessed and trypsin/EDTA was finally used in all future 
experimentation as it successfully broke down the ECM between cells allowing for 
accurate cell counts for seeding. The relationship between cell seeding numbers per cm 
and the absorbance values achieved after exposure to MTT for 3 hour was assessed and 
showed that between 10,000 and 50,000 cells cm' was most suitable for assessing 
changes in cell number in the XO treatments assays (figure 5.9).
Neonatal human dermal fibroblasts were treated with XO using a range of 
concentrations from 0-100mU m l1, that were the concentrations previously used by 
Murrell et al (1990). Treatment o f the cells at these concentrations showed a significant 
dose dependent decrease in the absorbance at concentrations o f XO above ImU m l1 as 
compared with the control (Figure 5.10). This suggests that the reductive metabolism and 
therefore, viability o f the fibroblasts is significantly reduced at 10, 100 and lOOOmU ml'1
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XO; it is likely that the fibroblast’s antioxidant systems are unable to cope with the 02*~ 
and H2O2 that is generated at these concentrations (chapter 4). Neonatal human dermal 
fibroblasts exposed to lower concentrations o f XO in the range of 0-1 mU ml’1 showed no 
significant difference in viability in comparison with the control. These findings were 
identical to those reported by Murrell et al (1990) using adult fibroblasts who observed 
cell death at concentrations above ImU ml'1 XO.
The effects of XO on nHDF at concentrations above ImU ml"1 XO was examined 
more extensively. Figure 5.11 showed that the viability o f cells between 1.5- and 6.25mU 
ml"1 was slightly increased compared with the control, suggesting a possible increase in 
viability or cell number, which could be a result of the generation of low levels o f ROS by 
XO. Although others have described the proliferative effect o f XO on fibroblasts, this is 
the first study showing the enhanced proliferation o f neonatal human dermal fibroblasts. 
Furthermore, as expected, and in agreement with Murrell et al (1990), at high 
concentrations o f XO (12.5-100mU ml'1) there was a significant reduction in cell viability 
(i.e cell death), which also supports the data shown in (Figure 5.10).
The effect of a range o f XO concentrations was assessed at varying seeding 
densities (Figure 5.12). These assays showed that at a seeding density o f 10,000-15,000 
cells cm'2, fibroblasts were slightly less sensitive to the effects o f XO than cells seeded at
5,000 cells cm'2. Seeding densities at 5,000 and above showed a reduction in viability at 
12.5mU ml'1 XO, but at 5,000 cells cm'2 there was also a reduction in viability at 6.25mU 
ml"1 XO. This is probably due to the scavenging systems o f the increased number o f cells 
being able to more effectively scavenge XO-generated ROS.
Preliminary experiments of the treatment of fibroblasts with XO were later
repeated for reproducibility with a new batch o f FCS. These experiments (Figure 5.13)
showed that the viability of nHDF was significantly impaired at lOOmU ml'1 XO as
previously shown in figure 5.10. However, at lOmU ml'1 XO cell viability was
comparable to the control (figure 5.13), whereas in figure 5.10 cell viability at this
concentration was decreased by around 50%. Therefore the killing effects o f the XO when
using the new batch of FCS were not quite as effective as when using the previous batch,
and tests on the enzyme ensured that the activity had not decreased. Studies carried out on
human dermal fibroblasts have previously reported a cytoprotective function for FCS
(Hidalgo and Dominguez, 1998). Serum is high in growth and survival factors, and
protects fibroblasts from possible toxic effects. FCS also contains growth factors which
favour cell migration (Bartold and Raben, 1996) and protective factors against oxidative
damage which provokes lipid peroxidation in cell membranes. Repeats of these assays
carried out using a more extensive range of XO (Figure 5.14) confirmed that there was a
195
slight decrease in the cytotoxic effects of XO which only showed around an 80% decrease 
in viability at 25mU ml'1 XO compared with the previous assay shown in figure (figure 
5.11) which showed a 50% reduction in viability at 12.5mU ml'1 XO. These results 
clearly indicate that the levels of cytoprotective factors in the new batch o f FCS were 
greater than in the initial batch. Due to these changes in the sensitivity o f fibroblasts to 
XO, the new batch of FCS was kept constant for all further experimentation.
Several studies have reported the proliferative effects XO and inhibitor studies by 
Murrell et al (1990) showed that both O2 *” and H2O2 were responsible with H2 O2 being 
more potent. Direct application of low concentrations o f H2O2 has also been shown to 
enhance the proliferation of a range o f mammalian cells including human endothelial cells 
and human dermal fibroblasts (Luczak et al, 2004; Murrell et al, 1990). As previously 
mentioned, the MTT assay has also been used for an indication of enhanced proliferation 
however cells need to be incubated for extended periods of time so that changes in cell 
number can be detected. Therefore, the MTT assay was used to assess the enhanced 
proliferation of human dermal fibroblasts. Preliminary assays were carried out using H2 O2 
as a positive control for oxidant-derived proliferation. The experiments to examine the 
effects o f varying concentrations of FCS that were done on the growth o f nHDF also had 
the purpose of optimising the FCS level to achieve the best H202-induced proliferation 
assessment. The growth of nHDF was shown to dose dependently decrease with 
decreasing concentrations of FCS in figures 5.15 and 5.16 by two different methods. Fig 
5.15 was made using data from a trypan blue viable cell count method using a microscope 
and manual counting. Although this is a very accurate and informative method, it is also 
very labour intensive and includes wash steps that might cause the loss of some cells. This 
could result in significant underestimation o f cell number particularly when the total cell 
number is low. The method used for all other viable cell counts in this was the MTT 
assay. This does not actually measure individual cells but can estimate cell number by the 
amount of formazan crystals that form inside viable cells. It is a very efficient method as 
the count estimation can be made using a 96-well plate reader allowing for multiple 
experiments to be performed at once.
Initial assays to assess the proliferative effects of H2O2 showed that very low
concentrations of FCS did not allow for the resolution o f any differences in proliferation.
Much better results were obtained when the FCS was increased ten fold to 2%. This was
still a relatively low concentration but enough to allow cells to proliferate at a measurable
rate without providing an inhibitory amount o f substances such as catalase (Korhonen et
al, 1983). The FCS concentration was also increased in a further assay to 5% (Figure
5.19) and H2 O2 was also added at between 0 and 10,000pM, this assay showed a
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significant increase in the number of viable cells at 0.01, 1 and lOpM H2 O2 and a decrease 
in the number of viable cells at concentrations above lOOOpM H2O2 . These results concur 
with the study of Kim et al (2001) who was examining the proliferative effect o f H2O2 on 
Chinese hamster lung fibroblastic (V79) cells. The study also used 5% FCS that gave them 
a positive proliferative response to 50pM H2O2 . Figure 5.19 shows that in this study a pro 
proliferative response was achieved at much lower concentrations o f H2O2 . There are 
many possible reasons for this including the possibility that the different FCS has an 
effect, as was found here between two different batches, but the most likely reason is that 
the V79 cell type was either less sensitive to H2O2 or that they contained intrinsic 
protection against reactive oxygen species.
All previous assays were carried out in the presence o f HEPES to try to replicate 
the proliferation studies carried out by Murrell et al (1990). However, as HEPES is 
reported to have radical scavenging activity, H2 O2 assays were carried out in the presence 
and absence o f HEPES (Figure 5.20A-B). Figure 5.20B showed that, after 48 hours 
exposure to H2 O2 , there was a significant increase in the number o f viable cells at 5, 25 
and IOOjiM H2 O2 in the absence o f HEPES, whereas, in the presence of HEPES there was 
a significant decrease in the number of viable cells at 100 and 500pM H2 O2 . This may be 
because HEPES is known to contribute to the breakdown of H2O2 and the formation of 
hydroxyl radicals which cause damage to cellular DNA via the fenton reaction. This 
implies that the proliferative response to H2O2 may be enhanced in the absence o f HEPES 
buffer and therefore it was removed for future assays. A further assay carried out with 
varying concentrations of XO in the absence of HEPES showed an increase in viability at 
ImU ml'1 XO and a decrease in viability at 10, 20 and 50mU ml"1 XO after 72 hours 
exposure (Figure 5.21), which also supported the findings shown by Murrell et al (1990).
The effects o f varying concentrations of bFGF on nHDF were tested in the 
proliferation assays for use as a positive control. Increasing concentrations of bFGF 
showed increased viability at 24, 48 and 72 hours (Figure 5.22). Basic fibroblast growth 
factor gave the best response at 50ng ml'1 at 24, 48 and 72 hours exposure. Before adult 
fibroblasts were exposed to XO, a sensitivity assay was carried out to ascertain the optimal 
duration o f incubation with MTT and the most suitable seeding densities for detection of 
changes in cell number (figure 5.23). This figure showed that a 3 or 4 hour incubation 
period was similarly sensitive for the detection o f changes in cell number; however, a 4 
hour incubation with MTT was chosen for maximum sensitivity. This figure also showed 
that a minimum seeding density of around 3-4000 cells per cm'2 would be suitable for 
detecting changes in cell number.
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Unfortunately, due to an error in seeding, the experimental assays for the treatment 
of aHDF with XO at 0% oxygen had low cell numbers. These results were therefore kept 
separate from other fibroblast assays Figure 5.24. This figure did not show any significant 
changes in cell viability between 0 and 50mU m l1 XO at 0% oxygen indicating that, in the 
absence o f oxygen, XO, even at high concentration, is unable to produce species that 
affect the viability o f adult dermal fibroblasts. This is unsurprising as, the complete 
absence of oxygen XO cannot generate O2 ’” or H2 O2 and consequently ONOO- and 
hydroxyl radical formation is not possible.
The results shown in section 5.3.2.4 that examines the effects of XO on the 
viability of human dermal fibroblasts in a range of oxygen tensions, demonstrate that in 
conditions likely to be prevailing in a chronic wound, the enzyme does not have an 
adverse effect. The eventual aim of this work is to develop a dressing that can be applied 
to chronic wounds containing XO. For this to be a viable proposal the enzyme while 
exposed to the tissue, must not have deleterious effects on the patients own tissue for the 
duration o f the dressing application (up to 24 hours). On the contrary it is hoped that the 
pro-proliferative effect o f XO products will be a beneficial aid to the healing process. The 
results of varying the levels of enzyme on aHDF at different oxygen tensions clearly 
confirm that there is no toxic effect o f the enzyme under a range o f conditions that might 
be expected in the ulcer. The most relevant oxygen tensions to the chronic wound are 1 - 
2%, at these levels it can be seen that, not only are the cells viable, but they are actually 
showing an increase in number (figure 5.28). This effect is likely to be due to the 
generation o f low levels o f ROS that would have a proliferative effect in a similar way to 
the hydrogen peroxide effects shown earlier in the chapter 5 (figure 5.19 for example). 
The data also indicate that the cells are tolerant to the highest concentrations o f enzyme 
used (50mU ml'1). This is at the upper end o f the range o f enzyme concentrations that 
would be considered for a dressing and is a concentration that has antimicrobial capability, 
as will be seen in chapter 6. The only significant adverse effects were seen with prolonged 
exposures (72 hours) of high enzyme concentration under hyperoxic conditions (21%), 
these experiments were only done for completeness as the conditions are well outside the 
range of any envisaged in vivo situation.
Figure 5.29 also shows pictures of fibroblasts taken after exposure to 0-50mU ml'1
XO for 24 hours at 21% O2 . At high XO concentrations greater than 5mU ml'1 XO there is
an increase in the roundness of the fibroblasts and visible damage and detachment from
the culture surface, suggesting that excessive toxicity has damaged these cells beyond
repair, resulting in apoptosis. These cells also appear condensed but relatively intact, and
the cytoplasm appears to have a granular appearance which may be due to the presence of
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enlarged vacuoles in the cytoplasm which are features o f apoptosis. These observations 
correspond with the assays shown in figure (5.27-5.28) which show that the fibroblasts do 
not reduce MTT suggesting that the cells are dead. However, figure 5.29 does not show 
and obvious visual signs of cell death at 5mU ml'1 XO, whereas, the MTT assay suggests 
that the metabolic viability of fibroblasts exposed to these concentrations o f XO in 
hyperoxia (21% O2) is significantly reduced.
Normal aHDF were also exposed to XO in varying oxygen concentrations for 72 
hours (Figure 5.30). At 1% oxygen fibroblasts showed a significant decrease in viability at 
50mU ml'1 XO, however, it was only around a 25% decrease in viability. At 2% oxygen a 
slight increase in viability is observed at 5mU ml'1 XO again suggesting that XO at low 
oxygen concentrations could be increasing cell numbers. At 5% oxygen (normoxia) there 
is around a 20% decrease in cell viability at lOmU ml'1 and 50mU ml'1 appears to be toxic 
to the cells as there is no MTT reduction. Xanthine oxidase at 5, 10 and 50mU ml"1 is also 
toxic to fibroblasts as shown after 24 hours exposure. This result was similar for the 
fibroblasts derived from chronic ulcer patients (Figure 5.31). With increased viability 
observed at 2% oxygen at 50mU ml'1 XO, and decreased viability and toxicity observed at 
50mU ml'1 XO in normoxia (5% oxygen) and at 5, 10 and 50mU ml"1 XO in hyperoxia 
(21% oxygen).
5.4.3 Effects of XO on the proliferation of HDF
As with the MTT assay (section 5.3.2), a number o f experiments were carried out 
to determine the optimum cell number and incubation period required for accurate 
assessment of proliferation (Figure 5.32-5.41). Finally, it was decided that a 96-well BrdU 
ELISA would provide a fast and sensitive method of assaying multiple samples, and 
would also be easier to transfer in and out of the oxygen controlled cabinet for 
experiments in reduced oxygen.
The BrdU ELISA assays in varying oxygen tensions were carried out at the same 
time as the MTT assays shown in section 5.2.3.4. Initial sensitivity assays showed that a 
concentration o f 1000 cells cm'2 and an incubation of 4 hours with BrdU, as used by 
Murrell et al (1990), would be sufficient for the assessment o f DNA synthesis (Figure 
5.42-5.43). At 0% oxygen the level of BrdU incorporation was considerably reduced but 
this was expected as it is likely that there would be little or no proliferation at this oxygen 
concentration. It is also possible that the pC>2 inside the cabinet was not absolute zero 
oxygen as very low levels of oxygen may be contained in the nitrogen and CO2 cylinders 
and possibly also introduced through the sleeves.
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Adult HDF were treated with bFGF as a positive control for proliferation (Figure 
5.45A). A significant proliferative response was observed at 1, 2, 5 and 21% oxygen 
confirming that the assay was working well and effectively detected proliferative 
responses. When the same control was run on dermal fibroblasts from the skin o f a chronic 
wound patient (VI), there appeared to be a clear increase in proliferation at 2% oxygen 
over the higher oxygen levels (Figure 5.46A) This increase in proliferation might suggest 
that these cells are better conditioned and adapted to hypoxia as they are from a patient 
with a vascular ulcer. Similar adaptations to hypoxia have been suggested in skin 
fibroblasts in studies by Panchenko et al (2000). These cells also appear to prefer lower 
oxygen levels in the XO-stimulated proliferation assays. Comparing graphs 5.45B and 
5.46B it can be seen that the VI cells show very poor growth at 21% oxygen and 
particularly robust proliferation at 2% oxygen compared to normal fibroblasts. This is a 
strikingly good result in support of the hypothesis that XO will provide valuable pro­
healing effects in chronic wound beds where the oxygen tension will be predominantly in 
the region of 2% (Falanga et al, 1992b).
5.4.4 Chapter summary
This chapter confirms previous reports that XO can enhance the growth o f aHDF 
which are essential for wound healing using standard culture conditions in air. 
Furthermore, I have observed similar proliferative effects of XO on nHDF, which are used 
in commercially available skin grafts. This chapter also shows that the viability and 
proliferation o f aHDF, including patients with chronic wounds, were not adversely 
affected when exposed to XO in low oxygen tensions relavent to the chronic wound. 
Furthermore, these results do in fact appear to show some evidence of enhanced 
proliferation at high enzyme concentration in low oxygen. The XO concentrations 
investigated in this study provide a range with which to test the sensitivity o f bacteria for a 




6 Effects of XO-generated products on bacteria 
relevant to the chronic wound
6.1 Introduction
As discussed previously (Chapter 2), poor vascular supply and systemic factors 
mean that the tissues o f individuals prone to chronic ulcers are at an increased risk of 
bacterial invasion (Falanga, 1993a). Chronic ulcers are characteristically hypoxic, and can 
support a diverse microbial flora including aerobic, facultative anaerobes and anaerobic 
bacteria. There is no single unifying theory as to the aetiology of chronic ulcers and it is 
likely to be multifactorial, however, it is a universally supported view that bacteria can 
contribute to non-healing. A wide range of bacteria have been isolated from a variety of 
chronic wounds, although cultural analyses have documented that staphylococci, 
streptococci, enterococci and facultative gram-negative bacilli are the bacterial groups 
frequently recovered from chronic ulcers (Hansson et al, 1995).
6.1.1 Facultative anaerobes and chronic wound infection
The facultative anaerobes that have been investigated for the purposes o f his thesis 
are strains that are known to have been isolated from infected ulcers and are 
Staphylococcus aureus (S. aureus), Streptococcus faecalis (S. faecalis), Proteus mirabilis 
(P. mirabilis), Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) 
(Bowler and Davies, 1999; Abdulrazak et al, 2005; Howell-Jones et al, 2005) and are 
therefore covered in more detail in section 6.1.2.1.
6.1.1.1 Gram positive bacteria S. aureus and S. faecalis
Gram-positive S. aureus are part of the normal flora present on the skin surfaces 
and mucosal and nasal membranes of most healthy humans, and also represents a large 
spectrum of bacteria that are important pathogens in chronic wound infections. S. aureus 
is an immobile coccus which forms grape-like clusters and is grouped with the Bacillus 
species. It is also a facultative anaerobe, allowing it to grow in a range of oxygen tensions. 
S. aureus can cause a range of infections from mild, such as skin infections and food 
poisoning, to life-threatening, such as pneumonia, sepsis, osteomyelitis, and infectious
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endocarditis. S. aureus is one o f the major causes o f community-acquired and hospital- 
acquired infections, causing high morbidity and mortality in the UK and throughout the 
world. It produces numerous toxins including superantigens that cause unique disease 
entities such as toxic-shock syndrome and staphylococcal scarlet fever, and has acquired 
resistance to practically all antibiotics. S. aureus has been considered a serious bacterial 
pathogen since the organism developed a resistance to penicillin in the 1950s. In 1961 it 
developed resistance to meticillin, invalidating almost all antibiotics including the most 
potent p-lactams. Since the 1970s, meticillin-resistant S. aureus (MRSA) has become the 
main cause of nosocomial infection worldwide. The proportion of MRSA has risen 
worldwide during the last two decades, with increasing epidemics in UK hospitals 
(Ayliffe, 1997). The therapeutic glycopeptide vancomycin was the only antimicrobial 
agent effective against MRSA, but there has since been the emergence o f vancomycin 
resistance in enterococci in 1988 (Nicas et al, 1989), in coagulase-negative staphylococci 
in 1987 (Schwalbe et al, 1987) and in MRSA with reduced vancomycin susceptibility in 
1996 (Hiramatsu et al, 1997), therefore there has been speculation that the incidence of 
vancomycin-resistant S. aureus (VRSA) will increase. The spread of antimicrobial- 
resistant nosocomial pathogens such as MRSA and VRSA is secondary to both over- and 
misuse of antimicrobials and incomplete compliance with recommended infection control 
precautions. We are now exposed to the threat of MRSA without having developed any 
antibiotics with greater activity than vancomycin. Epidemic and endemic infections in 
healthcare facilities are now emerging around the globe as the cause o f severe infection in 
the community. All this is compounded by very limited pharmaceutical research and 
development on new antimicrobial agents. There is, therefore, an urgent need to revitalise 
the pipeline o f new antimicrobial agents to effectively meet this challenge. According to 
Armstrong and Lipsky (2004) Gram-positive cocci particularly S. aureus, are the most 
important pathogens in diabetic foot infections, where peripheral vascular (i.e. arterial) 
insufficiency and the increasing prevalence of antibiotic resistance are primary barriers to 
successfully managing these infections. The Streptococcus faecalis is a gram-positive 
facultative anaerobe. It belongs to the genus streptococcus and is arranged as cocci in 
chains. It causes many of the same problems as other members o f the intestinal flora, 
including opportunistic urinary tract infections and wound infections. Little is known 
about its pathogenesis.
6.1.1.2 Gram-negative bacteria P. mirabilis, P. aeruginosa andE.coli
P. mirabilis is a facultative anaerobic, Gram-negative rod-shaped bacterium. It 
belongs to the Enterobacteriaceae family and is a highly motile swarmer bacterium and
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does not form regular colonies. Instead, Proteus forms what are known as "swarming 
colonies" when plated on non-inhibitory media. P. mirabilis are often found as free living 
organisms in soil and water but they also cause urinary tract infections, wound infections, 
septicaemia and pneumonias, mostly in hospitalised patients. Most strains o f P. mirabilis 
are sensitive to ampicillin and cephalosporins. E. coli is also a Gram-negative facultative 
anaerobe, it has a rod-shaped morphology and belongs to the family Enterobacteriaceae 
and are characterised by their ability to produce potent enterotoxins. Pseudomonas 
aeruginosa is also a Gram-negative, aerobic rod belonging to the bacterial family 
Pseudomonadaceae. These bacteria are common inhabitants o f soil and water, but are also 
the epitome of an opportunistic pathogen in humans. A major factor in its prominence as a 
pathogen is its intrinsic resistance to antibiotics and disinfectants. The bacterium almost 
never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect if  
the tissue defenses are compromised in some manner. P. aeruginosa contaminates surgical 
wounds, abscesses and bums and can cause urinary tract infections, respiratory system 
infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, 
gastrointestinal infections and a variety of systemic infections. P. aeruginosa is primarily 
a nosocomial pathogen and occurs in about 20-30% of all ulcers (Halbert et al, 1992; 
Hansson et al, 1995). Previous studies have shown that around 50% of all chronic ulcer- 
derived P. aeruginosa isolates express elastase. From the clinical point of view, this 
finding could perhaps underlie the observation that not all chronic ulcers deteriorate 
during P. aeruginosa infection, a finding that has caused some debate as to whether this 
pathogen causes wound delay or not. Studies have since shown the production of a highly 
conserved metalloproteinase, elastase, by ulcer derived strains o f P. aeruginosa which 
degrades wound fluid and human skin proteins during infection ex vivo. Furthermore, 
elastase producing P. aeruginosa degraded various antiproteinases, complement C3, 
kininogens (KIN), fibroblast proteins and the proteoglycan decorin, and inhibited 
fibroblast growth (Schmidtchen et al, 2003).
The complete sequence of the P. aeruginosa strain PAOl that has been used in this 
study has been elucidated, and is known to have a large bacterial genome at 6.3 million 
base pairs (Stover et al, 2000). The sequence provides insights into the basis o f the 
versatility and intrinsic dmg resistance. Consistent with its larger genome size and 
environmental adaptability, P. aeruginosa contains a high proportion o f regulatory genes 
for a bacterial genome and a large number of genes involved in the catabolism, transport 
and efflux of organic compounds as well as four potential chemotaxis systems. The size 
and complexity o f the genome also reflects an evolutionary adaptation permitting it to
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thrive in diverse environments and resist the effects o f a variety o f antimicrobial 
substances.
6.1.2 XOR and bacterial killing
Previous work has demonstrated the ability o f XOR to mediate cell death in both 
Escherichia coli and Salmonella enteritides (Stevens et al, 2000). Furthermore, the 
expression o f this enzyme in mammalian milk combined with its bactericidal properties, 
have suggested a role in the reduction of infective bacteria in the neonatal gut. The ability 
of breast milk-derived XOR to limit the growth of both Escherichia coli and salmonella 
enteritides has been successfully demonstrated in vitro. Recent results have also 
demonstrated bactericidal properties of XOR in vitro in calves highlighting the importance 
of maternal milk in the treatment of neonatal infections. Previous work has also suggested 
an antibacterial role in the digestive tract for XOR, which is present in intestinal epithelial 
cells (Godber, 2000a). This case was based on the enzyme’s capacity to generate ‘NO. It 
was supported by the literature reports that nitrite levels in the immediate vicinity of 
enteric bacteria could achieve millimolar concentrations and that XOR has affinity for acid 
polysaccharides such as occur in bacterial capsules. Similar and even stronger arguments 
apply to XOR-derived ONOO- generation across a very wide range of oxygen tensions, 
encompassing all situations likely to be encountered physiologically. The following 
experiments were designed to assess the effect of chemically generated oxidants and XOR 
on the growth and viability of bacteria relevant to the chronic wound with a view to 
developing a novel anti-bacterial dressing. It is in these ischaemic wounds that XOR could 
be most beneficial as peripheral vascular insufficiency, impaired healing and increased 
antibiotic resistance are the main problems in these types o f wound.
6.1.3 Bacterial survival and antioxidant mechanisms
White blood cells produce H2O2 to kill bacteria. In both cases catalase prevents the 
H2 O2 from harming the cell itself. Prokaryotes, organisms like bacteria that lack a nuclear 
membrane, also lack membrane bound organelles such as peroxisomes, where catalase is 
contained in animal cells. Antioxidant enzymes like catalase and SOD are located in the 
periplasmic space which is the space between the inner and outer membranes o f the cell 
wall. There are numerous enzymes located here that would be toxic if  they were found 
inside the cell. The catalase found here can act on toxic molecules that are transported to 
the periplasm or the enzyme can be released outside the bacterial wall where it can act on
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toxic molecules in the environment. Catalase that is released by the bacteria plays a role in 
protecting the bacteria from being destroyed by white blood cells during an infection.
The presence of oxygen radical detoxification systems in bacteria is well 
documented (Fee, 1991; Nunoshiba, 1996). E. coli possess a SOD-like enzyme which 
generates H2O2 . This species is then detoxified by a catalase-like enzyme to oxygen and 
water (McCormick et al, 1998). The importance of SOD in the defence o f bacteria against 
O2 *" generation was assessed by Gort and Imlay (1998). They controlled the expression of 
cytoplasmic SOD within the E. coli to show the relative amounts o f O2 ’" generation that 
were required to cause enzyme inactivation, growth deficiencies and DNA damage. These 
studies showed a graded response to the loss of SOD in the cells. At small reductions in 
SOD activity, a substantial reduction in the activity of labile dehydratases was seen. A 
greater than four-fold increase sensitised cells to DNA damage.
Schwartz et al (1983), however, showed the cytotoxicity o f neutrophils to bacteria 
and suggested that even though the bacteria contained the protective antioxidant enzymes, 
under the conditions within the phagosome, the flux of 0 2 *" and H2O2 generated was 
sufficient to overwhelm the cells antioxidant mechanisms. Other enzymes have been 
associated with antioxidant mechanisms. Lundberg et al (1999) suggested that Glucose-6- 
phosphate dehydrogenase is required in S typhimurium resistance to reactive oxygen 
species. The DNA repair enzyme formamidopyrimidine-DNA glycosylase was also 
essential to antioxidant defence from E. coli treated with high levels of H2O2 (Alhama et 
al, 1998).
The individual cytotoxicity of *N0 and 02*" relies on the susceptibility o f the target 
organism to the stress derived from these free radical species. Nunoshiba et al (1992 and 
1995) have shown that ’NO signals E. coli through the same transcription factors as O2 ’", 
and the genes induced by *N0 are those essential for the protection against oxidative 
damage. Also in Salmonella typhimurium Crawford and Goldberg (1998) have shown that 
a flavohaem protein regulates gene expression on stimulation by ‘NO. It has also been 
confirmed in E. coli that a flavohaem affords protection from *NO. Specifically, the haem 
serves a dioxygenase function that produces mainly nitrate. These studies identify 
enzymes with reactions that were thought to occur only by chemical means. It was also 
emphasised that the reactions of *N0 with haemoglobins were evolutionary conserved and 
have been adapted for cell-specific functions (Hausladen et al, 1998).
It is clear then that bacteria and viruses can be susceptible to free radical attack but
also have some relevant antioxidant enzymes to survive particular stresses. XO has been
shown previously to generate O2 *” and ’NO. XO-derived O2 *" and H2O2 have been
implicated in antiviral activity by causing apoptosis in the infected cells (Skulachev,
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1998), in association with duodenal ulcers and Helicobacter pylori infections (Ben- 
Hamida et al, 1998) and in vitro susceptibility of Mycobacterium leprae to oxygen- 
mediated damage (Dhople, 1996). However the effectiveness of either (V - or *NO alone 
has been questioned in the light o f their possible reaction products.
6.1.4 Chapter aim
This chapter deals with the susceptibility of bacteria relevant to the chronic wound 
to a range of reactive species generated either enzymatically or by chemical means. It also 
aims to investigate changes in the growth and viability of bacteria treated with XOR in 
situations where the oxygen tension is variable as in the chronic wound. The ability of 
XOR generated species to reduce the number of infectious bacteria will provide 
justification for the addition o f this enzyme into an ulcer dressing or for incorporation into 
a tissue engineered dermal graft.
6.2 Principles, methods and materials
6.2.1 Culture of bacterial strains
6.2.1.1 Materials
Agar No. 1, Tryptone-Soya Broth (TSB) (Oxoid Limited. Hampshire, UK); Luria- 
Bertani Broth, Glycerol (Sigma Aldrich Company Ltd. Dorset, UK); Petri dishes (Fisher 
Scientific UK Ltd. Leicestershire, UK).
A range o f severe disease, chronic wound and abscess S. aureus isolates were 




Mu 3 171 Pus from a surgical wound Moderate vancomycin resistance (VRSA). 
(Hiramatsu et al, 1997).
Mu 50 Isolated from pus of a 
Japanese baby with a 
surgical wound infection 
that did not respond to 
vancomycin in 1997
Derivative of Mu3. Moderate vancomycin 
hetero-resistance (hVRSA) (Kuroda et al, 
2001).
117(138) Isolated from a septicaemia 
patent
Penicillin, ciproflaxin, trimethoprin resistant 
and meticillin susceptible S. aureus (MSSA). 
(Oxford hospital collection).
N315 Pharyngeal smear of a 
Japanese patient isolated in 
1982
*
Prototype of meticillin resistant S. aureus
(MRSA) (Kuroda et al, 2001).
* Prototypic in the sense that it was the first MRSA 
isolate to have the resistance determinant mecA 
sequenced.
Table 6.1 Severe disease S. aureus isolates.
S. aureus strains used also came from the Oxford strain collection (from Enright et 
al, 2000) and were isolates from pus drains and abscess sites: 197, 357, 13, 283 were 
community-acquired and 301 and 307 were hospital-acquired. Bacterial isolates were 
selected from prospectively selected patients with invasive S. aureus disease identified in 
the Oxford region in 1997 or 1998. Invasive S. aureus disease was defined as the isolation 
of the organism from a normally sterile site in a patient with clinical signs and symptoms 
consistent with S. aureus infection. Isolates from patients with deep local infections 
associated with prosthetic material were excluded, as were isolates from patients with 
septicemia in which S. aureus was isolated from only one blood culture bottle (of at least 
two inoculated). Patients were assigned to one of two groups on the basis of clinical 
details: those with community-acquired disease and those with hospital-acquired disease. 
Community-acquired disease was defined as an illness consistent with invasive S. aureus 
disease that required admission to hospital and that resulted in the isolation of S', aureus 
from a specimen taken from a normally sterile site within 24 hours o f admission. In 
addition, patients hospitalised for any reason within the preceding 6 months were excluded 
from this category.
Other bacterial species that are known to have been isolated from chronic wounds,
and were used in the present study are Pseudomonas aeruginosa (P. aeruginosa) PAOl
Escherichica coli (E. coli) MC4100, Proteus mirabilis (P. mirabilis) DV429,
Streptococcus faecalis (S. faecalis) 775, Staphylococcus aureus (S. aureus) NCTC
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(National collection o f Type Cultures) 6571 all strains were obtained from University of 
Bath (Dr. Wood).
6.2.1.2 Protocol
S. aureus disease isolates were cultured on nutrient Tryptone-Soya Agar (TSA) at 
37°C by streaking out using a sterile plastic loop from frozen stock cultures. Manipulation 
of the bacteria was carried out in a laminar flow cabinet (class II) to prevent contamination 
of the cultures and provide some protection for the user. Colony formation occurred with 
overnight incubation. Single colonies were inoculated into 6mls o f Tryptone-Soya Broth 
(TSB) and grown overnight in air before each experiment. Alternatively TSB was directly 
inoculated from stocks and grown overnight in air. Cells were cultured at 37°C in glass 
bijous with shaking at 200 revolutions min A control tube was also set up which 
contained TSB alone.
The long-term storage of bacterial stocks of P. aeruginosa, E. coli, P. mirabilis, S. 
faecalis and S. aureus was achieved by dilution of bacteria in Luria-Bertani Broth (LB) 
with 20% glycerol and freezing at -70°C. Using a flamed loop, bacteria from the long-term 
storage stock were streaked-out onto an agar plate (see section 8.2.2 in the appendix for 
agar plate preparation) and incubated at 37°C until colonies were formed. Once colonies 
had formed plates were stored at 4°C for up to two weeks. When required single colonies 
were used to inoculate baffled flasks containing 20mls LB and cultures were incubated 
overnight at 37°C in air with continuous agitation at 100 revolutions min ].
6.2.2 Chemically generated oxidants, XO and reduced Oxygen 
on bacterial growth
The rate of cell growth after treatment with H2O2 and ONOO- and XO was 
assessed by utilising the change in absorbance over time of bacteria in nutrient broth. The 
effect of reduced or low oxygen concentration on bacterial growth rate was also measured 
to characterise this parameter during further experiments that required manipulation of the 
oxygen environment. The bacteria used in this study are facultative anaerobes being able 
to utilise a range of electron donors, other than oxygen in its absence.
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6.2 .2 .1 Peroxynitrite generation
6.2.2.1.1 Materials
Sodium nitrite, hydrogen peroxide, sodium hydroxide, manganese dioxide (Sigma 
Aldrich Company Ltd. Dorset, UK), hydrochloric acid (BDH Laboratory supplies, Poole, 
UK) 0.22pm syringe filter (Fisher Scientific UK Ltd. Leicestershire, UK).
6.2.2.1.2 Protocol
Peroxynitrite was generated using a quenched flow reaction apparatus as described 
by Reed et al (1974). An aqueous solution of 10ml sodium nitrite (0.6M) was rapidly 
mixed with 10ml of hydrochloric acid (HCL, 0.6M) and hydrogen peroxide (H2 O2 , 0.7M) 
this was achieved using Y-shaped tubing and two plastic syringes to plunge the solutions 
together. The combined solutions were immediately quenched with 20ml sodium 
hydroxide (NaOH, 3M). All reaction solutions were kept on ice. This method leads to 
some residual nitrite and H2 O2 contamination. The H2 O2 was removed by reacting 
solutions of chemically formed ONOCT with 4g manganese dioxide (Mn02) for 4-5 
minutes followed by filtration through 0.22pm filter (Haenen et al, 1997). The 
concentration of the resulting solution containing ONOCT was calculated by measuring 
the absorbance (Hitachi, U-2010) at 302nm of a 1 in 10 and a 1 in 100 dilution in 1M 
NaOH and using equation 6.1. Stock solutions were stable for several weeks at -20°C 
(Crow, 1997). However, stock ONOO" was generated weekly and was not used after 7 
days of synthesis. Also ONOO" was allowed to decompose (dONOO") at room 
temperature for 3 days to be used as the control for the residual nitrite/nitrate and NaOH 
(Bauer et al, 1992; Pfeiffer et al, 1997). Sufficient buffering and dilution in PBS reduced 
the effect of the residual NaOH further.
A = scl (e = Extinction coefficient of ONOO" = 1670M'1 cm'1 Hughes and Nicklin 1968)
If A3 0 2nm = 2.3 (1 in 10 dilution)
2.3 = 1670 x e x  1 
Therefore, 2.3 / 1670 = c
Therefore c = 1.38 xlO'3 x 10 (dilution factor) = 0.0138 M = 13.8mM
Equation 6.1. Calculation of the concentration of peroxynitrite using the Beer-Lambert equation.
A=absorbance, 8 = extinction coefficient (Molar absorbtivity with units of M"1 cm'1), c = concentration of 
the compound in solution expressed in M, 1 = Pathlength of the sample (Pathlength o f cuvette in which 
sample is contained in cm. The pathlength of the cuvette is 1 cm).
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In order to try and improve the yield of ONOO" from 13.8mM (See equation 2.) 
The apparatus for the ONOO" generation was improved based on that described by 
Koppenol et al (1996) who used a vacuum pump to draw the sodium nitrite and HCL, 
H2O2 into Y-shaped tubing where they were eventually reacted together along a 4cm 
stretch of tubing at a rate of 30ml min'1. The combined solutions were then drawn along, 
and quenched in a collection tube containing 1.5M NaOH. For this method the solutions 
remained the same apart from the NaOH quenching solution that was reduced to a 
concentration of 1.5M. The rest of the procedure was as stated previously. The yield for 
the improved method was 74mM ONOO".
6.2.2.2 The effect of H20 2 and ONOO" and XO on bacterial growth
6.2.2.2.1 Materials
Allopurinol, hypoxanthine, hydrogen peroxide, sodium hydroxide, disposable 
polystyrene cuvettes, (Sigma Aldrich Company Ltd. Dorset, UK), hydrochloric acid (BDH 
Laboratory supplies, Poole, UK), XO (Biozyme Laboratories. Gwent, UK).
6.2.2.2.2 Protocol
Assays were carried out in cuvettes in 2 or 3 ml volumes and followed at 600nm at 
37°C (Hitachi, U-2010). Alternatively, the assay was automated using a 96-well plate 
reader (Dynex Technologies, MRX TC II), a 595nm filter and clear bottomed sterile 96- 
well plates. The plate reader was temperature controlled at 37°C and the plates were left in 
situ during the experiments. For the XO assays, reagents were sterile filtered through a 
0.22pm syringe filter and diluted in LB giving final concentrations o f ImM hypoxanthine, 
lmM allopurinol and 0.5, 1, 5, 10 and 50mU ml'1 XO. For the H20 2 concentrations 
between O-lOOmM were used and ONOO" was diluted between 0-0.5mM (see 
experiments for specific concentrations). A final volume o f 200pl was used for these 
experiments. A program of measurement steps was written for the spectrophotometer to 
follow, including multiple readings and incubation times of 15 minutes between each 
measurement for a duration of 4-6 hours. This technique allowed for large throughput 
experiments to be carried out in triplicate or quadruplicate with little intervention once the 
assay was running. This assay was used to assess the effect o f treatments on the growth of 
a range of bacteria. By calculating the mean generation time (See section 6.2.2.3) in the 
absence and presence o f a range of concentrations of oxidants it was possible to determine 
the growth rate relative to an untreated control.
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6.2.2.3 The effect of reduced oxygen on bacterial growth
6.2.2.3.1 Materials
2% O2 and 5% CO2 balanced nitrogen (BOC Gases. Guildford, UK), disposable 
polystyrene cuvettes, magnetic stirrers (Sigma Aldrich Company Ltd. Dorset, UK), 
parafilm (Fischer Scientific UK Ltd. Leicestershire, UK).
6.2.2.3.2 Protocol
E. coli and S. aureus were cultured overnight as stated previously and then added 
to 2mls o f LB in 3ml cuvettes which were either saturated with room air or equilibrated to 
2% O2 , 5% CO2 balanced nitrogen overnight in the miniMACS Anaerobic Workstation 
(Don Whitley Scientific Ltd). For experiments in 2% O2 the overnight cultures were 
diluted inside the Anaerobic Workstation, the cuvettes were covered with parafilm and 
removed from the Workstation at hourly intervals for measurements. All cuvettes were 
incubated at 37°C whilst being stirred with sterile magnetic stirrers and the absorbance at 
600nm was measured at hourly intervals to compare the growth rates.
6.2.2.4 Mean growth rate constant and generation time
For the bacterial growth experiments, the mean growth rate constant and 
generation time for the cell population was calculated. The mean growth rate constant and 
generation time may be calculated from the following equation (Equation 6.2) using data 
from the exponential growth phase of cell division.
k = n/t 
=  (log Nt -  log No)/ 0.301/
If the population doubles t = g, therefore N t = 2N0, which can be substituted into 
the above equation:
k = (log(2No) -  log No) /  0.301g 
= (log2 + logNo -  log N0) /  0.30lg  
k =  1 /g
The mean generation time is the reciprocal of the mean growth rate constant (k):
g = 1/fc
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Equation 6.2. Calulation of the Mean Growth Rate Constant and Generation Time of a Bacterial Cell 
Culture.
Where g = mean generation time; k = mean growth rate constant; n = number of generations in time t; N0 = 
the initial population number; N, = the population at time t; t = time (Prescott et al, 1996).
Absorbance values were used to determine the region o f the growth curve for 
which the growth was logarithmic. This was evaluated by plotting the absorbance data on 
a logarithmic (logio) scale. The growth rate constant was determined by replotting the data 
over the linear time period and converting the absorbance data into log2  values (divide by 
0.301). A straight line was plotted through the points of the growth slope to give the mean 
growth rate constant as a function of time (e.g log2A6oo min). The inverse o f this slope 
shows how many minutes it takes for the culture to increase its density by log2 A 6oo 
absorbance units. Since it is log2 , a change of 1 absorbance unit means that the culture 
absorbance has doubled (mean generation time).
6.2.3 Effect of H20 2 and XO on bacterial viability in air
6.2.3.1 Assessment of viability using disk inhibition assays
The sensitivity of strains to H2O2 and XO-generated species were determined using 
a disk inhibition assay (Ballion et al, 1999 and Elvers et al, 2004) in which the zone of 
killing is measured.
6.2.3.1.1 Materials
Whatman filter paper disks, (3M, 6 mm Diameter) (Fisher Scientific, UK Ltd. 
Leicestershire, UK), sodium nitrite, Hypoxanthine, H2O2 (Sigma Aldrich Company Ltd. 
Dorset, UK), XO (Biozyme Laboratoritories. Gwent, UK).
6.2.3.1.2 Protocol
S. aureus were grown overnight in air in LB at 37°C. Agar plates were also
prepared prior to experiments as described in the appendix (section 8.2.2). Culture
samples were adjusted to an Abs6oo o f 0.45 and 2.5ml samples o f the diluted culture were
added to 50ml o f soft agar (0.4%, see appendix 8.2 for recipe) for a final abs6oonm of 0.021.
Sterile filtered ImM hypoxanthine and ImM nitrite were included in the 50ml final
volume o f soft agar for certain experiments. All additions were made to the melted agar
which was maintained at 45°C in a waterbath. The soft LB agar overlay (4mls) was
subsequently poured onto over-dried LB plates (see appendix 8.2 for preparation).
Samples (25pl) of H2 O2 in PBS or XO with or without its substrates were added to sterile
filter paper disks and transferred to the soft agar surface using flame sterilised forceps.
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The zone of killing (no growth visible) was measured after incubating the disks for 24 
hours at 37°C.
6.2.4 Effect of XO on bacterial viability in variable oxygen
6.2.4.1 Assessment of viable cells by colony counts
The number o f viable cells o f control and XO treated bacteria were assessed at a 
range o f oxygen tensions by counting of the number of colony forming units (CFU) on 
agar. Assessments o f viability were carried out using the Miles-Mizra count technique. 
This technique counts the viable population and involves the preparation of a dilution 
series of the test culture, and the division of an agar plate into an appropriate number of 
sectors. A pipette is then used to place drops of the diluted suspension onto each sector. 
Sectors which receive a dilution with a high concentration of cells will show overlapping 
growth. At lower concentration the number of colonies will be able to be counted. This 
method depends on the use o f several replicate tests.
6.2.4.1.1 Materials
LB (Sigma Aldrich Company Ltd. Dorset, UK), Agar No. 1 (Oxoid Limited. 
Hampshire, UK), Petri dishes (Fisher Scientific UK Ltd. Leicestershire, UK), 96-well 
plates, Sodium nitrite, Hypoxanthine (Sigma Aldrich Company Ltd. Dorset, UK), XO 
(Biozyme Laboratoritories. Gwent, UK).
6.2.4.1.2 Protocol
Bacteria from overnight cultures were inoculated into 96-well plates in air using 
sterile technique in the presence of a Bunsen flame and then placed in a 37°C incubator. 
Alternatively, the plates were inoculated in the hypoxia cabinet which was set up prior to 
the experiment as described in section (4.2.5). For the XO treatment studies the plates 
were treated with XO 0, 10 and 50mU ml'1, ImM hypoxanthine and ImM nitrite. Plates 
were removed from the incubator or the hypoxia cabinet at hourly or 3 hourly intervals 
and 20pl samples were taken from test wells and repeatedly diluted in 180pl of LB (10- 
fold dilutions). For each sample, four or three 10-fold dilutions were plated onto agar 
plates (see appendix 8.2 for plate preparation) for a countable number of cells and 20pl of 
each dilution was added to the plate in triplicate (Figure 6.1). The inoculated plates were 
incubated at 37°C overnight. Each batch of incubated cells also had a non-inoculated plate 
that had undergone the air drying procedure to show the level o f background 
contamination. Two agar plates were required per test condition for the hypoxia
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experiments for an n = number of four. 64 plates were used at each oxygen concentration 
(4 test conditions x 4 strains of bacteria x 2 time points).
The number of viable cells ml’1 were determined as follows:
Average viable count per 20pl drop x dilution factor x 50 = CFUml'1 of original sample. 
Figure 6.1
Figure 6.1 Agar plate layout for colony counts.
(A) Agar plates were initially divided into four quadrants to culture four 10-fold dilutions o f a sample taken 
from one well o f the 96-well plate. (B) However, later experiments which required a higher n number 
showed that the plates could be divided into six segments allowing for two lots o f three 10-fold dilutions of 
2 different samples therefore halving the number of plates required.
6.2.5 Statistical analysis
Statistical analysis of data collected was performed using GraphPad Prism Version 
4.00 (GraphPad Software Inc.). Statistical analysis performed was, a one-way ANOVA 
statistical test with Dunnett’s post test for analysis of variance between treatments.
6.3 Results
6.3.1 Effect of H20 2 and ONOO" on the growth of S. aureus 
disease Isolates
6.3.1.1 Growth curves of S. aureus strains
Initial assays were carried out to assess the growth of the S. aureus disease isolates 
(Mu 3, Mu 50, 117, N317) in 96-well plates at varying dilutions of the bacterial culture. 
The overnight cultures were diluted 1 in 10 (lxlO '1) and 1 in 20 (5x10'2), the cultures were 
then serially diluted 1 in 10 giving 22 different dilutions. The results which are shown 
below, demonstrate that clear sigmoidal growth curves (shown below in red) were only 
achieved at a lx l 0 '1 and 5x10'2 dilution of the overnight culture, therefore these dilutions 
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Figure 6.2 Growth curves of S. aureus (Isolate Mu 3) at varying concentrations.
Dilutions of overnight cultures o f S. aureus began at A): 1:10 dilution (1 x 10”1) as indicated by the red line 
and B): a 1:20 dilution (5x10 ") as indicated by the red line. Further log dilutions made across a 96-well plate 
in TSB for a 200pl final volume per well. The changes in absorbance readings over time indicated growth 
and were recorded at 595nm at 20 min intervals over a 4 hour time period, n = 1.
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Figure 6.3Growth curves of S. aureus (Isolate Mu 50) at varying concentrations.
Dilutions of overnight cultures o f S. aureus began at A): 1:10 dilution (1 x 10”1) as indicated by the red line 
and B): a 1:20 dilution (5x1 O'") as indicated by the red line. Further log dilutions made across a 96-well plate 
in TSB for a 200pl final volume per well. The changes in absorbance readings over time indicated growth 
and were recorded at 595nm at 20 min intervals over a 4 hour time period, n = 1.
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Figure 6.4 Growth curves of S. aureus (Isolate 117) at varying concentrations.
Dilutions of overnight cultures o f S. aureus began at A): 1:10 dilution ( lx lO 1) as indicated by the red line 
and B): a 1:20 dilution (5x10'2) as indicated by the red line. Further log dilutions made across a 96-well plate 
in TSB for a 200pl final volume per well. The changes in absorbance readings over time indicated growth 
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Figure 6.5 Growth curves of S. aureus (Isolate N317) at varying concentrations.
Dilutions of overnight cultures of S. aureus began at A): 1:10 dilution ( lx lO 1) as indicated by the red line 
and B): a 1:20 dilution (5x1 O'2) as indicated by the red line. Further log dilutions made across a 96-well plate 
in TSB for a 200jul final volume per well. The changes in absorbance readings over time indicated growth 
and were recorded at 595nm at 20 min intervals over a 4 hour time period, n = 1.
The growth rates (Table 6.2) and doubling times (Table 6.3) at a 1x10'' and 5xl0 '2 
dilution of the start culture were calculated and show that the growth rates are faster and 
doubling time shorter at 5x1 O'2 dilution of the start culture compared with a lxlO '1 
dilution. The growth rates and doubling times of the four strains are similar; however, Mu 
3 has the fastest growth rate and shortest doubling time.
Table 6.2
Dilution of start 
culture
Mu 3 (171) Mu 50 117(138) N317
lx lO 1 0.0156 0.0136 0.0150 0.0132
5x101 0.0186 0.0147 0.0173 0.0161
Table 6.2 Rate of bacterial growth (log2 A595nm min ') of four S. aureus strains.
Growth rates at a lx l 0 '1 and a 5x10'2 dilution of the start culture were calculated from the raw data in figure 
6.2-6.5. n = 1.
Table 6.3
Dilution of start 
culture
Mu 3 (171) Mu 50 117(138) N317
l x l O1 64.23 73.53 66.58 75.64
5x102 53.68 68.03 57.74 62.31
Table 6.3 Doubling times of bacterial growth (minutes) of four S. aureus strains.
Doubling times at a lx lO '1 and a 5x1 O'2 dilution of the start culture were calculated from the raw data in 
figure 6.2-6.5. n = 1.
6.3.1.2 Effects of H20 2 on the growth of S. aureus strains
The growth of S. aureus strains Mu 3 (171), Mu 50, 117 (138) and N317 was 
followed after the treatment of both a lxlO '1 and a 5x10’2 dilution of the start culture with 
H20 2 (Figure 6.6-6.9). At a 5x10'2 dilution of the culture lOOmM H20 2 slowed bacterial
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growth to a greater extent than when bacteria are treated at a lx l O’1 dilution as shown in 
the growth curves in figure 6.6-6.9 (shown in red) and in the growth rates (figure 6.10). 
H2O2 has a significant effect on the growth of S. aureus at lOOmM 117, Mu 50 and N315 
were most sensitive at this concentration, whereas Mu 3 was the least sensitive (figure 
6.10). At lOmM H2O2 the only strain to show a significant reduction in the growth rate 
when compared with the control was 117 (figure 6.10).
Figure 6.6-6.9
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Figure 6.6 Growth Curves of S. aureus (Isolate Mu 3) Treated with H20 2
Experiments were carried out in air at a lx lO '1 (A) and 5xl0 '2 (B) dilution of the overnight culture. Bacteria 
were treated with H20 2 at 0, 0.1, 1, 10 and lOOmM. The effects of lOOmM H20 2 are indicated by the red 
line. Absorbance readings were taken at 595nm at 20min intervals for 4 hours at 37°C. Mean±SD. n = 4.
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Figure 6.7 Grow th curves of S. aureus (Isolate Mu 50) Treated with H20 2
Experiments were carried out in air at a 1 x 10 '1 (A) and 5x10'2 (B) dilution of the overnight culture. Bacteria 
were treated with H20 2 at 0, 0.1, 1, 10 and lOOmM. The effects of lOOmM H20 2 are indicated by the red 
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Figure 6.8 Grow th curves of S. aureus (Isolate 117) Treated with H20 2
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Experiments were carried out in air at a lx lO '1 (A) and 5x10': (B) dilution o f the overnight culture. Bacteria 
were treated with H20 2 at 0, 0.1, 1, 10 and lOOmM. The effects of lOOmM H20 2 are indicated by the red 
line. Absorbance readings were taken at 595nm at 20min intervals for 4 hours at 37°C. Mean±SD. n = 4.
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Figure 6.9 Growth curves of S. aureus (Isolate N315) treated with H20 2.
Experiments were carried out in air at a lx lO '1 (A) and 5xl0’2 (B) dilution of the overnight culture. Bacteria 
were treated with H20 2 at 0, 0.1, 1, 10 and lOOmM. The effects of lOOmM H20 2 are indicated by the red 
line. Absorbance readings were taken at 595nm at 20min intervals for 4 hours at 37°C. Mean±SD. n = 4.
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Figure 6.10 Maximal growth rates of S. aureus Isolates treated with H20 2.
Experiments were carried out in air at a lx lO '1 (as shown in red) and 5xl0 '2 (as shown in blue) dilution of 
the overnight culture o f strains Mu3, Mu50, N317, 117. Bacteria were treated with H20 2 at 0.1, 1, 10 and 
lOOmM at 37°C. Rates were calculated from the log phase of growth using the growth curves in figure 6.6- 
6.9. Mean±SD. n = 4. The statistical analysis used was One-way ANOVA with Dunnett’s post test.
A range of isolates from pus drains and abscess sites that were hospital or 
community acquired were also tested for sensitivity to H2O2 . The effect of H2O2 on isolate 
13, 357, 197, 283, 301 and 307 was assessed using a 5x10‘2 and a 2.5x10 2 dilution of the 
start culture (Figure 6.11-6.16). The starting concentrations of the bacterial culture were 
based on the results in section 6.3.1.2 showing that the lower concentration showed
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greater sensitivity to H2O2 . The results show that at a 2.5x102 dilution of the start culture, 
10 and lOOmM H2O2 completely inhibits the growth of the S. aureus isolates. However, at 
a 5x1 O'2 dilution of the start culture only lOOmM H2O2 is effective (Figure 6.17). The 
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Figure 6.11 Growth curves of S. aureus (Isolate 13) treated w ith H20 2.
Experiments were carried out in air using a 5x1 O'2 (A) and a 2.5x1 O'2 (B) dilution o f the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2 by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Mean ± SD. 5x l0 '2: n = 4 (Except lOOmM n =1). 2.5xl0 '2: n = 1
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Figure 6.12 Growth curves of S. aureus (Isolate 357) treated w ith H20 2.
Experiments were carried out in air using a 5xl0 '2 (A) and a 2.5xl0 '2 (B) dilution o f the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Mean ±  SD. 5x l0 '2: n = 4 (Except lOOmM n = 1). 2 .5xl0 '2: n = 1.
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Figure 6.13 Growth curves of S. aureus (Isolate 197) treated with H20 2.
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Experiments were carried out in air using a 5x l0 '2 (A) and a 2.5xl0 '2 (B) dilution of the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Mean ± SD. 5x10'2: n = 4 (Except lOOmM n = 1). 2.5x1 O'2: n = 1.
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Figure 6.14 Growth curves of S. aureus (Isolate 283) treated with H20 2.
Experiments were carried out in air using a 5x1 O'2 (A) and a 2.5x1 O'2 (B) dilution of the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Mean ± SD. 5x10'2: n = 4 (Except lOOmM n = 1). 2.5x10'2: n = 1.
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Figure 6.15 Growth curves of S. aureus (Isolate 301) treated with H20 2.
Experiments were carried out in air using a 5xl0"2 (A) and a 2.5x10'2 (B) dilution o f the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Mean ± SD. 5x l0 '2: n = 4 (Except lOOmM n = 1). 2 .5xl0 '2: n = 1.
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Figure 6.16 Growth curves of S. aureus (Isolate 13) treated with H20 2.
Experiments were carried out in air using a 5x l0 '2 (A) and a 2.5xl0 '2 (B) dilution o f the overnight culture. 
Bacteria were treated with H20 2 at 0, 0.1, 1, 10 and 100 mM. The effects o f lOOmM H20 2 are indicated by 
the red line and lOmM H20 2by the blue line. Absorbance readings were taken at 595 nm at 20 min intervals 
for 4 hours at 37°C. Isolate 307 5x l0 '2 n = 1 and 2.5xl0 '2 n = 1.
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Figure 6.17
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Figure 6.17 Growth rates of S. aureus strains after treatment with H2O 2
Experiments were carried out at a 5x1 O’2 (as shown in red) and 2.5x10'2 (as shown in blue) dilution of the 
overnight cultures of isolate 13, 357, 197, 301 and 307. Bacteria were treated with E^Cbat 0, 0.1, 1, 10 and 
lOOmM. (See figure 6.5 for the examples of growth curves). Mean±SD. Isolate 13, 357, 197, 283, 301 : 
5x l0 '2 n = 4 Except lOOmM n = 1. 2.5xl0 '2 n =  1. Isolate 301 5xl0 '2 n = 1 and 2.5xl0‘2 n = 1. Statistical 
analysis was not performed as the number for some o f the conditions was too small.
6.3.1.3 Effects of ONOO" on the growth of S. aureus strains
Peroxynitrite was generated on the lab bench as in section 6.2.2.1. A method by 
Reed et al (1974) was initially used however this produced a low yield of 13.5mM. In an 
attempt to improve the yield modifications of the methodology and equipment were 
experimented with based around the method described by Koppenol et al (1996) 
eventually resulting in an improved yield up to 74mM ONOO". Initial experiments to 
examine the efficacy of a range of ONOO" concentrations to kill bacteria were performed. 
These experiments indicated that a concentration of 0.5mM was sufficient to kill bacteria 
but the effect was lost on further dilution to O.lmM. These preliminary experiments could
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not be expanded upon or reproduced because of a laboratory safety audit of procedural 
risk assessments. This resulted in a change in laboratory safety policy that prohibited the 
use o f pathogenic strains o f bacteria such as the S. aureus disease isolates that were being 
used in this study.
As it became impossible to use these bacteria for any further experiments, it was 
decided to move directly onto the XO treatment experiments. Furthermore, because o f the 
change in safety policy with regard to S. aureus disease strains it was impossible to use 
these strains for the experiments in variable oxygen which would involve the use of 
multiple plates on the lab bench. Therefore, four laboratory strain facultative bacteria that 
are known to be relevant to the chronic wound and could be used on the lab bench, and 
could be easily accessed on a daily basis were supplied by Dr. Pauline Wood for future 
experiments.
6.3.2 Effect of H20 2 and XO on the growth of bacterial species 
relevant to the chronic wound
6.3.2.1 Growth curves of S. faecalis, E. coli, S. aureus, P. aeruginosa
The facultative anaerobes S. faecalis, E. coli, S. aureus, P. aeruginosa supplied by 
Dr. Pauline Wood were used to check that the bacteria followed normal sigmoidal growth 
in 96-well plates in air. Varying concentrations of the bacterial overnight cultures were 
used and growth was followed over 6 hours. The growth of S. aureus, E. coli and S. 
faecalis follow sigmoidal growth characteristics with a lag phase log phase and stationary 
phase of growth. P. aeruginosa, however, shows a reduced growth rate and extended lag 
phase compared with the other bacteria (Figure 6.18).
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Figure 6.18
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Figure 6.18 Growth curves of four facultative anaerobes with varying cell concentration.
Overnight cultures were diluted in cuvettes to an A60onm of 0.08 and doubling dilutions of the strains were 
carried out in 5ml bijous. lOOpl of each dilution was added to the wells of a 96-well plate along with lOOpl 
of LB for final concentrations of 0.0025, 0.005, 0.01, 0.02, 0.04 A b s 60onm in a 200pl total volume. The plate 
was read at 37°C every 30mins for 6 hours. Mean ± SD. n = 4.
6.3.2.2 Correlation of absorbance versus viable cell counts.
Experiments were carried out to determine the relationship between the growth 
curve absorbance readings taken in a 96-well plate and the corresponding number of 
viable cells ml'1 for S. aureus, P. mirabilis, S. faecalis and E. coli (Figure 6.19-6.21). P. 
mirabilis, was included in these studies as a substitute for P. aeruginosa. However, P. 
aeruginosa was included in some of the later XO studies in air. The results in figure 6.19 
follow a similar profile until around four hours, after this time the absorbance values begin 
to plateau suggesting that the cells have reached stationary phase. This effect however, is 
not mirrored in several o f the cell counts which continue to rise after 4 hours. The E. coli 
appear to show a reduction in viability at 6 hours. The results in figure 6.20 and show that 
for staphylococcus aureus and proteus mirabilis there appears to be a linear relationship 
until the stationary phase is reached {Staphylococcus aureus ~0.4 abssgsnm, Proteus 
mirabilis DV429 -0.5 abs595nn,) where the number of viable cells appear to continue to 
increase and the absorbance plateaus. There is a linear relationship between abs 595 nm 





















































































Figure6.19 Correlation of Abs595Dm versus cells ml'1 of S. aureus, P. mirabilis, S. faecalis, E. coli
Overnight cultures of S. aureus, P. mirabilis, S. faecalis, E. coli were each diluted to 0.02 Abs60onm in LB 
and 200)0.1 added to 6 wells of a 96-well plate. Cultures were grown at 37°C in air for 6 hours. (A) 
Absorbance at 595 nm was taken at hourly intervals and, (B) Viable counts (Cells ml'1) determined 
simultaneously for colony counts at hourly intervals. This was achieved by removal of 20)0.1 of sample and 
diluted using the Miles-Mizra technique for a countable number of colonies on agar n = 1.
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Figure 6.20 Correlation of absorbance against viable count.
Using the raw data in figure 6.27 the cells ml'1 were plotted against Abs595nm to determine if there is a linear 
relationship. There appears to be a linear relationship in the first few hours of growth (See figure 6.29).
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Figure 6.21 Linear relationship between abs595nra and cells ml'1 before stationary phase is reached.
There is a linear relationship in the first 4-5 hours of growth as indicated by the r2 values on the graphs 
above.
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6.3.2.3 Treatment of S. aureus and S. faecalis with H20 2
The effect of a range of concentrations of H20 2 on the growth of S. aureus (Figure 
6.22) and S. faecalis (Figure 6.23) was assessed. Hydrogen peroxide at 2mM slowed the 
growth of S. aureus with complete inhibition of growth at 5mM H20 2 and above. 
Hydrogen peroxide at 1 and 2mM slowed the growth of S. faecalis with complete 
inhibition at 5mM H20 2.
Figure 6.22A)
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Figure 6.22 Treatment of S. aureus with H20 2
Experiments were carried out in air in a 96-well plate. The overnight culture was diluted to 0.04 Abs6oonm 
and lOOpl added to the plate. Bacteria were then treated with lOOpl H20 2 diluted in LB for final 
concentrations o f 0, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20 and 50mM and a 200pl final volume. The plate was 
maintained at 37°C and absorbance readings were taken at 595nm at 30min intervals over 6 hours. Graph A 
shows growth curves o f S. aureus at varying concentrations of H20 2. Graph B shows maximal growth rates 
o f S. aureus. The effect of H20 2 added on the growth rate which was calculated from the log phase A595nm 
readings over time. Data was then analysed using One-Way ANOVA with Dunnett’s post test using OmM 
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Figure 6.23 Treatment of S. faecalis with H20 2.
Experiments were carried out in air in a 96-well plate. The overnight culture was diluted to 0.04 Abs6oonm 
and lOOpl added to the plate. Bacteria were then treated with lOOpl H20 2 diluted in LB for final 
concentrations o f 0, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20 and 50mM and a 200pl final volume. The plate was 
maintained at 37°C and absorbance readings were taken at 595nm at 30min intervals over 6 hours. Graph A 
shows growth curves o f S. faecalis at varying concentrations of H20 2. Graph B shows maximal growth rates 
of S. faecalis. The effect of H20 2 added on the growth rate which was calculated from log phase A595nm 
readings over time. Data was then analysed using One-Way ANOVA with Dunnetf s post test using OmM 
H20 2 as a control. Results are from two experiments performed in quadruplicate, therefore n = 8. Mean±SD.
6.3.2.4 Treatment of S. faecalis with SIN-1
A brief study was carried out to assess the effects of the peroxynitrite generator 
SIN-1 on the growth of S. faecalis. Prior to this study, ONOO" generation by SIN-1 was 
measured in PBS and LB to provide information on the activity of the SIN-1 stock in PBS 
as compared with in LB. Experiments were also carried out in the presence of iron
227
chelator DTPA which prevents iron mediated hydroxyl radical formation which can 
oxidase DHR. The comparison between PBS and LB without DTPA shows that the rate of 
DHR oxidation is considerably slower in the LB suggesting a decrease in ONOO" 
generation. DHR oxidation by SIN-1 in PBS in the presence o f DTPA is marginally 
decreased. This is also the case in the LB although the reduction in DHR oxidation is far 
more evident in this case (Figure 6.24). Figure 6.25 shows the inhibition of the growth of 
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Figure 6.24 Oxidation of DHR with SIN-1 in PBS and LB with and without DTPA.
Experiments were carried out in air in a 96-well plate using DHR (O.lmM) and SIN-1 (0, 31.25, 125, 500 
and lOOOpM) diluted in both LB and PBS with and without the addition of DTPA (O.lmM). Absorbance 
readings were taken at 490nm over a 6 hour time period at 37°C (See section 4.2.2.2 for methodology). 













Figure 6.25 Treatment of S. faecalis with ONOO"
228
Overnight cultures of S. faecalis were diluted to 0.04 Abs60onm in cuvettes with LB and lOOjil added to a 96- 
well plate. SIN-1 (0, 31.25, 125, 500 and lOOOpM) was diluted in LB and lOOpl added to the plate for a 
200pl final concentration. The plate was incubated at 37°C and readings were taken at 595nm every 30 
minutes over 6 hours. This figure shows a growth curve of S. faecalis treated with SIN-1. Inhibition of 
growth is shown in blue (500pM) and red (1000pM). n = 4. Mean ± SD.
6.3.2.S Treatment of E. coli with XO in air (cuvette method)
Initial experiments to assess the effects of XO on bacteria relevant to the chronic 
wound were carried out in cuvettes using E. coli. Figure 6.26A and B suggests that XO 
does not affect the growth of E. coli in stirred cuvettes at 1 and 5mU m l'1 XO. However, 
there does appear to be a slight slowing of growth at 50mU m f1 XO (Figure 6.24A and B). 
Subsequent assays were performed in 96-well plates to increase the number of samples 
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Figure 6.26 Growth curves of E. coli treated with XO in air.
Experiments were carried out in air at 37°C in stirred cuvettes. The overnight culture was diluted in LB to 
0.04 Abs60onm the E. coli bacteria (B) were then treated with 0, 1,5, 50 mU m l'1 XO and ImM hypoxanthine 









over 4 hours. Graph A shows growth curves o f E. coli treated with hypoxanthine and XO. Graph B shows 
maximal growth rates (log phase) o f E. coli treated with XO. n = 1.
6.3.2.6 Treatment of bacterial species with XO in air (96-well plate 
method)
The effect o f a range of concentrations of XO in air on the growth o f S. aureus, S. 
faecalis, E. coli, P. aeruginosa, P. mirabilis were assessed in 96-well plates (Figure 6.27- 
6.36). For each bacterial species there are two figures, the first shows the relevant controls 
for the experiment and the second figure shows the treatment of the bacterial species with 
hypoxanthine and a range of XO concentrations (0-50mU ml'1). The treatment o f S. 
aureus (Figure 6.27A and B controls) shows that ImM hypoxanthine and allopurinol 
alone do not affect the growth of S. aureus. However, XO (50 mU ml'1) appears to slow 
the growth of S. aureus both with and without the addition o f hypoxanthine which 
suggests that substrates for XO are present in the LB. Addition o f allopurinol reverses this 
effect confirming that the slowing of growth is due to XO. Treatment o f the bacteria with 
a range of XO concentrations and hypoxanthine (figure 6.28A and B) shows that lOmU 
ml"1 XO significantly slows the growth of S. aureus, and 50mU ml'1 XO completely 
inhibits the growth o f S. aureus. Allopurinol completely reverses this inhibition of growth 
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Figure 6.27 Treatment of S. aureus with XO in air (Controls).
Overnight cultures o f S.aureus were diluted to 0.04 Abs60onm in cuvettes and lOOpl added to a 96-well plate. 
Bacteria (B) were then treated with combinations o f ImM hypoxanthine (H), 50 mU m l'1 XO and ImM 
allopurinol (A) diluted in LB for a final volume per well of 200gl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6 hours. A) Growth curves o f S. aureus treated with 
varying combinations of hypoxanthine, XO and allopurinol. B) Maximal growth (log phase) o f S. aureus 
treated with varying combinations o f hypoxanthine, XO and allopurinol. Statistical analysis was performed 
using One-way ANOVA with Dunnett’s post test and LB+B as the control. ** =P<0.01. Data is from two 



































0 . 000 '
S. a u r e u s
X
n z i
0.5 1 10 50 50+A
[XO mU ml*1]
Figure 6.28 Treatment of S. aureus with XO in air.
Overnight cultures of S. aureus were diluted to 0.04 A b s 60onm in cuvettes and lOOpl added to a 96-well plate. 
Bacteria (B) were then treated with ImM hypoxanthine (H), 0, 0.5, 1,5, 10 and 50 mU m l'1 XO and ImM 
allopurinol ( A )  diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6 hours. A )  Growth curves o f S. aureus treated with 
varying concentrations of XO and allopurinol. B) Maximal growth (log phase) o f S. aureus treated with 
hypoxanthine, XO and allopurinol. Statistical analysis used was One-way A N O V A  with Dunnett’s post test 
using OmU m l'1 XO as the control. ** =P<0.01. Data is from two experiments carried out on two separate 
occasions in quadruplicate, therefore n = 8. Mean ± SD.
For S. faecalis the controls shown in Figure 6.29A and B suggest that ImM 
hypoxanthine and allopurinol alone do not affect the growth of S. faecalis. Furthermore, in 
this case XO (50 mU ml'1) in LB without the addition of hypoxanthine does not slow the 
growth of S. faecalis which maybe because the S. aureus is more sensitive to XO 
generated species than S. faecalis. Treatment of S. faecalis with a range of XO 
concentrations in the presence of hypoxanthine (Figure 6.30A and B) shows that 10 and
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50mU m l'1 XO in the presence of hypoxanthine significantly slows the growth of S. 
faecalis, however, at 50 mU m l'1 XO does not completely inhibit growth as found for S. 
aureus (Figure 6.28). This inhibition growth is completely reversed in the presence of 
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Figure 6.29Treatment of S. faecalis with XO in air (Controls).
Overnight cultures o f S. faecalis were diluted to 0.04 A b s 6oonm in cuvettes and 100^1 added to a 96-well 
plate. Bacteria (B) were then treated with combinations of ImM hypoxanthine (H), 50 mU ml’1 XO and 
ImM allopurinol ( A )  diluted in LB for a final volume per well o f 200pl. The plate was incubated at 37°C 
and readings were taken at 595nm every 30 minutes over 6 hours. A )  Growth curves o f S. faecalis treated 
with varying combinations o f hypoxanthine, XO and allopurinol. B) Maximal growth (log phase) of S. 
faecalis treated with varying combinations o f hypoxanthine, XO and allopurinol. Statistical analysis was 
performed using One-way A N O V A  with Dunnett’s post test and LB+B as the control. ** =P<0.01. Data is 
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Figure 6.30 Treatment of S. faecalis with XO in air.
Overnight cultures of S faecalis were diluted to 0.04 A b s 6oonm in  cuvettes and lOOgl added to a 96-well 
plate. Bacteria (B) were then treated with ImM hypoxanthine (H), 0, 0.5, 1 ,5 , 10 and 50mU m l'1 XO and 
ImM allopurinol (A) diluted in LB for a final volume per well o f 200pl. The plate was incubated at 37°C 
and readings were taken at 595nm every 30 minutes over 6 hours. A )  Growth curves o f S. faecalis treated 
with varying concentrations o f XO and allopurinol. B) Maximal growth (log phase) o f S. faecalis treated 
with hypoxanthine, XO and allopurinol. Statistical analysis was performed using One-way ANOVA with 
Dunnett’s post test and OmU m l'1 XO as the control. ** =P<0.01. Data are from two experiments carried out 
on two separate occasions in quadruplicate, therefore n = 8. Mean ± SD.
Treatment with E. coli (Figure 6.31 A and B controls) shows that ImM 
hypoxanthine and allopurinol alone do not affect the growth of E. coli, and as for S. 
faecalis, XO (50 mU m l'1) in LB without the addition of hypoxanthine also does not slow 
the growth of E. coli. Treatment with XO (Figure 6.32A and B) shows that 5, 10 and 
50mU m l'1 XO in the presence of hypoxanthine significantly slows the growth of E. coli
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(F igure 6 .32A  and B). T he inhibition  o f  the grow th o f  E. coli w as reversed  in the presence 
o f  X O  inhib itor, a llopurino l (F igure 6.32A  and B).
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Figure 6.31Treatm ent of E. coli with XO in air (Controls).
Overnight cultures o f E. coli were diluted to 0.04 Abs60onm in cuvettes and lOOgl added to a 96-well plate. 
Bacteria (B) were then treated with combinations of ImM hypoxanthine (H), 50mU m l'1 XO and ImM 
allopurinol (A) diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6 hours. A) Growth curves o f E. coli treated with 
varying combinations o f hypoxanthine, XO and allopurinol. B) Maximal growth (log phase) o f E. coli 
treated with varying combinations o f hypoxanthine, XO and allopurinol. Statistical analysis was performed 
using One-way ANOVA with Dunnett’s post test and LB+B as the control. ** =P<0.01. Data is from two 
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Figure 6.32 T reatm ent of E. coli with XO in air.
Overnight cultures o f E. coli were diluted to 0.04 A b s 6oonm in cuvettes and lOOpl added to a 96-well plate. 
Bacteria (B) were then treated with ImM hypoxanthine (H), 0, 0.5, 1 ,5, 10 and 50mU m l'1 XO and ImM 
allopurinol (A) diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6 hours. A) Growth curves o f E. coli treated with 
varying concentrations o f XO and allopurinol. B) Maximal growth (log phase) o f E. coli treated with 
hypoxanthine, XO and allopurinol. Statistical analysis was performed using One-way ANOVA with 
Dunnett’s post test and OmU m l'1 XO as the control. ** =P<0.01. Data is from two experiments carried out 
on two separate occasions in quadruplicate, therefore n = 8. Mean ± SD.
A s show n prev iously , the grow th curve for P. aeruginosa in a ir show s an ex tended  
lag phase  and a reduced  grow th  rate com pared  with the o ther bac te ria  (F igure  6 .33A  and 
6 .34A ). T he con tro ls for the X O  experim ent again show s that the g row th  o f  P. aeruginosa 
is unaffec ted  by Im M  hypoxanth ine. H ow ever, the results suggest tha t a llopurino l and X O  
(50 m U  m l"1) sign ifican tly  reduces the grow th rate o f  P. aeruginosa (F igure  6.33 A and B). 
T reatm en t o f  P.aeruginosa w ith  X O  (F igure 6.34 A and B) show s tha t 5, 10 and 50m U  ml" 
1 X O  in the p resence  o f  hypoxanth ine significantly  slow s the g row th  o f  P. aeruginosa
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(F igure 6.34). The inh ib ition  o f  the grow th o f  E. coli by  X O  is reversed  in the p resence  of, 
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Figure 6.33 T reatm ent of P. aeruginosa with XO in air (Controls).
Overnight cultures o f P. aeruginosa were diluted to 0.04 A b s 60onm >n cuvettes and 100|il added to a 96-well 
plate. Bacteria (B) were then treated with combinations of ImM hypoxanthine (H), 50mU m l'1 XO and ImM 
allopurinol (A) diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6  hours. A )  Growth curves of P. aeruginosa treated 
with varying combinations of hypoxanthine, XO and allopurinol. B) Maximal growth (log phase) of P. 
aeruginosa treated with varying combinations o f hypoxanthine, XO and allopurinol. Statistical analysis was 
performed using One-way ANOVA with Dunnett’s post test and LB+B as the control. ** =P<0.01. Data is 
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Figure 6.34 T reatm ent of P. aeruginosa with XO in air.
Overnight cultures o f P. aeruginosa were diluted to 0.04 Abs6oomn >n cuvettes and lOOpl added to a 96-well 
plate. Bacteria (B) were then treated with ImM hypoxanthine (H), 0, 0.5, 1 ,5 , 10 and 50mU m l'1 XO and 
ImM allopurinol (A) diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C 
and readings were taken at 595nm every 30 minutes over 6 hours. A) Growth curves of P. aeruginosa 
treated with varying concentrations o f XO and allopurinol. B) Maximal growth (log phase) of P. aeruginosa 
treated with hypoxanthine, XO and allopurinol. Statistical analysis was performed using One-way ANOVA 
with Dunnett’s post test and XO OmU m l'1 as the control. * = P<0.05, ** =P<0.01. Data is from an
experiment carried out in quadruplicate, therefore n = 4. Mean ± SD.
T he control experim en ts for P. mirabilis (Figure 6.35A  and  B) show  that
h ypoxan th ine  (Im M ), a llopurino l (Im M ), and X O  (50 mU m l '1) added  to the bacterial
cu ltu re  ind iv idually  do not affect the grow th o f  P. mirabilis. F igure 6 .36A  and B show s 
tha t 50m U  m l '1 X O  in the presence o f  hypoxanth ine sign ifican tly  slow s the g row th  o f  P. 
mirabilis. H ow ever, the grow th rate o f  P. mirabilis is also inhibited  in the presence  o f  XO  
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Figure 6.35 T reatm ent of P. mirabilis with XO in air (Controls).
Overnight cultures of P. mirabilis were diluted to 0.04 A b s 600nm >n cuvettes and lOOjil added to a 96-well 
plate. Bacteria (B) were then treated with combinations of ImM hypoxanthine (H), 50mU m l'1 XO and ImM 
allopurinol ( A )  diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C and 
readings were taken at 595nm every 30 minutes over 6  hours. A )  Growth curves o f P. mirabilis treated with 
varying combinations of hypoxanthine, XO and allopurinol. B) Maximal growth (log phase) of P. mirabilis 
treated with varying combinations o f hypoxanthine, XO and allopurinol. Statistical analysis was performed 
using One-way A N O V A  with Dunnett’s post test and LB+B as the control. ** =P<0.01. Data is from an 
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Figure 6.36. T reatm ent of P. mirabilis with XO in air.
Overnight cultures of P. mirabilis were diluted to 0.04 Abs60onm in cuvettes and lOOpl added to a 96-well 
plate. Bacteria (B) were then treated with ImM hypoxanthine (H), 0, 0.5, 1, 5, 10 and 50mU ml’1 XO and 
ImM allopurinol (A) diluted in LB for a final volume per well of 200pl. The plate was incubated at 37°C 
and readings were taken at 595nm every 30 minutes over 6 hours. A) Growth curves o f P. mirabilis treated 
with varying concentrations o f XO and allopurinol. B) Maximal growth (log phase) o f P. mirabilis treated 
with hypoxanthine, XO and allopurinol. Statistical analysis was performed using One-way ANOVA with 
Dunnett’s post test and OmU m l'1 XO as the control. ** =P<0.01. Data is from an experiment carried out in 
quadruplicate, therefore n = 4. Mean ± SD.
6.3.3 Effects of H20 2 and XO on the viability of bacteria in air
T he effects o f  vary ing  treatm ents on bacteria have p rev io u sly  been  assessed  by 
fo llow ing  grow th by  m easurem ents o f  absorbance over tim e. H ow ever, a lthough this 
m ethod  gives an idea o f  the effects o f  varying treatm ents on  grow th , it is unab le  to 
de term ine  the v iab le  cells in the culture. Therefore this section a im s to  develop  a m ethod  
for the m easurem ent o f  v iab ility  in a range o f  oxygen tensions.
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6.3.3.1 Disk inhibition assays
6 .3 .3 .1 .1  T r e a tm e n t  o f  S. aureus w ith  H 20 2
R esistance to the ox idative stress inducer H 20 2 w as assessed  as a positive  contro l 
to  check that the d isk  inh ib ition  assay w as w orking. The agar p la te s  show n in F igure 6.37 
show  clear inh ib ition  o f  the grow th o f  S. aureus as dem onstra ted  by  the zones form ed 
around the filter paper d isks. T he assays show  that zones are fo rm ed  at a 1 in 100 d ilu tion 
(88m M ) and above o f  the H 20 2 stock. The diam eters o f  the zones that w ere form ed are 
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Figure 6.37 Inhibition of the growth of S. aureus using H20 2.
Overnight S. aureus cultures were added to soft agar (0.4%) for a final concentration of 0.02 abs6oonm 
(~1.3xl0 '7 cells m l'1) and 4mls added to an over-dried LB plate. The soft agar was allowed to set and 
samples o f H20 2 (20pl) diluted in PBS were added to sterile filter paper disks and carefully laid onto the 
surface of the agar using flamed forceps. The Zone of killing was measured (no growth visible) was 
measured in millimeters (mm) after incubating the plates for 24 hours at 37°C.
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H20 2 dilution in PBS Initial H20 2 (mM) concentration 
on disk
Mean diam eter of disk inhibition 





1:100 88 14, 15,22
1:10 880 30, 29
1:5 1760 33
1:2 4400 38
Neat 8800 Zone too large for accurate
measurement
Table 6.4 Sensitivity of S. aureus to H 2O2.
*Values are expressed as a mean diameter of the zone of killing.
6 .3 .3 .1 .2  T r e a tm e n t  o f  S. aureus w ith  X O
B ased on the H 20 2 assay d iffusion zone assays, experim ents w ere set up to assess 
the effect o f  X O  on the v iab ility  o f  S. aureus. The agar p lates show n in figure 6.38 show  
that fa in t zones o f  inh ib ition  can be seen around the disks con ta in ing  X O  w hen com pared  
w ith  a PBS alone contro l. H ow ever, the zones are considerab ly  sm alle r than those seen 
w ith  the H 20 2 and as a result quantita tive m easurem ents are not possib le . The inhibition  
zones are also  not obvious w hen the X O  is boiled , suggesting that the  zones seen w ith  the 
X O  are not a result o f  p reservatives in the enzym e stock.
PBS in disks
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1cm r^eat XO in disk 1cm 1:2 XO in disk
  1 : 5 X 0  in disk   .
1cm  1 cm  1:10 XO m disks
  X ea* XO boi,cd 1:5 XO boiled in
1 cm  in disks 1 cm  disks
Figure 6.38 T reatm ent of S. aureus with XO in air
Overnight 5". aureus cultures were added to soft agar (0.4%) for a final concentration o f 0.02 Abs6oonm 
(~1.3xl0'7 cells m l'1) with nitrite (ImM ) and hypoxanthine (ImM ), 4mls was then added to an over-dried 
LB plate. Samples of XO were prepared by diluting the stock 1:10 (l,061mU m l1), 1:5 (2,122mU m l1), 1:2 
(5,305mU m l1) and Neat (10,610mU m l'1) in PBS. The soft agar was allowed to set and XO dilutions (20pl) 
were added to sterile filter paper disks and carefully laid onto the surface o f the agar using flamed forceps. 
The boiled XO samples were prepared by boiling at 60°C for 5 minutes. The plates were then incubated for 
24 hours at 37°C.
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D iffusion  zone assays w ere again  set up with bacteria  alone added  to  the soft agar layer 
w ithou t substrates. The d isks w ere d ipped  into a reaction m ix tu re  con taing  both  the X O  
and substra tes before  addition  to  the test plates (Figure 6.39). It w as thought that this 
m ethod  m ay  overcom e problem s w ith diffusion o f  the substrate  in the  soft agar layer. 
H ow ever, figure 6.39 does show  any obvious clearance zones, th is  m ay be beause  the 
reaction  w as over rap id ly  before  any reactive species could d iffuse from  the disk.
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Figure 6.39 T reatm ent of S. aureus with XO in air
Overnight S. aureus cultures were added to soft agar (0.4%) for a final concentration of 0.02 Abs6oonm 
(~1.3xl0‘7 cells m l1) and 4mls added to an over-dried LB plate. The soft agar was allowed to set and a 2ml 
reaction was prepared containing final concentrations of ImM hypoxanthine (H), nitrite (N) and XO 
1061mU m l'1 diluted in PBS. The sterile filter paper disks were rapidly dipped into the reaction and carefully 
laid onto the surface of the agar using flamed forceps. The plates were then incubated for 24 hours at 37°C.
6.3.4 Effects of XO on the viability of bacteria in varying 
oxygen concentrations
6.3.4.1 Growth of E. coli and S. aureus in air (21%) and 2% oxygen.
T he bacteria  used  in this study are facultative anaerobes, m ean in g  that they  are 
able to u tilise  a range o f  electron donors o ther than oxygen in its absence , and thus g row  in
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a range o f  oxygen  tensions. The effect o f  lo w  oxygen  concentration on bacterial growth  
w as m easured in order to characterise this parameter prior to the experim ents in reduced  
oxygen  (Figure 6 .40).
E. Coli 21% Oxygen S. aureus 21% Oxygen
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Figure 6.40 Growth curves of E. coli and S. aureus in 21 % and 2 % oxygen.
Overnight cultures o f S. aureus and E. coli were diluted in 2mls LB in cuvettes with sterile magnetic stirrers. 
The spectrophotometer was blanked with LB alone, and the change in absorbance at 600nm of LB and 
bacteria was recorded at 37°C over 5 hours. For experiments in 2% oxygen overnight cultures were diluted 
in the hypoxia cabinet in LB that was equilibrated in the hypoxia cabinet overnight. The cuvettes were 
covered with parafilm and removed from the hypoxia cabinet at hourly intervals and replaced after the 
absorbance readings were taken at 600nm. n = 1.
6.3.4.2 Treatment of bacteria with XO in variable oxygen for 1 and
3 hours
E xperim ents in variable oxygen  w ere carried out u sin g  the controlled oxygen  
cabinet set at 0, 1, 2, 5 and 21%  oxygen  to try and m im ic the environm ent o f  the chronic 
ulcer (0-2% ) normal tissue (2-5% ) and hyperoxia (21% ). X O  w as used  at 10 and 50m U  
ml"1 to treat the bacteria w hich  w ere concentrations previously show n to reduce the growth  
rate o f  bacteria in air (21% ) in the presence o f  hypoxanthine. For the assays show n b elow  
nitrite w as also included as a X O  substrate for the production o f  ‘N O  in hypoxia. Each o f  
the bacterial species (S. aureus, S. faecalis, P. mirabilis and E. coli) w ere treated w ith  
hypoxanthine (Im M ) and nitrite (Im M ) for 1 and 3 hours to determ ine whether these  
substrates a lone decreased the v iability  o f  the bacteria w hen com pared w ith  LB, figure 
6 .4 1 -6 .4 4 A  show ed that w as not the case.
The bacterial species w ere then treated w ith hypoxanthine and nitrite and 10 and 
50m U  m l'1 X O  for 1 and 3 hours. After an hour exposure, S. aureus show ed  a reduction in
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the num ber o f  v iab le ce lls  inhibition o f  growth at 0, 1 and 2% O 2 at 50m U  ml*1 X O . 
H ow ever, there a lso  appears to be a slight increase in v iable ce lls  com pared w ith  the 
control at 1 and 5% O 2 at lOmU m f 1 (Figure 6 .4 IB). A fter a 3 hour exposure to 50m U  ml' 
1 X O , S. aureus show ed  a significant decrease in the number o f  v iab le  ce lls  at 0, 1 and 2%  
oxygen  (-5 0 %  reduction), there w as also a decrease in the num ber o f  v iab le  ce lls  at 5% 
o xygen  (-2 5 %  reduction) and at 21%  oxygen  (-50%  reduction). A fter a 3hour exposure at 
lOm U m l'1 S. aureus show ed a reduction in the number o f  v iab le  ce lls  at 0% and 21%  
oxygen , how ever, there w as also an increase in the number o f  v iab le  ce lls  at 2% oxygen  as 
show n after an hour’s exposure to lOmU m l'1 X O  in low  oxygen  (Figure 6 .41B ).
A fter 1 hour S. faecalis show ed a reduction in the num ber o f  v iab le ce lls  at 1, 2 
and 5% O 2 at lO m U m l'1 X O  and at 1% O2 w ith 50m U  m l'1 X O  (Figure 6 .42B ). A fter 3 
hours X O  sh ow ed  a reduction in viability  at 50m U  m l'1 X O  at 1% O 2 and a slight increase  
in the num ber o f  viable ce lls  at lOmU ml"1 X O  at 2% and 21%  O 2 . The decrease in viable  
ce lls  w as not as great as show n previously w ith S. aureus (Figure 6 .42B ).
P. mirabilis show ed  a reduction in viability  at 5 and 21%  O 2 w ith  lOm U m l'1, and 
at 1, 5 and 21%  O 2 w ith 50m U  m l'1, after 1 hour’s exposure (Figure 6 .43B ). A fter 3 hours 
there w as a reduction in v iab le ce lls at 2% O 2 (-25% ) and at 21%  O 2 (-7 0 % ) w ith  lOmU  
m l'1 X O . A t 50m U  m l'1 X O  there w as a reduction in the v iab le ce lls  at 0% (-2 5 % ), 1% 
(-4 0 % ) and 2% O 2 (-50% ). There w as also a decrease in v iab ility  at 5% oxygen  (-4 0 % )  
and at 21%  O 2 ( -6 5 % ) reduction (Figure 6 .43B ).
E. coli did not show  as m uch growth inhibition at low  o x y g en  tensions as show n  
w ith  the previous bacteria. A fter 1 hour there w as a slight reduction in v iab le ce lls on ly  at 
50m U  m l'1 X O  at 5% O2 and 21%  O 2 (Figure 6.44B ). After 3 hours exposure o f  E. coli to 
X O  there appeared to be a significant increase in viable ce lls at 2% oxygen  at both 10 and 
50m U  m l'1 X O  and a decrease in the number o f  viable cells at 10 and 50m U  ml"1 (Figure 
6.44B ).
T hese data suggests that S. aureus, S. faecalis and P. mirabilis are sensitive to the 
effects o f  X O  in lo w  oxygen  concentrations betw een 0-2%  O 2 . S. aureus and P. mirabilis 
appear to be the m ost sensitive to X O -generated species.
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Figure 6.41 T reatm ent of S. aureus with XO in variable oxygen.
9 6 - well plates were inoculated with an overnight bacterial culture diluted to at A b s 6oonm- A )  Controls: 
Bacteria were treated with hypoxanthine (ImM) and nitrite (ImM) for 1 hour at 0, 1, 2, 5 and 21% oxygen. 
The numbers of viable cells were assessed by colony counts and the data is presented as a percentage of the 
control (untreated bacteria). B) Bacteria were treated with 10 and 50mU ml’1 X O  for 1 hour in the presence 
of hypoxanthine (ImM ) and nitrite (ImM ) at 0, 1, 2, 5 and 21% oxygen. The numbers of viable cells were 
assessed by colony counts and the data is presented as a percentage of the control (OmU ml’1, cells treated 
with hypoxanthine (ImM ) and nitrite (ImM ) alone), n = 4. Mean ± SEM Statistical analysis was performed 
using one way analysis o f variance ( A N O V A )  and Dunnett’s post test using OmU ml’1 as the control.
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Figure 6.42Treatm ent of S. faecalis with XO in variable oxygen.
96-well plates were inoculated with an overnight bacterial culture diluted to at Abs6oonm- A) Controls: 
Bacteria were treated with ImM hypoxanthine and ImM nitrite for 1 hour at 0, 1, 2, 5 and 21% oxygen. The 
numbers o f viable cells were assessed by colony counts and the data is presented as a percentage of the 
control (untreated bacteria). B) Bacteria were treated with 10 and 50mU m l'1 XO for 1 hour in the presence 
of ImM hypoxanthine and ImM nitrite at 0, 1, 2, 5 and 21% oxygen. The numbers o f viable cells were 
assessed by colony counts and the data is presented as a percentage of the control (0 mU m l'1- Cells treated 
with ImM hypoxanthine and ImM nitrite alone), n = 4. Mean ± SEM. Statistical analysis was performed 
using one way analysis o f variance (ANOVA) and Dunnett’s post test using OmU m l'1 as the control.
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Figure 6.43Treatment of P. mirabilis with XO in variable oxygen.
96-well plates were inoculated with an overnight bacterial culture diluted to at A b s 6oonm- A) Controls: 
Bacteria were treated with hypoxanthine (ImM) and nitrite (ImM) for 1 hour at 0, 1, 2, 5 and 21% oxygen. 
The numbers of viable cells were assessed by colony counts and the data is presented as a percentage of the 
control (untreated bacteria). B) Bacteria were treated with 10 and 50mU m l'1 XO for 1 hour in the presence 
of hypoxanthine (ImM ) and nitrite (ImM ) at 0, 1, 2, 5 and 21% oxygen. The numbers o f viable cells were 
assessed by colony counts and the data is presented as a percentage of the control (OmU m l'1, cells treated 
with hypoxanthine (ImM ) and nitrite (ImM ) alone), n = 4. Mean ± SEM. Statistical analysis was performed 
using one way analysis o f variance (ANOVA) and Dunnett’s post test using OmU m l'1 as the control.
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Figure 6.44 Treatment of E. coli with XO in variable oxygen.
96-well plates were inoculated with an overnight bacterial culture diluted to at Abs6oonm' A) Controls: 
Bacteria were treated with hypoxanthine (ImM ) and nitrite (ImM) for 1 hour at 0, 1, 2, 5 and 21% oxygen. 
The numbers o f viable cells were assessed by colony counts and the data is presented as a percentage of the 
control (untreated bacteria). B) Bacteria were treated with 10 and 50mU m l'1 XO for 1 hour in the presence 
of hypoxanthine (ImM ) and nitrite (ImM ) at 0, 1, 2, 5 and 21% oxygen. The numbers o f viable cells were 
assessed by colony counts and the data is presented as a percentage of the control (OmU m l'1, cells treated 
with hypoxanthine (ImM ) and nitrite (ImM) alone), n = 4. Mean ± SEM Statistical analysis was performed 
using one way analysis of variance (ANOVA) and Dunnett’s post test using OmU m l'1 as the control.
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6.4 Discussion
6.4.1 The effect of H20 2 and ONOO" on the growth of S. aureus 
disease isolates
X O R -generated R O N S such as H 2 O 2 and O N O O ” have been  show n in previous 
studies to have antibacterial properties (Stevens et al, 2000). H ydrogen peroxide is know n  
to have strong oxid isin g  properties and has been used as an antiseptic and anti-bacterial 
agent for m any years, w ith  strong solutions o f  H 2 O 2 has h istorically  b ein g  used  c lin ica lly  
to d isin fect w ounds. H ow ever, a 3% solution is often  recom m ended to c leanse w ounds, as 
high concentrations can be dam aging to the tissues.
Initial assays in this chapter w ere carried out to determ ine the effectiven ess o f  
H2 O 2 in reducing the growth o f  S. aureus iso lates from chronic d isease  tissues. T hese  
iso lates include M R SA  and V R S A  strains w hich  are known to contam inate chronic leg  
ulcers. T hese experim ents w ere to h ighlight the potential benefits o f  including a H 2O 2 - 
generating enzym e in a w ound dressing. Growth curves for S. aureus iso lates (M u 3, M u  
50, 117 and N 3 1 7 ) w ere produced at tw o concentrations o f  the overnight culture (Figure 
6.2 -6 .5 ). Further analysis o f  these growth rates show ed  that the grow th w as faster (Table  
6.2) and the doubling tim e reduced (Table 6 .3 ) w hen culture m edium  w as inoculated w ith  
few er bacteria (figure 6 .2 -6 .5 ). This m ay be due to the higher bacterial concentration in  
the test w e ll depleting available nutrients and oxygen  more qu ick ly  g iv in g  suboptim al 
growth rates. The grow th o f  all o f  these isolates were broadly sim ilar, h ow ever  
interestingly, isolate M u 3 (V R S A ) had the fastest growth rate and shortest doubling tim e  
(Table 6 .2  and 6.3).
Treatm ent o f  these strains w ith H 2 O 2 show ed that higher concentrations o f  the 
overnight culture w ere less sensitive to the effects o f  H 2 O2 (Figure 6 .6 -6 .9 ). A t the higher  
concentration o f  the overnight culture ( lx lO '1 dilution), lOmM and lOOmM H 2O 2 on ly  
sign ificantly  slow ed  the growth rate o f  one o f  the four isolates (1 7 7 ), w hereas the low er  
concentration o f  the overnight culture (dilution 5x1 O'2) a llow ed H 2 O 2 to be m ore effective  
at sign ificantly  reducing the growth rate o f  all iso lates (Figure 6 .10 ). The reasons for the 
differences in the reduced sensitiv ity  o f  the bacterial cultures higher concentrations o f  the 
overnight culture m ight sim ply be due to the num ber o f  Staphylococci, w hich  are know n  
to be vigorous catalase-producers. Isolate M u 3, w hich  is a V R S A  appears to be the least 
sensitive to the effects o f  H 2 O 2 and isolate 117 w hich is neither m eticillin  nor vancom ycin
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resistant appears to be m ost sensitive to H 2 O 2 . This finding is interesting as the bacterial 
strains w ith antibiotic resistance appear to be less sensitive to the effects o f  H 2O 2 . This 
result suggests that the bacteria have not on ly  developed antibiotic resistance but m ay also  
have enhanced their defences against oxidative stress to m ake them  better adapted to 
survive in the w ound environm ent. It w as also  interesting to note that, particularly at the 
higher concentration o f  the overnight culture ( lx lO ’1), growth had o b v iou sly  been slow ed  
at lOOmM H 2 O2 , although the bacterial numbers were able to  eventually  clim b to reach  
control values (Figure 6 .6 -6 .10 ) This effect could be due to the selection  o f  a resistant 
bacterial population or m ore likely , that the bacterial catalase has rem oved  the H 2O 2 effect 
by breaking it dow n into H 2 O and oxygen  and the rem aining viab le  bacteria are able to 
grow  and repair the dam age to reach a sim ilar absorbance value to the control. The 
bacteria m ay also up-regulate catalase in the later stages o f  growth.
A  range o f  iso lates from  pus drains and abscess sites that w ere hospital or 
com m unity  acquired (13, 357, 197, 283 , 301 and 307) w ere a lso  tested for sensitiv ity  to
9 9
H 2 O2 in the sam e w a y  as before but a dilution o f  5x10' and a 2 .5 x 1 0 ' o f  the start culture 
w as used  (Figure 6 .1 1 -6 .16 ). T hese experim ents produced results that w ere com parable to 
the previous experim ents on the S. aureus isolates d iscussed  above. The sensitiv ity  o f  
these strains to H 2 O 2 w as also very sim ilar to that found in the previous experim ents. A t a 
higher concentration (5x1 O'2 dilution) o f  the start culture lOOmM H 2 O 2 clearly reduced the 
growth rate o f  all S. aureus strains. H ow ever, at a lower concentration (2 .5 x l0 '2 dilution) 
o f  the overnight culture both lOmM and lOOmM H 2 O2 reduced the grow th o f  the S. aureus 
iso lates (Figure 6 .17 ).
A s described in section  3.2.5 X O  can lead to the production o f  the potent
antim icrobial ONOO". Experim ents w ere therefore designed to exam ine the effects o f
ONOO" on the S. aureus isolates. Peroxynitrite was generated on  the lab bench as in
section  6 .2 .2 .1  and several problem s w ere encountered w ith  this procedure in terms o f
generating a reasonable y ie ld  w ith w hich to treat the bacteria. It is  p ossib le  to purchase
authentic O N O O ”, but it is  expensive and does not w ithstand long-term  storage so it is
m ore cost effective  i f  it can be generated on the lab bench. A  m ethod by R eed  et al (1974)
w as in itia lly  used  w hich  produced a lo w  yield  o f  13.5m M . M odifications o f  the
m eth od ology  and equipm ent w ere experim ented with in an attem pt to im prove the y ield
based around the m ethod described b y  K oppenol et al (1996) eventually  resulting in an
im proved y ie ld  up to 74m M  O N O O ”. Initial experim ents to exam ine the efficacy  o f  a
range o f  O N O O ” concentrations to kill bacteria were perform ed. T hese experim ents
indicated that a concentration o f  0 .5m M  w as sufficient to k ill bacteria but the effect w as
lost on further d ilution  to O .lm M . These prelim inary experim ents cou ld  not be expanded
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upon or reproduced because o f  a laboratory safety audit o f  procedural risk assessm ents. 
This resulted in a change in laboratory safety p o licy  that prohibited the use o f  pathogenic  
strains o f  bacteria such as the S. aureus disease isolates that w ere b ein g  used  in this study.
6.4.2 Effect of H20 2, SIN-1 and XO on the growth of bacterial 
species relevant to the chronic wound
Further investigations into the growth o f  bacteria w ere carried out after exposure to 
H 2 O 2 , and SIN-1 (a peroxynitrite generator) to assess their antim icrobial effects, and also  
X O  itself. Four sp ecies o f  bacteria that are com m only isolated  from  infected chronic 
w ounds (T able 2 .1 ) w ere supplied b y  Dr. Pauline W ood, S. faecalis, E. coli, and S. aureus 
and P. mirabilis. Investigations into the growth o f  these bacterial sp ecies show ed  norm al 
sigm oidal growth in a 9 6 -w e ll plate in air for S. faecalis, E. coli, and S. aureus. 
Pseudomonas aeruginosa (P A O l) how ever, show ed a reduced growth rate and an 
extended  lag phase w h en  com pared w ith the other species o f  bacteria (figure 6 .18). This 
observation w as confirm ed in a study by Sabra et al (2002) w h o  also show ed that P. 
aeruginosa (P A O l)  prefers m icroaerobic conditions (i.e. d isso lved  oxygen  tension  value  
around 1% o f  air saturation) for growth and for the form ation o f  som e o f  its virulence  
factors such as elastase. This study also show ed that P A O l can create these growth  
conditions b y  strongly reducing the transfer rate o f  oxygen  from  the gas into the liquid  
phase, causing oxygen -lim ited  or m icroaerophilic conditions in the culture after a short 
period o f  cultivation, even  at high aeration rates w ith pure oxygen . It is thought that 
P A O l can generate th is m icroaerophilic growth environm ent b y  at least tw o m echanism s: 
(i) b lockage o f  the transfer o f  oxygen  and (ii) formation o f  a polysaccharide capsule on the 
ce ll surface w hich  m ay act as a physical barrier to prevent d iffu sion  o f  oxygen  into the 
cells.
M ore exten sive investigations into the growth o f  these bacterial strains also  
in vo lved  viab le ce ll counts at hourly intervals over 6 hours o f  grow th to determ ine the 
relationship betw een  the absorbance values and the number o f  v iab le  ce lls  m l'1 (Figure 
6 .1 9 -6 .2 1 ). P. mirabilis w as included in these studies as a substitute for P. aeruginosa. 
T hese studies show ed  that the profile o f  absorbance values in a 9 6 -w e ll plate versus 
co lo n y  counts for the corresponding number o f  cells w ere very  sim ilar until around 4  
hours w hen the absorbance values plateau as the culture reached stationary phase and the 
ce ll num ber appears to continue to rise (Figure 6 .19-6 .20). This result is a com m on  
observation  in bacterial cultures and is likely  to be due to p h ysio log ica l changes in the 
ce lls  as they  reach stationary phase. Furthermore, absorbance values at this stage o f
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grow th m ay not g ive  an accurate indication o f  what is actually happening in the culture in 
term s o f  ce ll number. H ow ever, there is a linear relationship b etw een  absorbance and ce ll 
num ber for the first four hours o f  growth (figure 6.21).
Treatm ent o f  Gram positive S. aureus and S. faecalis w ith  H 2 O 2 show ed  that both  
w ere m ore sensitive to the effects o f  H 2O 2 than previously found w ith  the S. aureus 
disease isolates. H ow ever, this effect m aybe due to the H2 O 2 stock  lo sin g  its activity  
because it is know n to decom pose over tim e, the stock w as not tested  routinely over tim e  
so  it w as not p ossib le  to com pare experim ents that were carried out on separate occasions. 
H ow ever, the experim ents in figure (6 .22 -6 .23 ) show  that H 2 O 2 d oes have an antibacterial 
or bacteriostatic effect on  these bacteria. There w as a slightly  reduced leve l o f  sensitiv ity  
to  the effects o f  H 2O 2 o f  S. aureus com pared w ith S. faecalis sign ificant inhibition o f  
grow th occurred at 2m M  H 2O 2 and com plete inhibition at 5m M  H 2O 2 . The bacterium  S. 
faecalis show ed  significant inhibition at Im M  H 2O 2 and com p lete  inhibition at 5m M  
H 2 O2 . The sensitiv ity  o f  bacteria to H 2O 2 is know n to vary (Schaeffer et al, 1980) and m ay  
be affected  b y  the growth phase o f  the organism , the culture m edium  and the temperature 
(A m in  and O lson , 1968; Cam pbell and D im m ick, 1966; Y oshpe-Purer and H enis, 1976). 
H ow ever, this slight d ifference in sensitiv ity  is probably due to the fact that Staphylococci 
are vigorous catalase producers whereas Streptococci or enterococci are catalase negative  
or on ly  w eak ly  positive. The bacterium S. aureus also has a peptidoglycan  protective  
layer, w h ich  is 80nm  thick (Jawetz et al, 1984), studies have su ggested  the thicker this 
peptidoglycan  layer; the m ore resilient the bacteria are to surface-active antim icrobial 
agents.
A  b r ie f study w as carried out to assess the effects o f  the peroxynitrite generator
SIN-1 on the growth o f  S. faecalis. Prior to this study, peroxynitrite generation by SIN-1
w as m easured in PB S and LB to provide inform ation on the activ ity  o f  the SEN-1 stock
both in PB S and in bacteria culture m edium  (LB). The D H R  oxidation  is considerably
slow er in LB com pared with PB S suggesting a decrease in ONOO" generation in LB.
T hese findings are lik ely  to be due to the rapid reaction o f  O N O O ” w ith  proteins and other
com ponents present in the culture m edium . These experim ents w ere also repeated in the
presence o f  iron chelator D T P A  w hich prevents iron m ediated hydroxyl radical form ation
w h ich  can also  ox id ise  D H R . Peroxynitrite generation by SIN-1 in P B S and the presence
o f  D T P A  appears to be m arginally decreased; how ever, as this is expected  as there should
be little iron or other m etal ions present in the PBS to catalyse hydroxyl radical form ation
(Figure 6 .24 ). The oxidation  o f  D H R  in LB w as considerably decreased in the presence o f
D T PA , this is probably a result o f  hydroxyl radical form ation catalysed  b y  the fenton
reaction u sin g  iron present in the LB (Figure 6.24). Treatment o f  S. faecalis w ith SIN-1
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show ed  that growth w as in inhibited at 500 and lOOOjaM SIN -1 (Figure 6 .25). T im e  
constraints m eant that these experim ents w ere not carried out on all o f  the strains; 
how ever, this w ould  be an interesting study for further experim entation. H ow ever, this 
b rief assay indicates that peroxynitrite is capable o f  inhibiting the growth o f  bacteria  
relevant to the chronic wound.
It has long been know n that X O  can generate ROS in air such as H 2 O 2 and 02*".
Therefore these species have conferred an antim icrobial role to the enzym e for an equally
long tim e. Therefore it w as interesting to assess whether X O  in  air in the presence o f
hypoxanthine w as e ffective  against bacterial species known to be found in chronic ulcers.
A n initial experim ent carried out in cuvettes show ed a slight inhibition o f  grow th at 50m U
m l'1 X O  in the presence o f  hypoxanthine (Figure 6.26). Further experim entation w as
carried out in 96 -w ell plates to confirm  this finding (Figure 6 .2 7 -6 .3 6 ). Control
experim ents carried out w ith  each bacterial species in itially  confirm ed that neither
hypoxanthine nor allopurinol added to the bacterial cultures a lone inhibited growth o f  the
bacterial sp ecies, m eaning that any alterations in the culture grow th rates w ere due to X O
activity and the generation o f  RO S (Figure 6 .27 , 6 .29 , 6 .31, 6 .33 and 6 .35). In som e cases
the X O  added to the culture m edium  w ithout hypoxanthine sh ow ed  som e inhibition o f
grow th suggesting  that there m ay be endogenous substrate that can be utilised  b y  the
enzym e in the culture m edium  This inhibition was also inhibited b y  allopurinol w hich
confirm s that the reduction in growth rate w as due to XO (Figure 6 .2 7 , 6 .29 , 6 .31 , 6.33
and 6 .35). U sin g  a range o f  X O  concentrations in the presence o f  hypoxanthine (Im M ) it
w as d iscovered  that X O  has antibacterial properties and sign ificantly  reduced the growth
rates o f  all the bacterial strains (Figure 6.28, 6 .30, 6 .32, 6 .34 , and 6 .36). The bacterial
species P. aeruginosa and E. coli appeared to be the m ost sensitive to the effects o f  X O
w ith  a reduction in growth rate at 5, 10 and 50m U  m l'1. The grow th rate o f  S. faecalis and
S. aureus w ere inhibited at 10 and 50m U  m l'1 and P. mirabilis w as the least sensitive to
the effects o f  X O  w ith a reduction in growth rate on ly  occurring at 5OmU m l'1 X O . The
effects o f  50m U  m l'1 X O  w ere inhibited by allopurinol, supporting the role o f  X O  as the
antibacterial agent. The im plications o f  X O ’s antibacterial activity are d iscu ssed  in m ore
detail in the m ain d iscussion  chapter. It w as also interesting to note that b y  the end o f  the
culture incubation tim e, as found previously using H 2 O 2 , all cultures reached
approxim ately the sam e A b s5 95nm value (Figure 6.28, 6 .30, 6 .32 , 6 .3 4 , and 6 .36). This
could  be due to the selection  o f  a resistant bacterial population, rem oval o f  RO S by
antioxidant system s allow ing  growth to resum e or m ore likely, that the substrate becom es
exhausted and rem aining viable cells continue growing. The differences in sensitiv ity  to
X O  o f  the bacterial species m ay be explained by varying catalase activ ity  w hich  can
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counteract the dam aging effects o f  the H 2O2 generation. In 1972, Taylor and Achanzar  
dem onstrated differences in the catalase activity o f  a variety o f  gram -negative organism s. 
Catalase production is high in Proteus spp, whereas Escherichia spp. and Pseudomonas 
spp. have little activity. G ram -positive Staphylococcus spp. a lso  produce catalase w hereas 
Streptococcus spp. do not (Schaeffer et al, 1980).
6.4.3 Effect of H20 2 and XO on the viability of bacterial species 
relevant to the chronic wound
D isk  inhibition assays clearly show ed that H2 O2 inhibited the grow th o f  S. aureus 
producing clear zones on the agar. The S. aureus show ed clear zon es o f  inhibition at 
88m M  but not at 8.8m M  H 2 O 2 . T hese assays do not appear to be as sensitive as the 
previous growth assays w hich  show ed com plete inhibition o f  S. aureus grow th at 5m M  
H 2 O 2 . T his d ifference in sensitiv ity  is probably due to the fact that in the zone inhibition  
assays the H 2 O 2 needs to d iffuse through soft agar in order to k ill the bacteria, w hereas in 
the previous assays the H 2O 2 w as diffusing through liquid culture m edium . H ow ever, 
these assays did show  that the assay w as working (Figure 6.37 and Table 6 .4).
W hen X O  substrates hypoxanthine and nitrite w ere included in the soft agar layer 
w ith  the S. aureus, and X O  in the disks on ly  sm all faint inhibition zon es w ere form ed even  
w ith  the concentrated stock. H ow ever, the zones were likely  to be due to the activ ity  o f  the 
X O  as b o ilin g  the enzym e before addition to the disks appeared to abolish  the slight zone  
effect as seen  w ith  the concentrated enzym e. The apparent insensitiv ity  o f  the S. aureus to 
X O  m ay be due to a reduced rate o f  ROS production by X O  as a result o f  the slow  
diffusion  o f  substrates in the soft agar (Figure 6 .38). A  second assay  w as set up in w hich  
the substrates and enzym e w ere all added into the filter paper disk. This assay did not 
sh ow  any inhibition zones at all this m ay be because the substrate is rapidly used b y  the 
X O  in the disk before it d iffuses into the agar (Figure 6.39).
6.4.4 Effect of XO on the viability of bacteria relevant to the 
chronic wound in variable oxygen
B acteria w ere also exposed  to X O  in the presence o f  hypoxanthine (Im M ) and 
nitrite (Im M ) at a range o f  oxygen  tensions. Bacteria were exp osed  to X O  and in the 
linear phase o f  growth (1 and 3 hours) assessm ent o f  the num ber o f  v iab le  ce lls  w ere 
a ssessed  b y  co lon y  counts (Figure 6 .41-44). A ll bacterial strains apart from  E. coli show ed  
a reduction in the num ber o f  viable cells at a range o f  hypoxic o x y g en  concentrations 
relevant to the chronic ulcer both at 10 and 50m U  m l'1 X O . H ow ever, the inhibitory
257
effects w ere generally  enhanced in the presence o f  50m U  m l'1 X O . Interestingly, it w as the 
organism s w ith  high cellular catalase activity {Staphylococcus aureus and Proteus 
mirabilis) that w ere m ore sensitive to the effects o f  X O  in hypoxia  (Schaeffer et al, 1980), 
w hich  perhaps suggests that the tox ic  species are not H 2O2 . T hese results provide further 
evidence o f  an anti-bacterial role for XO . H ow ever, there a lso  appeared to be a slight 
increase in the numbers o f  viab le ce lls in som e cases in lo w  oxygen  or at low  
concentrations o f  X O . In this case low  levels o f  XO -generated sp ecies m ay act to induce 
gen es or up-regulate antioxidant enzym es such as SO D leading to an increase in growth  
above control levels . For exam ple, in bacteria it has been show n that the O xyR  protein  
w hich  functions as a transcriptional regulator o f  H 2 0 2 -inducible gen es is d irectly activated  
b y  oxidation  and the E. coli SoxR  transcription factor is know n to be sensitive to oxidation  
b y  O 2 ’” (Thannickal and Fanburg, 2000; Farr and K ogom a, 1991).
6.4.5 Chapter summary
The results show n in this chapter suggest that the antim icrobial properties o f  X O  
cou ld  be b en eficia l in the chronic w ound setting, and that 50m U  m l'1 X O  m ay provide the 
m ost e ffective  antim icrobial activity. H ow ever, the levels o f  bacterial k illing  are perhaps 
sligh tly  d isappointing for som e o f  the bacterial species. It is p ossib le  that addition o f  X O  
in the lo g  phase o f  growth and using different com binations o f  substrates (see  general 
d iscu ssion ) m ay enhance the antim icrobial effects. In vivo, anaerobic bacteria also form a 
m ajor source o f  in fection  and it is p ossib le  that these m ight be m ore susceptib le to 
oxidative k illing. It m ay also be p ossib le  that bacteria used, b ein g  long term m aintained  




7 General Discussion-A potential role for XO in 
the healing of chronic wounds
The studies in this thesis w ere designed to evaluate a potential new  approach to  
addressing a major problem  in current healthcare particularly in elderly  populations. 
Chronic ulcers cost the N H S over £1 b illion  per annum m ainly because current treatment 
regim es are inadequate in m ost cases. E ffective treatment o f  such lesion s requires a 
com bination  o f  factors to work in unison to result in healing. T issu e regeneration m ust be  
induced at the sam e tim e as inhibiting bacterial infection. The h yp ox ic  nature o f  the beds 
o f  chronic ulcers is not conducive for the natural healing process to be effective  in affected  
patients, but yet provides an ideal environm ent for bacterial in fection . Xanthine oxidase is 
an enzym e that has properties that could  potentially exploit the hyp oxic environm ent to 
induce tissue regeneration and k ill bacteria. The experim ents perform ed in this study w ere 
aim ed at substantiating the hypothesis that X O R  incorporated into a form  o f  dressing  
w ou ld  provide an efficaciou s com bination o f  actions. The experim ental section  o f  this 
thesis confines itse lf  to three aspects o f  the role o f  XO R in relation to the chronic w ound. 
The first aim ed to characterise the properties o f  the enzym e in  relation to relevant 
environm ents at sam e tim e as refining the m easuring m ethods em ployed . The second role 
investigated  w as the pro-proliferative activity o f  the enzym e at lev e ls  that w ere not toxic  
to dermal fibroblasts. The final role investigated was that o f  an anti-in fective agent for 
com m on w ound-related bacteria.
In the literature and anecdotally, a w ide range o f  ev idence ex ists to support a role 
for X O -generated sp ecies in w ound healing, and also more sp ec ifica lly  o f  interest in this 
thesis a role in proliferation and bacterial killing. Probably the best anecdotal ev idence that 
supports the hypothesis com es from a traditional N epalese treatm ent for w ounds w hich  
con sists o f  a dressing (poultice) soaked in Y ak s’ m ilk directly applied to the lesion. Y ak s’ 
m ilk  is particularly rich in protein and fat, and is likely  to have h igh  lev e ls  o f  X O R , but 
this has not been confirm ed here. The proliferation studies w ere based on literature 
provided b y  M urrell et al, (1990) w ho previous reported increased proliferation o f  adult 
hum an derm al fibroblasts for exposure to XO. N um erous studies also describe the 
proliferation o f  a w id e range o f  m am m alian cells as a response to X O -generated products 
and R O N S. Furthermore X O  is know n to be present in high concentrations in the
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com ponents o f  m ilk  such as w h ey , and also in colostrum  (the first breastm ilk from  
pregnant m others), w h ich  are so ld  as health food  supplem ents and are reported to have  
ben eficia l effects on w ound healing (Rayner et al, 2000). Studies have generally  
attributed the benefic ia l effects to the presence o f  certain growth factors in conjunction  
w ith  the high protein content, m uch o f  w hich  is XO R.
The bactericidal properties o f  X O R  in the presence o f  the substrate hypoxanthine  
have long been  know n (Green and Pauli, 1943). The defensive properties o f  X O R  have  
also  been  dem onstrated in m ice infected  w ith Salmonella typhimurium (U m ezaw a et al, 
1997) w here the generation o f  not just 02*” but also O N O O ” w ere proposed to be  
antibacterial. A lso , X O -derived RO S are important for phagocytic k illin g  in m acrophages 
(Takao et al, 1996; Potoka et al, 1998). A necdotally  a com m on and e ffectiv e  treatment for 
the bacterial conjunctivitis in babies is expressed breast m ilk. A s p rev iou sly  stated human  
breastm ilk is particularly rich in  X O R  (Stevens et al, 2000), it is here that the enzym e  
disp lays perhaps its m ost important physio log ica l role. In the presence o f  nitrite, the 
ability  o f  X O R  to generate ONOO" (review ed in the introductory chapters), a pow erful 
bactericidal agent (Brunelli et al, 1995), have lead researchers to speculate that the high  
quantities o f  X O R  in m ilk  m ay act to sterilise the gut. Indeed the generation o f  ‘N O  by  
hum an m ilk  X O R  is greatest in the first 5 w eeks postpartum, w here protection o f  the 
neonatal gut w ould  be m ost beneficia l (Stevens et al, 2000). A lthough nitrite 
concentrations in the gut are not particularly high, the source o f  substrate for O N O O ” 
generation b y  X O R  m ay actually be derived from bacterial pathogens them selves  
(D eM oss and H su, 1991). It is thought that X O R  m ay attach to bacterial pathogens via  
G A G -like structures on the bacterial surface (Roberts, 1996) and therefore catalyse the 
generation o f  R O N S in the bacterial m icroenvironm ent where nitrite is secreted and 
concentrations are adequate. Therefore the bacteria m ay initiate their ow n  destm ction.
Investigations into the hypothesis that the pro-proliferative and antim icrobial
properties o f  X O R  m ay be b en efic ia l in the healing o f  chronic ulcers began with
m easurem ents o f  X O -generated sp ecies at X O  concentrations in a range that included
concentrations that w ere previously  found to be proliferative to hum an derm al fibroblasts
(M urrell et al, 1990). A ssays for the m easurem ent o f  X O -generated species w ere
optim ised  in Chapter 4 (first experim ental chapter). Xanthine ox id ase  (B iozym e) w as
characterised for protein content and w as not found to contain any o f  the dehydrogenase
form  o f  the enzym e (Pterin assay). Superoxide generation b y  X O  (C ytochrom e c assay)
w as m easured in a variety o f  environm ents including in fibroblast culture m edium ,
bacterial culture m edium , and at 21%  and 1% oxygen . Superoxide generation b y  X O  w as
found to be dram atically reduced at 1% oxygen , as com pared w ith 21%  oxygen , w ith little
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or no O 2 *-  being detected. Superoxide generation by X O  w as a lso  found to be decreased in 
both fibroblast culture m edium  and bacterial culture m edium  as com pared w ith  in PB S  
w h ich  w as particularly noticeable at 21%  oxygen. Superoxide generation by X O  at 
variable enzym e and substrate concentrations w as also assessed. Peroxynitrite generation  
b y  X O  (D H R  assay) w as also assessed  and results suggested that O N O O - generation w as 
increased in low  oxygen  concentrations.
In Chapter 5 the effects o f  X O  on H D F w hich are directly  related to the w ound- 
healing process w ere investigated. W ounds produced in the derm is are healed  by  
m echanism s o f  epithelialisation, contraction and matrix deposition. It is in this phase that 
synthesis and collagen  accum ulation, proteoglycans and binding proteins are produced. In 
the w ound healing process, dermal fibroblasts are the m ain ce ll type in vo lved  in matrix 
production (M oulin , 1995; D eigelm ann, 1997) and were chosen  for this study since they  
are the primary m atrix-producing ce lls , even though the more com p lex  process o f  w ound  
healing cannot be correlated sim ply w ith fibroblasts proliferation. Furthermore, in vitro 
assessm ent o f  hum an fibroblast cytotoxicity  has previously been  used  as a usefu l m ethod  
for characterising ce ll tox ic ity  m echanism s o f  topically-applied antiseptics. X O -generated  
species are know n to vary in changing oxygen  concentrations and low  lev e ls  o f  these  
species are know n to have proliferative whereas high levels o f  these sp ecies are know n to 
have toxic  effects. Therefore human dermal fibroblasts were exp osed  to varying lev e ls  o f  
X O  in an attempt to determ ine the level o f  enzym e at w hich proliferation is enhanced but 
w hich  is not cytotoxic. M ore im portantly these fibroblasts w ere exp osed  to a range o f  
h ypoxic oxygen  concentrations to sim ulate conditions encountered w ithin  the chronic 
w ound. Experim ents o f  ce ll viab ility  (M TT) and proliferation (B rdU ) u sin g  a range o f  
dermal fibroblasts show ed, that at in hyperoxia (21% O2), X O  decreased ce ll v iab ility  and 
D N A  synthesis at high concentrations o f  X O  (5-50m U  m l’1), h ow ever there w ere also  
indications o f  proliferation at low  X O  (0 .1 - lm U  m l'1) as suggested  in  the literature. A s the 
oxygen  concentrations decreased, it w as noted that the toxic effects o f  the X O , even  at 
high concentrations also  decreased. In fact, there were even  su ggestion s o f  enhanced  
proliferation at h igh X O  concentrations in lo w  oxygen tensions that are know n to prevail 
in the chronic w ound. This effect m ay be due to XO  acting to provide lo w  levels  o f  R O N S  
in lo w  oxygen  to enhance proliferation. H ow ever, for this effect to occur high lev e ls  o f  
X O  are required w hich  p ossib ly  suggests that the high X O  concentration provides a burst 
o f  RO S w ith  the low  levels  o f  available oxygen  to enhance proliferation. T hese results 
suggest that in the lo w  oxygen  environm ent o f  the chronic w ou n d  the tox ic  effects on  
H D F are lim ited  and high  concentrations o f  X O  m ay even serve to enhance proliferation  
o f  hum an dermal fibroblasts in the w ound bed.
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The third experim ental chapter (chapter 6) investigated the anti-bacterial role o f  
X O  on bacterial sp ecies relevant to chronic wounds. Bacterial v iab ility  w as assessed  by  
grow th curves, d iffusion  zone assays and viable colony counts. A t 21%  oxygen  5, 10 and 
50m U  m l'1 X O  w as found to slow  the growth o f  bacteria relevant to the chronic w ound. 
C olon y  counts o f  bacteria exp osed  to varying oxygen  concentrations at 10 and 50m U  m l'1 
X O  sh ow ed  differential effects on bacteria relevant to the chronic w ound. H ow ever, there 
w ere suggestions that X O  w as capable o f  affecting the bacterial ce ll num bers sign ificantly  
in hyperoxia and h ypoxia  after 3 hours exposure. Equivalent concentrations w ere also  
show n to be tox ic  to human dermal fibroblasts after 3 hours but on ly  at 21%  oxygen  
(hyperoxia). H ow ever, w h ilst the findings show n in this thesis support an antibacterial role 
for X O , the effects o f  X O -generated species in low  oxygen  on bacteria relevant to the 
chronic w ound w as not as obvious as expected. This suggests that further w ork m ay be 
needed  to enhance the sensitiv ity  o f  the assays used to assess the antim icrobial effects o f  
the enzym e in low  oxygen . It m ay be that the effects o f  the enzym e w ou ld  be enhanced in 
vivo as there w ould  be a continuous supply a substrate, for the in vitro assays show n in 
this thesis the substrate w as on ly  added at the start o f  the assay. It is p ossib le  that a future 
experim ent could  be designed w ith m ultiple substrate additions to the plate to prevent 
depletion, how ever, using  the oxygen  controlled cabinet it w ou ld  increase the risk o f  
affecting the pC>2 inside the cabinet during the experiment. Therefore, for the assays in this 
thesis, entry into the cabinet w as kept at a m inim um . Furthermore, research carried out in 
our lab (H ew inson , 2005) show ed that inflam m atory mediators such as thrombin appeared 
to upregulate X O  activity after a short incubation (m ins) prior to en zym e activity assays. 
T hese studies also show ed that although thrombin increased X O  electron-donating  
substrate turnover a statistically  significant increase in the generation o f  O 2 *" b y  X O  w as 
not observed, h ow ever the presence o f  thrombin enhanced X O ’s antibacterial properties 
w hich  cou ld  be due to increase H 2O 2 generation. Furthermore, analysis o f  the X O  am ino- 
acid sequence and crystal structure revealed an accessib le throm bin c leavage sequence  
h om ologou s to that found in the fibrinogen A a  chain. Theses results su ggest that thrombin 
could  c leave  X O , a process that could  potentially alter enzym e conform ation and therefore 
activity. It is therefore, p ossib le  that in the chronic wound setting the activ ity  o f  X O  m ay  
be enhanced b y  inflam m atory factors present in the chronic w ound. It is also d ifficult to 
com pare the results from the in vitro assays to what w ould  actually occur in vivo, as X O  
u ses oxygen  as it a substrate so  at high X O  concentrations the X O  m ay rapidly use oxygen  
present in the culture dish w hereas in vitro there m ay be a m ore gradual supply o f  oxygen  
from  b lood  vesse ls  distant from the wound bed.
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The lim ited  effects o f  X O  on the chronic w ound bacteria cou ld  be also  to do with  
the eventual urate generation by X O  and its reported O N O O ” scavenging  ability. 
H ypoxanthine w as routinely used  in these experim ents, and the oxidation  o f  hypoxanthine  
b y X O  is know n produce xanthine as its product. H ow ever, oxidation  o f  xanthine b y  X O  
w ill also  produce urate. I f  an alternative substrate such as N A D H  w ere used then urate 
generation w ould  be avoided. H ow ever, for the purposes o f  this study hypoxanthine w as 
u sed  throughout in order to draw a com parison betw een the fibroblast proliferation studies 
and bacterial killing. Furthermore, in the chronic wound XO  is lik e ly  to encounter a range 
o f  substrates including both N A D H  and hypoxanthine w hich m ay act as electron donors. 
A lthough the levels  o f  substrate that w ou ld  be present in chronic w ounds is unknow n, 
based on lev e ls  o f  hypoxanthine detected in disease states after periods o f  chronic 
ischaem ia it is  h igh ly  likely  that X O  w ould  have sufficient substrate present in the w ound  
w ithout the exogen ou s addition o f  an pharm aceutically acceptable substrate.
Furthermore, facultative anaerobes (as used in these studies) tend to produce antioxidants 
to com bat the negative effects o f  RO S. For exam ple, the Staphylococci sp used  here are 
vigorous catalase-producers. Anaerobic bacteria (as com m only found in a chronic w ound) 
are m ore susceptib le to the effects o f  X O , as oxygen  and its m etabolites are tox ic  to them  
and they have low er or undetectable levels  o f  antioxidants like SO D  and catalase.
It is also  d ifficult to com pare the effects o f  XO on H D F  and bacteria as they are 
both grow n in different culture m edia, w hich contain various com ponents w hich  act to 
scavenge X O -generated products. Furthermore, these are com plex  culture m edia w hich  are 
designed to m eet all o f  the ce lls  nutritional requirements and are for optim al growth. In the 
chronic w ound environm ent the growth characteristics o f  the fibroblasts and bacteria 
w ould  be very  different.
The data presented in this thesis suggest that the addition o f  X O , above
p h ysio log ica l lev e ls  that m ay be encountered in normal tissues (2m U  m l'1), m ay have
beneficia l effects w hen incorporated into a w ound dressing or derm al graft for application
to a chronic w ound (Figure 7.1). A lthough adequate levels o f  the purine degradation
product hypoxanthine w ou ld  be available for X O R  activity in the chronic w ound, X O  can
also use a variety o f  other electron donors, potentially enhancing the generating capacity
o f  the enzym e, since on ly  the effects hypoxanthine w ere tested  in this thesis. A
pharm aceutically acceptable electron donor system  could also  be used  to supplem ent
substrate levels  already present in the wound. It is possib le that X O  m ay be incorporated
into a dressing in a dried form w hich activates upon w etting b y  exudates from  the w ound
bed. A lternatively, X O  could  be incorporated into a collagen gel m atrix graft a long with
fibroblasts to cover the w ound, and prom ote healing by enhancing the proliferation o f
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fibroblasts and killing bacteria. XO could be derived from a variety of sources; it can be 
cheaply derived from dairy waste products such as buttermilk and whey, both of which 
contain very high levels of the active enzyme. XO could also be cheaply produced large 
amounts in bioreactors using Aspergillus niger which is a filamentous fungi expression 
system developed as host for the production of secreted proteins. This source would avoid 
any potential concern over the transfer of bovine pathogens. A. niger was first used 
commercially as host for the production of the mammalian protein bovine chymosin in the 
manufacture of cheese.








Chronic ulcer (Hypoxic environment)
Figure 7.1 The Proposed model of XO-Release from a dermal graft or dressing for enhanced healing in 
a chronic ulcer
Prolonged hypoxia and ischaemia causes the breakdown o f the skin, resulting chronic ulcer formation. 
Pathogens are able to enter the wound and the hypoxic environment encourages the growth o f  a range o f  
facultative and anaerobic bacteria. XO is known to be capable o f producing a range o f  RONS in hypoxia. 
Therefore, incorporation o f XO into a dermal graft or dressing has the potential to resolve wound healing by 
increasing the proliferation o f  HDF (Chapter 5) and killing bacteria (Chapter 6).
Interestingly, the usage of honey as a wound dressing in ancient and traditional
medicine has recently been re-discovered, and is in fairly widespread use as a topical
antibacterial agent for the treatment of wounds, bums and skin ulcers, there being many
reports of its effectiveness (Molan et al, 2001). Much of the effectiveness of honey as a
dressing appears to be due to its antimicrobial properties. The major antibacterial activity
has been found to be due to H20 2 produced enzymatically in the honey (Bang et al, 2003).
The glucose oxidase enzyme is secreted from the hypopharyngeal gland of the bee into the
nectar to assist in the formation of honey from the nectar. As the healing process will not
occur unless infection is cleared from a lesion: swabbing of wounds dressed with honey
has shown that the infecting bacteria are rapidly cleared. Therefore, in this respect honey
is superior to the expensive modem hydrocolloid wound dressings as a moist dressing.
This is because, although tissue re-growth in the healing process is enhanced by a moist
environment, and deformity is prevented if the re-growth is not forced down by a dry scab
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form ing on the surface, m oist conditions favour the grow th o f  in fecting bacteria. 
A ntib iotics are in effective in this situation, and antiseptics cause tissue dam age, so  slo w  
the healing process. It is p ossib le  that X O  could work on a sim ilar principle to honey  
w hich  has already been  show n to be effective in wound healing as a dressing. H ow ever, 
X O  has the added advantage o f  being able to produce a range o f  R O N S in a range o f  
hyp oxic oxygen  concentrations.
In sum m ary the data presented in this thesis suggest that, under conditions that 
sim ulate the lo w  oxygen  tension o f  the chronic wound, X O -generated sp ecies are capable  
o f  the proliferation o f  H DF w hilst also show ing som e inhib ition  o f  bacteria that are 
relevant to the chronic w ound.
7.1 Future work
The studies presented in this thesis provide a sound basis on w hich  to d evelop  an 
X O -based  treatment for chronic w ounds. N evertheless, further studies could  be undertaken  
to ex ten sively  characterise the system . T hese could include the exposure o f  human  
um bilical vein  endothelial ce lls  (H U V E C s) to XO and assessm ent o f  an giogen esis by  
tubule form ation assays and in vivo w ounding studies. W ound healing could  be assessed  
by derm al fibroblast migration, using the m onolayer scratch-w ound m odel assay. 
Experim ents m ay be conducted to assess the sensitivity o f  keratinocytes to X O -generated  
products. It w ou ld  also be relevant to carry out further studies u sin g  fibroblasts derived  
from the bed o f  a chronic wound; how ever these cells are d ifficu lt to culture. Further 
research could  also be carried out to elucidate the signalling m echanism s in fibroblasts 
using sp ecific  inhibitors (eg  M A P kinase inhibitors), and gene expression  b y  gene arrays, 
m atrix production, M M P production and growth factor production. The effects o f  X O  on  
co-cultures o f  w ound-relevant ce lls  such as endothelial ce lls , sm ooth m uscle  ce lls  and 
keratinocytes m ay also be studied. The chronic w ound environm ent could  also  be  
sim ulated m ore e ffectiv ely  using a bioreactor system  flow  system  to carefully  m onitor the 
behaviour o f  the ce lls , and allow  for regular addition o f  substrates, for exam ple, or 
rem oval o f  m edium  for analysis.
In addition, it w ould  be interesting to repeat the bacterial assays to determ ine the 
effects o f  X O  on bacteria w ith different electron donating substrates such as N A D H . M ore 
exten sive studies o f  the effects o f  X O  on b iofilm s and anaerobic bacteria that have been  
isolated  from  chronic w ounds w ould  also provide more inform ation on the antibacterial 
effects that X O  m ay have in a chronic w ound setting.
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The experim ents carried out in this thesis provide prelim inary fundam ental data on  
the action o f  X O  on  w ound relevant ce lls in low  oxygen  to sim ulate conditions w hich  m ay  
be encountered w ithin  the chronic wound. H ow ever, in order for X O  to be beneficia l in 
this setting this research should be extended to determine h ow  XO  cou ld  be incorporated  
into a dressing or a dermal graft to a llow  effic ien t delivery to the u lcer bed. It m ay be that 
X O  could  be incorporated into a hydrogel dressing, or a co llagen  gel w ith in  w hich  
fibroblasts are a lso  incorporated. Furthermore, it is important to understand that the 
chronic w ound represents a com plex  environm ent, and w hilst every effort w as m ade in 
these in vitro studies to m im ic certain aspects o f  this environm ent, it is important that the 
effects o f  this enzym e are also studied in anim al w ounding experim ents, and in m odels o f  
delayed  healing.
The results presented here are encouraging, and since X O  is a constitutive protein  
in hum ans and has not show n any adverse effects o f  being applied directly to skin, it is 




8.1.1 Fibroblast growth Medium
T o 500m l D u lb e c c o ’s M odified  E ag le’s m edium  (D M E M ), w as added 50m l o f
foetal c a lf  serum (F C S). T o this 5m l o f  the antibiotics pen ic illin  and streptom ycin and L-
G lutam ine w ere added at a final concentration o f  100U m l'1 P en icillin  (S tock  10 ,000U  ml'
]), lOOpg m l'1 streptom ycin (S tock  10,000jig  m l’1) and 2m M  L-G lutam ine (stock 200m M
L -G lutam ine). T his w as used  for the isolation  and serial culture o f  hum an dermal
fibroblasts. D M E M  w ith  and w ithout phenol red w as used (S ee  table 8 for ingredients).
Component 31885 (With Phenol Red) 11880 (Without Phenol Red)
 1 X Liquid mg/ L_______________ 1 X Liquid mg/ L_______
INORGANIC SALTS:
CaCl2. 2H20 264.00 264.00
Fe(N03) . 9H20 0.10 0.10
KC1 400.00 400.00
M gS04 • 7H20 200.00 200.00
NaCl 6400.00 6400.00
NaHC03 3700.00 3700.00
NaH2P 0 4 • 2 H20 141.00 141.00
OTHER COMPONENTS:
D-Glucose 1000.0 1000.0
Phenol Red 15.0 -
Sodium Pyruvate 110.00 110.00
AMINO ACIDS:




L-Histidine HC1 • H20 42.00 42.00
L-Isoleucine 105.00 105.00
L-Leucine 105.00 105.00









D-Ca pantothenate 4.00 4.00
Choline Chloride 4.00 4.00
Folic Acid 4.00 4.00
i-Inositol 7.20 7.20
Nicotinamide 4.00 4.00
Pyridoxine HC1 4.00 4.00
Riboflavin 0.40 0.40
Thiamine HC1 4.00 4.00
Table 8.1Dulbecco’s Modified Eagle’s Medium with and without the addition of phenol Red
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8.1.2 Trypsin/EDTA
For detaching ce lls  from  growth substrates, a pre-m ixed X  10 concentrate (50g /L  
porcine trypsin and 2 0 g /L  E D T A ), w as diluted to IX  in PB S, and stored in 50m l aliquots 
containing (0 .0 2 5 g  trypsin and 0 .0 l g  E D T A ) at -20°C. 5m ls o f  the IX  stock w as used  to 
dissociate cells
8.2 Bacterial Growth medium
8.2.1 Luria Broth (LB)
500m l m illiQ  w ater w as added to 12.5g  LB (L 3522, Sigm a). This solution  w as  
sterilised  by autoclaving for 30m ins at 121°C.
8.2.2 LB agar plates
A gar plates w ere set up b y  first d isso lv in g  12.5g LB and 6 g  agar (12.5% ) (L P 0 0 1 1 
O xoid  Ltd, B asingstoke, H am pshire, England) in 500m l o f  M illiQ  water. This solution  
w as then sterilised b y  autoclaving for 30 m inutes at 121°C, coo led  to ~50°C  then poured  
into sterile p lastic Petri d ishes. On cooling  the agar solid ified  to form  a gel that w as  
covered w ith  the Petri dish lid  and the plates kept at 4°C until use, w h ich  w as typ ically  
w ithin one w eek. Prior to u se , the agar plates required air drying to rem ove condensation  
that form ed w ithin  the Petri d ishes during storage. This w as ach ieved  b y  inverting each  
plate and rem oving the lid  in a warm  room (37°C ). The plates w ere a llo w ed  to dry until all 
signs o f  condensation  had been rem oved w hich was typ ically  w ith in  35 m inutes. The 
plates w ere then recovered  w ith  their lids and stored at room temperature before use w hich  
w as w ithin  6 hours o f  air drying.
8.2.3 Soft agar overlay (0.4%)
0 .2 g  A gar 1 .25g  LB 5 0m ls m illiQ  water
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